data_2l52_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l52 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 132.14 51.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.17 129.39 35.08 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -139.66 -172.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.317 0.579 . . . . 0.0 110.438 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -128.46 158.23 38.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.475 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.0 t -134.4 131.37 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -114.97 137.61 51.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.08 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.16 160.88 16.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -145.75 158.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.39 -145.67 0.27 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.543 0.337 . . . . 0.0 111.258 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -56.13 -12.01 1.35 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.7 -31.62 61.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 109.708 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -70.23 -32.42 70.28 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.17 0.588 . . . . 0.0 110.052 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.75 -32.53 71.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.866 0.467 . . . . 0.0 111.651 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 -23.51 23.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.395 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.47 -17.71 35.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.698 0.227 . . . . 0.0 110.722 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.84 3.29 59.27 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 p -143.94 148.71 43.29 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 123.915 0.886 . . . . 0.0 109.792 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.94 -25.55 11.88 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.954 2.436 . . . . 0.0 110.821 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.04 163.0 20.71 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.855 0.462 . . . . 0.0 110.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -159.59 155.72 23.57 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.279 0.632 . . . . 0.0 110.583 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.59 154.85 35.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.23 2.62 . . . . 0.0 110.217 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 mt -163.38 -175.31 4.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.197 0.999 . . . . 0.0 108.696 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -145.88 160.21 42.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 111.254 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.8 146.73 5.11 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -78.57 -24.51 45.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.137 -0.625 . . . . 0.0 110.379 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -132.13 171.02 14.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.931 0.892 . . . . 0.0 109.593 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -55.21 -49.12 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.5 -32.73 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -68.61 -21.91 64.46 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.6 -46.07 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.53 -39.93 68.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.469 1.107 . . . . 0.0 111.803 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.3 mt -72.4 -18.24 61.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -88.38 -30.93 19.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.957 0.344 . . . . 0.0 110.409 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.77 -48.97 79.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -70.64 -14.77 62.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.135 0.574 . . . . 0.0 111.824 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 -40.99 71.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.251 0.478 . . . . 0.0 111.964 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.53 -18.32 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.026 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -116.97 75.84 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.949 0.899 . . . . 0.0 109.085 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -64.88 -16.81 57.22 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.887 2.391 . . . . 0.0 110.303 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.31 -0.64 8.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.113 0.965 . . . . 0.0 111.489 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.7 mt -124.86 -5.19 7.49 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 110.96 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.61 -24.17 67.5 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.4 25.08 10.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.165 0.586 . . . . 0.0 109.838 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.55 -15.19 5.52 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 124.296 1.039 . . . . 0.0 108.755 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.16 -21.05 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.783 0.833 . . . . 0.0 109.316 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.86 159.65 35.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.224 0.535 . . . . 0.0 111.446 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.83 135.5 37.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.881 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.5 tttt . . . . . 0 N--CA 1.453 -0.296 0 C-N-CA 125.114 1.366 . . . . 0.0 111.449 178.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.1 mt . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.04 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.086 0.469 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -126.35 130.29 50.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -114.8 144.29 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.43 160.23 32.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.83 0.452 . . . . 0.0 109.963 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -132.19 108.43 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 54.86 10.71 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.943 0.497 . . . . 0.0 111.502 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.35 -3.04 43.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.889 0.757 . . . . 0.0 112.637 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.64 -0.95 25.34 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.15 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.731 1.212 . . . . 0.0 113.849 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.6 pt -51.47 -21.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.931 -0.48 . . . . 0.0 112.264 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -62.84 -12.21 23.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -118.18 9.4 12.6 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.564 0.746 . . . . 0.0 110.83 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.81 -155.73 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.219 1.008 . . . . 0.0 109.6 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -70.34 -3.79 19.08 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.7 -139.48 21.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.89 2.29 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 112.773 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.2 mt-10 -128.17 23.44 6.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.433 0.693 . . . . 0.0 111.466 -174.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.2 m -61.92 -0.8 0.53 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.119 0.967 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 mt 53.02 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.83 0.824 . . . . 0.0 113.045 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.05 174.78 0.59 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 111.57 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -140.91 166.23 25.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.182 0.993 . . . . 0.0 110.785 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.38 5.4 0.28 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.1 t -153.04 16.35 0.56 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.861 0.3 . . . . 0.0 110.232 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.03 177.94 2.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 111.345 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -149.19 151.95 35.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.07 154.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.74 134.93 7.39 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.7 mt -116.54 129.42 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.29 146.98 63.15 Favored Pre-proline 0 N--CA 1.454 -0.261 0 C-N-CA 122.342 0.257 . . . . 0.0 110.855 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.01 174.89 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.558 3.505 . . . . 0.0 110.626 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.454 -0.829 0 C-N-CA 122.775 2.316 . . . . 0.0 110.912 175.262 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.1 mtp . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.33 51.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -78.53 133.02 37.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.42 -173.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 0.0 110.403 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -127.75 155.69 43.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.51 125.32 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -105.82 153.67 21.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.074 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.73 155.94 45.79 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.06 159.0 43.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.55 -146.18 0.25 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.523 0.329 . . . . 0.0 110.938 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -56.36 -12.78 1.8 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.83 -30.99 64.47 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.096 0.862 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -69.26 -31.15 69.49 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.286 0.634 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.78 -19.75 58.77 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.74 0.816 . . . . 0.0 112.181 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 1.69 56.48 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.14 -9.41 3.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.731 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.62 56.87 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.297 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.3 p -142.35 140.66 19.37 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.977 0.889 . . . . 0.0 110.458 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.37 -16.16 15.44 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.263 2.642 . . . . 0.0 111.396 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.68 159.47 18.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 110.792 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.72 157.1 22.97 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 123.392 0.677 . . . . 0.0 111.19 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.99 154.2 22.55 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.308 2.672 . . . . 0.0 110.517 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 mt -161.61 -176.13 5.13 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.567 1.147 . . . . 0.0 108.829 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -148.77 162.27 40.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.66 156.63 10.16 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.48 -24.22 42.48 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.518 0.659 . . . . 0.0 110.001 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -140.57 172.06 13.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.086 0.954 . . . . 0.0 109.85 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.22 -44.85 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.42 -34.01 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.5 -23.12 63.57 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.8 -0.562 . . . . 0.0 111.179 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.44 -39.8 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.9 -31.62 71.54 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.095 -0.378 . . . . 0.0 111.155 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.56 -20.62 58.51 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.094 0.406 . . . . 0.0 110.697 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -85.55 -26.77 25.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.895 0.878 . . . . 0.0 110.351 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.82 -50.63 61.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.332 0.653 . . . . 0.0 109.452 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.2 p -68.25 -13.49 62.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.696 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.34 -37.93 74.76 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -106.77 -18.02 14.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.452 0.47 . . . . 0.0 111.107 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -116.98 74.06 6.78 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 123.953 0.901 . . . . 0.0 108.744 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.98 -16.91 57.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.748 2.299 . . . . 0.0 110.308 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.08 0.45 7.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.952 0.901 . . . . 0.0 111.525 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.5 mt -123.41 -4.91 8.28 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.52 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 78.1 tttt -62.36 -23.51 66.83 Favored 'General case' 0 CA--C 1.526 0.041 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.68 26.16 8.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.217 0.607 . . . . 0.0 109.579 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.24 -8.85 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.327 1.051 . . . . 0.0 108.754 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.12 -19.99 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.181 0.992 . . . . 0.0 109.332 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -132.46 162.09 32.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.098 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -78.09 135.47 37.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.292 0.637 . . . . 0.0 109.882 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.9 tttt . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 125.129 1.371 . . . . 0.0 111.487 177.582 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--O 1.226 -0.163 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.057 0.456 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.81 131.58 53.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.14 143.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.69 160.62 31.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.73 0.412 . . . . 0.0 110.215 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mm -132.06 108.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 54.52 11.02 0.38 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.997 0.519 . . . . 0.0 111.598 -170.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.73 -3.7 42.3 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.71 0.671 . . . . 0.0 112.259 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -77.07 -0.41 24.6 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.23 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.774 1.23 . . . . 0.0 114.207 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 pt -51.41 -21.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.862 -0.524 . . . . 0.0 112.012 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -62.97 -11.65 20.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.053 0.541 . . . . 0.0 112.256 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.76 9.89 11.5 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.522 0.729 . . . . 0.0 110.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.6 mt -124.62 -155.73 0.68 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.361 1.065 . . . . 0.0 109.269 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -69.6 -4.75 20.58 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 78.9 -138.54 20.92 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.11 1.18 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 79' ' ' GLY . 37.4 mt-10 -129.48 26.52 5.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.294 0.638 . . . . 0.0 111.403 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.6 m -62.93 0.42 0.55 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.529 0.731 . . . . 0.0 112.916 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.6 mt 51.82 83.64 0.05 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.42 169.58 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.77 1.228 . . . . 0.0 111.097 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -140.01 166.91 23.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.579 1.152 . . . . 0.0 110.051 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.04 4.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 115.805 1.779 . . . . 0.0 115.805 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -152.81 16.83 0.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.334 0.516 . . . . 0.0 110.576 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.25 177.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.67 0.747 . . . . 0.0 110.886 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.64 153.41 36.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.734 0.814 . . . . 0.0 109.067 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.28 157.01 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.24 134.59 6.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.81 131.12 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.46 145.38 56.23 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 122.658 0.383 . . . . 0.0 111.11 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.19 171.68 15.86 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.947 3.765 . . . . 0.0 110.554 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.179 2.586 . . . . 0.0 113.368 -179.154 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 128.66 36.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.035 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 128.49 34.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.401 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.23 -175.8 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 110.451 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -120.35 154.22 35.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.851 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -134.1 124.59 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -113.29 133.34 55.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.222 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -102.56 161.31 13.82 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -145.35 159.03 43.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.35 -148.77 0.2 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.365 0.266 . . . . 0.0 111.359 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -56.29 -12.21 1.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.34 -30.55 66.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.058 0.845 . . . . 0.0 110.002 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -68.44 -32.62 72.77 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.321 0.648 . . . . 0.0 109.964 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.45 -31.9 65.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.796 0.438 . . . . 0.0 111.508 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.98 -26.44 25.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.299 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.78 -18.35 44.46 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.855 0.298 . . . . 0.0 110.436 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.4 2.16 59.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.4 p -144.36 150.3 47.58 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 124.094 0.958 . . . . 0.0 109.653 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.19 -25.0 12.0 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.065 2.51 . . . . 0.0 111.135 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -166.51 163.85 17.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.593 0.235 . . . . 0.0 110.99 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.32 155.73 17.53 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.555 0.742 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.58 155.36 31.61 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.216 2.611 . . . . 0.0 109.844 171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' HZ2' ' A' ' 40' ' ' LYS . 6.2 mt -160.26 -175.44 5.05 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.686 0.794 . . . . 0.0 108.925 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -149.21 158.98 44.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.06 157.1 14.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.57 -25.71 38.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.506 0.653 . . . . 0.0 109.291 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.18 165.96 25.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.502 1.121 . . . . 0.0 109.089 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 t -45.55 -54.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.19 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.12 -32.58 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -66.58 -21.57 66.14 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.634 -0.666 . . . . 0.0 111.169 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.98 -45.04 16.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.11 -36.45 65.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.733 0.813 . . . . 0.0 111.605 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.16 -17.83 60.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -86.22 -33.65 20.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.128 0.422 . . . . 0.0 110.161 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.55 -49.56 75.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.98 0.512 . . . . 0.0 109.624 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.1 p -69.57 -16.55 63.43 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.789 0.436 . . . . 0.0 112.025 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.21 -37.26 72.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 111.945 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HZ2' HD22 ' A' ' 25' ' ' LEU . 7.5 pttm -103.28 -20.27 14.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.784 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.95 74.65 13.24 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.95 0.9 . . . . 0.0 108.837 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.78 -17.22 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.914 2.409 . . . . 0.0 110.054 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.58 1.78 6.1 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 111.563 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -125.11 -6.42 7.21 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.576 0.75 . . . . 0.0 111.36 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 33.2 ttpt -63.34 -26.74 68.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.088 -0.383 . . . . 0.0 111.796 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.536 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 m-85 -117.56 27.37 9.1 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.267 0.627 . . . . 0.0 110.067 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.9 -7.47 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.274 1.03 . . . . 0.0 108.99 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.87 -23.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.129 0.972 . . . . 0.0 109.121 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.62 164.62 21.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.801 0.44 . . . . 0.0 110.113 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -75.91 174.42 9.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.436 0.694 . . . . 0.0 110.451 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.536 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 34.0 ttmt . . . . . 0 CA--C 1.532 0.262 0 C-N-CA 124.357 1.063 . . . . 0.0 110.015 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.226 -0.176 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.48 129.22 52.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.98 138.42 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 35.3 mt -125.6 161.62 26.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.472 0.177 . . . . 0.0 110.723 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.2 mm -132.66 106.31 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 171.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 54.84 9.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.266 0.626 . . . . 0.0 112.2 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.91 -4.02 36.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.778 0.704 . . . . 0.0 112.257 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.31 -4.33 38.59 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 27.0 t-20 47.64 106.75 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.765 1.626 . . . . 0.0 114.989 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -53.04 -21.59 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -67.58 -10.21 49.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.586 0.754 . . . . 0.0 111.51 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.84 9.47 13.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.756 0.822 . . . . 0.0 110.664 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.61 -156.54 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 109.132 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -67.1 -8.64 32.28 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.23 -139.2 18.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.85 -0.82 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.842 0.857 . . . . 0.0 113.054 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 83' ' ' LEU . 38.5 mt-10 -127.83 26.05 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.052 0.541 . . . . 0.0 111.347 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.7 m -66.08 -1.64 3.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.415 0.686 . . . . 0.0 111.296 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.406 ' H ' ' C ' ' A' ' 81' ' ' GLU . 19.5 mt 59.95 167.76 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.024 0.929 . . . . 0.0 111.249 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.41 174.41 10.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.398 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -142.22 166.37 24.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 110.348 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.04 7.24 0.41 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -149.96 14.36 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.2 179.11 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.73 0.776 . . . . 0.0 110.853 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.08 152.7 32.71 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 mm -131.34 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.59 138.09 8.74 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.34 128.39 74.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.61 144.9 51.06 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.569 0.348 . . . . 0.0 111.037 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.35 172.25 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 125.262 3.975 . . . . 0.0 110.99 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 N--CA 1.458 -0.578 0 C-N-CA 123.336 2.691 . . . . 0.0 113.039 178.477 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.49 126.51 28.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.95 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.27 126.61 31.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.249 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.14 -172.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 110.777 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -123.58 152.5 41.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.696 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.44 133.33 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -113.68 148.21 36.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.102 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.0 mt -127.03 157.91 38.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -145.05 160.36 41.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -173.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.08 -145.44 0.2 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.6 0.36 . . . . 0.0 110.88 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -58.91 -9.95 2.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.61 -30.92 61.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.082 0.855 . . . . 0.0 110.054 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -69.89 -33.08 71.73 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -72.54 -22.93 60.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.672 0.789 . . . . 0.0 111.808 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.283 0.365 . . . . 0.0 111.053 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.12 -7.37 3.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.523 0.729 . . . . 0.0 110.731 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 7.42 44.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.596 0.617 . . . . 0.0 112.152 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.8 p -142.75 144.68 30.78 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-N 117.825 0.812 . . . . 0.0 110.193 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.63 -16.14 13.32 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.097 2.531 . . . . 0.0 111.722 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -164.81 158.67 17.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.124 0.42 . . . . 0.0 111.585 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.72 155.01 26.16 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 123.615 0.766 . . . . 0.0 111.238 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.21 152.34 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.802 3.001 . . . . 0.0 110.857 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 mt -162.92 -176.9 5.16 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.355 0.662 . . . . 0.0 109.659 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -148.12 159.39 43.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.709 0.29 . . . . 0.0 111.564 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 155.49 11.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 174.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.57 -28.69 56.32 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.007 -0.702 . . . . 0.0 110.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -137.16 167.39 21.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.171 0.988 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.46 -54.71 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.71 -32.51 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -66.8 -21.74 66.04 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 121.473 -0.767 . . . . 0.0 111.118 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.81 -44.15 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -37.4 66.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.9 mt -73.74 -16.68 61.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 -25.79 17.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.928 0.394 . . . . 0.0 110.174 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.37 -48.81 76.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.405 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.9 p -69.08 -15.98 63.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.056 0.542 . . . . 0.0 111.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -71.52 -46.9 58.39 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.921 0.328 . . . . 0.0 111.524 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -92.88 -19.3 21.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.253 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -118.25 77.21 12.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.681 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.89 -16.62 56.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.009 2.472 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.89 2.22 7.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.696 0.798 . . . . 0.0 111.41 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.69 -6.62 7.43 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.707 0.803 . . . . 0.0 111.021 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 80.3 tttt -62.07 -22.91 66.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.84 0.456 . . . . 0.0 111.978 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.74 25.35 8.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.058 0.543 . . . . 0.0 109.817 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.7 t -126.57 -8.51 4.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.459 1.104 . . . . 0.0 109.07 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.29 -19.17 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.113 0.965 . . . . 0.0 109.18 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.94 161.05 32.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.023 0.44 . . . . 0.0 110.907 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.9 133.24 35.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.367 0.667 . . . . 0.0 109.997 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 124.992 1.317 . . . . 0.0 110.556 175.863 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.8 mt . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.7 mm . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.869 0.366 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -117.71 124.88 49.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.6 mt -121.35 148.18 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.213 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.9 mt -130.08 162.71 28.17 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.175 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.31 108.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.22 10.24 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.949 0.5 . . . . 0.0 111.74 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.69 -3.05 39.09 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.874 0.75 . . . . 0.0 112.386 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -77.05 0.37 21.6 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.29 97.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.838 1.255 . . . . 0.0 114.202 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.7 pt -50.38 -20.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -64.03 -16.88 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.575 0.625 . . . . 0.0 111.878 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -110.99 6.9 21.35 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.492 0.717 . . . . 0.0 110.579 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.03 -157.34 0.76 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.788 0.835 . . . . 0.0 109.399 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -73.56 -0.54 15.49 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.97 -137.11 20.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.87 -2.48 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.837 0.855 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.68 21.62 7.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.345 0.521 . . . . 0.0 111.421 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.3 m -65.61 -0.9 2.28 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.779 0.832 . . . . 0.0 112.261 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt 60.38 164.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.231 1.012 . . . . 0.0 110.918 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.4 mt -138.45 169.98 16.83 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.697 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 4.5 mptt -136.49 167.36 21.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.03 0.932 . . . . 0.0 111.475 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.84 7.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.685 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.7 t -152.05 16.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -69.76 -179.97 1.98 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.592 0.71 . . . . 0.0 110.365 174.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -155.32 152.57 29.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mm -127.45 154.55 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.08 127.41 2.77 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.21 132.36 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.79 146.41 60.1 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.174 0.59 . . . . 0.0 110.683 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.43 173.19 14.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.78 3.653 . . . . 0.0 110.252 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.191 2.594 . . . . 0.0 112.893 178.286 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.37 131.82 50.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.35 129.56 35.14 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.03 -173.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.179 0.592 . . . . 0.0 110.422 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -127.43 157.2 40.64 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.345 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -136.69 128.03 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -113.71 139.96 48.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.766 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.97 160.55 16.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.63 159.64 42.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.84 -151.79 0.17 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.379 0.272 . . . . 0.0 110.719 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -56.11 -11.97 1.33 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.36 -30.71 69.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.877 0.762 . . . . 0.0 109.92 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.45 -33.39 69.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.601 0.76 . . . . 0.0 110.35 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -70.6 -32.13 69.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 122.845 0.458 . . . . 0.0 111.653 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.82 -23.74 25.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.683 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.09 -17.49 37.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.321 0.248 . . . . 0.0 110.351 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.06 2.74 58.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.2 p -143.77 149.39 46.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.61 0.764 . . . . 0.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.56 -26.69 11.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.954 2.436 . . . . 0.0 110.952 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.66 163.23 19.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.987 0.515 . . . . 0.0 110.185 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.09 156.72 24.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.967 0.507 . . . . 0.0 110.766 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.34 156.01 36.98 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.1 2.533 . . . . 0.0 110.287 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -163.61 -175.39 4.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.958 0.903 . . . . 0.0 108.782 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -146.55 160.48 42.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 111.275 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.02 150.93 6.63 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.93 -24.18 41.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.647 0.723 . . . . 0.0 110.275 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -134.98 171.48 14.36 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.282 1.033 . . . . 0.0 109.826 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -56.42 -45.5 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.13 -35.54 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.94 -22.92 64.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.737 0.699 . . . . 0.0 111.008 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.04 -44.13 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -32.03 73.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.201 0.2 . . . . 0.0 111.373 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.8 -18.43 60.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -86.23 -30.96 21.96 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.966 0.412 . . . . 0.0 110.025 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.94 -46.8 89.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.1 p -70.96 -15.2 62.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.075 0.55 . . . . 0.0 111.771 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.18 -40.89 70.97 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.301 0.5 . . . . 0.0 112.14 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -101.92 -18.55 15.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.175 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -117.13 75.04 7.72 Favored Pre-proline 0 N--CA 1.454 -0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.115 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.2 -16.62 56.0 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.892 2.395 . . . . 0.0 110.382 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 0.08 6.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.042 0.937 . . . . 0.0 111.65 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.4 mt -125.52 -4.85 7.14 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.868 0.867 . . . . 0.0 110.825 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.6 tttt -62.35 -23.98 67.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.65 0.38 . . . . 0.0 112.013 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.7 28.64 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.718 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.7 -10.08 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.45 1.1 . . . . 0.0 109.123 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.7 mt -121.49 -18.65 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.972 0.909 . . . . 0.0 108.936 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.13 163.16 29.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.43 0.634 . . . . 0.0 111.147 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.42 169.33 17.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.512 1.125 . . . . 0.0 109.646 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 tttt . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 124.952 1.301 . . . . 0.0 109.235 -176.056 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 CA--C 1.52 -0.182 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.7 mm . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.85 125.06 53.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.0 mt -123.04 147.56 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.786 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 33.9 mt -130.76 158.02 41.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.566 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.32 108.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 m120 54.12 10.42 0.29 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.211 0.605 . . . . 0.0 111.835 -170.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.29 33.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.913 0.768 . . . . 0.0 112.615 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.97 -0.1 23.13 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.9 t-20 50.73 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 113.767 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.1 pt -49.99 -21.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -63.21 -15.61 57.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -115.75 9.73 15.23 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.464 0.706 . . . . 0.0 110.608 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.6 mt -123.19 -154.52 0.61 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.872 0.869 . . . . 0.0 109.069 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.59 -14.73 61.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.609 0.764 . . . . 0.0 111.774 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 85.61 -137.99 15.85 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -174.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.16 4.95 0.11 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.818 0.847 . . . . 0.0 113.242 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.5 mt-10 -131.62 27.38 4.68 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.453 0.701 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.8 m -62.96 -1.01 0.78 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt 53.33 83.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.671 0.748 . . . . 0.0 112.643 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.98 170.67 0.61 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.036 1.334 . . . . 0.0 111.417 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -140.45 166.36 24.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.043 0.937 . . . . 0.0 110.65 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -62.6 4.65 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -151.91 15.51 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.383 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.3 175.11 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.703 0.764 . . . . 0.0 111.933 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.94 150.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.985 0.914 . . . . 0.0 109.103 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -133.81 155.51 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.84 133.88 6.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.6 mt -117.94 129.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.46 146.77 59.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.41 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.02 171.22 18.37 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.852 3.035 . . . . 0.0 110.673 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 C-N-CA 123.777 2.985 . . . . 0.0 113.067 177.439 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.25 128.62 36.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.99 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.8 129.85 35.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 110.09 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 m -140.11 -175.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.348 0.594 . . . . 0.0 110.458 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -119.97 156.42 30.88 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.52 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.93 123.84 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 53.0 mtmt -108.39 152.23 24.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.27 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -127.22 156.46 41.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -143.62 158.35 43.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -150.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.53 0.332 . . . . 0.0 110.95 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -55.95 -11.17 0.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.41 -30.66 67.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.271 0.942 . . . . 0.0 110.028 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -68.89 -38.75 79.83 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.234 0.613 . . . . 0.0 109.705 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.54 -37.43 79.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.648 0.779 . . . . 0.0 111.286 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.13 -0.5 19.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.086 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.85 -6.01 4.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.519 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.33 35.31 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.152 0.882 . . . . 0.0 113.028 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.5 p -141.22 144.46 34.6 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 118.077 0.939 . . . . 0.0 110.472 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.47 -24.73 8.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.284 2.656 . . . . 0.0 111.574 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -167.41 162.72 14.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -161.03 155.58 19.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.239 0.616 . . . . 0.0 110.659 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.35 154.33 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.261 2.64 . . . . 0.0 110.62 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 HD22 ' HZ3' ' A' ' 40' ' ' LYS . 6.4 mt -161.86 -177.55 5.9 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.797 0.839 . . . . 0.0 108.885 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -147.54 160.48 42.58 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.009 0.433 . . . . 0.0 111.774 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.72 158.16 16.31 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.23 -25.76 39.44 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.937 -0.743 . . . . 0.0 109.466 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -138.1 165.95 25.35 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.638 1.175 . . . . 0.0 109.225 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.9 t -45.56 -54.3 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.93 -32.26 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -68.19 -21.58 64.87 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.595 -0.69 . . . . 0.0 111.34 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.48 -45.79 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.45 -36.99 64.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.64 0.776 . . . . 0.0 111.573 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.32 -17.66 60.81 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -87.7 -32.53 19.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.78 -50.63 72.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.8 p -71.05 -14.37 62.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.46 0.704 . . . . 0.0 111.815 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.88 -37.22 70.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 118.339 0.518 . . . . 0.0 112.166 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HZ3' HD22 ' A' ' 25' ' ' LEU . 8.3 pttm -103.7 -19.31 14.36 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.37 75.16 11.74 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 123.97 0.908 . . . . 0.0 108.963 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.08 -17.99 61.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.113 2.542 . . . . 0.0 110.087 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 1.21 5.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.089 0.955 . . . . 0.0 111.277 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.72 -5.71 6.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.675 0.79 . . . . 0.0 111.249 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.34 -24.05 67.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.096 -0.378 . . . . 0.0 112.005 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.96 24.58 10.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.46 0.704 . . . . 0.0 109.635 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.49 -6.78 5.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 C-N-CA 124.592 1.157 . . . . 0.0 109.006 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.63 -21.55 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.73 0.812 . . . . 0.0 109.217 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -131.08 163.55 27.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.898 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.92 157.97 35.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.997 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.4 tttt . . . . . 0 N--CA 1.451 -0.407 0 C-N-CA 124.002 0.921 . . . . 0.0 112.525 -174.011 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.6 mt . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -123.27 129.15 50.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.32 146.23 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 mt -130.65 163.51 27.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.5 0.32 . . . . 0.0 110.45 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.4 mm -134.77 106.74 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 54.45 8.81 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.984 0.514 . . . . 0.0 112.119 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.94 -3.76 35.86 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.666 0.65 . . . . 0.0 112.317 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -74.39 -1.69 22.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 50.75 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 113.55 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.0 pt -49.68 -21.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -63.46 -13.98 46.09 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -113.73 7.85 17.3 Favored 'General case' 0 N--CA 1.46 0.044 0 C-N-CA 123.3 0.64 . . . . 0.0 110.73 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.88 -156.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.225 1.01 . . . . 0.0 108.948 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.41 -2.32 18.95 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.66 21.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.28 -2.32 0.45 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.892 0.877 . . . . 0.0 112.703 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 83' ' ' LEU . 37.1 mt-10 -124.63 24.57 7.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.172 0.589 . . . . 0.0 111.256 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.9 m -65.59 -1.62 2.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.324 0.65 . . . . 0.0 111.293 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 81' ' ' GLU . 19.5 mt 59.62 168.02 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 110.558 -175.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.7 mt -138.15 172.66 12.59 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.626 0.77 . . . . 0.0 110.008 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -140.74 167.77 21.38 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.933 0.893 . . . . 0.0 109.818 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.37 8.71 0.29 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t -150.65 15.79 0.78 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.135 0.493 . . . . 0.0 110.035 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.59 -179.83 2.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.693 0.759 . . . . 0.0 110.28 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -154.26 152.89 30.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.42 155.84 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.91 7.1 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 mt -122.52 127.6 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mp -131.79 144.82 54.85 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.272 0.629 . . . . 0.0 110.361 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.75 172.36 11.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 124.634 3.556 . . . . 0.0 109.869 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.451 -0.983 0 C-N-CA 123.099 2.533 . . . . 0.0 111.008 172.808 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.33 131.34 47.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.36 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.27 133.39 38.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -143.11 -171.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.175 0.512 . . . . 0.0 110.777 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -131.16 156.98 44.37 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.782 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.0 t -128.45 137.53 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.85 138.65 52.58 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.877 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -111.75 160.53 17.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -145.79 158.61 43.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.68 -147.09 0.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.461 0.305 . . . . 0.0 111.318 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -57.16 -8.69 0.74 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.86 -31.75 59.43 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.345 0.975 . . . . 0.0 109.771 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -71.46 -32.65 68.54 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.092 0.557 . . . . 0.0 109.888 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -68.34 -35.41 77.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.718 0.407 . . . . 0.0 110.19 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.27 -27.23 38.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.42 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.61 -17.86 27.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.781 0.432 . . . . 0.0 110.944 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.14 4.88 69.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.2 p -144.19 145.31 29.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.656 0.782 . . . . 0.0 109.658 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.08 -25.43 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.047 2.498 . . . . 0.0 110.823 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.86 161.65 23.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.444 0.298 . . . . 0.0 111.265 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.99 155.18 23.88 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.526 0.73 . . . . 0.0 111.759 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.4 150.68 19.74 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.001 3.134 . . . . 0.0 111.386 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.8 mt -160.96 -174.63 4.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.159 0.984 . . . . 0.0 109.655 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -147.95 163.39 36.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.33 154.39 9.09 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.17 -23.92 43.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.475 0.637 . . . . 0.0 109.848 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -140.12 172.92 12.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.162 0.985 . . . . 0.0 109.767 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.85 -49.56 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -62.01 -31.53 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.83 -20.9 63.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.553 -0.717 . . . . 0.0 110.856 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.19 -42.08 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.98 -40.95 77.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.866 0.866 . . . . 0.0 111.499 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.3 -15.63 60.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.661 0.267 . . . . 0.0 111.245 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -93.61 -23.01 18.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.456 1.102 . . . . 0.0 110.712 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.57 -51.3 29.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.424 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -66.47 -13.33 60.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.824 0.45 . . . . 0.0 111.048 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.62 -44.74 70.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.485 0.314 . . . . 0.0 111.671 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -98.34 -17.73 18.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.077 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -117.86 75.99 10.69 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 109.454 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.62 -16.93 57.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.724 2.283 . . . . 0.0 110.506 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.7 0.36 9.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.009 0.923 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.7 -5.04 8.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.825 0.85 . . . . 0.0 110.886 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.36 -23.32 66.95 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.57 27.76 8.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.992 0.517 . . . . 0.0 109.659 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.5 -38.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -85.05 -24.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -130.5 165.7 22.12 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.038 0.535 . . . . 0.0 111.035 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -87.51 142.76 27.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt . . . . . 0 CA--C 1.533 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 111.838 179.265 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.9 mt . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -125.49 123.86 40.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -111.9 135.67 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -122.13 161.28 23.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -125.54 111.61 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 56.02 10.13 0.55 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.203 0.601 . . . . 0.0 112.154 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.38 15.31 9.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.335 0.493 . . . . 0.0 111.971 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -123.66 93.74 4.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.683 1.193 . . . . 0.0 109.438 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -39.15 109.73 0.12 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.749 1.62 . . . . 0.0 111.961 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 pt -50.03 -23.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.22 -8.36 12.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.898 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -121.76 8.21 9.98 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.386 1.074 . . . . 0.0 110.644 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.78 -153.89 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.538 1.135 . . . . 0.0 108.659 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.53 -15.37 60.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.54 0.736 . . . . 0.0 111.864 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 89.3 -142.56 16.85 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.0 5.27 0.06 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.881 0.873 . . . . 0.0 112.895 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.7 mt-10 -130.51 26.92 5.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.606 0.639 . . . . 0.0 111.587 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -63.47 -0.13 0.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.603 0.761 . . . . 0.0 112.838 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt 52.61 79.67 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.505 0.669 . . . . 0.0 112.777 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.45 165.25 1.14 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.942 1.297 . . . . 0.0 111.107 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.77 167.42 20.57 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.205 1.002 . . . . 0.0 109.558 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.98 5.98 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -153.76 19.58 0.53 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.812 -0.555 . . . . 0.0 110.175 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.73 178.22 3.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.758 0.79 . . . . 0.0 110.468 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.05 151.52 31.22 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.83 150.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.63 130.33 5.95 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.52 128.38 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.62 147.72 65.71 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 122.451 0.3 . . . . 0.0 110.642 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.61 175.23 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.9 3.733 . . . . 0.0 110.244 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 C-N-CA 122.826 2.35 . . . . 0.0 110.727 174.658 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.72 131.98 50.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 130.24 35.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.29 -173.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 110.54 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -127.76 157.52 40.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 169.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.8 127.47 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -108.49 152.34 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.494 0.717 . . . . 0.0 109.5 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.78 156.71 43.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.56 159.77 42.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.11 -148.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.504 0.322 . . . . 0.0 111.219 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.14 -9.99 0.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.63 -31.89 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.292 0.951 . . . . 0.0 109.724 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.08 -35.83 74.49 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.322 0.649 . . . . 0.0 110.071 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -68.22 -33.59 74.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.885 0.874 . . . . 0.0 110.723 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -2.74 40.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.875 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.0 -5.83 3.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.533 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.17 11.22 44.92 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.659 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.0 p -141.54 144.21 32.65 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 118.276 1.038 . . . . 0.0 110.571 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 -20.13 11.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.425 2.75 . . . . 0.0 111.62 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.12 162.02 19.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.65 0.38 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.91 155.24 24.19 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.235 0.614 . . . . 0.0 111.247 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.27 154.03 28.21 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.244 2.629 . . . . 0.0 110.09 172.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -163.75 -176.04 4.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.948 0.899 . . . . 0.0 109.253 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.26 161.66 40.5 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.69 155.76 10.32 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -79.09 -24.99 43.08 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.529 0.664 . . . . 0.0 110.047 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -140.61 172.5 12.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.944 0.898 . . . . 0.0 109.733 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.7 t -55.72 -43.89 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.47 -35.01 74.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.98 -21.44 65.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.696 -0.628 . . . . 0.0 110.638 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -86.23 -45.27 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.71 -29.54 70.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 119.546 -0.264 . . . . 0.0 111.389 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -74.44 -19.12 60.52 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.098 0.408 . . . . 0.0 111.928 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.86 -31.13 20.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.077 0.465 . . . . 0.0 109.876 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.65 -48.87 79.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 73.5 p -71.44 -13.97 62.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.404 0.681 . . . . 0.0 112.11 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.65 -38.6 70.68 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.284 0.493 . . . . 0.0 111.769 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -104.34 -17.66 14.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.331 0.394 . . . . 0.0 111.575 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -117.4 75.8 9.1 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.44 -17.68 60.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.052 2.502 . . . . 0.0 110.224 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 0.25 6.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.974 0.91 . . . . 0.0 111.568 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.8 -6.83 7.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.903 0.881 . . . . 0.0 110.937 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 82.0 tttt -65.38 -23.37 66.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.431 0.292 . . . . 0.0 111.621 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -118.96 27.67 8.74 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.078 0.551 . . . . 0.0 109.894 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.94 -35.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 123.849 0.86 . . . . 0.0 108.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.414 ' HA ' HG13 ' A' ' 65' ' ' ILE . 96.8 mt -88.11 -24.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.37 163.27 30.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.689 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.11 147.57 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.688 0.795 . . . . 0.0 109.409 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.5 tttt . . . . . 0 N--CA 1.453 -0.324 0 C-N-CA 124.75 1.22 . . . . 0.0 110.756 175.214 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.414 HG13 ' HA ' ' A' ' 48' ' ' ILE . 18.1 mm . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -121.14 126.23 49.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.75 143.03 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.4 mt -125.93 159.87 31.46 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.4 mm -130.93 107.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 54.38 11.2 0.38 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.192 0.597 . . . . 0.0 111.604 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.86 39.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.861 0.743 . . . . 0.0 112.596 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.44 -1.33 26.52 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.06 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.97 1.308 . . . . 0.0 113.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.62 -21.33 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.725 -0.609 . . . . 0.0 112.177 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.54 -11.53 25.07 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.291 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.37 9.95 11.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.443 0.697 . . . . 0.0 110.79 175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.7 -155.49 0.67 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.216 1.006 . . . . 0.0 109.436 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.13 -5.57 18.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.74 0.416 . . . . 0.0 111.965 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.19 -141.16 22.05 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.82 5.82 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 113.079 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.4 mt-10 -130.38 25.53 5.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.406 0.682 . . . . 0.0 111.308 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.5 m -62.26 0.97 0.37 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.986 0.914 . . . . 0.0 113.168 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.7 mt 51.77 84.27 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.63 171.56 0.61 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.963 1.305 . . . . 0.0 111.422 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -139.82 166.74 23.82 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.187 0.995 . . . . 0.0 110.877 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.57 4.6 0.24 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -151.96 15.58 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.992 -0.443 . . . . 0.0 110.363 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.99 177.76 1.62 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.541 0.686 . . . . 0.0 111.593 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -149.4 151.28 33.78 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.05 0.94 . . . . 0.0 108.786 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.41 157.81 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.72 133.18 5.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.62 130.43 66.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.21 146.48 56.43 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 122.858 0.463 . . . . 0.0 110.911 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.93 166.77 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.437 3.425 . . . . 0.0 110.755 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo . . . . . 0 N--CA 1.457 -0.672 0 C-N-CA 124.286 3.324 . . . . 0.0 113.267 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 131.14 48.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.04 132.92 37.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 m -142.1 -174.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.226 0.536 . . . . 0.0 111.022 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -126.67 155.77 42.09 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -137.77 128.07 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -113.9 138.61 50.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.903 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -109.74 161.12 15.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -145.87 158.88 43.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.78 -147.66 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.421 0.288 . . . . 0.0 111.239 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.93 -11.38 1.44 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.56 -31.06 64.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.193 0.906 . . . . 0.0 110.084 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -70.26 -33.32 71.46 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.047 0.539 . . . . 0.0 109.922 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.22 -31.84 69.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.881 0.472 . . . . 0.0 111.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.05 -23.1 22.64 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.611 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.69 -18.56 34.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.707 0.23 . . . . 0.0 110.841 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.37 62.65 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.2 p -144.4 145.85 30.61 Favored Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.833 0.853 . . . . 0.0 109.727 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.92 -26.03 11.46 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.114 2.543 . . . . 0.0 110.953 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -164.95 163.85 20.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 110.095 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -162.58 157.78 19.09 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.081 0.553 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.3 155.0 28.68 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.145 2.564 . . . . 0.0 110.136 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -161.25 -176.64 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.046 0.938 . . . . 0.0 108.678 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -147.72 157.77 43.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 111.452 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.82 148.77 5.8 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -77.71 -24.97 49.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.783 0.791 . . . . 0.0 110.452 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.03 170.84 15.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.946 0.898 . . . . 0.0 109.939 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.7 -45.28 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -33.92 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -69.87 -20.98 63.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.359 0.527 . . . . 0.0 111.537 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.86 -40.58 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.23 -33.31 75.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.875 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.76 -18.73 60.94 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.87 0.304 . . . . 0.0 110.936 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -26.75 20.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.923 0.889 . . . . 0.0 110.729 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -67.75 -51.28 50.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.425 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 76.3 p -67.48 -13.37 61.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.119 0.568 . . . . 0.0 111.634 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.76 -39.43 80.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -106.26 -17.38 14.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -116.58 73.08 5.63 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.969 . . . . 0.0 108.98 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -64.14 -17.18 58.76 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.904 2.403 . . . . 0.0 110.444 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -1.07 9.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.006 0.922 . . . . 0.0 111.434 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 -4.73 8.99 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.889 0.875 . . . . 0.0 110.906 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.3 -22.68 66.87 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.15 28.91 6.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.8 t -125.48 -41.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.04 -24.69 10.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -130.0 167.46 18.22 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.231 0.612 . . . . 0.0 109.903 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.07 146.84 23.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.6 tttt . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 124.814 1.246 . . . . 0.0 112.044 178.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -118.4 126.43 52.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.5 mt -124.67 136.61 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.756 0.789 . . . . 0.0 110.141 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.18 152.9 45.38 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.966 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.403 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 37.8 mm -124.17 100.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 64.55 0.92 1.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.189 0.995 . . . . 0.0 110.475 -172.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.81 -0.0 19.8 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.403 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 17.9 p30 -75.83 -4.13 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 49.06 93.83 0.01 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.181 1.392 . . . . 0.0 113.782 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 pt -49.2 -22.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -67.09 -10.88 54.73 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.888 0.875 . . . . 0.0 112.402 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -118.21 6.97 11.99 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.29 0.636 . . . . 0.0 110.348 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.0 mt -123.81 -154.94 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.158 0.983 . . . . 0.0 109.587 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.26 -4.49 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -132.6 19.24 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.76 -0.97 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.297 1.039 . . . . 0.0 113.61 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.35 25.81 5.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.641 0.655 . . . . 0.0 111.523 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.0 m -64.99 2.71 0.68 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.1 mt 51.95 85.0 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.77 168.9 1.55 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.915 1.286 . . . . 0.0 110.718 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -139.91 167.87 21.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.056 0.942 . . . . 0.0 110.21 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.04 5.96 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -153.08 16.8 0.56 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.316 0.507 . . . . 0.0 110.381 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 178.57 1.92 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.758 0.79 . . . . 0.0 111.202 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.81 151.54 34.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.039 0.935 . . . . 0.0 108.502 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.5 152.0 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.72 131.95 5.84 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.5 mt -118.08 131.77 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.54 148.31 66.93 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.8 0.44 . . . . 0.0 110.362 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.21 174.02 13.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.322 3.348 . . . . 0.0 110.316 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.455 -0.784 0 C-N-CA 122.852 2.368 . . . . 0.0 110.365 173.804 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.1 mtp . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.6 127.71 32.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.06 126.53 30.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.242 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.33 -175.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.939 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -117.68 154.39 31.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.251 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.15 119.46 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.08 151.13 22.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.557 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -129.76 155.69 45.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -144.17 157.56 44.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.15 -152.5 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.243 0.217 . . . . 0.0 110.627 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -53.47 -14.85 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.04 -30.48 70.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.075 0.852 . . . . 0.0 110.029 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -70.7 -37.28 73.55 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.015 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -37.99 76.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.094 0.558 . . . . 0.0 111.656 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.76 -1.03 20.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.231 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.85 -7.64 5.55 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.039 0.936 . . . . 0.0 110.307 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 12.9 50.72 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.32 0.962 . . . . 0.0 112.76 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.7 p -142.01 141.86 23.08 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 118.06 0.93 . . . . 0.0 110.929 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.51 -20.91 13.58 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.585 2.857 . . . . 0.0 111.164 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.79 161.97 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.712 0.405 . . . . 0.0 110.424 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.73 156.1 27.96 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.145 0.578 . . . . 0.0 110.861 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.42 153.0 23.71 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.271 2.647 . . . . 0.0 110.299 172.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -163.71 -179.42 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.18 0.992 . . . . 0.0 108.865 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -148.19 158.83 44.31 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.36 157.27 13.81 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.63 -26.9 50.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.037 -0.684 . . . . 0.0 109.911 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -137.59 166.59 23.53 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.032 0.933 . . . . 0.0 109.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -46.75 -49.19 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.799 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.44 -34.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.52 -20.95 65.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.567 -0.708 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.53 -45.24 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.54 -24.63 67.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -79.05 -18.58 53.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 122.048 -0.407 . . . . 0.0 112.078 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.9 -28.98 22.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 110.196 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.14 -48.61 79.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -71.65 -17.22 62.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.258 0.623 . . . . 0.0 111.925 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.22 -39.61 78.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 117.995 0.362 . . . . 0.0 111.828 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -102.38 -18.32 15.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.442 0.464 . . . . 0.0 111.247 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -117.53 74.9 8.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.743 . . . . 0.0 109.117 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.56 -17.4 59.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.81 2.34 . . . . 0.0 110.356 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.36 1.51 6.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.22 1.008 . . . . 0.0 111.29 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.91 -6.24 6.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.5 0.72 . . . . 0.0 111.529 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.6 ttpt -64.25 -27.81 69.3 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.048 -0.408 . . . . 0.0 111.92 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -115.76 26.63 9.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 110.397 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.78 -12.22 3.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.284 1.034 . . . . 0.0 109.128 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.17 -19.85 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 109.692 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.52 162.56 30.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.28 138.68 34.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.106 0.562 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 N--CA 1.451 -0.404 0 C-N-CA 125.293 1.437 . . . . 0.0 111.151 175.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 mt . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mm . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -125.38 122.4 36.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 mm -108.51 144.99 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -128.82 162.37 27.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.692 0.397 . . . . 0.0 110.349 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -133.53 105.74 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.82 8.78 0.24 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.234 0.614 . . . . 0.0 111.792 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.88 33.07 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.825 0.726 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -72.47 -2.18 18.62 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.04 97.35 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.804 1.242 . . . . 0.0 113.748 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.61 -20.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -62.78 -14.67 47.93 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.273 0.488 . . . . 0.0 112.113 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -112.59 6.85 18.59 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.303 0.641 . . . . 0.0 110.685 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.8 mt -123.81 -156.1 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.144 0.978 . . . . 0.0 109.604 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.57 -15.66 63.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.894 0.878 . . . . 0.0 112.345 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -139.41 15.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.75 -2.09 0.49 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 112.793 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -125.89 25.5 6.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.567 0.622 . . . . 0.0 111.595 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.7 m -66.29 -2.09 4.05 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.096 0.558 . . . . 0.0 111.491 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.98 166.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 110.332 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.3 mt -137.21 175.59 9.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.63 0.772 . . . . 0.0 110.414 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.64 167.39 22.28 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.748 0.819 . . . . 0.0 110.877 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.17 7.26 0.77 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.6 t -150.38 13.8 0.76 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.359 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.98 -179.5 1.51 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.498 0.666 . . . . 0.0 110.632 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -152.54 153.33 33.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mm -131.16 158.2 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.62 140.52 9.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.84 126.92 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.43 147.56 66.61 Favored Pre-proline 0 N--CA 1.452 -0.326 0 O-C-N 123.224 0.328 . . . . 0.0 110.689 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.8 174.02 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.812 3.674 . . . . 0.0 110.749 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 123.234 2.623 . . . . 0.0 110.431 174.125 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.03 132.42 52.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.38 130.81 35.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.05 -173.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.282 0.563 . . . . 0.0 110.504 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -128.12 157.98 39.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.384 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.51 131.2 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -115.16 137.95 51.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.353 0.661 . . . . 0.0 109.532 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -110.26 160.01 16.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -145.05 159.17 43.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -152.63 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.313 0.245 . . . . 0.0 110.756 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -53.77 -14.06 0.85 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.59 -30.6 70.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.111 0.869 . . . . 0.0 109.844 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.57 -36.58 73.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.454 0.702 . . . . 0.0 109.967 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -40.52 81.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.73 0.412 . . . . 0.0 110.995 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.18 -27.43 59.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.792 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.31 -18.23 39.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.214 -0.303 . . . . 0.0 110.56 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.26 3.09 64.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.9 p -145.25 149.54 41.83 Favored Pre-proline 0 C--O 1.232 0.133 0 C-N-CA 123.642 0.777 . . . . 0.0 109.822 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.78 -24.65 11.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.182 2.588 . . . . 0.0 110.946 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -164.87 163.23 21.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.53 0.332 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.42 155.33 20.85 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 123.487 0.715 . . . . 0.0 110.724 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 154.01 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.16 2.573 . . . . 0.0 110.29 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -161.3 -174.39 4.28 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.038 0.935 . . . . 0.0 108.889 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -148.86 161.09 42.55 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.761 0.315 . . . . 0.0 111.749 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.19 155.93 9.85 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.08 -24.03 43.77 Favored 'General case' 0 C--O 1.23 0.056 0 O-C-N 122.091 -0.652 . . . . 0.0 109.97 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.51 172.92 12.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.727 0.811 . . . . 0.0 109.659 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.42 -43.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.76 -36.01 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.65 -22.03 64.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.424 0.556 . . . . 0.0 111.055 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.2 t -86.64 -46.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.43 -29.4 70.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.444 0.298 . . . . 0.0 111.58 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.7 mt -75.18 -16.45 60.5 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -88.67 -30.99 18.73 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 109.979 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.95 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 70.5 p -70.2 -15.64 62.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.237 0.615 . . . . 0.0 111.769 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.81 -38.53 73.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.324 0.511 . . . . 0.0 111.847 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -104.49 -18.25 14.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.138 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -116.86 75.5 7.35 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 124.115 0.966 . . . . 0.0 108.884 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -64.7 -16.55 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.042 2.495 . . . . 0.0 110.47 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -0.9 10.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.819 0.848 . . . . 0.0 111.486 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.53 -5.09 8.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.967 0.907 . . . . 0.0 110.958 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 76.9 tttt -63.63 -24.69 67.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.85 31.54 5.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.34 0.59 . . . . 0.0 109.46 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.23 -41.03 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.05 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.61 163.94 26.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.493 0.664 . . . . 0.0 110.989 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.83 172.13 12.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.2 tttt . . . . . 0 N--CA 1.452 -0.374 0 C-N-CA 124.366 1.067 . . . . 0.0 108.905 -177.42 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.341 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mm . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.64 126.63 42.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.2 145.22 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.7 mt -129.16 159.49 35.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.9 mm -130.71 108.24 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 55.33 10.5 0.46 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.198 0.599 . . . . 0.0 111.333 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.28 -2.1 40.3 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.15 0.881 . . . . 0.0 112.424 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -81.14 1.65 30.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.57 101.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.84 1.256 . . . . 0.0 114.079 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.5 -26.41 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.964 -0.46 . . . . 0.0 112.214 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -60.87 -11.61 8.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -122.91 13.38 9.84 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.491 0.716 . . . . 0.0 111.278 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.04 -84.91 0.66 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.697 0.399 . . . . 0.0 110.558 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -144.35 1.64 1.08 Allowed 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 118.481 0.582 . . . . 0.0 111.772 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 74.67 -141.29 28.29 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.4 1.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' GLY . 36.7 mt-10 -128.63 25.38 5.7 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.602 0.637 . . . . 0.0 111.834 -175.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -63.71 0.81 0.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.9 mt 51.66 84.85 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.76 170.42 1.13 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 111.619 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 64.5 mttp -139.48 167.2 22.62 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.449 1.1 . . . . 0.0 111.657 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.29 4.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 t -153.07 16.03 0.55 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.074 -0.391 . . . . 0.0 110.201 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 6.7 m-20 -67.32 177.36 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.963 0.887 . . . . 0.0 111.351 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -148.07 151.15 35.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.44 1.096 . . . . 0.0 108.55 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.11 153.36 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.19 133.98 7.16 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.46 128.58 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.61 147.45 61.59 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 122.705 0.402 . . . . 0.0 111.006 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.41 174.2 12.21 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.052 3.835 . . . . 0.0 110.467 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 123.139 2.559 . . . . 0.0 111.291 175.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.61 130.95 48.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.39 132.58 39.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.27 -173.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.18 0.592 . . . . 0.0 110.14 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.01 158.41 38.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.3 t -130.05 138.12 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.75 152.29 37.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt -128.49 155.58 44.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.03 159.22 42.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.73 -146.18 0.27 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.432 0.293 . . . . 0.0 111.17 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -56.69 -10.68 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.05 -30.52 61.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.342 0.974 . . . . 0.0 110.125 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -70.39 -33.49 71.47 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.076 0.55 . . . . 0.0 109.6 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -72.01 -21.98 61.47 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.468 0.707 . . . . 0.0 111.718 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 1.98 56.7 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.288 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.27 -7.54 2.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.326 0.65 . . . . 0.0 110.709 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.4 9.0 48.23 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.337 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 p -141.26 144.75 35.56 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.056 0.928 . . . . 0.0 110.39 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.22 -22.4 9.77 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.319 2.68 . . . . 0.0 111.574 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.07 160.82 14.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.517 0.327 . . . . 0.0 110.639 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.64 154.42 23.07 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.06 152.65 24.58 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.684 2.923 . . . . 0.0 110.976 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 mt -163.6 -173.17 3.18 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.994 0.518 . . . . 0.0 110.284 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -148.36 160.64 42.81 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 111.099 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.2 149.48 6.15 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -81.24 -24.8 37.11 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 117.708 0.754 . . . . 0.0 110.388 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -132.22 170.82 14.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.245 1.018 . . . . 0.0 109.227 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.68 -48.33 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.51 -32.32 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.628 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.77 -22.61 64.28 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.654 -0.654 . . . . 0.0 110.703 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.65 -45.03 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -38.79 71.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.121 0.968 . . . . 0.0 111.821 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 mt -74.22 -14.34 60.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.91 -26.21 16.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 174.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.09 -49.65 71.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.3 p -68.3 -14.25 62.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.902 0.481 . . . . 0.0 111.484 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.96 -44.98 64.92 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.089 0.404 . . . . 0.0 111.397 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -95.44 -17.84 21.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -118.69 76.57 13.83 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 123.859 0.864 . . . . 0.0 109.666 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -17.19 57.96 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.102 2.535 . . . . 0.0 111.03 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.44 2.02 8.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.334 0.654 . . . . 0.0 111.358 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.0 -7.08 8.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.556 0.743 . . . . 0.0 110.718 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.09 -24.2 67.61 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.891 0.477 . . . . 0.0 112.198 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -121.17 28.57 7.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.938 0.495 . . . . 0.0 109.989 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.3 -36.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.272 1.029 . . . . 0.0 108.244 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.05 -25.4 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.607 0.763 . . . . 0.0 109.187 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.24 161.84 30.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.992 0.517 . . . . 0.0 110.791 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.81 141.41 31.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.3 tttt . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.064 1.346 . . . . 0.0 110.994 177.475 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 mm . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.077 0.465 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -128.98 126.58 39.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.81 145.99 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.53 160.76 32.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.99 0.516 . . . . 0.0 109.642 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.13 105.58 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 55.07 8.61 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.039 0.536 . . . . 0.0 111.856 -169.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.88 -3.88 32.03 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.066 0.841 . . . . 0.0 112.419 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -76.4 -0.15 21.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 49.33 99.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 114.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.07 -21.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.62 -11.67 12.53 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -119.58 9.02 11.37 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.755 0.822 . . . . 0.0 111.541 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.73 -156.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.059 0.944 . . . . 0.0 109.485 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.89 -5.67 22.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.39 -139.44 20.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.82 2.08 0.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.896 0.878 . . . . 0.0 113.132 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' GLY . 37.9 mt-10 -129.22 25.87 5.47 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.398 0.545 . . . . 0.0 111.553 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.9 m -62.16 -0.57 0.55 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.762 0.825 . . . . 0.0 112.991 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.29 83.51 0.06 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.72 170.89 0.72 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.039 1.335 . . . . 0.0 111.896 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -138.36 167.88 20.95 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.27 1.028 . . . . 0.0 110.404 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -64.94 7.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.8 t -152.86 17.21 0.58 Allowed 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.889 -0.507 . . . . 0.0 110.599 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.72 -179.34 2.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.199 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.42 155.26 36.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.386 0.674 . . . . 0.0 109.576 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 mm -125.79 155.13 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.01 120.95 1.63 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.7 mt -108.97 129.97 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.72 149.04 70.88 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 122.632 0.373 . . . . 0.0 110.763 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 73.1 Cg_endo -78.34 174.75 11.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 125.007 3.804 . . . . 0.0 110.076 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 C-N-CA 122.65 2.233 . . . . 0.0 111.344 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.75 131.91 50.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.437 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.56 130.08 35.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.228 0.537 . . . . 0.0 109.753 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.69 -172.42 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.342 0.592 . . . . 0.0 110.659 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -129.88 155.98 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.903 171.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.83 135.27 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.87 139.12 50.52 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.965 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -110.8 160.13 17.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -145.75 159.98 42.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.62 -147.06 0.22 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.219 0.207 . . . . 0.0 111.094 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -56.47 -12.51 1.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.51 -31.87 65.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.937 0.79 . . . . 0.0 110.006 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -70.92 -32.81 69.84 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.76 -33.55 72.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.337 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.87 -24.71 26.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.265 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 -18.97 33.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.556 0.217 . . . . 0.0 110.677 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 3.17 63.01 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.8 p -144.3 148.45 41.01 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.35 -23.69 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.004 2.47 . . . . 0.0 110.883 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -163.58 162.51 24.41 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.4 0.28 . . . . 0.0 111.39 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 154.36 26.6 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.634 0.774 . . . . 0.0 111.515 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.77 151.59 21.92 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.599 2.866 . . . . 0.0 110.649 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -162.0 -175.3 4.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.251 0.62 . . . . 0.0 110.04 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -147.74 162.11 39.86 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 111.444 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.14 152.26 7.7 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.51 -26.66 60.13 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.561 0.68 . . . . 0.0 110.467 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -139.9 174.43 10.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 109.897 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.76 -45.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 tp -63.79 -34.64 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.95 -22.6 65.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.466 0.575 . . . . 0.0 110.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.0 -44.76 16.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.38 -29.87 70.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.198 -0.313 . . . . 0.0 111.425 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.2 -17.89 60.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.143 -0.348 . . . . 0.0 111.472 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.62 -25.09 19.33 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.7 -49.09 76.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 81.8 p -68.68 -16.51 63.85 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.744 0.418 . . . . 0.0 111.571 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.69 -46.24 66.47 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.207 0.458 . . . . 0.0 111.809 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.0 -18.77 21.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -117.26 76.83 9.29 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.804 0.841 . . . . 0.0 109.881 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.06 -16.86 57.31 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.792 2.328 . . . . 0.0 110.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.01 2.16 7.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.792 0.837 . . . . 0.0 111.287 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.2 mt -126.77 -3.41 6.55 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 75.9 tttt -62.53 -24.46 67.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.472 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 24.2 m-85 -124.17 29.44 6.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.428 0.632 . . . . 0.0 109.422 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.41 -10.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.895 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.44 -18.38 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.835 0.854 . . . . 0.0 109.131 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -132.96 161.12 35.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.793 0.437 . . . . 0.0 110.961 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -69.44 168.63 14.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.72 0.808 . . . . 0.0 110.427 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 33.8 ttmt . . . . . 0 CA--C 1.527 0.095 0 C-N-CA 123.799 0.84 . . . . 0.0 110.579 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.9 mt . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.5 mm . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -118.71 126.43 51.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.26 144.09 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt -128.14 159.45 35.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.73 107.95 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.67 10.75 0.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.26 0.624 . . . . 0.0 111.628 -170.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.49 -3.49 37.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.036 0.827 . . . . 0.0 112.436 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -77.26 -0.64 26.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 51.46 100.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.696 1.198 . . . . 0.0 113.751 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.2 pt -51.3 -21.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -64.32 -11.42 31.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.966 0.506 . . . . 0.0 112.224 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -116.86 8.95 13.7 Favored 'General case' 0 N--CA 1.46 0.038 0 C-N-CA 123.66 0.784 . . . . 0.0 110.77 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.5 -155.63 0.69 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.053 0.941 . . . . 0.0 109.201 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.59 -3.23 17.19 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.74 -140.17 22.24 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.15 3.25 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.993 0.917 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.6 mt-10 -128.34 22.72 6.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.535 0.734 . . . . 0.0 111.513 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.2 m -62.15 0.65 0.39 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.524 1.13 . . . . 0.0 113.333 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.27 85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.778 0.799 . . . . 0.0 112.999 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.34 171.69 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.158 1.383 . . . . 0.0 111.409 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.41 166.28 24.97 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.428 1.091 . . . . 0.0 110.88 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.3 5.25 0.28 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 t -152.7 16.6 0.59 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 117.883 0.311 . . . . 0.0 110.503 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.0 m-20 -67.44 177.57 1.88 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.878 0.847 . . . . 0.0 111.344 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.18 151.48 34.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.192 0.997 . . . . 0.0 108.526 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.52 154.39 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.39 132.37 6.06 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -115.21 129.22 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.93 144.37 50.11 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 122.654 0.382 . . . . 0.0 110.439 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -80.12 169.09 18.04 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.57 3.513 . . . . 0.0 111.174 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 123.787 2.991 . . . . 0.0 111.055 172.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 127.2 30.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.74 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.99 128.38 34.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.6 m -140.65 -172.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.35 0.595 . . . . 0.0 110.677 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -124.87 153.97 41.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.956 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.62 133.02 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -114.59 136.1 53.41 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.443 0.465 . . . . 0.0 109.811 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.49 160.34 15.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.94 160.19 41.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.68 -146.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.393 0.277 . . . . 0.0 110.991 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -57.71 -11.59 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.5 mt -72.13 -29.05 63.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.354 0.979 . . . . 0.0 109.922 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.98 -32.01 70.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.144 0.578 . . . . 0.0 109.472 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.17 -23.2 60.4 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 111.249 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 -5.72 52.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.676 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.15 -11.34 12.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.164 0.586 . . . . 0.0 110.319 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.26 3.01 36.08 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.6 p -143.71 149.51 47.04 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 123.896 0.878 . . . . 0.0 109.548 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.07 -22.9 14.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.829 2.353 . . . . 0.0 110.994 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.48 163.57 22.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.898 0.317 . . . . 0.0 111.547 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.03 153.98 23.34 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.893 0.877 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.44 151.07 19.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.684 2.923 . . . . 0.0 110.796 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.7 -175.54 4.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 110.002 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -148.58 159.06 44.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.92 0.391 . . . . 0.0 111.736 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.18 154.54 10.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.94 -27.81 57.72 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 117.603 0.701 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -137.62 165.87 25.3 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.026 0.93 . . . . 0.0 109.698 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -46.05 -52.16 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 122.966 0.506 . . . . 0.0 110.196 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.0 -32.45 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -67.98 -21.22 65.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.52 -0.737 . . . . 0.0 111.137 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -45.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -54.77 -37.52 66.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.534 0.734 . . . . 0.0 111.446 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.7 mt -73.97 -16.8 61.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.44 -26.12 17.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.939 0.399 . . . . 0.0 110.025 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.0 -50.24 71.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.412 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 72.1 p -67.51 -16.17 64.05 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.59 -45.57 65.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.852 0.296 . . . . 0.0 111.467 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -93.97 -18.32 22.02 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.247 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -118.31 77.42 13.25 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 123.955 0.902 . . . . 0.0 109.909 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.75 -17.58 59.95 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.873 2.382 . . . . 0.0 110.867 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.72 1.78 7.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.539 0.735 . . . . 0.0 111.445 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.8 mt -124.35 -5.83 7.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.704 0.802 . . . . 0.0 110.858 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.2 tttt -65.17 -23.32 67.08 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -124.27 28.06 6.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.43 -39.4 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -82.78 -28.06 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.25 164.08 23.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.891 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -73.9 171.99 12.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.277 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.8 tttt . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.382 1.073 . . . . 0.0 108.676 -178.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -128.38 123.16 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.0 145.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -133.32 159.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.923 0.889 . . . . 0.0 109.21 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 71' ' ' GLY . 34.8 mm -130.06 109.25 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 170.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.42 5.88 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.328 0.651 . . . . 0.0 111.996 -169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 114.18 -2.6 23.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.028 0.823 . . . . 0.0 112.811 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.413 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 18.8 p30 -74.64 -3.39 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.42 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 113.421 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -46.89 -23.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -63.34 -19.49 64.67 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -102.64 2.46 36.01 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.87 -153.89 0.57 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.445 1.098 . . . . 0.0 109.675 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.08 -15.03 58.69 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.952 0.901 . . . . 0.0 112.146 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 84.7 -138.22 16.61 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.18 1.33 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.187 0.995 . . . . 0.0 112.87 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 79' ' ' GLY . 40.9 mt-10 -129.39 25.61 5.44 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.687 0.676 . . . . 0.0 111.625 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -62.04 -8.51 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.79 0.836 . . . . 0.0 112.706 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.47 125.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.689 1.196 . . . . 0.0 112.164 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 4.5 mp -100.4 174.4 6.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.038 1.335 . . . . 0.0 110.422 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -139.91 168.61 19.42 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.752 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -68.04 8.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -151.95 18.28 0.68 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.006 -0.434 . . . . 0.0 109.939 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.01 178.92 2.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.548 0.69 . . . . 0.0 110.585 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.99 149.73 29.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -133.24 151.21 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.4 134.68 7.72 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 108.404 -1.879 . . . . 0.0 108.404 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.01 128.66 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.21 148.19 66.87 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.48 174.81 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.934 3.756 . . . . 0.0 109.94 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.453 -0.856 0 C-N-CA 122.695 2.263 . . . . 0.0 111.26 174.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 132.55 52.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.14 128.11 33.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.32 -172.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 123.376 0.671 . . . . 0.0 110.781 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -129.85 154.78 46.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.617 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.26 136.1 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -118.16 138.14 52.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.037 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.04 160.35 16.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.88 160.38 41.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.65 -146.89 0.23 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.284 0.234 . . . . 0.0 111.085 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -57.49 -10.38 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.96 -30.71 62.66 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.129 0.877 . . . . 0.0 110.06 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -71.76 -32.07 67.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.975 0.51 . . . . 0.0 109.772 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -70.21 -30.79 67.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.0 111.531 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.79 -24.54 22.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.536 -176.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -18.34 35.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 2.11 60.45 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 149.27 45.5 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 123.82 0.848 . . . . 0.0 109.193 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.98 -20.79 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.07 2.513 . . . . 0.0 111.519 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -165.54 162.2 18.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.965 0.348 . . . . 0.0 111.359 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.02 155.75 26.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.603 0.761 . . . . 0.0 111.582 178.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.62 153.02 20.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.859 3.039 . . . . 0.0 110.846 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 mt -162.96 -173.46 3.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.252 0.621 . . . . 0.0 110.114 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.75 161.78 40.53 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 120.711 0.291 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 154.2 8.39 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -79.94 -30.45 39.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 117.489 0.644 . . . . 0.0 110.117 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -133.34 172.13 13.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.1 0.96 . . . . 0.0 109.589 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.92 -43.24 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -64.15 -34.63 70.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -68.49 -21.71 64.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 121.781 -0.574 . . . . 0.0 110.876 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.77 -44.33 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.71 -29.31 70.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.219 -0.301 . . . . 0.0 111.391 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.83 -13.93 60.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.991 0.359 . . . . 0.0 111.451 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.09 -24.05 16.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 109.966 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.4 -48.65 76.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.0 p -68.72 -17.87 64.13 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.009 0.524 . . . . 0.0 111.427 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.75 -44.24 74.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.155 -0.34 . . . . 0.0 111.725 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -96.2 -18.8 19.81 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.164 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.17 75.53 11.4 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.855 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.49 -16.35 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.734 2.29 . . . . 0.0 110.367 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.59 1.6 7.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.933 0.893 . . . . 0.0 111.587 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -125.38 -4.65 7.25 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.632 0.773 . . . . 0.0 111.176 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.9 ttpt -64.39 -27.84 69.29 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.78 26.21 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.406 0.683 . . . . 0.0 110.039 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 t -129.1 -11.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.972 0.909 . . . . 0.0 109.16 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.8 mt -120.45 -20.21 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.565 0.746 . . . . 0.0 109.174 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.84 159.83 38.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.611 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -70.06 154.19 42.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.636 0.774 . . . . 0.0 110.12 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 123.667 0.787 . . . . 0.0 111.558 -177.094 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.84 126.94 52.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.88 146.9 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.95 161.55 30.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.0 mm -132.37 108.3 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 54.29 10.05 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.286 0.635 . . . . 0.0 111.701 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.58 -2.38 36.67 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.109 0.862 . . . . 0.0 112.586 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -79.75 1.91 24.87 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.39 99.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.77 1.228 . . . . 0.0 114.063 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 pt -50.12 -25.93 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -62.46 -10.01 10.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.313 0.645 . . . . 0.0 112.581 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -122.43 12.66 10.13 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.595 0.758 . . . . 0.0 111.105 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.14 -83.94 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.906 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -144.25 2.7 1.15 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.629 0.65 . . . . 0.0 111.558 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 74.35 -142.58 30.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.67 6.28 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.8 mt-10 -129.45 20.25 5.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.269 0.627 . . . . 0.0 111.301 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.6 m -61.35 -8.16 3.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.7 mt 61.32 132.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.956 1.302 . . . . 0.0 112.537 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.78 176.44 5.14 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.137 0.975 . . . . 0.0 110.319 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.6 mttt -144.4 166.28 25.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.141 0.977 . . . . 0.0 110.716 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.31 6.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -153.61 16.59 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.175 -0.328 . . . . 0.0 110.376 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 4.4 m-20 -67.55 176.6 2.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.844 0.83 . . . . 0.0 111.097 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.58 151.06 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.75 151.36 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.83 6.69 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -114.9 129.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.32 145.63 54.66 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 122.827 0.451 . . . . 0.0 110.102 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.84 170.84 17.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.108 3.206 . . . . 0.0 110.307 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.456 -0.683 0 C-N-CA 123.398 2.732 . . . . 0.0 112.356 175.824 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.486 0.66 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.29 142.93 56.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.711 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.58 134.22 35.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.17 -175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.998 0.519 . . . . 0.0 110.392 -173.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -126.79 155.9 42.09 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.48 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.72 117.71 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 123.686 0.794 . . . . 0.0 108.956 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.36 158.81 15.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.873 0.469 . . . . 0.0 109.96 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.8 mt -134.24 152.18 51.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -141.33 158.75 43.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 -148.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.482 0.313 . . . . 0.0 110.693 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -55.33 -14.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -68.91 -30.35 68.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.016 0.825 . . . . 0.0 110.263 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -69.01 -30.97 69.46 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.227 0.611 . . . . 0.0 110.038 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.99 -18.69 58.05 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.694 0.798 . . . . 0.0 111.611 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.91 2.33 56.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.431 0.292 . . . . 0.0 111.042 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.56 -5.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.506 0.722 . . . . 0.0 111.109 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.9 10.31 38.42 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.636 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.8 p -142.9 144.08 27.9 Favored Pre-proline 0 C--N 1.341 0.205 0 CA-C-N 117.893 0.847 . . . . 0.0 110.069 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.42 -20.23 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.39 2.727 . . . . 0.0 111.462 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -165.6 161.31 18.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.209 0.604 . . . . 0.0 110.486 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 153.3 26.97 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 122.645 0.378 . . . . 0.0 110.862 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.79 152.03 32.24 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.469 2.779 . . . . 0.0 109.897 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.86 -174.37 4.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -147.33 162.46 38.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.776 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.34 151.91 8.44 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.3 -25.35 46.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -140.46 173.83 11.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.824 1.25 . . . . 0.0 108.961 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -54.87 -51.37 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -59.19 -33.94 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -67.0 -20.71 65.92 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.416 -0.802 . . . . 0.0 111.157 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.43 -45.18 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.29 -38.5 71.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.196 0.999 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.85 -16.91 61.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -88.62 -32.06 18.26 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.821 0.344 . . . . 0.0 110.161 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.57 -46.43 90.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 p -73.14 -13.05 61.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.502 0.321 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.84 -42.91 63.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -100.66 -19.07 16.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.37 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -117.97 77.81 12.45 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.627 0.771 . . . . 0.0 108.996 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.96 -15.94 52.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.641 2.228 . . . . 0.0 110.158 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.19 2.22 4.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.492 1.117 . . . . 0.0 111.55 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.1 mt -124.23 -9.8 7.56 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.818 0.847 . . . . 0.0 110.675 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.86 -25.6 67.64 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -123.68 26.92 7.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.103 0.478 . . . . 0.0 109.728 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.13 -10.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 C-N-CA 124.571 1.148 . . . . 0.0 108.658 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.53 -20.55 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.78 0.832 . . . . 0.0 109.326 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.97 159.1 36.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 110.752 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.59 136.78 36.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.416 0.686 . . . . 0.0 109.439 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.7 tttt . . . . . 0 CA--C 1.535 0.38 0 C-N-CA 124.975 1.31 . . . . 0.0 110.891 176.238 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.225 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -121.86 129.39 52.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -124.39 148.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.391 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -129.13 160.14 33.8 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 mm -132.43 109.79 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 170.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 54.06 11.39 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.059 0.544 . . . . 0.0 111.714 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.19 -1.63 43.82 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.035 0.826 . . . . 0.0 112.509 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -80.29 0.42 32.88 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.43 99.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.623 1.169 . . . . 0.0 113.652 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.5 pt -51.29 -21.55 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 112.071 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -66.67 -10.42 46.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.516 0.727 . . . . 0.0 112.23 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.56 9.92 11.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.769 0.828 . . . . 0.0 110.211 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.81 -156.27 0.71 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 108.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.73 -2.33 14.3 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 76.58 -136.77 19.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.61 1.76 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.17 0.988 . . . . 0.0 113.35 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.7 mt-10 -129.72 23.57 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.589 0.631 . . . . 0.0 111.917 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.8 m -63.37 0.24 0.73 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.938 0.895 . . . . 0.0 113.354 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt 52.73 85.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.74 171.1 0.95 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.018 1.327 . . . . 0.0 111.364 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -140.72 164.59 29.79 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.643 1.177 . . . . 0.0 109.891 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.01 3.81 0.06 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 t -152.4 18.07 0.63 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 110.013 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.59 177.24 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.696 0.76 . . . . 0.0 110.355 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.39 153.76 37.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -135.16 157.19 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 133.72 5.02 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.96 134.33 61.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.3 144.37 53.19 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.383 0.673 . . . . 0.0 110.29 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.41 175.26 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.693 3.595 . . . . 0.0 110.187 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo . . . . . 0 N--CA 1.457 -0.654 0 C-N-CA 123.168 2.578 . . . . 0.0 112.176 174.863 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.85 128.02 34.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.109 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.21 128.75 35.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 110.282 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 m -140.18 -175.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.14 0.495 . . . . 0.0 110.643 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.809 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.24 132.36 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -109.73 147.63 32.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.6 mt -126.1 155.53 41.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -143.64 159.55 42.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.37 -147.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.458 0.303 . . . . 0.0 111.033 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -56.13 -13.65 2.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.59 -30.94 66.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.16 0.891 . . . . 0.0 110.072 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.83 -30.13 67.56 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.347 0.659 . . . . 0.0 109.711 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -78.89 -18.66 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.282 0.633 . . . . 0.0 112.133 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.28 3.23 54.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.763 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.02 -8.99 3.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.789 0.836 . . . . 0.0 110.673 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 8.25 50.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.6 p -141.35 144.48 34.27 Favored Pre-proline 0 N--CA 1.457 -0.12 0 CA-C-N 118.05 0.925 . . . . 0.0 110.41 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.84 -21.14 12.77 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.244 2.629 . . . . 0.0 111.197 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -164.93 159.6 18.34 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.738 0.415 . . . . 0.0 110.776 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.15 29.7 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.367 0.667 . . . . 0.0 111.759 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.58 150.24 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.669 2.913 . . . . 0.0 111.741 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -160.63 -176.77 5.75 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.257 1.023 . . . . 0.0 109.817 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -149.06 158.16 43.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.06 158.15 15.54 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.75 -26.84 40.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.51 0.655 . . . . 0.0 109.703 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -137.92 165.9 25.39 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.437 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -46.73 -47.89 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.85 -32.48 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -68.92 -20.68 64.23 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.382 0.537 . . . . 0.0 111.439 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.9 t -93.04 -39.63 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.34 -29.26 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.321 0.51 . . . . 0.0 110.921 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.9 mt -76.87 -16.15 59.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.323 0.249 . . . . 0.0 111.221 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -94.34 -21.45 18.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.879 0.872 . . . . 0.0 110.362 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.84 -49.63 61.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.489 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.9 p -67.75 -16.03 63.92 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.038 0.535 . . . . 0.0 111.247 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.34 -44.41 75.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -97.7 -18.13 19.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -118.56 76.17 13.12 Favored Pre-proline 0 N--CA 1.455 -0.219 0 C-N-CA 123.385 0.674 . . . . 0.0 109.778 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.42 -17.22 58.88 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.89 2.393 . . . . 0.0 110.444 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.3 1.17 8.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 111.666 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.58 -6.38 8.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.487 0.715 . . . . 0.0 111.183 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 35.7 ttpt -63.11 -26.95 69.06 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.545 ' CE2' ' HE2' ' A' ' 51' ' ' LYS . 20.7 m-85 -117.38 27.45 9.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 109.89 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.95 -9.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.407 1.083 . . . . 0.0 108.817 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.78 -20.2 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.118 0.967 . . . . 0.0 109.268 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -131.69 162.76 29.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.695 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -83.98 132.61 34.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.274 0.63 . . . . 0.0 109.988 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.545 ' HE2' ' CE2' ' A' ' 46' ' ' TYR . 51.6 tttm . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 125.115 1.366 . . . . 0.0 111.976 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 C--O 1.225 -0.217 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.947 0.403 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.24 146.15 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -129.95 163.18 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.715 0.406 . . . . 0.0 110.403 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 mm -134.05 105.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 55.07 7.69 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.195 0.598 . . . . 0.0 111.952 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.14 -4.64 31.73 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.731 0.681 . . . . 0.0 112.175 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -73.12 -2.57 22.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.08 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 113.729 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.72 -20.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -66.01 -10.01 35.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.947 0.499 . . . . 0.0 111.655 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -117.79 8.21 12.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.532 0.733 . . . . 0.0 110.656 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.01 -156.68 0.72 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.269 1.028 . . . . 0.0 109.162 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.0 -3.44 19.54 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -137.62 20.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.12 -0.66 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.91 25.32 5.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.303 0.502 . . . . 0.0 111.349 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.1 m -65.77 -2.29 3.58 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.352 0.661 . . . . 0.0 111.381 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt 60.37 166.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.257 1.023 . . . . 0.0 110.958 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.47 171.55 14.21 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.829 0.852 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -139.96 167.29 22.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.892 0.877 . . . . 0.0 109.86 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -66.97 8.39 0.28 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -151.78 17.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.06 -179.7 2.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.75 0.786 . . . . 0.0 109.993 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -153.54 153.37 32.27 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mm -128.99 156.88 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.49 138.34 8.38 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.01 127.62 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.81 144.87 55.05 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.935 0.494 . . . . 0.0 110.623 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.98 173.13 12.28 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.621 3.547 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 122.911 2.407 . . . . 0.0 111.723 175.117 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.38 31.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.25 128.87 35.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.72 -172.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -125.52 155.48 40.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.76 134.74 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -115.56 137.02 52.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.083 0.553 . . . . 0.0 109.901 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -109.76 160.62 16.17 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.62 159.07 43.67 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.92 -146.04 0.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.503 0.321 . . . . 0.0 111.101 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -56.66 -12.82 2.02 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -72.41 -31.35 65.44 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.07 0.85 . . . . 0.0 110.018 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -70.9 -31.04 67.56 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.003 0.521 . . . . 0.0 110.168 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.41 -33.12 69.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.783 0.433 . . . . 0.0 111.332 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.55 -23.24 25.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.615 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.5 -19.56 33.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.197 0.199 . . . . 0.0 110.495 174.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.97 1.98 60.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.6 p -144.47 149.95 45.95 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 123.798 0.839 . . . . 0.0 109.575 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 -24.52 11.77 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.776 2.317 . . . . 0.0 110.876 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.95 161.73 22.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.935 0.334 . . . . 0.0 111.395 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.36 155.74 26.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 111.59 -178.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.22 149.6 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.963 3.109 . . . . 0.0 111.733 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt -159.99 -177.11 6.08 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.265 1.026 . . . . 0.0 109.432 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -148.47 158.32 44.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 111.71 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.27 158.07 15.6 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.9 -27.39 49.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.355 0.577 . . . . 0.0 109.982 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -138.54 166.24 24.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.185 0.994 . . . . 0.0 109.588 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.62 -47.85 7.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.951 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.24 -32.93 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.91 -21.89 64.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.474 0.579 . . . . 0.0 111.412 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.05 -38.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.29 -30.45 70.87 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.633 -0.667 . . . . 0.0 110.87 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.49 -16.51 59.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.488 0.315 . . . . 0.0 111.386 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -92.53 -23.3 19.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.887 0.875 . . . . 0.0 110.613 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.91 -50.89 61.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.2 p -67.12 -15.11 63.51 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.965 0.506 . . . . 0.0 111.085 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.74 -44.22 74.26 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -98.29 -17.45 18.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.228 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -117.8 75.3 10.03 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 123.767 0.827 . . . . 0.0 109.665 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.54 -17.39 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 110.415 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.99 1.63 6.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.665 0.786 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.32 -3.59 7.41 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.724 0.81 . . . . 0.0 110.763 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.4 tttt -64.53 -23.69 67.36 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -123.19 27.68 7.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.285 0.564 . . . . 0.0 109.583 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.43 -14.57 3.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 C-N-CA 124.231 1.012 . . . . 0.0 108.832 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.35 -21.27 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.955 0.902 . . . . 0.0 108.938 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.44 160.69 33.29 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.778 0.431 . . . . 0.0 109.889 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -84.03 136.59 33.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.916 0.486 . . . . 0.0 110.099 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 124.957 1.303 . . . . 0.0 111.027 175.473 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -124.75 123.54 40.2 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -109.6 144.97 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.8 mt -128.51 161.41 29.62 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.161 0.584 . . . . 0.0 109.836 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -133.09 107.37 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 170.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 54.86 9.66 0.31 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.24 0.616 . . . . 0.0 111.623 -169.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.14 -4.08 35.51 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 123.899 0.761 . . . . 0.0 112.258 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.72 -1.36 21.54 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 50.81 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.6 1.16 . . . . 0.0 113.994 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.42 -21.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -62.08 -15.6 46.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.917 0.487 . . . . 0.0 112.267 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -113.55 8.02 17.59 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.427 0.691 . . . . 0.0 110.643 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -123.75 -155.61 0.67 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 108.986 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.08 -2.62 19.13 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.937 -0.477 . . . . 0.0 112.012 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.6 -140.17 21.57 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.87 -5.43 1.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.444 0.698 . . . . 0.0 112.591 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.82 22.55 12.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.417 0.687 . . . . 0.0 111.944 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.7 m -66.08 0.65 1.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.661 0.784 . . . . 0.0 112.12 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt 59.63 169.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.581 0.753 . . . . 0.0 110.645 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.54 170.76 15.18 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.759 1.224 . . . . 0.0 109.231 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.9 167.26 22.52 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.951 0.9 . . . . 0.0 109.929 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -66.56 7.59 0.32 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -151.92 17.61 0.68 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.211 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.7 178.49 2.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.86 0.838 . . . . 0.0 110.313 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -153.35 149.67 28.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.69 153.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.39 136.35 8.44 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.6 mt -118.31 128.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.57 146.36 60.19 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 122.884 0.473 . . . . 0.0 110.511 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.25 173.46 13.83 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.688 3.592 . . . . 0.0 110.497 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.454 -0.852 0 C-N-CA 122.984 2.456 . . . . 0.0 111.02 175.474 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.99 130.68 46.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -76.99 132.02 38.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -142.25 -172.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.299 0.571 . . . . 0.0 110.593 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -130.35 153.97 48.15 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.254 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.58 137.58 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -117.74 150.01 39.81 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.659 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -127.26 156.78 41.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.29 160.31 41.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.35 -147.63 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.588 0.355 . . . . 0.0 111.108 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -56.86 -10.91 1.19 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.79 -31.58 63.34 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.41 1.005 . . . . 0.0 110.189 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.35 -32.4 71.45 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.086 0.554 . . . . 0.0 109.679 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 111.637 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.8 56.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.18 -7.02 3.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.54 0.736 . . . . 0.0 110.709 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.69 43.9 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.481 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.0 p -142.15 143.98 29.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 117.996 0.898 . . . . 0.0 110.215 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.45 -17.69 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.463 2.775 . . . . 0.0 111.732 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -164.28 160.14 20.71 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.159 -0.338 . . . . 0.0 111.259 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 154.61 25.32 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 123.665 0.786 . . . . 0.0 111.47 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.49 153.0 20.54 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.848 3.032 . . . . 0.0 110.518 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -162.95 -174.81 4.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.715 0.406 . . . . 0.0 110.341 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -146.62 160.78 41.73 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 146.69 4.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.52 -25.42 50.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.668 0.734 . . . . 0.0 110.973 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -134.45 170.89 15.07 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 124.097 0.959 . . . . 0.0 109.792 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.67 -44.35 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.84 -34.64 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -69.94 -23.39 63.19 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.731 -0.606 . . . . 0.0 110.842 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.31 -45.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.12 -30.08 71.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.625 0.37 . . . . 0.0 111.733 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 mt -75.57 -16.81 60.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.149 0.431 . . . . 0.0 111.419 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.25 -25.28 19.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.988 0.423 . . . . 0.0 110.007 175.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.88 -50.5 68.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.5 p -67.51 -15.09 63.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.15 0.58 . . . . 0.0 111.579 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.29 -44.27 68.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.263 0.483 . . . . 0.0 111.377 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -95.85 -17.98 20.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.506 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.48 76.1 12.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.512 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.53 -17.61 60.15 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.118 2.545 . . . . 0.0 111.013 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.66 1.72 9.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.56 0.744 . . . . 0.0 111.257 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.46 -6.14 8.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 111.048 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.3 tttt -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.421 ' CD2' ' HD3' ' A' ' 51' ' ' LYS . 22.2 m-85 -122.77 28.23 7.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.114 0.483 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.57 -37.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.03 -24.58 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.489 0.716 . . . . 0.0 109.125 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.75 160.98 32.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.116 0.566 . . . . 0.0 110.584 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -84.91 138.6 32.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 46' ' ' TYR . 26.8 ttpp . . . . . 0 C--O 1.231 0.099 0 C-N-CA 123.07 0.548 . . . . 0.0 110.002 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.192 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -127.08 126.47 43.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.85 144.83 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.11 160.27 32.51 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.7 mm -130.64 107.76 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.74 9.92 0.32 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.224 0.609 . . . . 0.0 111.704 -170.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.47 34.34 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.504 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.89 0.05 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.84 99.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.858 1.263 . . . . 0.0 114.145 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 pt -51.3 -21.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -61.95 -13.06 21.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -117.85 9.68 12.99 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.596 0.759 . . . . 0.0 111.018 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -124.81 -155.94 0.7 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.04 0.936 . . . . 0.0 109.497 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -70.89 -2.83 16.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 77.77 -138.2 21.19 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.15 0.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.782 0.833 . . . . 0.0 112.689 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.9 mt-10 -127.54 23.78 6.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.144 0.578 . . . . 0.0 111.453 -174.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 84.9 m -62.12 -0.26 0.5 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.916 0.886 . . . . 0.0 113.297 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt 52.56 83.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.08 169.86 0.74 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.924 1.289 . . . . 0.0 110.962 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.99 167.75 21.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.371 1.069 . . . . 0.0 109.924 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.48 5.95 0.16 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.1 t -153.48 17.37 0.54 Allowed 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.894 -0.503 . . . . 0.0 110.184 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -69.09 177.06 2.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.559 0.695 . . . . 0.0 111.049 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -149.54 151.47 33.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.29 152.57 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.08 129.95 4.97 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -111.45 130.92 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.05 147.96 64.78 Favored Pre-proline 0 N--CA 1.453 -0.289 0 C-N-CA 122.801 0.44 . . . . 0.0 110.593 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -79.63 174.01 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.637 3.558 . . . . 0.0 110.584 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 123.186 2.591 . . . . 0.0 110.68 174.114 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.6 mtp . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.689 0.757 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.77 131.03 45.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.822 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.52 134.29 38.34 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -142.25 -175.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.168 0.509 . . . . 0.0 110.31 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -118.48 154.94 31.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.225 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.84 124.57 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.9 153.1 25.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.25 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.7 mt -127.02 157.6 39.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.49 159.47 42.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.19 -146.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.53 0.332 . . . . 0.0 111.26 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -56.94 -10.71 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.58 -30.11 61.59 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.258 0.935 . . . . 0.0 110.292 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -71.62 -33.24 68.79 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.303 0.641 . . . . 0.0 109.708 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.09 -23.71 60.56 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.692 0.797 . . . . 0.0 112.04 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.43 1.87 56.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.32 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.8 -6.46 4.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.491 0.717 . . . . 0.0 110.581 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.87 10.42 45.55 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.661 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -140.84 143.89 33.57 Favored Pre-proline 0 N--CA 1.455 -0.196 0 CA-C-N 117.853 0.826 . . . . 0.0 110.288 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.89 -20.87 10.02 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.379 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -166.99 162.81 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.921 0.328 . . . . 0.0 111.242 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.1 155.97 16.28 Favored Pre-proline 0 N--CA 1.456 -0.148 0 C-N-CA 123.632 0.773 . . . . 0.0 110.407 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.28 156.13 33.04 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.054 2.503 . . . . 0.0 110.08 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 mt -161.61 -176.22 5.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.134 0.973 . . . . 0.0 108.85 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -149.63 158.69 44.4 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.867 0.365 . . . . 0.0 111.689 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.62 156.45 13.32 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -77.8 -26.83 49.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.358 0.579 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -139.36 166.34 24.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.605 1.162 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -45.82 -48.61 4.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 tp -62.27 -33.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -68.11 -20.19 64.9 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.604 0.638 . . . . 0.0 111.304 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.41 -43.42 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.29 -27.54 69.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.336 -0.228 . . . . 0.0 111.108 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.07 -18.53 57.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -86.81 -31.22 20.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.8 -48.98 78.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.98 0.512 . . . . 0.0 109.654 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 p -71.64 -15.2 62.23 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.887 0.475 . . . . 0.0 111.405 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.46 -38.55 65.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.249 0.477 . . . . 0.0 111.179 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -23.25 17.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -121.52 79.22 37.85 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 123.899 0.879 . . . . 0.0 109.22 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.82 -17.28 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.022 2.481 . . . . 0.0 110.232 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.41 0.92 7.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.162 0.985 . . . . 0.0 111.374 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.98 -5.53 6.8 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.7 0.8 . . . . 0.0 111.11 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.02 -24.1 67.76 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -122.06 25.31 9.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.303 0.641 . . . . 0.0 109.808 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.04 -9.96 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.228 1.011 . . . . 0.0 108.899 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.23 -19.84 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.778 0.831 . . . . 0.0 109.509 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -130.66 161.05 32.47 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.116 0.484 . . . . 0.0 110.937 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -71.22 152.35 43.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.547 0.739 . . . . 0.0 109.634 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 CA--C 1.53 0.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.567 -178.274 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.911 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.5 mm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -124.15 123.82 41.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.9 144.36 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -127.79 162.18 27.24 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -133.09 105.88 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 55.23 8.4 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.133 0.573 . . . . 0.0 112.137 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.26 -4.84 33.49 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.973 0.797 . . . . 0.0 112.349 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.47 -1.99 20.7 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.49 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 113.808 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -49.8 -21.29 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -63.02 -13.62 37.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -114.52 7.75 16.24 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.491 0.716 . . . . 0.0 110.556 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.73 -154.95 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.025 0.93 . . . . 0.0 109.345 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.2 -13.2 61.74 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.06 0.944 . . . . 0.0 112.3 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 85.91 -141.54 18.62 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -174.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.38 4.14 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.901 0.88 . . . . 0.0 113.333 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 79' ' ' GLY . 43.9 mt-10 -129.03 23.15 5.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.177 0.591 . . . . 0.0 111.181 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -66.49 -1.82 4.0 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.1 mt 60.54 167.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.549 0.74 . . . . 0.0 110.747 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.63 170.53 15.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.761 0.824 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -141.35 166.5 24.59 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.57 1.148 . . . . 0.0 109.888 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.96 -5.55 0.45 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.9 t -143.77 14.87 1.75 Allowed 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.89 179.04 2.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.494 0.664 . . . . 0.0 110.569 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.73 152.63 30.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mm -131.75 155.18 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.94 135.18 5.75 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 172.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.85 127.97 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.8 146.56 62.34 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 122.733 0.413 . . . . 0.0 110.467 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.31 172.71 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.653 3.569 . . . . 0.0 110.353 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 C-N-CA 122.843 2.362 . . . . 0.0 110.592 175.591 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.468 ' CG ' ' N ' ' A' ' 3' ' ' MET . 70.4 t60 57.31 170.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.999 1.319 . . . . 0.0 113.119 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.468 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.7 mtp -146.46 104.39 3.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 132.14 51.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.17 129.39 35.08 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -139.66 -172.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.317 0.579 . . . . 0.0 110.438 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -128.46 158.23 38.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.475 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.0 t -134.4 131.37 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -114.97 137.61 51.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.08 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.16 160.88 16.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -145.75 158.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.39 -145.67 0.27 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.543 0.337 . . . . 0.0 111.258 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -56.13 -12.01 1.35 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.7 -31.62 61.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 109.708 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -70.23 -32.42 70.28 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.17 0.588 . . . . 0.0 110.052 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.75 -32.53 71.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.866 0.467 . . . . 0.0 111.651 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 -23.51 23.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.395 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.47 -17.71 35.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.698 0.227 . . . . 0.0 110.722 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.84 3.29 59.27 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 p -143.94 148.71 43.29 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 123.915 0.886 . . . . 0.0 109.792 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.94 -25.55 11.88 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.954 2.436 . . . . 0.0 110.821 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.04 163.0 20.71 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.855 0.462 . . . . 0.0 110.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -159.59 155.72 23.57 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.279 0.632 . . . . 0.0 110.583 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.59 154.85 35.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.23 2.62 . . . . 0.0 110.217 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.6 mt -163.38 -175.31 4.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.197 0.999 . . . . 0.0 108.696 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -145.88 160.21 42.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 111.254 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.8 146.73 5.11 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -78.57 -24.51 45.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.137 -0.625 . . . . 0.0 110.379 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -132.13 171.02 14.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.931 0.892 . . . . 0.0 109.593 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -55.21 -49.12 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.5 -32.73 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -68.61 -21.91 64.46 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.6 -46.07 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.53 -39.93 68.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.469 1.107 . . . . 0.0 111.803 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.3 mt -72.4 -18.24 61.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -88.38 -30.93 19.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.957 0.344 . . . . 0.0 110.409 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.77 -48.97 79.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -70.64 -14.77 62.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.135 0.574 . . . . 0.0 111.824 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 -40.99 71.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.251 0.478 . . . . 0.0 111.964 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.53 -18.32 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.026 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -116.97 75.84 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.949 0.899 . . . . 0.0 109.085 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -64.88 -16.81 57.22 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.887 2.391 . . . . 0.0 110.303 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.31 -0.64 8.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.113 0.965 . . . . 0.0 111.489 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.7 mt -124.86 -5.19 7.49 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 110.96 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.61 -24.17 67.5 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.4 25.08 10.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.165 0.586 . . . . 0.0 109.838 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.55 -15.19 5.52 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 124.296 1.039 . . . . 0.0 108.755 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.16 -21.05 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.783 0.833 . . . . 0.0 109.316 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.86 159.65 35.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.224 0.535 . . . . 0.0 111.446 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.83 135.5 37.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.881 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -75.95 54.19 0.82 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.114 1.366 . . . . 0.0 111.449 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.7 -179.81 17.77 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 55' ' ' LYS . 30.2 m-20 45.56 44.22 9.8 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.709 0.804 . . . . 0.0 111.987 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.5 15.84 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.141 0.976 . . . . 0.0 113.572 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 53' ' ' ASP . 54.8 mtmt -131.69 13.05 4.91 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.071 0.948 . . . . 0.0 110.368 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -150.0 -167.07 2.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 124.317 1.047 . . . . 0.0 109.265 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -117.03 10.78 14.06 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.594 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.5 mm -74.04 134.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.8 mt -133.2 168.4 18.62 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.596 0.759 . . . . 0.0 109.794 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.1 mt -141.0 131.81 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 tp -61.83 143.34 56.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.0 t -57.46 159.38 4.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.98 18.74 55.34 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.7 m -137.79 -5.68 1.72 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.508 0.723 . . . . 0.0 112.023 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.7 mm -91.33 160.6 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.086 0.469 . . . . 0.0 110.588 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -126.35 130.29 50.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -114.8 144.29 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.43 160.23 32.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.83 0.452 . . . . 0.0 109.963 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -132.19 108.43 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 54.86 10.71 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.943 0.497 . . . . 0.0 111.502 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.35 -3.04 43.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.889 0.757 . . . . 0.0 112.637 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.64 -0.95 25.34 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.15 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.731 1.212 . . . . 0.0 113.849 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.6 pt -51.47 -21.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.931 -0.48 . . . . 0.0 112.264 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -62.84 -12.21 23.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -118.18 9.4 12.6 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.564 0.746 . . . . 0.0 110.83 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.81 -155.73 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.219 1.008 . . . . 0.0 109.6 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -70.34 -3.79 19.08 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.7 -139.48 21.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.89 2.29 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 112.773 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.2 mt-10 -128.17 23.44 6.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.433 0.693 . . . . 0.0 111.466 -174.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.2 m -61.92 -0.8 0.53 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.119 0.967 . . . . 0.0 113.26 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 mt 53.02 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.83 0.824 . . . . 0.0 113.045 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.05 174.78 0.59 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 111.57 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -140.91 166.23 25.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.182 0.993 . . . . 0.0 110.785 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.38 5.4 0.28 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.1 t -153.04 16.35 0.56 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.861 0.3 . . . . 0.0 110.232 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.03 177.94 2.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 111.345 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -149.19 151.95 35.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.07 154.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.74 134.93 7.39 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.7 mt -116.54 129.42 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.29 146.98 63.15 Favored Pre-proline 0 N--CA 1.454 -0.261 0 C-N-CA 122.342 0.257 . . . . 0.0 110.855 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -78.01 174.89 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.558 3.505 . . . . 0.0 110.626 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.66 169.92 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.775 2.316 . . . . 0.0 110.912 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.75 161.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.104 0.961 . . . . 0.0 110.321 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.5 m 52.74 18.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.728 0.811 . . . . 0.0 112.956 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.18 179.05 45.49 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 117.25 -1.861 . . . . 0.0 110.797 179.494 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.109 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 3' ' ' MET . 35.8 t60 -153.89 170.02 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.24 0.616 . . . . 0.0 109.948 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.429 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 80.1 mtp -139.57 97.51 3.29 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.33 51.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -78.53 133.02 37.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.42 -173.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 0.0 110.403 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -127.75 155.69 43.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.51 125.32 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -105.82 153.67 21.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.074 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.73 155.94 45.79 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.06 159.0 43.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.55 -146.18 0.25 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.523 0.329 . . . . 0.0 110.938 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -56.36 -12.78 1.8 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.83 -30.99 64.47 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.096 0.862 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -69.26 -31.15 69.49 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.286 0.634 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.78 -19.75 58.77 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.74 0.816 . . . . 0.0 112.181 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.71 1.69 56.48 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.952 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.14 -9.41 3.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.731 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.62 56.87 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.297 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.3 p -142.35 140.66 19.37 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.977 0.889 . . . . 0.0 110.458 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.37 -16.16 15.44 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.263 2.642 . . . . 0.0 111.396 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.68 159.47 18.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 110.792 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.72 157.1 22.97 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 123.392 0.677 . . . . 0.0 111.19 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.99 154.2 22.55 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.308 2.672 . . . . 0.0 110.517 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.9 mt -161.61 -176.13 5.13 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.567 1.147 . . . . 0.0 108.829 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -148.77 162.27 40.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.66 156.63 10.16 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.48 -24.22 42.48 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.518 0.659 . . . . 0.0 110.001 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -140.57 172.06 13.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.086 0.954 . . . . 0.0 109.85 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.5 t -56.22 -44.85 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.42 -34.01 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.5 -23.12 63.57 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.8 -0.562 . . . . 0.0 111.179 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.44 -39.8 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.9 -31.62 71.54 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.095 -0.378 . . . . 0.0 111.155 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.56 -20.62 58.51 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.094 0.406 . . . . 0.0 110.697 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -85.55 -26.77 25.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.895 0.878 . . . . 0.0 110.351 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.82 -50.63 61.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.332 0.653 . . . . 0.0 109.452 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.2 p -68.25 -13.49 62.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.696 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.34 -37.93 74.76 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -106.77 -18.02 14.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.452 0.47 . . . . 0.0 111.107 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -116.98 74.06 6.78 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 123.953 0.901 . . . . 0.0 108.744 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.98 -16.91 57.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.748 2.299 . . . . 0.0 110.308 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.08 0.45 7.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.952 0.901 . . . . 0.0 111.525 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.5 mt -123.41 -4.91 8.28 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.52 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 78.1 tttt -62.36 -23.51 66.83 Favored 'General case' 0 CA--C 1.526 0.041 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.68 26.16 8.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.217 0.607 . . . . 0.0 109.579 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.24 -8.85 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.327 1.051 . . . . 0.0 108.754 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.12 -19.99 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.181 0.992 . . . . 0.0 109.332 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -132.46 162.09 32.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.098 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 52' ' ' GLY . 81.5 mt-10 -78.09 135.47 37.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.292 0.637 . . . . 0.0 109.882 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -74.5 30.45 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.129 1.371 . . . . 0.0 111.487 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -80.92 0.79 86.36 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 122.076 -0.39 . . . . 0.0 112.391 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -142.06 126.01 17.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.866 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -143.15 4.79 1.45 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.324 0.649 . . . . 0.0 111.985 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -145.88 158.17 43.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.899 0.88 . . . . 0.0 110.01 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.08 1.94 29.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.164 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.05 131.95 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.4 mt -140.13 173.03 11.92 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.564 0.746 . . . . 0.0 110.235 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.1 mt -139.35 127.45 26.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.94 133.77 55.77 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.98 162.79 2.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.082 0.468 . . . . 0.0 111.497 -176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.42 18.88 52.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.8 p -138.5 -5.19 1.59 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.269 0.628 . . . . 0.0 112.096 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.74 159.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 122.9 0.48 . . . . 0.0 110.625 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.81 131.58 53.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.14 143.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.7 mt -127.69 160.62 31.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.73 0.412 . . . . 0.0 110.215 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mm -132.06 108.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 54.52 11.02 0.38 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.997 0.519 . . . . 0.0 111.598 -170.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.73 -3.7 42.3 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.71 0.671 . . . . 0.0 112.259 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -77.07 -0.41 24.6 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.23 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.774 1.23 . . . . 0.0 114.207 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 pt -51.41 -21.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.862 -0.524 . . . . 0.0 112.012 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -62.97 -11.65 20.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.053 0.541 . . . . 0.0 112.256 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.76 9.89 11.5 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.522 0.729 . . . . 0.0 110.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.6 mt -124.62 -155.73 0.68 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.361 1.065 . . . . 0.0 109.269 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -69.6 -4.75 20.58 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 78.9 -138.54 20.92 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -177.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.11 1.18 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 79' ' ' GLY . 37.4 mt-10 -129.48 26.52 5.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.294 0.638 . . . . 0.0 111.403 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.6 m -62.93 0.42 0.55 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.529 0.731 . . . . 0.0 112.916 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.6 mt 51.82 83.64 0.05 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.42 169.58 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.77 1.228 . . . . 0.0 111.097 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -140.01 166.91 23.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.579 1.152 . . . . 0.0 110.051 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.04 4.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 115.805 1.779 . . . . 0.0 115.805 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -152.81 16.83 0.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.334 0.516 . . . . 0.0 110.576 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.25 177.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.67 0.747 . . . . 0.0 110.886 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.64 153.41 36.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.734 0.814 . . . . 0.0 109.067 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.28 157.01 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.24 134.59 6.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.81 131.12 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.46 145.38 56.23 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 122.658 0.383 . . . . 0.0 111.11 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -79.19 171.68 15.86 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.947 3.765 . . . . 0.0 110.554 177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.01 -13.71 41.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.179 2.586 . . . . 0.0 113.368 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -83.5 8.11 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.416 0.553 . . . . 0.0 111.304 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -156.82 177.89 10.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.384 0.274 . . . . 0.0 110.558 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.22 -16.08 0.11 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.505 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 117.378 -1.79 . . . . 0.0 110.867 179.123 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 59.4 t60 -152.68 169.22 23.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.256 0.622 . . . . 0.0 110.193 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.5 mtp -140.61 102.75 4.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 128.66 36.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.035 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 128.49 34.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.401 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.23 -175.8 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 110.451 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -120.35 154.22 35.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.851 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -134.1 124.59 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -113.29 133.34 55.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.222 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -102.56 161.31 13.82 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -145.35 159.03 43.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.35 -148.77 0.2 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.365 0.266 . . . . 0.0 111.359 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -56.29 -12.21 1.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.34 -30.55 66.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.058 0.845 . . . . 0.0 110.002 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -68.44 -32.62 72.77 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.321 0.648 . . . . 0.0 109.964 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.45 -31.9 65.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.796 0.438 . . . . 0.0 111.508 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.98 -26.44 25.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.299 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.78 -18.35 44.46 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.855 0.298 . . . . 0.0 110.436 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.4 2.16 59.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.4 p -144.36 150.3 47.58 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 124.094 0.958 . . . . 0.0 109.653 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.19 -25.0 12.0 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.065 2.51 . . . . 0.0 111.135 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -166.51 163.85 17.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.593 0.235 . . . . 0.0 110.99 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.32 155.73 17.53 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.555 0.742 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.58 155.36 31.61 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.216 2.611 . . . . 0.0 109.844 171.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' HZ2' ' A' ' 40' ' ' LYS . 6.2 mt -160.26 -175.44 5.05 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.686 0.794 . . . . 0.0 108.925 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -149.21 158.98 44.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.06 157.1 14.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.57 -25.71 38.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.506 0.653 . . . . 0.0 109.291 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.18 165.96 25.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.502 1.121 . . . . 0.0 109.089 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 t -45.55 -54.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.19 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.12 -32.58 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -66.58 -21.57 66.14 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.634 -0.666 . . . . 0.0 111.169 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.98 -45.04 16.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.11 -36.45 65.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.733 0.813 . . . . 0.0 111.605 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.16 -17.83 60.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -86.22 -33.65 20.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.128 0.422 . . . . 0.0 110.161 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.55 -49.56 75.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.98 0.512 . . . . 0.0 109.624 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.1 p -69.57 -16.55 63.43 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.789 0.436 . . . . 0.0 112.025 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.21 -37.26 72.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 111.945 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.53 ' HZ2' HD22 ' A' ' 25' ' ' LEU . 7.5 pttm -103.28 -20.27 14.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.784 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.95 74.65 13.24 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.95 0.9 . . . . 0.0 108.837 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.78 -17.22 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.914 2.409 . . . . 0.0 110.054 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.58 1.78 6.1 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 111.563 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -125.11 -6.42 7.21 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.576 0.75 . . . . 0.0 111.36 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 33.2 ttpt -63.34 -26.74 68.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.088 -0.383 . . . . 0.0 111.796 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.536 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 m-85 -117.56 27.37 9.1 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.267 0.627 . . . . 0.0 110.067 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.9 -7.47 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.274 1.03 . . . . 0.0 108.99 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.87 -23.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.129 0.972 . . . . 0.0 109.121 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.62 164.62 21.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.801 0.44 . . . . 0.0 110.113 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -75.91 174.42 9.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.436 0.694 . . . . 0.0 110.451 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.536 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 34.0 ttmt -119.23 32.36 6.15 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.357 1.063 . . . . 0.0 110.015 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.25 23.44 9.73 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.781 0.705 . . . . 0.0 112.805 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -137.85 132.26 32.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.4 6.21 2.3 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.424 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -142.13 8.98 1.87 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.214 0.606 . . . . 0.0 111.72 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -149.82 -165.66 2.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.04 0.536 . . . . 0.0 109.948 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.06 14.76 7.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 128.55 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.34 167.56 12.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.278 0.631 . . . . 0.0 110.063 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.7 mt -141.41 123.64 14.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.42 132.17 52.89 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.7 t -57.4 161.05 3.63 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 111.245 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.76 18.67 54.63 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.8 m -137.08 -1.87 2.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.379 0.671 . . . . 0.0 111.684 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.31 157.96 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.089 0.556 . . . . 0.0 110.374 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.48 129.22 52.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.98 138.42 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 35.3 mt -125.6 161.62 26.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.472 0.177 . . . . 0.0 110.723 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.2 mm -132.66 106.31 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 171.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 54.84 9.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.266 0.626 . . . . 0.0 112.2 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.91 -4.02 36.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.778 0.704 . . . . 0.0 112.257 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.31 -4.33 38.59 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 27.0 t-20 47.64 106.75 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.765 1.626 . . . . 0.0 114.989 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -53.04 -21.59 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -67.58 -10.21 49.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.586 0.754 . . . . 0.0 111.51 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.84 9.47 13.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.756 0.822 . . . . 0.0 110.664 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.61 -156.54 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 109.132 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -67.1 -8.64 32.28 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.23 -139.2 18.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.85 -0.82 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.842 0.857 . . . . 0.0 113.054 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 83' ' ' LEU . 38.5 mt-10 -127.83 26.05 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.052 0.541 . . . . 0.0 111.347 -176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.7 m -66.08 -1.64 3.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.415 0.686 . . . . 0.0 111.296 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.406 ' H ' ' C ' ' A' ' 81' ' ' GLU . 19.5 mt 59.95 167.76 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.024 0.929 . . . . 0.0 111.249 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.41 174.41 10.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.398 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -142.22 166.37 24.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 110.348 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.04 7.24 0.41 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -149.96 14.36 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.2 179.11 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.73 0.776 . . . . 0.0 110.853 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.08 152.7 32.71 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 mm -131.34 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.59 138.09 8.74 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.34 128.39 74.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.61 144.9 51.06 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.569 0.348 . . . . 0.0 111.037 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.35 172.25 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 125.262 3.975 . . . . 0.0 110.99 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.65 -13.62 29.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.336 2.691 . . . . 0.0 113.039 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -145.05 140.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 118.489 0.586 . . . . 0.0 109.657 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 t -152.76 171.78 17.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.873 0.469 . . . . 0.0 110.249 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.84 178.32 48.42 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.475 -1.736 . . . . 0.0 110.262 -179.623 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.21 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 66.7 t60 -152.85 168.99 23.93 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.077 0.551 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 88.2 mtp -140.61 105.24 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.49 126.51 28.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.95 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.27 126.61 31.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.249 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.14 -172.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 110.777 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -123.58 152.5 41.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.696 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.44 133.33 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -113.68 148.21 36.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.102 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.0 mt -127.03 157.91 38.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -145.05 160.36 41.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -173.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.08 -145.44 0.2 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.6 0.36 . . . . 0.0 110.88 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -58.91 -9.95 2.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.61 -30.92 61.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.082 0.855 . . . . 0.0 110.054 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -69.89 -33.08 71.73 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -72.54 -22.93 60.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.672 0.789 . . . . 0.0 111.808 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.283 0.365 . . . . 0.0 111.053 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.12 -7.37 3.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.523 0.729 . . . . 0.0 110.731 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 7.42 44.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.596 0.617 . . . . 0.0 112.152 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.8 p -142.75 144.68 30.78 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-N 117.825 0.812 . . . . 0.0 110.193 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.63 -16.14 13.32 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.097 2.531 . . . . 0.0 111.722 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -164.81 158.67 17.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.124 0.42 . . . . 0.0 111.585 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.72 155.01 26.16 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 123.615 0.766 . . . . 0.0 111.238 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.21 152.34 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.802 3.001 . . . . 0.0 110.857 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 mt -162.92 -176.9 5.16 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.355 0.662 . . . . 0.0 109.659 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -148.12 159.39 43.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.709 0.29 . . . . 0.0 111.564 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 155.49 11.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 174.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.57 -28.69 56.32 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.007 -0.702 . . . . 0.0 110.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -137.16 167.39 21.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.171 0.988 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.46 -54.71 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.71 -32.51 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -66.8 -21.74 66.04 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 121.473 -0.767 . . . . 0.0 111.118 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.81 -44.15 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -37.4 66.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 39.9 mt -73.74 -16.68 61.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 -25.79 17.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.928 0.394 . . . . 0.0 110.174 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.37 -48.81 76.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.405 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.9 p -69.08 -15.98 63.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.056 0.542 . . . . 0.0 111.289 177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -71.52 -46.9 58.39 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.921 0.328 . . . . 0.0 111.524 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -92.88 -19.3 21.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.253 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -118.25 77.21 12.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.681 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.89 -16.62 56.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.009 2.472 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.89 2.22 7.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.696 0.798 . . . . 0.0 111.41 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.69 -6.62 7.43 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.707 0.803 . . . . 0.0 111.021 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 80.3 tttt -62.07 -22.91 66.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.84 0.456 . . . . 0.0 111.978 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.74 25.35 8.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.058 0.543 . . . . 0.0 109.817 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.7 t -126.57 -8.51 4.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.459 1.104 . . . . 0.0 109.07 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.29 -19.17 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.113 0.965 . . . . 0.0 109.18 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.94 161.05 32.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.023 0.44 . . . . 0.0 110.907 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.9 133.24 35.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.367 0.667 . . . . 0.0 109.997 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -75.26 47.84 0.39 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.992 1.317 . . . . 0.0 110.556 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.31 1.0 46.76 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.141 0.4 . . . . 0.0 112.423 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -80.4 25.95 0.39 Allowed 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.599 0.759 . . . . 0.0 111.988 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.07 0.29 1.33 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -140.48 11.02 2.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.848 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 t -150.26 -163.5 1.79 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.793 0.806 . . . . 0.0 110.909 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.43 25.03 3.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.352 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.7 mm -119.13 114.53 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.17 0.988 . . . . 0.0 109.649 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.47 171.5 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.168 0.509 . . . . 0.0 111.115 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.8 mt -140.25 125.96 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.2 135.69 57.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 11.3 t -58.92 165.94 2.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.098 0.475 . . . . 0.0 111.176 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.44 20.06 28.25 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.9 m -138.24 -0.84 1.99 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.875 0.87 . . . . 0.0 111.578 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.7 mm -102.12 149.3 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 122.912 0.485 . . . . 0.0 110.025 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -117.71 124.88 49.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.6 mt -121.35 148.18 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.213 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.9 mt -130.08 162.71 28.17 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.175 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -135.31 108.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.22 10.24 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.949 0.5 . . . . 0.0 111.74 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.69 -3.05 39.09 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.874 0.75 . . . . 0.0 112.386 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -77.05 0.37 21.6 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.29 97.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.838 1.255 . . . . 0.0 114.202 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.7 pt -50.38 -20.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -64.03 -16.88 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.575 0.625 . . . . 0.0 111.878 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -110.99 6.9 21.35 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.492 0.717 . . . . 0.0 110.579 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.03 -157.34 0.76 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.788 0.835 . . . . 0.0 109.399 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -73.56 -0.54 15.49 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.97 -137.11 20.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.87 -2.48 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.837 0.855 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.68 21.62 7.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.345 0.521 . . . . 0.0 111.421 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.3 m -65.61 -0.9 2.28 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.779 0.832 . . . . 0.0 112.261 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt 60.38 164.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.231 1.012 . . . . 0.0 110.918 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.4 mt -138.45 169.98 16.83 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.697 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 4.5 mptt -136.49 167.36 21.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.03 0.932 . . . . 0.0 111.475 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.84 7.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.685 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.7 t -152.05 16.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -69.76 -179.97 1.98 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.592 0.71 . . . . 0.0 110.365 174.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -155.32 152.57 29.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mm -127.45 154.55 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.08 127.41 2.77 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.21 132.36 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.79 146.41 60.1 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.174 0.59 . . . . 0.0 110.683 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -78.43 173.19 14.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.78 3.653 . . . . 0.0 110.252 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.21 -2.46 7.03 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.191 2.594 . . . . 0.0 112.893 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.4 t -66.38 -13.51 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 C-N-CA 122.965 0.506 . . . . 0.0 110.884 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.4 t -157.16 177.0 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.219 -0.301 . . . . 0.0 110.348 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.85 -14.97 0.09 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.961 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.382 -1.788 . . . . 0.0 110.823 179.499 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' CG ' ' N ' ' A' ' 3' ' ' MET . 79.3 t60 -153.02 167.78 28.05 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.977 0.511 . . . . 0.0 110.394 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.438 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 88.1 mtp -141.48 105.09 4.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.37 131.82 50.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.35 129.56 35.14 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.03 -173.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.179 0.592 . . . . 0.0 110.422 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -127.43 157.2 40.64 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.345 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -136.69 128.03 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -113.71 139.96 48.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.766 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.97 160.55 16.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.63 159.64 42.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.84 -151.79 0.17 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.379 0.272 . . . . 0.0 110.719 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -56.11 -11.97 1.33 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.36 -30.71 69.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.877 0.762 . . . . 0.0 109.92 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.45 -33.39 69.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.601 0.76 . . . . 0.0 110.35 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -70.6 -32.13 69.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 122.845 0.458 . . . . 0.0 111.653 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.82 -23.74 25.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.683 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.09 -17.49 37.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.321 0.248 . . . . 0.0 110.351 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.06 2.74 58.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.2 p -143.77 149.39 46.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.61 0.764 . . . . 0.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.56 -26.69 11.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.954 2.436 . . . . 0.0 110.952 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.66 163.23 19.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.987 0.515 . . . . 0.0 110.185 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.09 156.72 24.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.967 0.507 . . . . 0.0 110.766 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.34 156.01 36.98 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.1 2.533 . . . . 0.0 110.287 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.4 mt -163.61 -175.39 4.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.958 0.903 . . . . 0.0 108.782 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -146.55 160.48 42.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 111.275 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.02 150.93 6.63 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.93 -24.18 41.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.647 0.723 . . . . 0.0 110.275 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -134.98 171.48 14.36 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.282 1.033 . . . . 0.0 109.826 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -56.42 -45.5 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.13 -35.54 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.94 -22.92 64.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.737 0.699 . . . . 0.0 111.008 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.04 -44.13 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -32.03 73.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.201 0.2 . . . . 0.0 111.373 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.8 -18.43 60.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -86.23 -30.96 21.96 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.966 0.412 . . . . 0.0 110.025 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.94 -46.8 89.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.1 p -70.96 -15.2 62.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.075 0.55 . . . . 0.0 111.771 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.18 -40.89 70.97 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.301 0.5 . . . . 0.0 112.14 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -101.92 -18.55 15.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.175 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -117.13 75.04 7.72 Favored Pre-proline 0 N--CA 1.454 -0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.115 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.2 -16.62 56.0 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.892 2.395 . . . . 0.0 110.382 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 0.08 6.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.042 0.937 . . . . 0.0 111.65 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.4 mt -125.52 -4.85 7.14 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.868 0.867 . . . . 0.0 110.825 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.6 tttt -62.35 -23.98 67.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.65 0.38 . . . . 0.0 112.013 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.7 28.64 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.718 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.7 -10.08 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.45 1.1 . . . . 0.0 109.123 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.7 mt -121.49 -18.65 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.972 0.909 . . . . 0.0 108.936 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.13 163.16 29.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.43 0.634 . . . . 0.0 111.147 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.42 169.33 17.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.512 1.125 . . . . 0.0 109.646 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -121.42 32.17 6.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.952 1.301 . . . . 0.0 109.235 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.85 -3.87 69.5 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.575 -0.569 . . . . 0.0 113.524 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -144.15 131.05 20.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.064 0.932 . . . . 0.0 109.281 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.13 15.01 8.44 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.056 0.943 . . . . 0.0 111.048 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.75 -0.04 3.9 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.067 0.947 . . . . 0.0 110.564 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 m -146.74 163.95 34.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.521 1.128 . . . . 0.0 110.452 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.85 4.5 29.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.579 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.04 127.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.2 mt -136.18 165.66 25.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.043 0.937 . . . . 0.0 110.097 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -144.33 138.7 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.402 HD11 ' H ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -58.25 144.68 40.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.402 ' H ' HD11 ' A' ' 61' ' ' LEU . 5.5 t -58.56 -1.76 0.17 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.87 5.61 9.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.837 1.208 . . . . 0.0 114.574 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.3 m -138.94 -13.88 1.2 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.44 1.12 . . . . 0.0 112.391 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.7 mm -73.12 150.52 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.85 125.06 53.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.0 mt -123.04 147.56 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.786 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 33.9 mt -130.76 158.02 41.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.566 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.32 108.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 m120 54.12 10.42 0.29 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.211 0.605 . . . . 0.0 111.835 -170.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.29 33.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.913 0.768 . . . . 0.0 112.615 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.97 -0.1 23.13 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.9 t-20 50.73 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 113.767 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.1 pt -49.99 -21.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -63.21 -15.61 57.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -115.75 9.73 15.23 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.464 0.706 . . . . 0.0 110.608 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.6 mt -123.19 -154.52 0.61 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.872 0.869 . . . . 0.0 109.069 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.59 -14.73 61.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.609 0.764 . . . . 0.0 111.774 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 85.61 -137.99 15.85 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -174.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.16 4.95 0.11 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.818 0.847 . . . . 0.0 113.242 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.5 mt-10 -131.62 27.38 4.68 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.453 0.701 . . . . 0.0 111.155 -175.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.8 m -62.96 -1.01 0.78 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt 53.33 83.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.671 0.748 . . . . 0.0 112.643 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.98 170.67 0.61 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.036 1.334 . . . . 0.0 111.417 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -140.45 166.36 24.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.043 0.937 . . . . 0.0 110.65 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -62.6 4.65 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -151.91 15.51 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.383 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -66.3 175.11 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.703 0.764 . . . . 0.0 111.933 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.94 150.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.985 0.914 . . . . 0.0 109.103 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -133.81 155.51 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.84 133.88 6.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.6 mt -117.94 129.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.46 146.77 59.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.41 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.02 171.22 18.37 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.852 3.035 . . . . 0.0 110.673 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.95 0.79 6.64 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.777 2.985 . . . . 0.0 113.067 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.1 m 40.42 26.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.265 1.826 . . . . 0.0 115.037 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.6 t -153.9 3.55 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.615 0.366 . . . . 0.0 111.407 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -172.03 18.32 0.06 OUTLIER Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.701 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.28 -1.844 . . . . 0.0 110.87 -177.476 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 51.1 t60 -153.68 170.58 20.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.368 0.667 . . . . 0.0 110.196 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 83.3 mtp -140.68 100.72 3.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.25 128.62 36.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.99 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.8 129.85 35.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 110.09 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 m -140.11 -175.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.348 0.594 . . . . 0.0 110.458 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -119.97 156.42 30.88 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.52 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.93 123.84 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 53.0 mtmt -108.39 152.23 24.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.27 176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -127.22 156.46 41.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -143.62 158.35 43.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -150.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.53 0.332 . . . . 0.0 110.95 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -55.95 -11.17 0.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.41 -30.66 67.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.271 0.942 . . . . 0.0 110.028 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -68.89 -38.75 79.83 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.234 0.613 . . . . 0.0 109.705 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.54 -37.43 79.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.648 0.779 . . . . 0.0 111.286 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.13 -0.5 19.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.086 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.85 -6.01 4.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.519 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.33 35.31 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.152 0.882 . . . . 0.0 113.028 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.5 p -141.22 144.46 34.6 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 118.077 0.939 . . . . 0.0 110.472 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.47 -24.73 8.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.284 2.656 . . . . 0.0 111.574 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -167.41 162.72 14.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -161.03 155.58 19.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.239 0.616 . . . . 0.0 110.659 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.35 154.33 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.261 2.64 . . . . 0.0 110.62 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 HD22 ' HZ3' ' A' ' 40' ' ' LYS . 6.4 mt -161.86 -177.55 5.9 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.797 0.839 . . . . 0.0 108.885 177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -147.54 160.48 42.58 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.009 0.433 . . . . 0.0 111.774 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.72 158.16 16.31 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.23 -25.76 39.44 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.937 -0.743 . . . . 0.0 109.466 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -138.1 165.95 25.35 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.638 1.175 . . . . 0.0 109.225 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.9 t -45.56 -54.3 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.93 -32.26 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -68.19 -21.58 64.87 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.595 -0.69 . . . . 0.0 111.34 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.48 -45.79 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.45 -36.99 64.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.64 0.776 . . . . 0.0 111.573 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.3 mt -74.32 -17.66 60.81 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -87.7 -32.53 19.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.78 -50.63 72.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.8 p -71.05 -14.37 62.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.46 0.704 . . . . 0.0 111.815 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.88 -37.22 70.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 118.339 0.518 . . . . 0.0 112.166 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HZ3' HD22 ' A' ' 25' ' ' LEU . 8.3 pttm -103.7 -19.31 14.36 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.37 75.16 11.74 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 123.97 0.908 . . . . 0.0 108.963 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.08 -17.99 61.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.113 2.542 . . . . 0.0 110.087 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 1.21 5.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.089 0.955 . . . . 0.0 111.277 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.72 -5.71 6.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.675 0.79 . . . . 0.0 111.249 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.34 -24.05 67.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.096 -0.378 . . . . 0.0 112.005 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.96 24.58 10.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.46 0.704 . . . . 0.0 109.635 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.49 -6.78 5.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 C-N-CA 124.592 1.157 . . . . 0.0 109.006 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.63 -21.55 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.73 0.812 . . . . 0.0 109.217 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -131.08 163.55 27.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.898 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.92 157.97 35.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.997 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -89.49 22.65 2.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.002 0.921 . . . . 0.0 112.525 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.12 -176.95 44.31 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-O 121.947 0.748 . . . . 0.0 113.913 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -146.43 147.91 31.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 0.0 107.62 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.2 -10.01 55.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -143.93 -0.74 1.01 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.237 0.926 . . . . 0.0 113.208 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 t -157.07 -157.69 0.7 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 110.616 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -127.9 11.6 6.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.891 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.66 119.8 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.81 164.48 10.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.291 0.637 . . . . 0.0 111.669 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.6 mt -139.49 129.01 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.72 130.79 48.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.8 t -54.31 153.52 5.3 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.882 0.372 . . . . 0.0 111.099 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 13.54 66.1 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.608 -0.551 . . . . 0.0 112.801 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.55 -6.4 1.34 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.912 0.856 . . . . 0.0 112.465 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm -82.19 159.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.663 0.785 . . . . 0.0 110.257 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -123.27 129.15 50.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.32 146.23 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 mt -130.65 163.51 27.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.5 0.32 . . . . 0.0 110.45 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.4 mm -134.77 106.74 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 54.45 8.81 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.984 0.514 . . . . 0.0 112.119 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.94 -3.76 35.86 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.666 0.65 . . . . 0.0 112.317 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -74.39 -1.69 22.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 50.75 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 113.55 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.0 pt -49.68 -21.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -63.46 -13.98 46.09 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -113.73 7.85 17.3 Favored 'General case' 0 N--CA 1.46 0.044 0 C-N-CA 123.3 0.64 . . . . 0.0 110.73 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.88 -156.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.225 1.01 . . . . 0.0 108.948 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.41 -2.32 18.95 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.66 21.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.28 -2.32 0.45 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.892 0.877 . . . . 0.0 112.703 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 83' ' ' LEU . 37.1 mt-10 -124.63 24.57 7.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.172 0.589 . . . . 0.0 111.256 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.9 m -65.59 -1.62 2.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.324 0.65 . . . . 0.0 111.293 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 81' ' ' GLU . 19.5 mt 59.62 168.02 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 110.558 -175.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.7 mt -138.15 172.66 12.59 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.626 0.77 . . . . 0.0 110.008 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -140.74 167.77 21.38 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.933 0.893 . . . . 0.0 109.818 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.37 8.71 0.29 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t -150.65 15.79 0.78 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.135 0.493 . . . . 0.0 110.035 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.59 -179.83 2.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.693 0.759 . . . . 0.0 110.28 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -154.26 152.89 30.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.42 155.84 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.91 7.1 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 mt -122.52 127.6 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mp -131.79 144.82 54.85 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.272 0.629 . . . . 0.0 110.361 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.75 172.36 11.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 124.634 3.556 . . . . 0.0 109.869 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.38 176.3 5.84 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.099 2.533 . . . . 0.0 111.008 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.27 16.5 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.974 0.51 . . . . 0.0 110.808 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -150.9 13.15 0.7 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.323 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.04 179.24 46.45 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.938 -1.479 . . . . 0.0 111.428 179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.442 ' CG ' ' N ' ' A' ' 3' ' ' MET . 47.8 t60 -153.87 170.17 21.65 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.338 0.655 . . . . 0.0 110.234 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.442 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 82.2 mtp -140.34 99.81 3.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.33 131.34 47.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.36 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.27 133.39 38.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -143.11 -171.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.175 0.512 . . . . 0.0 110.777 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -131.16 156.98 44.37 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.782 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.0 t -128.45 137.53 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.85 138.65 52.58 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.877 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -111.75 160.53 17.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -145.79 158.61 43.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.68 -147.09 0.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.461 0.305 . . . . 0.0 111.318 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -57.16 -8.69 0.74 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.86 -31.75 59.43 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.345 0.975 . . . . 0.0 109.771 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -71.46 -32.65 68.54 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.092 0.557 . . . . 0.0 109.888 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -68.34 -35.41 77.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.718 0.407 . . . . 0.0 110.19 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.27 -27.23 38.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.42 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.61 -17.86 27.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.781 0.432 . . . . 0.0 110.944 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.14 4.88 69.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.2 p -144.19 145.31 29.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.656 0.782 . . . . 0.0 109.658 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.08 -25.43 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.047 2.498 . . . . 0.0 110.823 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.86 161.65 23.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.444 0.298 . . . . 0.0 111.265 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.99 155.18 23.88 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.526 0.73 . . . . 0.0 111.759 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.4 150.68 19.74 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.001 3.134 . . . . 0.0 111.386 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.8 mt -160.96 -174.63 4.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.159 0.984 . . . . 0.0 109.655 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -147.95 163.39 36.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.33 154.39 9.09 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.17 -23.92 43.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.475 0.637 . . . . 0.0 109.848 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -140.12 172.92 12.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.162 0.985 . . . . 0.0 109.767 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.85 -49.56 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -62.01 -31.53 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.83 -20.9 63.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.553 -0.717 . . . . 0.0 110.856 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.19 -42.08 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.98 -40.95 77.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.866 0.866 . . . . 0.0 111.499 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.3 -15.63 60.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.661 0.267 . . . . 0.0 111.245 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 m -93.61 -23.01 18.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.456 1.102 . . . . 0.0 110.712 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.57 -51.3 29.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.424 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -66.47 -13.33 60.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.824 0.45 . . . . 0.0 111.048 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.62 -44.74 70.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.485 0.314 . . . . 0.0 111.671 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -98.34 -17.73 18.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.077 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -117.86 75.99 10.69 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 109.454 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.62 -16.93 57.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.724 2.283 . . . . 0.0 110.506 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.7 0.36 9.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.009 0.923 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.7 -5.04 8.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.825 0.85 . . . . 0.0 110.886 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.36 -23.32 66.95 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.57 27.76 8.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.992 0.517 . . . . 0.0 109.659 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.5 -38.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -85.05 -24.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -130.5 165.7 22.12 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.038 0.535 . . . . 0.0 111.035 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -87.51 142.76 27.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -73.41 39.05 0.1 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 111.838 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -17.88 65.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.709 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -150.0 113.72 5.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.063 0.931 . . . . 0.0 109.851 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.14 2.79 37.88 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -139.78 8.87 2.37 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.8 m -142.1 165.04 28.54 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.495 0.664 . . . . 0.0 111.518 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -77.78 -5.32 50.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.859 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.7 mp -72.75 126.39 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.8 mt -143.34 173.63 11.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.938 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.9 mt -139.06 123.19 19.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 127.5 31.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 t -55.45 147.77 16.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.62 17.21 45.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.719 0.676 . . . . 0.0 111.573 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.1 m -134.99 -7.92 2.35 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.779 -176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 mm -90.09 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.004 0.522 . . . . 0.0 110.456 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -125.49 123.86 40.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -111.9 135.67 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -122.13 161.28 23.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -125.54 111.61 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 56.02 10.13 0.55 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.203 0.601 . . . . 0.0 112.154 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.38 15.31 9.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.335 0.493 . . . . 0.0 111.971 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -123.66 93.74 4.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.683 1.193 . . . . 0.0 109.438 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -39.15 109.73 0.12 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.749 1.62 . . . . 0.0 111.961 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 pt -50.03 -23.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.22 -8.36 12.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.898 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -121.76 8.21 9.98 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.386 1.074 . . . . 0.0 110.644 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.78 -153.89 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.538 1.135 . . . . 0.0 108.659 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.53 -15.37 60.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.54 0.736 . . . . 0.0 111.864 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 89.3 -142.56 16.85 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.0 5.27 0.06 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.881 0.873 . . . . 0.0 112.895 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.7 mt-10 -130.51 26.92 5.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.606 0.639 . . . . 0.0 111.587 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.7 m -63.47 -0.13 0.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.603 0.761 . . . . 0.0 112.838 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt 52.61 79.67 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.505 0.669 . . . . 0.0 112.777 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.45 165.25 1.14 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.942 1.297 . . . . 0.0 111.107 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.77 167.42 20.57 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.205 1.002 . . . . 0.0 109.558 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.98 5.98 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -153.76 19.58 0.53 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.812 -0.555 . . . . 0.0 110.175 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.73 178.22 3.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.758 0.79 . . . . 0.0 110.468 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.05 151.52 31.22 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.83 150.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.63 130.33 5.95 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.52 128.38 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.62 147.72 65.71 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 122.451 0.3 . . . . 0.0 110.642 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -79.61 175.23 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.9 3.733 . . . . 0.0 110.244 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.22 170.89 12.36 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.826 2.35 . . . . 0.0 110.727 174.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.8 151.38 20.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.367 0.667 . . . . 0.0 109.467 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -153.22 175.85 12.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.969 0.508 . . . . 0.0 110.141 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.32 -15.85 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.184 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 117.168 -1.907 . . . . 0.0 110.62 178.943 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 3' ' ' MET . 68.2 t60 -152.64 168.25 26.24 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.812 0.445 . . . . 0.0 110.267 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.441 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.9 mtp -140.48 103.66 4.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.72 131.98 50.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 130.24 35.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.29 -173.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 110.54 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -127.76 157.52 40.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 169.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.8 127.47 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -108.49 152.34 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.494 0.717 . . . . 0.0 109.5 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.78 156.71 43.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.56 159.77 42.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.11 -148.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.504 0.322 . . . . 0.0 111.219 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.14 -9.99 0.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.63 -31.89 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.292 0.951 . . . . 0.0 109.724 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.08 -35.83 74.49 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.322 0.649 . . . . 0.0 110.071 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -68.22 -33.59 74.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.885 0.874 . . . . 0.0 110.723 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -2.74 40.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.875 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.0 -5.83 3.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.533 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.17 11.22 44.92 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.659 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.0 p -141.54 144.21 32.65 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 118.276 1.038 . . . . 0.0 110.571 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 -20.13 11.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.425 2.75 . . . . 0.0 111.62 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.12 162.02 19.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.65 0.38 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.91 155.24 24.19 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.235 0.614 . . . . 0.0 111.247 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.27 154.03 28.21 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.244 2.629 . . . . 0.0 110.09 172.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -163.75 -176.04 4.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.948 0.899 . . . . 0.0 109.253 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.26 161.66 40.5 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.69 155.76 10.32 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -79.09 -24.99 43.08 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.529 0.664 . . . . 0.0 110.047 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -140.61 172.5 12.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.944 0.898 . . . . 0.0 109.733 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.7 t -55.72 -43.89 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.47 -35.01 74.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.98 -21.44 65.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.696 -0.628 . . . . 0.0 110.638 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -86.23 -45.27 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.71 -29.54 70.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 119.546 -0.264 . . . . 0.0 111.389 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -74.44 -19.12 60.52 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.098 0.408 . . . . 0.0 111.928 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.86 -31.13 20.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.077 0.465 . . . . 0.0 109.876 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.65 -48.87 79.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 73.5 p -71.44 -13.97 62.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.404 0.681 . . . . 0.0 112.11 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.65 -38.6 70.68 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.284 0.493 . . . . 0.0 111.769 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -104.34 -17.66 14.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.331 0.394 . . . . 0.0 111.575 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -117.4 75.8 9.1 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.44 -17.68 60.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.052 2.502 . . . . 0.0 110.224 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 0.25 6.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.974 0.91 . . . . 0.0 111.568 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.8 -6.83 7.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.903 0.881 . . . . 0.0 110.937 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 82.0 tttt -65.38 -23.37 66.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.431 0.292 . . . . 0.0 111.621 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -118.96 27.67 8.74 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.078 0.551 . . . . 0.0 109.894 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.94 -35.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 123.849 0.86 . . . . 0.0 108.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.414 ' HA ' HG13 ' A' ' 65' ' ' ILE . 96.8 mt -88.11 -24.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.37 163.27 30.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.689 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' C ' ' H ' ' A' ' 52' ' ' GLY . 56.5 mt-10 -78.11 147.57 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.688 0.795 . . . . 0.0 109.409 173.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -75.22 36.76 0.12 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.75 1.22 . . . . 0.0 110.756 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -89.86 29.66 6.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.307 0.956 . . . . 0.0 112.354 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -130.13 20.24 5.37 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.546 0.738 . . . . 0.0 112.313 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.07 -1.55 4.35 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -141.4 8.83 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.902 0.881 . . . . 0.0 111.124 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -144.49 -170.04 3.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.797 0.839 . . . . 0.0 109.875 -176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -131.05 24.14 4.92 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.3 mm -124.0 116.5 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.143 0.977 . . . . 0.0 109.723 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.5 mt -84.24 175.05 9.68 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.297 0.57 . . . . 0.0 111.065 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -141.87 131.04 23.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.51 141.29 48.26 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.5 t -59.14 -2.39 0.27 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.06 7.11 15.32 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.373 0.987 . . . . 0.0 114.537 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -139.19 -14.77 1.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.254 1.027 . . . . 0.0 112.39 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.414 HG13 ' HA ' ' A' ' 48' ' ' ILE . 18.1 mm -71.01 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.259 0.624 . . . . 0.0 109.741 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -121.14 126.23 49.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.75 143.03 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.4 mt -125.93 159.87 31.46 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.4 mm -130.93 107.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 54.38 11.2 0.38 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.192 0.597 . . . . 0.0 111.604 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.86 39.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.861 0.743 . . . . 0.0 112.596 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.44 -1.33 26.52 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.06 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.97 1.308 . . . . 0.0 113.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.62 -21.33 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.725 -0.609 . . . . 0.0 112.177 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.54 -11.53 25.07 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.291 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.37 9.95 11.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.443 0.697 . . . . 0.0 110.79 175.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.7 -155.49 0.67 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.216 1.006 . . . . 0.0 109.436 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.13 -5.57 18.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.74 0.416 . . . . 0.0 111.965 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.19 -141.16 22.05 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.82 5.82 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 113.079 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.4 mt-10 -130.38 25.53 5.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.406 0.682 . . . . 0.0 111.308 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.5 m -62.26 0.97 0.37 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.986 0.914 . . . . 0.0 113.168 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.7 mt 51.77 84.27 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.63 171.56 0.61 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.963 1.305 . . . . 0.0 111.422 176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -139.82 166.74 23.82 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.187 0.995 . . . . 0.0 110.877 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.57 4.6 0.24 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -151.96 15.58 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.992 -0.443 . . . . 0.0 110.363 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.99 177.76 1.62 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.541 0.686 . . . . 0.0 111.593 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -149.4 151.28 33.78 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.05 0.94 . . . . 0.0 108.786 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.41 157.81 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.72 133.18 5.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.62 130.43 66.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.21 146.48 56.43 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 122.858 0.463 . . . . 0.0 110.911 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.93 166.77 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.437 3.425 . . . . 0.0 110.755 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -72.87 5.46 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.286 3.324 . . . . 0.0 113.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.01 14.1 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.385 0.674 . . . . 0.0 112.42 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 t -157.43 176.92 12.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.6 10.24 0.7 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.61 -1.661 . . . . 0.0 110.747 -179.674 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.443 ' CG ' ' N ' ' A' ' 3' ' ' MET . 68.1 t60 -153.13 169.06 23.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.025 0.53 . . . . 0.0 110.376 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.443 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.5 mtp -141.73 104.28 4.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 131.14 48.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.04 132.92 37.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 m -142.1 -174.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.226 0.536 . . . . 0.0 111.022 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -126.67 155.77 42.09 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -137.77 128.07 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -113.9 138.61 50.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.903 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -109.74 161.12 15.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -145.87 158.88 43.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.78 -147.66 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.421 0.288 . . . . 0.0 111.239 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.93 -11.38 1.44 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.56 -31.06 64.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.193 0.906 . . . . 0.0 110.084 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -70.26 -33.32 71.46 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.047 0.539 . . . . 0.0 109.922 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.22 -31.84 69.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.881 0.472 . . . . 0.0 111.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.05 -23.1 22.64 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.611 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.69 -18.56 34.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.707 0.23 . . . . 0.0 110.841 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.37 62.65 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.2 p -144.4 145.85 30.61 Favored Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.833 0.853 . . . . 0.0 109.727 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.92 -26.03 11.46 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.114 2.543 . . . . 0.0 110.953 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -164.95 163.85 20.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 110.095 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -162.58 157.78 19.09 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.081 0.553 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.3 155.0 28.68 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.145 2.564 . . . . 0.0 110.136 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -161.25 -176.64 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.046 0.938 . . . . 0.0 108.678 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -147.72 157.77 43.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 111.452 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.82 148.77 5.8 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -77.71 -24.97 49.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.783 0.791 . . . . 0.0 110.452 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.03 170.84 15.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.946 0.898 . . . . 0.0 109.939 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.7 -45.28 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -33.92 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -69.87 -20.98 63.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.359 0.527 . . . . 0.0 111.537 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.86 -40.58 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.23 -33.31 75.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.875 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.76 -18.73 60.94 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.87 0.304 . . . . 0.0 110.936 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -26.75 20.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.923 0.889 . . . . 0.0 110.729 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -67.75 -51.28 50.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.425 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 76.3 p -67.48 -13.37 61.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.119 0.568 . . . . 0.0 111.634 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.76 -39.43 80.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -106.26 -17.38 14.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -116.58 73.08 5.63 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.969 . . . . 0.0 108.98 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -64.14 -17.18 58.76 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.904 2.403 . . . . 0.0 110.444 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -1.07 9.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.006 0.922 . . . . 0.0 111.434 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 -4.73 8.99 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.889 0.875 . . . . 0.0 110.906 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.3 -22.68 66.87 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.15 28.91 6.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.8 t -125.48 -41.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.04 -24.69 10.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -130.0 167.46 18.22 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.231 0.612 . . . . 0.0 109.903 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' A' ' 52' ' ' GLY . 51.1 mt-10 -93.07 146.84 23.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -72.76 35.35 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.814 1.246 . . . . 0.0 112.044 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -78.12 26.0 2.2 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.403 1.001 . . . . 0.0 112.435 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.88 21.94 6.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.812 0.845 . . . . 0.0 111.659 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.59 -5.17 14.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.12 10.88 1.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.071 0.949 . . . . 0.0 110.916 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -144.05 -166.3 2.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.914 0.885 . . . . 0.0 109.701 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.93 24.53 4.27 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.427 0.691 . . . . 0.0 109.484 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mm -124.22 116.86 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.19 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.97 175.16 10.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.541 0.736 . . . . 0.0 111.123 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.79 122.74 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.56 123.47 17.48 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.5 t -58.98 136.6 57.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.83 81.7 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 m -84.0 -17.83 39.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.375 0.67 . . . . 0.0 111.439 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.53 151.08 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.64 0.776 . . . . 0.0 109.829 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -118.4 126.43 52.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.5 mt -124.67 136.61 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.756 0.789 . . . . 0.0 110.141 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.18 152.9 45.38 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.966 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.403 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 37.8 mm -124.17 100.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 64.55 0.92 1.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.189 0.995 . . . . 0.0 110.475 -172.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.81 -0.0 19.8 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.403 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 17.9 p30 -75.83 -4.13 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 49.06 93.83 0.01 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.181 1.392 . . . . 0.0 113.782 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 pt -49.2 -22.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -67.09 -10.88 54.73 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.888 0.875 . . . . 0.0 112.402 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -118.21 6.97 11.99 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.29 0.636 . . . . 0.0 110.348 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.0 mt -123.81 -154.94 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.158 0.983 . . . . 0.0 109.587 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.26 -4.49 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -132.6 19.24 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.76 -0.97 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.297 1.039 . . . . 0.0 113.61 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.35 25.81 5.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.641 0.655 . . . . 0.0 111.523 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.0 m -64.99 2.71 0.68 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.1 mt 51.95 85.0 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.77 168.9 1.55 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.915 1.286 . . . . 0.0 110.718 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -139.91 167.87 21.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.056 0.942 . . . . 0.0 110.21 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.04 5.96 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -153.08 16.8 0.56 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.316 0.507 . . . . 0.0 110.381 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 178.57 1.92 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.758 0.79 . . . . 0.0 111.202 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.81 151.54 34.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.039 0.935 . . . . 0.0 108.502 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.5 152.0 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.72 131.95 5.84 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.5 mt -118.08 131.77 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.54 148.31 66.93 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.8 0.44 . . . . 0.0 110.362 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.21 174.02 13.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.322 3.348 . . . . 0.0 110.316 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.24 160.76 46.07 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.852 2.368 . . . . 0.0 110.365 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.1 m -137.75 7.75 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.731 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -159.36 174.41 14.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.464 0.173 . . . . 0.0 110.68 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.28 -15.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.825 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.46 -1.744 . . . . 0.0 111.114 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.08 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 3' ' ' MET . 63.1 t60 -152.56 169.98 21.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.031 0.533 . . . . 0.0 110.063 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.456 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.1 mtp -140.96 103.21 4.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.6 127.71 32.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.06 126.53 30.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.242 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.33 -175.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.939 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -117.68 154.39 31.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.251 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.15 119.46 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.08 151.13 22.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.557 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -129.76 155.69 45.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -144.17 157.56 44.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.15 -152.5 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.243 0.217 . . . . 0.0 110.627 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -53.47 -14.85 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.04 -30.48 70.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.075 0.852 . . . . 0.0 110.029 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -70.7 -37.28 73.55 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.015 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -37.99 76.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.094 0.558 . . . . 0.0 111.656 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.76 -1.03 20.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.231 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.85 -7.64 5.55 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.039 0.936 . . . . 0.0 110.307 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 12.9 50.72 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.32 0.962 . . . . 0.0 112.76 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.7 p -142.01 141.86 23.08 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 118.06 0.93 . . . . 0.0 110.929 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.51 -20.91 13.58 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.585 2.857 . . . . 0.0 111.164 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.79 161.97 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.712 0.405 . . . . 0.0 110.424 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.73 156.1 27.96 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.145 0.578 . . . . 0.0 110.861 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.42 153.0 23.71 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.271 2.647 . . . . 0.0 110.299 172.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -163.71 -179.42 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.18 0.992 . . . . 0.0 108.865 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -148.19 158.83 44.31 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.36 157.27 13.81 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.63 -26.9 50.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.037 -0.684 . . . . 0.0 109.911 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -137.59 166.59 23.53 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.032 0.933 . . . . 0.0 109.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -46.75 -49.19 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.799 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.44 -34.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.52 -20.95 65.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.567 -0.708 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.53 -45.24 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.54 -24.63 67.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -79.05 -18.58 53.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 122.048 -0.407 . . . . 0.0 112.078 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.9 -28.98 22.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 110.196 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.14 -48.61 79.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -71.65 -17.22 62.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.258 0.623 . . . . 0.0 111.925 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.22 -39.61 78.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 117.995 0.362 . . . . 0.0 111.828 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -102.38 -18.32 15.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.442 0.464 . . . . 0.0 111.247 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -117.53 74.9 8.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.743 . . . . 0.0 109.117 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.56 -17.4 59.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.81 2.34 . . . . 0.0 110.356 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.36 1.51 6.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.22 1.008 . . . . 0.0 111.29 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.91 -6.24 6.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.5 0.72 . . . . 0.0 111.529 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.6 ttpt -64.25 -27.81 69.3 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.048 -0.408 . . . . 0.0 111.92 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -115.76 26.63 9.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 110.397 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.78 -12.22 3.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.284 1.034 . . . . 0.0 109.128 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.17 -19.85 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 109.692 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.52 162.56 30.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 52' ' ' GLY . 28.8 mt-10 -82.28 138.68 34.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.106 0.562 . . . . 0.0 110.248 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.09 35.0 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.293 1.437 . . . . 0.0 111.151 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -85.59 26.32 5.91 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 124.133 0.873 . . . . 0.0 112.858 -173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -138.39 131.34 29.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.178 0.514 . . . . 0.0 110.026 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.96 4.24 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.364 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -141.82 4.27 1.69 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.109 0.564 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -145.91 -173.02 4.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.717 0.807 . . . . 0.0 109.531 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.71 15.17 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.815 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.5 mm -79.1 127.16 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.22 169.39 8.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.806 0.442 . . . . 0.0 110.196 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 mt -140.5 122.37 15.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.33 130.12 43.27 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.9 t -56.1 155.45 6.49 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-O 121.039 0.447 . . . . 0.0 111.515 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.71 17.08 59.34 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -134.61 -5.96 2.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.694 0.798 . . . . 0.0 111.705 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.78 159.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.94 0.496 . . . . 0.0 109.88 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -125.38 122.4 36.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 mm -108.51 144.99 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -128.82 162.37 27.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.692 0.397 . . . . 0.0 110.349 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -133.53 105.74 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.82 8.78 0.24 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.234 0.614 . . . . 0.0 111.792 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.88 33.07 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.825 0.726 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -72.47 -2.18 18.62 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.04 97.35 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.804 1.242 . . . . 0.0 113.748 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.61 -20.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -62.78 -14.67 47.93 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.273 0.488 . . . . 0.0 112.113 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -112.59 6.85 18.59 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.303 0.641 . . . . 0.0 110.685 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.8 mt -123.81 -156.1 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.144 0.978 . . . . 0.0 109.604 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.57 -15.66 63.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.894 0.878 . . . . 0.0 112.345 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -139.41 15.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.75 -2.09 0.49 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 112.793 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -125.89 25.5 6.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.567 0.622 . . . . 0.0 111.595 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.7 m -66.29 -2.09 4.05 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.096 0.558 . . . . 0.0 111.491 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.98 166.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 110.332 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.3 mt -137.21 175.59 9.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.63 0.772 . . . . 0.0 110.414 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -141.64 167.39 22.28 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.748 0.819 . . . . 0.0 110.877 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.17 7.26 0.77 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.6 t -150.38 13.8 0.76 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.359 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.98 -179.5 1.51 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.498 0.666 . . . . 0.0 110.632 175.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -152.54 153.33 33.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mm -131.16 158.2 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.62 140.52 9.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.84 126.92 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.43 147.56 66.61 Favored Pre-proline 0 N--CA 1.452 -0.326 0 O-C-N 123.224 0.328 . . . . 0.0 110.689 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.8 174.02 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.812 3.674 . . . . 0.0 110.749 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.99 166.66 23.99 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.234 2.623 . . . . 0.0 110.431 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.65 -11.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.0 p -160.13 4.59 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.043 0.838 . . . . 0.0 113.068 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.5 47.44 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.241 -1.866 . . . . 0.0 110.755 -179.88 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.442 ' CG ' ' N ' ' A' ' 3' ' ' MET . 53.5 t60 -153.68 169.11 24.1 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.981 0.512 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.442 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.0 mtp -139.88 101.11 4.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.03 132.42 52.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.38 130.81 35.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.05 -173.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.282 0.563 . . . . 0.0 110.504 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -128.12 157.98 39.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.384 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.51 131.2 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -115.16 137.95 51.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.353 0.661 . . . . 0.0 109.532 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -110.26 160.01 16.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -145.05 159.17 43.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -152.63 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.313 0.245 . . . . 0.0 110.756 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -53.77 -14.06 0.85 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.59 -30.6 70.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.111 0.869 . . . . 0.0 109.844 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.57 -36.58 73.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.454 0.702 . . . . 0.0 109.967 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -40.52 81.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.73 0.412 . . . . 0.0 110.995 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.18 -27.43 59.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.792 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.31 -18.23 39.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.214 -0.303 . . . . 0.0 110.56 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.26 3.09 64.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.9 p -145.25 149.54 41.83 Favored Pre-proline 0 C--O 1.232 0.133 0 C-N-CA 123.642 0.777 . . . . 0.0 109.822 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.78 -24.65 11.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.182 2.588 . . . . 0.0 110.946 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -164.87 163.23 21.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.53 0.332 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.42 155.33 20.85 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 123.487 0.715 . . . . 0.0 110.724 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 154.01 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.16 2.573 . . . . 0.0 110.29 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -161.3 -174.39 4.28 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.038 0.935 . . . . 0.0 108.889 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -148.86 161.09 42.55 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.761 0.315 . . . . 0.0 111.749 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.19 155.93 9.85 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.08 -24.03 43.77 Favored 'General case' 0 C--O 1.23 0.056 0 O-C-N 122.091 -0.652 . . . . 0.0 109.97 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.51 172.92 12.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.727 0.811 . . . . 0.0 109.659 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.42 -43.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.76 -36.01 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.65 -22.03 64.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.424 0.556 . . . . 0.0 111.055 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.2 t -86.64 -46.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.43 -29.4 70.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.444 0.298 . . . . 0.0 111.58 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 32.7 mt -75.18 -16.45 60.5 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -88.67 -30.99 18.73 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 109.979 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.95 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.431 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 70.5 p -70.2 -15.64 62.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.237 0.615 . . . . 0.0 111.769 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.81 -38.53 73.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.324 0.511 . . . . 0.0 111.847 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -104.49 -18.25 14.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.138 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -116.86 75.5 7.35 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 124.115 0.966 . . . . 0.0 108.884 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -64.7 -16.55 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.042 2.495 . . . . 0.0 110.47 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -0.9 10.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.819 0.848 . . . . 0.0 111.486 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.53 -5.09 8.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.967 0.907 . . . . 0.0 110.958 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 76.9 tttt -63.63 -24.69 67.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.85 31.54 5.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.34 0.59 . . . . 0.0 109.46 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.23 -41.03 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.05 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.61 163.94 26.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.493 0.664 . . . . 0.0 110.989 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.83 172.13 12.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -121.49 35.06 4.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.366 1.067 . . . . 0.0 108.905 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.3 -7.96 64.76 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.758 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -146.35 130.14 17.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.608 0.704 . . . . 0.0 109.107 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.02 16.24 10.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.741 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -134.88 7.55 3.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.696 0.798 . . . . 0.0 110.716 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m -148.89 164.92 33.07 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.496 1.118 . . . . 0.0 110.015 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.23 3.29 31.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.65 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -65.34 127.27 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.46 169.91 16.78 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.717 0.807 . . . . 0.0 110.218 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.8 mt -144.3 133.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.99 127.82 34.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 49.6 t -54.75 144.17 23.09 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.301 0.572 . . . . 0.0 111.34 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.33 15.65 16.88 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.968 0.794 . . . . 0.0 112.019 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.1 m -135.77 -8.96 2.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.266 0.626 . . . . 0.0 111.988 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mm -87.36 159.77 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.0 110.326 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.64 126.63 42.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.2 145.22 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.7 mt -129.16 159.49 35.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.9 mm -130.71 108.24 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 55.33 10.5 0.46 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.198 0.599 . . . . 0.0 111.333 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.28 -2.1 40.3 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.15 0.881 . . . . 0.0 112.424 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -81.14 1.65 30.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.57 101.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.84 1.256 . . . . 0.0 114.079 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.5 -26.41 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.964 -0.46 . . . . 0.0 112.214 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -60.87 -11.61 8.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -122.91 13.38 9.84 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.491 0.716 . . . . 0.0 111.278 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.04 -84.91 0.66 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.697 0.399 . . . . 0.0 110.558 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -144.35 1.64 1.08 Allowed 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 118.481 0.582 . . . . 0.0 111.772 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 74.67 -141.29 28.29 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.4 1.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' GLY . 36.7 mt-10 -128.63 25.38 5.7 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.602 0.637 . . . . 0.0 111.834 -175.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -63.71 0.81 0.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.9 mt 51.66 84.85 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.76 170.42 1.13 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 111.619 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 64.5 mttp -139.48 167.2 22.62 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.449 1.1 . . . . 0.0 111.657 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.29 4.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 t -153.07 16.03 0.55 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.074 -0.391 . . . . 0.0 110.201 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 6.7 m-20 -67.32 177.36 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.963 0.887 . . . . 0.0 111.351 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -148.07 151.15 35.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.44 1.096 . . . . 0.0 108.55 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.11 153.36 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.19 133.98 7.16 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.46 128.58 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.61 147.45 61.59 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 122.705 0.402 . . . . 0.0 111.006 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.41 174.2 12.21 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.052 3.835 . . . . 0.0 110.467 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.88 172.3 12.01 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.139 2.559 . . . . 0.0 111.291 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 p 43.8 31.95 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.542 1.537 . . . . 0.0 113.053 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 t -154.87 174.2 15.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.069 -0.395 . . . . 0.0 110.713 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -162.73 14.93 0.12 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.717 -0.491 . . . . 0.0 112.352 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.434 -1.759 . . . . 0.0 110.773 -179.135 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 69.4 t60 -154.05 168.71 25.53 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.25 0.62 . . . . 0.0 110.43 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.9 mtp -142.43 104.36 4.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.61 130.95 48.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.39 132.58 39.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.27 -173.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.18 0.592 . . . . 0.0 110.14 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.01 158.41 38.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.3 t -130.05 138.12 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.75 152.29 37.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt -128.49 155.58 44.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.03 159.22 42.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.73 -146.18 0.27 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.432 0.293 . . . . 0.0 111.17 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -56.69 -10.68 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.05 -30.52 61.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.342 0.974 . . . . 0.0 110.125 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -70.39 -33.49 71.47 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.076 0.55 . . . . 0.0 109.6 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -72.01 -21.98 61.47 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.468 0.707 . . . . 0.0 111.718 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 1.98 56.7 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.288 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.27 -7.54 2.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.326 0.65 . . . . 0.0 110.709 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.4 9.0 48.23 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.337 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 p -141.26 144.75 35.56 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.056 0.928 . . . . 0.0 110.39 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.22 -22.4 9.77 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.319 2.68 . . . . 0.0 111.574 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.07 160.82 14.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.517 0.327 . . . . 0.0 110.639 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.64 154.42 23.07 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -178.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.06 152.65 24.58 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.684 2.923 . . . . 0.0 110.976 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 mt -163.6 -173.17 3.18 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.994 0.518 . . . . 0.0 110.284 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -148.36 160.64 42.81 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 111.099 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.2 149.48 6.15 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -81.24 -24.8 37.11 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 117.708 0.754 . . . . 0.0 110.388 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -132.22 170.82 14.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.245 1.018 . . . . 0.0 109.227 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.68 -48.33 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.51 -32.32 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.628 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.77 -22.61 64.28 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.654 -0.654 . . . . 0.0 110.703 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.65 -45.03 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -38.79 71.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.121 0.968 . . . . 0.0 111.821 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 mt -74.22 -14.34 60.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.91 -26.21 16.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 174.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.09 -49.65 71.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.3 p -68.3 -14.25 62.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.902 0.481 . . . . 0.0 111.484 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.96 -44.98 64.92 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.089 0.404 . . . . 0.0 111.397 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -95.44 -17.84 21.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -118.69 76.57 13.83 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 123.859 0.864 . . . . 0.0 109.666 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -17.19 57.96 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.102 2.535 . . . . 0.0 111.03 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.44 2.02 8.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.334 0.654 . . . . 0.0 111.358 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.0 -7.08 8.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.556 0.743 . . . . 0.0 110.718 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.09 -24.2 67.61 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.891 0.477 . . . . 0.0 112.198 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -121.17 28.57 7.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.938 0.495 . . . . 0.0 109.989 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.3 -36.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.272 1.029 . . . . 0.0 108.244 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.05 -25.4 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.607 0.763 . . . . 0.0 109.187 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.24 161.84 30.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.992 0.517 . . . . 0.0 110.791 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.81 141.41 31.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.49 43.84 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.064 1.346 . . . . 0.0 110.994 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.78 -21.36 69.22 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.491 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -151.33 117.85 5.71 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.798 0.809 . . . . 0.0 110.175 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -88.48 0.8 55.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.6 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -137.2 7.89 2.91 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.607 -0.683 . . . . 0.0 112.676 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -143.52 166.16 25.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -1.59 21.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 mp -77.05 127.0 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.1 mt -138.86 168.77 19.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.13 122.79 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 125.43 21.32 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.2 t -53.18 146.54 11.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.069 0.461 . . . . 0.0 111.086 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.61 16.85 43.16 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.923 0.773 . . . . 0.0 111.584 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -134.26 -9.98 2.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.46 0.704 . . . . 0.0 111.495 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.24 161.03 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 122.871 0.468 . . . . 0.0 110.202 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -128.98 126.58 39.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.81 145.99 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.53 160.76 32.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.99 0.516 . . . . 0.0 109.642 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.13 105.58 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 55.07 8.61 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.039 0.536 . . . . 0.0 111.856 -169.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.88 -3.88 32.03 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.066 0.841 . . . . 0.0 112.419 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -76.4 -0.15 21.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 49.33 99.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 114.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.07 -21.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.62 -11.67 12.53 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -119.58 9.02 11.37 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.755 0.822 . . . . 0.0 111.541 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.73 -156.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.059 0.944 . . . . 0.0 109.485 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.89 -5.67 22.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.39 -139.44 20.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.82 2.08 0.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.896 0.878 . . . . 0.0 113.132 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 79' ' ' GLY . 37.9 mt-10 -129.22 25.87 5.47 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.398 0.545 . . . . 0.0 111.553 -175.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.9 m -62.16 -0.57 0.55 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.762 0.825 . . . . 0.0 112.991 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.29 83.51 0.06 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.72 170.89 0.72 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.039 1.335 . . . . 0.0 111.896 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -138.36 167.88 20.95 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.27 1.028 . . . . 0.0 110.404 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -64.94 7.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.8 t -152.86 17.21 0.58 Allowed 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.889 -0.507 . . . . 0.0 110.599 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.72 -179.34 2.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.199 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.42 155.26 36.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.386 0.674 . . . . 0.0 109.576 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 mm -125.79 155.13 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.01 120.95 1.63 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.7 mt -108.97 129.97 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.72 149.04 70.88 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 122.632 0.373 . . . . 0.0 110.763 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.4 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 73.1 Cg_endo -78.34 174.75 11.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 125.007 3.804 . . . . 0.0 110.076 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 45.9 Cg_endo -65.17 157.56 56.82 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.65 2.233 . . . . 0.0 111.344 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.2 m -142.67 172.94 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.658 1.183 . . . . 0.0 110.053 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -142.41 165.55 27.12 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 110.649 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.54 -15.01 0.15 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-O 119.895 -0.392 . . . . 0.0 112.395 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 CA-C-O 117.313 -1.826 . . . . 0.0 110.692 178.59 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 3' ' ' MET . 51.1 t60 -153.09 169.57 22.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.435 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.6 mtp -139.5 100.69 4.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.75 131.91 50.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.437 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.56 130.08 35.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.228 0.537 . . . . 0.0 109.753 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.69 -172.42 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.342 0.592 . . . . 0.0 110.659 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -129.88 155.98 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.903 171.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.83 135.27 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.87 139.12 50.52 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.965 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -110.8 160.13 17.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -145.75 159.98 42.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.62 -147.06 0.22 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.219 0.207 . . . . 0.0 111.094 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -56.47 -12.51 1.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.51 -31.87 65.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.937 0.79 . . . . 0.0 110.006 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -70.92 -32.81 69.84 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.76 -33.55 72.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.337 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.87 -24.71 26.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.265 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 -18.97 33.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.556 0.217 . . . . 0.0 110.677 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 3.17 63.01 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.8 p -144.3 148.45 41.01 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.35 -23.69 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.004 2.47 . . . . 0.0 110.883 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -163.58 162.51 24.41 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.4 0.28 . . . . 0.0 111.39 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 154.36 26.6 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.634 0.774 . . . . 0.0 111.515 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.77 151.59 21.92 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.599 2.866 . . . . 0.0 110.649 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -162.0 -175.3 4.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.251 0.62 . . . . 0.0 110.04 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -147.74 162.11 39.86 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 111.444 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.14 152.26 7.7 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.51 -26.66 60.13 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.561 0.68 . . . . 0.0 110.467 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -139.9 174.43 10.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 109.897 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.76 -45.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 tp -63.79 -34.64 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.95 -22.6 65.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.466 0.575 . . . . 0.0 110.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.0 -44.76 16.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.38 -29.87 70.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.198 -0.313 . . . . 0.0 111.425 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.2 -17.89 60.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.143 -0.348 . . . . 0.0 111.472 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.62 -25.09 19.33 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 175.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.7 -49.09 76.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 81.8 p -68.68 -16.51 63.85 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.744 0.418 . . . . 0.0 111.571 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.69 -46.24 66.47 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.207 0.458 . . . . 0.0 111.809 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.0 -18.77 21.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -117.26 76.83 9.29 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.804 0.841 . . . . 0.0 109.881 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.06 -16.86 57.31 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.792 2.328 . . . . 0.0 110.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.01 2.16 7.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.792 0.837 . . . . 0.0 111.287 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.2 mt -126.77 -3.41 6.55 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 75.9 tttt -62.53 -24.46 67.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.472 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 24.2 m-85 -124.17 29.44 6.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.428 0.632 . . . . 0.0 109.422 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.41 -10.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.895 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.44 -18.38 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.835 0.854 . . . . 0.0 109.131 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -132.96 161.12 35.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.793 0.437 . . . . 0.0 110.961 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -69.44 168.63 14.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.72 0.808 . . . . 0.0 110.427 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 33.8 ttmt -114.18 28.04 9.05 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.799 0.84 . . . . 0.0 110.579 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.18 3.21 78.23 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -141.13 124.75 16.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.38 11.4 3.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.473 0.709 . . . . 0.0 110.953 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -138.87 6.3 2.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -147.58 159.22 44.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.784 0.833 . . . . 0.0 110.155 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.46 1.52 28.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.448 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.19 131.74 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.0 mt -139.55 171.99 13.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.499 0.72 . . . . 0.0 110.107 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.9 mt -141.18 135.46 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.24 142.23 48.35 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 t -58.54 -2.31 0.2 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.19 3.84 7.24 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.808 1.194 . . . . 0.0 114.749 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 m -137.23 -4.37 1.9 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.35 1.075 . . . . 0.0 111.894 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.5 mm -81.61 159.9 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.328 0.651 . . . . 0.0 109.375 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -118.71 126.43 51.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.26 144.09 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt -128.14 159.45 35.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.73 107.95 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.67 10.75 0.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.26 0.624 . . . . 0.0 111.628 -170.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.49 -3.49 37.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.036 0.827 . . . . 0.0 112.436 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -77.26 -0.64 26.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 51.46 100.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.696 1.198 . . . . 0.0 113.751 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.2 pt -51.3 -21.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -64.32 -11.42 31.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.966 0.506 . . . . 0.0 112.224 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -116.86 8.95 13.7 Favored 'General case' 0 N--CA 1.46 0.038 0 C-N-CA 123.66 0.784 . . . . 0.0 110.77 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.5 -155.63 0.69 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.053 0.941 . . . . 0.0 109.201 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.59 -3.23 17.19 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.74 -140.17 22.24 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.15 3.25 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.993 0.917 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.6 mt-10 -128.34 22.72 6.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.535 0.734 . . . . 0.0 111.513 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.2 m -62.15 0.65 0.39 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.524 1.13 . . . . 0.0 113.333 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.27 85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.778 0.799 . . . . 0.0 112.999 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.34 171.69 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.158 1.383 . . . . 0.0 111.409 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.41 166.28 24.97 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.428 1.091 . . . . 0.0 110.88 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.3 5.25 0.28 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 t -152.7 16.6 0.59 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 117.883 0.311 . . . . 0.0 110.503 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.0 m-20 -67.44 177.57 1.88 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.878 0.847 . . . . 0.0 111.344 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.18 151.48 34.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.192 0.997 . . . . 0.0 108.526 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.52 154.39 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.39 132.37 6.06 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -115.21 129.22 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.93 144.37 50.11 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 122.654 0.382 . . . . 0.0 110.439 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -80.12 169.09 18.04 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.57 3.513 . . . . 0.0 111.174 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.16 -179.24 3.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.787 2.991 . . . . 0.0 111.055 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.84 154.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.2 0.6 . . . . 0.0 109.806 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.3 t -147.94 17.35 1.11 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.813 0.339 . . . . 0.0 111.545 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.11 16.99 0.53 Allowed Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.872 -0.517 . . . . 0.0 112.198 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 CA-C-O 117.23 -1.872 . . . . 0.0 111.125 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 64.8 t60 -152.6 169.25 23.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.007 0.523 . . . . 0.0 110.384 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.2 mtp -140.46 104.64 4.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 127.2 30.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.74 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.99 128.38 34.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.6 m -140.65 -172.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.35 0.595 . . . . 0.0 110.677 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -124.87 153.97 41.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.956 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.62 133.02 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -114.59 136.1 53.41 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.443 0.465 . . . . 0.0 109.811 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -107.49 160.34 15.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.94 160.19 41.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.68 -146.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.393 0.277 . . . . 0.0 110.991 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -57.71 -11.59 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.5 mt -72.13 -29.05 63.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.354 0.979 . . . . 0.0 109.922 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.98 -32.01 70.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.144 0.578 . . . . 0.0 109.472 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.17 -23.2 60.4 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 111.249 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 -5.72 52.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.676 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -115.15 -11.34 12.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.164 0.586 . . . . 0.0 110.319 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.26 3.01 36.08 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.6 p -143.71 149.51 47.04 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 123.896 0.878 . . . . 0.0 109.548 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.07 -22.9 14.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.829 2.353 . . . . 0.0 110.994 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.48 163.57 22.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.898 0.317 . . . . 0.0 111.547 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.03 153.98 23.34 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.893 0.877 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.44 151.07 19.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.684 2.923 . . . . 0.0 110.796 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.7 -175.54 4.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 110.002 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -148.58 159.06 44.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.92 0.391 . . . . 0.0 111.736 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.18 154.54 10.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.94 -27.81 57.72 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 117.603 0.701 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -137.62 165.87 25.3 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.026 0.93 . . . . 0.0 109.698 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -46.05 -52.16 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 122.966 0.506 . . . . 0.0 110.196 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.0 -32.45 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -67.98 -21.22 65.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.52 -0.737 . . . . 0.0 111.137 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -45.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -54.77 -37.52 66.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.534 0.734 . . . . 0.0 111.446 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.7 mt -73.97 -16.8 61.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.44 -26.12 17.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.939 0.399 . . . . 0.0 110.025 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.0 -50.24 71.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.412 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 72.1 p -67.51 -16.17 64.05 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.59 -45.57 65.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.852 0.296 . . . . 0.0 111.467 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -93.97 -18.32 22.02 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.247 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -118.31 77.42 13.25 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 123.955 0.902 . . . . 0.0 109.909 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.75 -17.58 59.95 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.873 2.382 . . . . 0.0 110.867 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.72 1.78 7.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.539 0.735 . . . . 0.0 111.445 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.8 mt -124.35 -5.83 7.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.704 0.802 . . . . 0.0 110.858 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.2 tttt -65.17 -23.32 67.08 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -124.27 28.06 6.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.43 -39.4 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -82.78 -28.06 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.25 164.08 23.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.891 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -73.9 171.99 12.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.277 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -125.03 64.42 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.382 1.073 . . . . 0.0 108.676 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.16 11.93 5.83 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.265 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.15 143.52 57.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.666 0.746 . . . . 0.0 110.943 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.68 45.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.376 1.47 . . . . 0.0 110.94 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 56.33 47.38 19.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.222 0.609 . . . . 0.0 110.62 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -139.95 165.63 26.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.634 1.173 . . . . 0.0 110.854 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.12 -2.51 37.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.66 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.53 129.7 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -136.11 176.21 8.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.361 0.664 . . . . 0.0 110.534 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.18 126.59 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.0 tp -57.7 136.13 56.83 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.68 151.98 23.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.859 0.362 . . . . 0.0 110.42 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.94 17.4 36.84 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.579 0.609 . . . . 0.0 111.981 -174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -138.59 -8.73 1.44 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.063 0.545 . . . . 0.0 112.403 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.5 mm -85.31 157.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 110.854 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -128.38 123.16 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.0 145.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -133.32 159.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.923 0.889 . . . . 0.0 109.21 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 71' ' ' GLY . 34.8 mm -130.06 109.25 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 170.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.42 5.88 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.328 0.651 . . . . 0.0 111.996 -169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 114.18 -2.6 23.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.028 0.823 . . . . 0.0 112.811 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.413 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 18.8 p30 -74.64 -3.39 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.42 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 113.421 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -46.89 -23.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -63.34 -19.49 64.67 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -102.64 2.46 36.01 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.87 -153.89 0.57 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.445 1.098 . . . . 0.0 109.675 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.08 -15.03 58.69 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.952 0.901 . . . . 0.0 112.146 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 84.7 -138.22 16.61 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.18 1.33 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.187 0.995 . . . . 0.0 112.87 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 79' ' ' GLY . 40.9 mt-10 -129.39 25.61 5.44 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.687 0.676 . . . . 0.0 111.625 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -62.04 -8.51 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.79 0.836 . . . . 0.0 112.706 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.47 125.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.689 1.196 . . . . 0.0 112.164 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 4.5 mp -100.4 174.4 6.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.038 1.335 . . . . 0.0 110.422 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -139.91 168.61 19.42 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.752 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -68.04 8.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -151.95 18.28 0.68 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.006 -0.434 . . . . 0.0 109.939 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.01 178.92 2.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.548 0.69 . . . . 0.0 110.585 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.99 149.73 29.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -133.24 151.21 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.4 134.68 7.72 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 108.404 -1.879 . . . . 0.0 108.404 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.01 128.66 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.21 148.19 66.87 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.48 174.81 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.934 3.756 . . . . 0.0 109.94 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.83 169.08 15.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.695 2.263 . . . . 0.0 111.26 174.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.5 t -142.45 149.41 19.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.671 0.788 . . . . 0.0 109.02 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -152.02 170.74 19.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.538 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.15 -179.75 48.4 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 117.494 -1.726 . . . . 0.0 110.817 -179.649 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.215 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 62.2 t60 -154.15 168.7 25.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.06 0.544 . . . . 0.0 110.193 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.4 mtp -139.82 101.48 4.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 132.55 52.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.14 128.11 33.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.32 -172.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 123.376 0.671 . . . . 0.0 110.781 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -129.85 154.78 46.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.617 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.26 136.1 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -118.16 138.14 52.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.037 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.04 160.35 16.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.88 160.38 41.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.65 -146.89 0.23 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.284 0.234 . . . . 0.0 111.085 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -57.49 -10.38 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.96 -30.71 62.66 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.129 0.877 . . . . 0.0 110.06 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -71.76 -32.07 67.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.975 0.51 . . . . 0.0 109.772 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -70.21 -30.79 67.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.0 111.531 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.79 -24.54 22.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.536 -176.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -18.34 35.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 2.11 60.45 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 149.27 45.5 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 123.82 0.848 . . . . 0.0 109.193 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.98 -20.79 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.07 2.513 . . . . 0.0 111.519 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -165.54 162.2 18.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.965 0.348 . . . . 0.0 111.359 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.02 155.75 26.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.603 0.761 . . . . 0.0 111.582 178.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.62 153.02 20.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.859 3.039 . . . . 0.0 110.846 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 mt -162.96 -173.46 3.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.252 0.621 . . . . 0.0 110.114 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.75 161.78 40.53 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 120.711 0.291 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 154.2 8.39 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -79.94 -30.45 39.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 117.489 0.644 . . . . 0.0 110.117 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -133.34 172.13 13.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.1 0.96 . . . . 0.0 109.589 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.92 -43.24 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -64.15 -34.63 70.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -68.49 -21.71 64.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 121.781 -0.574 . . . . 0.0 110.876 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.77 -44.33 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.71 -29.31 70.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.219 -0.301 . . . . 0.0 111.391 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.83 -13.93 60.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.991 0.359 . . . . 0.0 111.451 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.09 -24.05 16.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 109.966 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.4 -48.65 76.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.0 p -68.72 -17.87 64.13 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.009 0.524 . . . . 0.0 111.427 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.75 -44.24 74.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.155 -0.34 . . . . 0.0 111.725 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -96.2 -18.8 19.81 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.164 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.17 75.53 11.4 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.855 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.49 -16.35 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.734 2.29 . . . . 0.0 110.367 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.59 1.6 7.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.933 0.893 . . . . 0.0 111.587 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -125.38 -4.65 7.25 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.632 0.773 . . . . 0.0 111.176 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.9 ttpt -64.39 -27.84 69.29 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.78 26.21 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.406 0.683 . . . . 0.0 110.039 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 t -129.1 -11.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.972 0.909 . . . . 0.0 109.16 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.8 mt -120.45 -20.21 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.565 0.746 . . . . 0.0 109.174 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.84 159.83 38.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.611 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -70.06 154.19 42.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.636 0.774 . . . . 0.0 110.12 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.08 30.16 0.78 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.667 0.787 . . . . 0.0 111.558 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.35 178.72 43.22 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' A' ' 55' ' ' LYS . 24.8 m-20 44.83 48.62 9.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.829 0.852 . . . . 0.0 112.159 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.4 13.97 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.4 1.08 . . . . 0.0 113.87 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 53' ' ' ASP . 64.6 mttp -134.65 7.38 3.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.466 0.706 . . . . 0.0 111.428 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -146.68 166.81 25.46 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.476 0.71 . . . . 0.0 110.499 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.27 1.17 38.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.4 mm -68.43 131.96 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.4 mt -136.41 171.38 14.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.584 0.754 . . . . 0.0 110.046 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -139.22 134.24 40.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.33 143.62 44.3 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.6 t -57.63 -2.26 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.63 5.14 6.31 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.771 1.176 . . . . 0.0 114.932 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.3 m -139.03 -4.73 1.51 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.497 1.149 . . . . 0.0 111.928 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mm -80.58 160.3 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.84 126.94 52.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.88 146.9 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.95 161.55 30.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.0 mm -132.37 108.3 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 54.29 10.05 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.286 0.635 . . . . 0.0 111.701 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.58 -2.38 36.67 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.109 0.862 . . . . 0.0 112.586 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -79.75 1.91 24.87 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.39 99.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.77 1.228 . . . . 0.0 114.063 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 pt -50.12 -25.93 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -62.46 -10.01 10.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.313 0.645 . . . . 0.0 112.581 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -122.43 12.66 10.13 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.595 0.758 . . . . 0.0 111.105 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.14 -83.94 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.906 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -144.25 2.7 1.15 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.629 0.65 . . . . 0.0 111.558 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 74.35 -142.58 30.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -175.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.67 6.28 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.8 mt-10 -129.45 20.25 5.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.269 0.627 . . . . 0.0 111.301 -176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.6 m -61.35 -8.16 3.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.7 mt 61.32 132.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.956 1.302 . . . . 0.0 112.537 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.78 176.44 5.14 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.137 0.975 . . . . 0.0 110.319 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.6 mttt -144.4 166.28 25.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.141 0.977 . . . . 0.0 110.716 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.31 6.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -153.61 16.59 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.175 -0.328 . . . . 0.0 110.376 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 4.4 m-20 -67.55 176.6 2.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.844 0.83 . . . . 0.0 111.097 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.58 151.06 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.75 151.36 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.83 6.69 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -114.9 129.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.32 145.63 54.66 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 122.827 0.451 . . . . 0.0 110.102 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.84 170.84 17.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.108 3.206 . . . . 0.0 110.307 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.2 -7.64 21.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.398 2.732 . . . . 0.0 112.356 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.57 146.73 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 122.847 0.459 . . . . 0.0 110.013 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.6 t -153.6 171.42 18.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.678 0.391 . . . . 0.0 110.139 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.37 15.53 0.09 OUTLIER Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.73 -0.483 . . . . 0.0 112.318 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.3 -1.834 . . . . 0.0 111.148 -178.706 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.65 20.6 0.4 Allowed 'General case' 0 C--O 1.23 0.045 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp 54.96 85.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.486 0.66 . . . . 0.0 110.938 -169.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.29 142.93 56.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.711 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.58 134.22 35.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.17 -175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.998 0.519 . . . . 0.0 110.392 -173.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -126.79 155.9 42.09 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.48 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.72 117.71 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 123.686 0.794 . . . . 0.0 108.956 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.36 158.81 15.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.873 0.469 . . . . 0.0 109.96 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.8 mt -134.24 152.18 51.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -141.33 158.75 43.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 -148.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.482 0.313 . . . . 0.0 110.693 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -55.33 -14.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -68.91 -30.35 68.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.016 0.825 . . . . 0.0 110.263 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -69.01 -30.97 69.46 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.227 0.611 . . . . 0.0 110.038 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.99 -18.69 58.05 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.694 0.798 . . . . 0.0 111.611 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.91 2.33 56.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.431 0.292 . . . . 0.0 111.042 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.56 -5.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.506 0.722 . . . . 0.0 111.109 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.9 10.31 38.42 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.636 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.8 p -142.9 144.08 27.9 Favored Pre-proline 0 C--N 1.341 0.205 0 CA-C-N 117.893 0.847 . . . . 0.0 110.069 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.42 -20.23 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.39 2.727 . . . . 0.0 111.462 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -165.6 161.31 18.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.209 0.604 . . . . 0.0 110.486 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 153.3 26.97 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 122.645 0.378 . . . . 0.0 110.862 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.79 152.03 32.24 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.469 2.779 . . . . 0.0 109.897 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.86 -174.37 4.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -147.33 162.46 38.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.776 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.34 151.91 8.44 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.3 -25.35 46.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -140.46 173.83 11.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.824 1.25 . . . . 0.0 108.961 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -54.87 -51.37 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -59.19 -33.94 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -67.0 -20.71 65.92 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.416 -0.802 . . . . 0.0 111.157 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.43 -45.18 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.29 -38.5 71.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.196 0.999 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.85 -16.91 61.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -88.62 -32.06 18.26 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.821 0.344 . . . . 0.0 110.161 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.57 -46.43 90.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 p -73.14 -13.05 61.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.502 0.321 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.84 -42.91 63.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -100.66 -19.07 16.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.37 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -117.97 77.81 12.45 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.627 0.771 . . . . 0.0 108.996 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.96 -15.94 52.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.641 2.228 . . . . 0.0 110.158 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.19 2.22 4.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.492 1.117 . . . . 0.0 111.55 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.1 mt -124.23 -9.8 7.56 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.818 0.847 . . . . 0.0 110.675 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.86 -25.6 67.64 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -123.68 26.92 7.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.103 0.478 . . . . 0.0 109.728 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.13 -10.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 C-N-CA 124.571 1.148 . . . . 0.0 108.658 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.53 -20.55 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.78 0.832 . . . . 0.0 109.326 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.97 159.1 36.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 110.752 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 52' ' ' GLY . 25.4 mt-10 -79.59 136.78 36.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.416 0.686 . . . . 0.0 109.439 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -73.65 32.63 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.975 1.31 . . . . 0.0 110.891 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -91.05 31.3 5.72 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.175 0.893 . . . . 0.0 111.971 -174.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -125.24 17.75 8.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 111.884 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.98 3.01 2.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -139.17 3.84 2.2 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.25 1.02 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -141.38 -167.38 2.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.802 0.841 . . . . 0.0 110.2 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.79 22.73 4.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.109 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.3 mm -125.75 115.3 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.116 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.21 170.93 15.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.222 0.609 . . . . 0.0 110.646 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.27 134.03 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.01 144.43 56.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.8 t -61.0 169.65 1.88 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.153 0.501 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.97 21.07 13.84 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -137.76 -0.75 2.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.854 0.862 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.97 151.42 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.132 0.573 . . . . 0.0 110.117 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -121.86 129.39 52.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -124.39 148.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.391 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -129.13 160.14 33.8 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.5 mm -132.43 109.79 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 170.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 54.06 11.39 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.059 0.544 . . . . 0.0 111.714 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.19 -1.63 43.82 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.035 0.826 . . . . 0.0 112.509 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -80.29 0.42 32.88 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.43 99.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.623 1.169 . . . . 0.0 113.652 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.5 pt -51.29 -21.55 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 112.071 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -66.67 -10.42 46.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.516 0.727 . . . . 0.0 112.23 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.56 9.92 11.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.769 0.828 . . . . 0.0 110.211 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.81 -156.27 0.71 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 108.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.73 -2.33 14.3 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 76.58 -136.77 19.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.61 1.76 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.17 0.988 . . . . 0.0 113.35 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.7 mt-10 -129.72 23.57 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.589 0.631 . . . . 0.0 111.917 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.8 m -63.37 0.24 0.73 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.938 0.895 . . . . 0.0 113.354 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt 52.73 85.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.74 171.1 0.95 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.018 1.327 . . . . 0.0 111.364 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -140.72 164.59 29.79 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.643 1.177 . . . . 0.0 109.891 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.01 3.81 0.06 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 t -152.4 18.07 0.63 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 110.013 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.59 177.24 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.696 0.76 . . . . 0.0 110.355 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.39 153.76 37.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -135.16 157.19 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 133.72 5.02 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.96 134.33 61.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.3 144.37 53.19 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.383 0.673 . . . . 0.0 110.29 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -80.41 175.26 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.693 3.595 . . . . 0.0 110.187 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -72.18 5.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.168 2.578 . . . . 0.0 112.176 174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t 43.64 38.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.569 1.148 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.3 m 49.96 17.43 0.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.78 11.17 0.03 OUTLIER Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.15 0.886 . . . . 0.0 114.956 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.493 -1.726 . . . . 0.0 111.346 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 3' ' ' MET . 52.4 t60 -154.92 170.01 22.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.447 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.5 mtp -140.07 101.33 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.85 128.02 34.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.109 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.21 128.75 35.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 110.282 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 m -140.18 -175.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.14 0.495 . . . . 0.0 110.643 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.809 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.24 132.36 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -109.73 147.63 32.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.6 mt -126.1 155.53 41.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -143.64 159.55 42.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.37 -147.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.458 0.303 . . . . 0.0 111.033 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -56.13 -13.65 2.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.59 -30.94 66.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.16 0.891 . . . . 0.0 110.072 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.83 -30.13 67.56 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.347 0.659 . . . . 0.0 109.711 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -78.89 -18.66 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.282 0.633 . . . . 0.0 112.133 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.28 3.23 54.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.763 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.02 -8.99 3.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.789 0.836 . . . . 0.0 110.673 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 8.25 50.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.6 p -141.35 144.48 34.27 Favored Pre-proline 0 N--CA 1.457 -0.12 0 CA-C-N 118.05 0.925 . . . . 0.0 110.41 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.84 -21.14 12.77 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.244 2.629 . . . . 0.0 111.197 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -164.93 159.6 18.34 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.738 0.415 . . . . 0.0 110.776 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 156.15 29.7 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.367 0.667 . . . . 0.0 111.759 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.58 150.24 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.669 2.913 . . . . 0.0 111.741 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -160.63 -176.77 5.75 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.257 1.023 . . . . 0.0 109.817 177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -149.06 158.16 43.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.06 158.15 15.54 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.75 -26.84 40.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.51 0.655 . . . . 0.0 109.703 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -137.92 165.9 25.39 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.437 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -46.73 -47.89 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.85 -32.48 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -68.92 -20.68 64.23 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.382 0.537 . . . . 0.0 111.439 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.9 t -93.04 -39.63 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.34 -29.26 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.321 0.51 . . . . 0.0 110.921 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.9 mt -76.87 -16.15 59.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.323 0.249 . . . . 0.0 111.221 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.8 m -94.34 -21.45 18.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.879 0.872 . . . . 0.0 110.362 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.84 -49.63 61.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.489 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.9 p -67.75 -16.03 63.92 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.038 0.535 . . . . 0.0 111.247 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.34 -44.41 75.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -97.7 -18.13 19.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -118.56 76.17 13.12 Favored Pre-proline 0 N--CA 1.455 -0.219 0 C-N-CA 123.385 0.674 . . . . 0.0 109.778 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.42 -17.22 58.88 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.89 2.393 . . . . 0.0 110.444 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.3 1.17 8.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 111.666 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.4 mt -123.58 -6.38 8.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.487 0.715 . . . . 0.0 111.183 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 35.7 ttpt -63.11 -26.95 69.06 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.545 ' CE2' ' HE2' ' A' ' 51' ' ' LYS . 20.7 m-85 -117.38 27.45 9.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 109.89 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.95 -9.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.407 1.083 . . . . 0.0 108.817 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.78 -20.2 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.118 0.967 . . . . 0.0 109.268 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -131.69 162.76 29.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.695 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -83.98 132.61 34.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.274 0.63 . . . . 0.0 109.988 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.545 ' HE2' ' CE2' ' A' ' 46' ' ' TYR . 51.6 tttm -70.95 41.86 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.115 1.366 . . . . 0.0 111.976 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.45 -2.0 77.22 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -79.58 22.57 0.45 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.848 0.859 . . . . 0.0 112.249 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -66.9 -5.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.98 -0.45 . . . . 0.0 111.958 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -138.17 3.28 2.39 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.166 0.986 . . . . 0.0 111.191 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m -142.05 -169.4 2.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.185 0.994 . . . . 0.0 110.245 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -131.45 23.72 4.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.778 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.01 116.31 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.145 0.978 . . . . 0.0 109.872 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.33 171.32 15.05 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.225 0.61 . . . . 0.0 110.984 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -140.65 125.26 18.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.29 131.28 49.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.6 t -57.16 160.03 4.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.783 0.433 . . . . 0.0 111.635 -177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.12 18.29 55.85 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.5 m -136.38 -1.55 2.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.595 0.758 . . . . 0.0 111.657 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.96 157.45 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 122.918 0.487 . . . . 0.0 110.458 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.24 146.15 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -129.95 163.18 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.715 0.406 . . . . 0.0 110.403 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 mm -134.05 105.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 55.07 7.69 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.195 0.598 . . . . 0.0 111.952 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.14 -4.64 31.73 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.731 0.681 . . . . 0.0 112.175 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -73.12 -2.57 22.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.08 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 113.729 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.72 -20.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -66.01 -10.01 35.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.947 0.499 . . . . 0.0 111.655 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -117.79 8.21 12.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.532 0.733 . . . . 0.0 110.656 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.01 -156.68 0.72 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.269 1.028 . . . . 0.0 109.162 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.0 -3.44 19.54 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -137.62 20.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.12 -0.66 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.91 25.32 5.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.303 0.502 . . . . 0.0 111.349 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.1 m -65.77 -2.29 3.58 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.352 0.661 . . . . 0.0 111.381 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt 60.37 166.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.257 1.023 . . . . 0.0 110.958 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.47 171.55 14.21 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.829 0.852 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -139.96 167.29 22.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.892 0.877 . . . . 0.0 109.86 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -66.97 8.39 0.28 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -151.78 17.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.06 -179.7 2.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.75 0.786 . . . . 0.0 109.993 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -153.54 153.37 32.27 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mm -128.99 156.88 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.49 138.34 8.38 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.01 127.62 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.81 144.87 55.05 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.935 0.494 . . . . 0.0 110.623 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.98 173.13 12.28 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.621 3.547 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.13 -8.61 24.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.911 2.407 . . . . 0.0 111.723 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 p 44.78 19.84 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.618 1.967 . . . . 0.0 114.603 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -161.22 -32.94 0.05 Allowed 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.559 -0.713 . . . . 0.0 111.996 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.81 -21.47 1.63 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.219 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 CA-C-O 117.403 -1.776 . . . . 0.0 110.938 179.275 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.2 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.439 ' CG ' ' N ' ' A' ' 3' ' ' MET . 54.4 t60 -153.59 169.86 22.22 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.124 0.57 . . . . 0.0 110.123 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.439 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.2 mtp -140.46 101.0 4.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.38 31.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.25 128.87 35.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.72 -172.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -125.52 155.48 40.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.76 134.74 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -115.56 137.02 52.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.083 0.553 . . . . 0.0 109.901 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -109.76 160.62 16.17 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.62 159.07 43.67 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.92 -146.04 0.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.503 0.321 . . . . 0.0 111.101 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -56.66 -12.82 2.02 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -72.41 -31.35 65.44 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.07 0.85 . . . . 0.0 110.018 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -70.9 -31.04 67.56 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.003 0.521 . . . . 0.0 110.168 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.41 -33.12 69.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.783 0.433 . . . . 0.0 111.332 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.55 -23.24 25.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.615 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.5 -19.56 33.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.197 0.199 . . . . 0.0 110.495 174.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.97 1.98 60.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.6 p -144.47 149.95 45.95 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 123.798 0.839 . . . . 0.0 109.575 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 -24.52 11.77 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.776 2.317 . . . . 0.0 110.876 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.95 161.73 22.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.935 0.334 . . . . 0.0 111.395 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.36 155.74 26.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 111.59 -178.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.22 149.6 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.963 3.109 . . . . 0.0 111.733 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mt -159.99 -177.11 6.08 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.265 1.026 . . . . 0.0 109.432 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -148.47 158.32 44.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 111.71 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.27 158.07 15.6 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.9 -27.39 49.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.355 0.577 . . . . 0.0 109.982 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -138.54 166.24 24.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.185 0.994 . . . . 0.0 109.588 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.62 -47.85 7.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.951 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.24 -32.93 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.91 -21.89 64.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.474 0.579 . . . . 0.0 111.412 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.05 -38.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.29 -30.45 70.87 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.633 -0.667 . . . . 0.0 110.87 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.49 -16.51 59.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.488 0.315 . . . . 0.0 111.386 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -92.53 -23.3 19.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.887 0.875 . . . . 0.0 110.613 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.91 -50.89 61.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.2 p -67.12 -15.11 63.51 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.965 0.506 . . . . 0.0 111.085 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.74 -44.22 74.26 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -98.29 -17.45 18.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.228 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -117.8 75.3 10.03 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 123.767 0.827 . . . . 0.0 109.665 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.54 -17.39 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 110.415 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.99 1.63 6.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.665 0.786 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.32 -3.59 7.41 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.724 0.81 . . . . 0.0 110.763 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.4 tttt -64.53 -23.69 67.36 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -123.19 27.68 7.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.285 0.564 . . . . 0.0 109.583 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.43 -14.57 3.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 C-N-CA 124.231 1.012 . . . . 0.0 108.832 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.35 -21.27 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.955 0.902 . . . . 0.0 108.938 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.44 160.69 33.29 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.778 0.431 . . . . 0.0 109.889 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 52' ' ' GLY . 63.8 mt-10 -84.03 136.59 33.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.916 0.486 . . . . 0.0 110.099 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.61 38.49 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.957 1.303 . . . . 0.0 111.027 175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -83.9 21.78 9.08 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 123.818 0.723 . . . . 0.0 112.378 -174.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -138.52 131.73 30.09 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.379 0.609 . . . . 0.0 110.0 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -137.54 4.07 2.59 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.114 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -142.82 3.86 1.45 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.325 0.65 . . . . 0.0 111.621 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.6 m -145.09 -166.55 2.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.672 0.789 . . . . 0.0 109.498 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.78 19.09 6.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 111.179 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mp -85.64 129.65 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -115.54 166.13 12.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.98 0.912 . . . . 0.0 109.816 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.56 121.55 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.84 128.0 34.5 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 23.8 t -54.68 149.53 10.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.161 0.505 . . . . 0.0 111.4 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.78 16.53 56.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.5 m -133.64 -6.47 2.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.487 0.715 . . . . 0.0 111.506 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 mm -90.61 157.6 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.979 0.511 . . . . 0.0 110.128 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -124.75 123.54 40.2 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -109.6 144.97 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.8 mt -128.51 161.41 29.62 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.161 0.584 . . . . 0.0 109.836 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -133.09 107.37 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 170.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 54.86 9.66 0.31 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.24 0.616 . . . . 0.0 111.623 -169.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.14 -4.08 35.51 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 123.899 0.761 . . . . 0.0 112.258 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.72 -1.36 21.54 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 50.81 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.6 1.16 . . . . 0.0 113.994 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.42 -21.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -62.08 -15.6 46.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.917 0.487 . . . . 0.0 112.267 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -113.55 8.02 17.59 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.427 0.691 . . . . 0.0 110.643 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -123.75 -155.61 0.67 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 108.986 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.08 -2.62 19.13 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.937 -0.477 . . . . 0.0 112.012 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.6 -140.17 21.57 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.87 -5.43 1.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.444 0.698 . . . . 0.0 112.591 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.82 22.55 12.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.417 0.687 . . . . 0.0 111.944 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.7 m -66.08 0.65 1.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.661 0.784 . . . . 0.0 112.12 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt 59.63 169.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.581 0.753 . . . . 0.0 110.645 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.54 170.76 15.18 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.759 1.224 . . . . 0.0 109.231 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.9 167.26 22.52 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.951 0.9 . . . . 0.0 109.929 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -66.56 7.59 0.32 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -151.92 17.61 0.68 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.211 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.7 178.49 2.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.86 0.838 . . . . 0.0 110.313 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -153.35 149.67 28.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.69 153.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.39 136.35 8.44 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.6 mt -118.31 128.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.57 146.36 60.19 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 122.884 0.473 . . . . 0.0 110.511 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.25 173.46 13.83 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.688 3.592 . . . . 0.0 110.497 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.05 167.58 21.36 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.984 2.456 . . . . 0.0 111.02 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.25 6.66 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.352 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -160.17 177.26 10.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.073 -0.392 . . . . 0.0 110.471 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.49 -16.69 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.028 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 CA-C-O 117.52 -1.711 . . . . 0.0 110.734 178.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' CG ' ' N ' ' A' ' 3' ' ' MET . 72.0 t60 -153.17 168.62 25.33 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.012 0.525 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.438 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.4 mtp -142.05 104.87 4.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 174.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.99 130.68 46.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -76.99 132.02 38.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -142.25 -172.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.299 0.571 . . . . 0.0 110.593 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -130.35 153.97 48.15 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.254 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.58 137.58 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -117.74 150.01 39.81 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.659 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -127.26 156.78 41.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.29 160.31 41.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.35 -147.63 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.588 0.355 . . . . 0.0 111.108 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -56.86 -10.91 1.19 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.79 -31.58 63.34 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.41 1.005 . . . . 0.0 110.189 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.35 -32.4 71.45 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.086 0.554 . . . . 0.0 109.679 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 111.637 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.8 56.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.18 -7.02 3.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.54 0.736 . . . . 0.0 110.709 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.69 43.9 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.481 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.0 p -142.15 143.98 29.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 117.996 0.898 . . . . 0.0 110.215 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.45 -17.69 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.463 2.775 . . . . 0.0 111.732 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -164.28 160.14 20.71 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.159 -0.338 . . . . 0.0 111.259 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 154.61 25.32 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 123.665 0.786 . . . . 0.0 111.47 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.49 153.0 20.54 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.848 3.032 . . . . 0.0 110.518 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mt -162.95 -174.81 4.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.715 0.406 . . . . 0.0 110.341 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -146.62 160.78 41.73 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 146.69 4.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.52 -25.42 50.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.668 0.734 . . . . 0.0 110.973 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -134.45 170.89 15.07 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 124.097 0.959 . . . . 0.0 109.792 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.67 -44.35 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.84 -34.64 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -69.94 -23.39 63.19 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.731 -0.606 . . . . 0.0 110.842 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.31 -45.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.12 -30.08 71.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.625 0.37 . . . . 0.0 111.733 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 mt -75.57 -16.81 60.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.149 0.431 . . . . 0.0 111.419 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.25 -25.28 19.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.988 0.423 . . . . 0.0 110.007 175.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.88 -50.5 68.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.5 p -67.51 -15.09 63.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.15 0.58 . . . . 0.0 111.579 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.29 -44.27 68.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.263 0.483 . . . . 0.0 111.377 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -95.85 -17.98 20.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.506 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.48 76.1 12.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.512 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.53 -17.61 60.15 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.118 2.545 . . . . 0.0 111.013 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.66 1.72 9.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.56 0.744 . . . . 0.0 111.257 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.46 -6.14 8.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 111.048 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.3 tttt -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.421 ' CD2' ' HD3' ' A' ' 51' ' ' LYS . 22.2 m-85 -122.77 28.23 7.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.114 0.483 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.57 -37.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.03 -24.58 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.489 0.716 . . . . 0.0 109.125 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.75 160.98 32.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.116 0.566 . . . . 0.0 110.584 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -84.91 138.6 32.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 46' ' ' TYR . 26.8 ttpp -80.09 60.06 3.49 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.07 0.548 . . . . 0.0 110.002 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.04 -3.54 70.03 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.907 -175.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -146.15 131.58 18.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -118.39 13.14 13.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.869 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.16 3.37 2.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.343 0.657 . . . . 0.0 111.23 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m -149.25 165.02 33.15 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.058 0.943 . . . . 0.0 110.404 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.12 3.09 24.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.603 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.55 127.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -141.29 172.46 12.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.729 0.811 . . . . 0.0 110.099 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.5 mt -140.5 125.44 19.21 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.97 122.85 14.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.98 133.32 54.78 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.53 0.332 . . . . 0.0 110.745 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.18 -13.06 72.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m -89.73 -18.91 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.097 0.559 . . . . 0.0 111.881 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.48 159.24 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 110.276 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -127.08 126.47 43.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.85 144.83 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.11 160.27 32.51 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.7 mm -130.64 107.76 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.74 9.92 0.32 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.224 0.609 . . . . 0.0 111.704 -170.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.47 34.34 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.504 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.89 0.05 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.84 99.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.858 1.263 . . . . 0.0 114.145 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 pt -51.3 -21.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -61.95 -13.06 21.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -117.85 9.68 12.99 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.596 0.759 . . . . 0.0 111.018 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -124.81 -155.94 0.7 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.04 0.936 . . . . 0.0 109.497 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -70.89 -2.83 16.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 77.77 -138.2 21.19 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.15 0.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.782 0.833 . . . . 0.0 112.689 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.9 mt-10 -127.54 23.78 6.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.144 0.578 . . . . 0.0 111.453 -174.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 84.9 m -62.12 -0.26 0.5 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.916 0.886 . . . . 0.0 113.297 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt 52.56 83.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.08 169.86 0.74 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.924 1.289 . . . . 0.0 110.962 175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.99 167.75 21.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.371 1.069 . . . . 0.0 109.924 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.48 5.95 0.16 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.1 t -153.48 17.37 0.54 Allowed 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.894 -0.503 . . . . 0.0 110.184 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -69.09 177.06 2.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.559 0.695 . . . . 0.0 111.049 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -149.54 151.47 33.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.29 152.57 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.08 129.95 4.97 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -111.45 130.92 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.05 147.96 64.78 Favored Pre-proline 0 N--CA 1.453 -0.289 0 C-N-CA 122.801 0.44 . . . . 0.0 110.593 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -79.63 174.01 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.637 3.558 . . . . 0.0 110.584 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.51 168.77 17.24 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.186 2.591 . . . . 0.0 110.68 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.54 154.35 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 123.087 0.555 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.8 p -147.89 2.29 0.69 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.22 -16.59 0.15 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.261 0 CA-C-O 117.7 -1.611 . . . . 0.0 110.814 179.161 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.242 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.39 21.69 0.55 Allowed 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.6 mtp 47.81 84.22 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.087 0.955 . . . . 0.0 110.896 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.77 131.03 45.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.822 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.52 134.29 38.34 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -142.25 -175.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.168 0.509 . . . . 0.0 110.31 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -118.48 154.94 31.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.225 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.84 124.57 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.9 153.1 25.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.25 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.7 mt -127.02 157.6 39.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.49 159.47 42.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.19 -146.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.53 0.332 . . . . 0.0 111.26 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -56.94 -10.71 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.58 -30.11 61.59 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.258 0.935 . . . . 0.0 110.292 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -71.62 -33.24 68.79 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.303 0.641 . . . . 0.0 109.708 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.09 -23.71 60.56 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.692 0.797 . . . . 0.0 112.04 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.43 1.87 56.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.32 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.8 -6.46 4.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.491 0.717 . . . . 0.0 110.581 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.87 10.42 45.55 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.661 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -140.84 143.89 33.57 Favored Pre-proline 0 N--CA 1.455 -0.196 0 CA-C-N 117.853 0.826 . . . . 0.0 110.288 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.89 -20.87 10.02 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.379 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -166.99 162.81 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.921 0.328 . . . . 0.0 111.242 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.1 155.97 16.28 Favored Pre-proline 0 N--CA 1.456 -0.148 0 C-N-CA 123.632 0.773 . . . . 0.0 110.407 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.28 156.13 33.04 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.054 2.503 . . . . 0.0 110.08 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.1 mt -161.61 -176.22 5.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.134 0.973 . . . . 0.0 108.85 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -149.63 158.69 44.4 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.867 0.365 . . . . 0.0 111.689 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.62 156.45 13.32 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -77.8 -26.83 49.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.358 0.579 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -139.36 166.34 24.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.605 1.162 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -45.82 -48.61 4.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 tp -62.27 -33.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -68.11 -20.19 64.9 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.604 0.638 . . . . 0.0 111.304 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.41 -43.42 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.29 -27.54 69.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.336 -0.228 . . . . 0.0 111.108 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.07 -18.53 57.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -86.81 -31.22 20.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.8 -48.98 78.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.98 0.512 . . . . 0.0 109.654 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 p -71.64 -15.2 62.23 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.887 0.475 . . . . 0.0 111.405 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.46 -38.55 65.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.249 0.477 . . . . 0.0 111.179 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -23.25 17.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -121.52 79.22 37.85 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 123.899 0.879 . . . . 0.0 109.22 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.82 -17.28 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.022 2.481 . . . . 0.0 110.232 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.41 0.92 7.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.162 0.985 . . . . 0.0 111.374 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.98 -5.53 6.8 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.7 0.8 . . . . 0.0 111.11 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.02 -24.1 67.76 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -122.06 25.31 9.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.303 0.641 . . . . 0.0 109.808 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.04 -9.96 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.228 1.011 . . . . 0.0 108.899 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.23 -19.84 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.778 0.831 . . . . 0.0 109.509 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -130.66 161.05 32.47 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.116 0.484 . . . . 0.0 110.937 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -71.22 152.35 43.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.547 0.739 . . . . 0.0 109.634 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -87.66 24.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.567 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.03 174.65 42.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 55' ' ' LYS . 29.2 m-20 44.75 41.24 4.85 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.662 0.785 . . . . 0.0 112.071 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.97 15.46 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 53' ' ' ASP . 56.1 mtpt -131.33 7.62 4.59 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.674 0.789 . . . . 0.0 110.822 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.5 m -145.63 168.18 21.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.268 1.027 . . . . 0.0 110.447 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.44 0.53 37.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.0 mm -71.04 130.82 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.3 mt -137.96 168.73 19.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.792 0.837 . . . . 0.0 109.999 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -142.29 132.63 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.81 141.98 56.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.09 159.81 11.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.96 19.44 54.42 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 123.589 0.614 . . . . 0.0 111.746 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.0 p -140.66 -5.5 1.19 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.192 0.597 . . . . 0.0 112.344 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.5 mm -90.79 159.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.073 0.549 . . . . 0.0 110.33 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -124.15 123.82 41.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.9 144.36 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -127.79 162.18 27.24 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -133.09 105.88 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 55.23 8.4 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.133 0.573 . . . . 0.0 112.137 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.26 -4.84 33.49 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.973 0.797 . . . . 0.0 112.349 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.47 -1.99 20.7 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.49 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 113.808 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -49.8 -21.29 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -63.02 -13.62 37.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -114.52 7.75 16.24 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.491 0.716 . . . . 0.0 110.556 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.73 -154.95 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.025 0.93 . . . . 0.0 109.345 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.2 -13.2 61.74 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.06 0.944 . . . . 0.0 112.3 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 85.91 -141.54 18.62 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -174.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.38 4.14 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.901 0.88 . . . . 0.0 113.333 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 79' ' ' GLY . 43.9 mt-10 -129.03 23.15 5.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.177 0.591 . . . . 0.0 111.181 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.5 m -66.49 -1.82 4.0 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.1 mt 60.54 167.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.549 0.74 . . . . 0.0 110.747 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.63 170.53 15.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.761 0.824 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -141.35 166.5 24.59 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.57 1.148 . . . . 0.0 109.888 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.96 -5.55 0.45 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.9 t -143.77 14.87 1.75 Allowed 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.89 179.04 2.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.494 0.664 . . . . 0.0 110.569 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.73 152.63 30.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mm -131.75 155.18 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.94 135.18 5.75 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 172.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.85 127.97 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.8 146.56 62.34 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 122.733 0.413 . . . . 0.0 110.467 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.31 172.71 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.653 3.569 . . . . 0.0 110.353 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.08 159.09 53.71 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.843 2.362 . . . . 0.0 110.592 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -143.23 161.56 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 110.15 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.1 m 54.14 -171.52 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.002 0.921 . . . . 0.0 112.821 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.61 179.74 47.46 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.195 -1.892 . . . . 0.0 110.98 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 132.14 51.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.17 129.39 35.08 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -139.66 -172.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.317 0.579 . . . . 0.0 110.438 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -128.46 158.23 38.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.475 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.0 t -134.4 131.37 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -114.97 137.61 51.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.08 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -111.16 160.88 16.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -145.75 158.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.39 -145.67 0.27 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.543 0.337 . . . . 0.0 111.258 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -56.13 -12.01 1.35 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.7 -31.62 61.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 109.708 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -70.23 -32.42 70.28 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.17 0.588 . . . . 0.0 110.052 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.75 -32.53 71.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.866 0.467 . . . . 0.0 111.651 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 -23.51 23.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.395 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.47 -17.71 35.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.698 0.227 . . . . 0.0 110.722 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.84 3.29 59.27 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 p -143.94 148.71 43.29 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 123.915 0.886 . . . . 0.0 109.792 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.94 -25.55 11.88 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.954 2.436 . . . . 0.0 110.821 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.04 163.0 20.71 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.855 0.462 . . . . 0.0 110.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.5 pt? -159.59 155.72 23.57 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.279 0.632 . . . . 0.0 110.583 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.59 154.85 35.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.23 2.62 . . . . 0.0 110.217 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.6 mt -163.38 -175.31 4.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.197 0.999 . . . . 0.0 108.696 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -145.88 160.21 42.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 111.254 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.8 146.73 5.11 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -78.57 -24.51 45.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.137 -0.625 . . . . 0.0 110.379 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -132.13 171.02 14.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.931 0.892 . . . . 0.0 109.593 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -55.21 -49.12 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.5 -32.73 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -68.61 -21.91 64.46 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.6 -46.07 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.53 -39.93 68.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.469 1.107 . . . . 0.0 111.803 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.3 mt -72.4 -18.24 61.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -88.38 -30.93 19.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.957 0.344 . . . . 0.0 110.409 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.77 -48.97 79.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -70.64 -14.77 62.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.135 0.574 . . . . 0.0 111.824 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 -40.99 71.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.251 0.478 . . . . 0.0 111.964 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.53 -18.32 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.026 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -116.97 75.84 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.949 0.899 . . . . 0.0 109.085 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -64.88 -16.81 57.22 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.887 2.391 . . . . 0.0 110.303 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.31 -0.64 8.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.113 0.965 . . . . 0.0 111.489 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.7 mt -124.86 -5.19 7.49 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 110.96 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.61 -24.17 67.5 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.4 25.08 10.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.165 0.586 . . . . 0.0 109.838 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.55 -15.19 5.52 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 124.296 1.039 . . . . 0.0 108.755 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.16 -21.05 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.783 0.833 . . . . 0.0 109.316 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.86 159.65 35.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.224 0.535 . . . . 0.0 111.446 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.83 135.5 37.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.881 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.5 tttt . . . . . 0 N--CA 1.453 -0.296 0 C-N-CA 125.114 1.366 . . . . 0.0 111.449 178.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.1 mt . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.04 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.086 0.469 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -126.35 130.29 50.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -114.8 144.29 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 36.2 mt -128.43 160.23 32.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.83 0.452 . . . . 0.0 109.963 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -132.19 108.43 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 54.86 10.71 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.943 0.497 . . . . 0.0 111.502 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.35 -3.04 43.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.889 0.757 . . . . 0.0 112.637 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.64 -0.95 25.34 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.5 t-20 51.15 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.731 1.212 . . . . 0.0 113.849 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.6 pt -51.47 -21.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.931 -0.48 . . . . 0.0 112.264 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -62.84 -12.21 23.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -118.18 9.4 12.6 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.564 0.746 . . . . 0.0 110.83 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.81 -155.73 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.219 1.008 . . . . 0.0 109.6 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -70.34 -3.79 19.08 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.48 21.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.89 2.29 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 112.773 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.17 23.44 6.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.433 0.693 . . . . 0.0 111.466 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 82' ' ' THR . 87.2 m -61.92 -0.8 0.53 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.119 0.967 . . . . 0.0 113.26 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 mt 53.02 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.83 0.824 . . . . 0.0 113.045 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.05 174.78 0.59 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 111.57 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 55.2 mtpt -140.91 166.23 25.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.182 0.993 . . . . 0.0 110.785 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.38 5.4 0.28 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.1 t -153.04 16.35 0.56 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.861 0.3 . . . . 0.0 110.232 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 11.7 m-20 -68.03 177.94 2.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 111.345 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -149.19 151.95 35.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.07 154.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.74 134.93 7.39 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.7 mt -116.54 129.42 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.29 146.98 63.15 Favored Pre-proline 0 N--CA 1.454 -0.261 0 C-N-CA 122.342 0.257 . . . . 0.0 110.855 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 97.7 Cg_endo -78.01 174.89 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.558 3.505 . . . . 0.0 110.626 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.9 Cg_endo . . . . . 0 N--CA 1.454 -0.829 0 C-N-CA 122.775 2.316 . . . . 0.0 110.912 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.1 mtp . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.33 51.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -78.53 133.02 37.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.42 -173.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 0.0 110.403 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -127.75 155.69 43.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.51 125.32 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -105.82 153.67 21.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.074 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.73 155.94 45.79 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.06 159.0 43.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.55 -146.18 0.25 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.523 0.329 . . . . 0.0 110.938 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -56.36 -12.78 1.8 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.83 -30.99 64.47 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.096 0.862 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -69.26 -31.15 69.49 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.286 0.634 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.78 -19.75 58.77 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.74 0.816 . . . . 0.0 112.181 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -93.71 1.69 56.48 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.952 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.14 -9.41 3.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.731 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.62 56.87 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.297 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.3 p -142.35 140.66 19.37 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.977 0.889 . . . . 0.0 110.458 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.37 -16.16 15.44 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.263 2.642 . . . . 0.0 111.396 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.68 159.47 18.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 110.792 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.72 157.1 22.97 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 123.392 0.677 . . . . 0.0 111.19 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.99 154.2 22.55 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.308 2.672 . . . . 0.0 110.517 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.9 mt -161.61 -176.13 5.13 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.567 1.147 . . . . 0.0 108.829 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -148.77 162.27 40.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.66 156.63 10.16 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.48 -24.22 42.48 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.518 0.659 . . . . 0.0 110.001 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -140.57 172.06 13.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.086 0.954 . . . . 0.0 109.85 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 84' ' ' LEU . 43.5 t -56.22 -44.85 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.42 -34.01 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.5 -23.12 63.57 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.8 -0.562 . . . . 0.0 111.179 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.44 -39.8 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.9 -31.62 71.54 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.095 -0.378 . . . . 0.0 111.155 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.56 -20.62 58.51 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.094 0.406 . . . . 0.0 110.697 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -85.55 -26.77 25.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.895 0.878 . . . . 0.0 110.351 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.82 -50.63 61.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.332 0.653 . . . . 0.0 109.452 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.2 p -68.25 -13.49 62.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.696 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.34 -37.93 74.76 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -106.77 -18.02 14.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.452 0.47 . . . . 0.0 111.107 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -116.98 74.06 6.78 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 123.953 0.901 . . . . 0.0 108.744 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.98 -16.91 57.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.748 2.299 . . . . 0.0 110.308 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.08 0.45 7.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.952 0.901 . . . . 0.0 111.525 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 17' ' ' ALA . 91.5 mt -123.41 -4.91 8.28 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.52 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 78.1 tttt -62.36 -23.51 66.83 Favored 'General case' 0 CA--C 1.526 0.041 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.68 26.16 8.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.217 0.607 . . . . 0.0 109.579 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.24 -8.85 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.327 1.051 . . . . 0.0 108.754 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.12 -19.99 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.181 0.992 . . . . 0.0 109.332 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -132.46 162.09 32.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.098 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -78.09 135.47 37.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.292 0.637 . . . . 0.0 109.882 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.9 tttt . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 125.129 1.371 . . . . 0.0 111.487 177.582 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--O 1.226 -0.163 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.057 0.456 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.81 131.58 53.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.14 143.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.7 mt -127.69 160.62 31.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.73 0.412 . . . . 0.0 110.215 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mm -132.06 108.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 54.52 11.02 0.38 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.997 0.519 . . . . 0.0 111.598 -170.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.73 -3.7 42.3 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.71 0.671 . . . . 0.0 112.259 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -77.07 -0.41 24.6 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.4 t-20 51.23 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.774 1.23 . . . . 0.0 114.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 pt -51.41 -21.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.862 -0.524 . . . . 0.0 112.012 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -62.97 -11.65 20.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.053 0.541 . . . . 0.0 112.256 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.76 9.89 11.5 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.522 0.729 . . . . 0.0 110.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.6 mt -124.62 -155.73 0.68 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.361 1.065 . . . . 0.0 109.269 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -69.6 -4.75 20.58 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.9 -138.54 20.92 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.11 1.18 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.48 26.52 5.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.294 0.638 . . . . 0.0 111.403 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 82' ' ' THR . 85.6 m -62.93 0.42 0.55 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.529 0.731 . . . . 0.0 112.916 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.6 mt 51.82 83.64 0.05 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.42 169.58 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.77 1.228 . . . . 0.0 111.097 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -140.01 166.91 23.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.579 1.152 . . . . 0.0 110.051 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.04 4.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 115.805 1.779 . . . . 0.0 115.805 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -152.81 16.83 0.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.334 0.516 . . . . 0.0 110.576 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.25 177.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.67 0.747 . . . . 0.0 110.886 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.64 153.41 36.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.734 0.814 . . . . 0.0 109.067 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.28 157.01 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.24 134.59 6.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.81 131.12 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.46 145.38 56.23 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 122.658 0.383 . . . . 0.0 111.11 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 70.8 Cg_endo -79.19 171.68 15.86 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.947 3.765 . . . . 0.0 110.554 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 49.8 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.179 2.586 . . . . 0.0 113.368 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 128.66 36.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.035 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 128.49 34.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.401 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.23 -175.8 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 110.451 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -120.35 154.22 35.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.851 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -134.1 124.59 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -113.29 133.34 55.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.222 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -102.56 161.31 13.82 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -145.35 159.03 43.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.35 -148.77 0.2 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.365 0.266 . . . . 0.0 111.359 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -56.29 -12.21 1.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.34 -30.55 66.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.058 0.845 . . . . 0.0 110.002 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -68.44 -32.62 72.77 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.321 0.648 . . . . 0.0 109.964 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.45 -31.9 65.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.796 0.438 . . . . 0.0 111.508 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.98 -26.44 25.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.299 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.78 -18.35 44.46 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.855 0.298 . . . . 0.0 110.436 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.4 2.16 59.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.4 p -144.36 150.3 47.58 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 124.094 0.958 . . . . 0.0 109.653 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.19 -25.0 12.0 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.065 2.51 . . . . 0.0 111.135 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -166.51 163.85 17.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.593 0.235 . . . . 0.0 110.99 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.32 155.73 17.53 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.555 0.742 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.58 155.36 31.61 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.216 2.611 . . . . 0.0 109.844 171.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.2 mt -160.26 -175.44 5.05 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.686 0.794 . . . . 0.0 108.925 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -149.21 158.98 44.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.06 157.1 14.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.57 -25.71 38.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.506 0.653 . . . . 0.0 109.291 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.18 165.96 25.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.502 1.121 . . . . 0.0 109.089 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 t -45.55 -54.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.19 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.12 -32.58 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -66.58 -21.57 66.14 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.634 -0.666 . . . . 0.0 111.169 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.98 -45.04 16.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.11 -36.45 65.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.733 0.813 . . . . 0.0 111.605 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.16 -17.83 60.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -86.22 -33.65 20.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.128 0.422 . . . . 0.0 110.161 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.55 -49.56 75.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.98 0.512 . . . . 0.0 109.624 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.1 p -69.57 -16.55 63.43 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.789 0.436 . . . . 0.0 112.025 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.21 -37.26 72.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 111.945 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.28 -20.27 14.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.784 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.95 74.65 13.24 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.95 0.9 . . . . 0.0 108.837 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.78 -17.22 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.914 2.409 . . . . 0.0 110.054 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.58 1.78 6.1 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 111.563 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -125.11 -6.42 7.21 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.576 0.75 . . . . 0.0 111.36 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 33.2 ttpt -63.34 -26.74 68.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.088 -0.383 . . . . 0.0 111.796 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 m-85 -117.56 27.37 9.1 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.267 0.627 . . . . 0.0 110.067 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.9 -7.47 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.274 1.03 . . . . 0.0 108.99 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.87 -23.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.129 0.972 . . . . 0.0 109.121 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.62 164.62 21.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.801 0.44 . . . . 0.0 110.113 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -75.91 174.42 9.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.436 0.694 . . . . 0.0 110.451 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 34.0 ttmt . . . . . 0 CA--C 1.532 0.262 0 C-N-CA 124.357 1.063 . . . . 0.0 110.015 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.226 -0.176 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.48 129.22 52.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.98 138.42 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 35.3 mt -125.6 161.62 26.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.472 0.177 . . . . 0.0 110.723 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.2 mm -132.66 106.31 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 171.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 54.84 9.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.266 0.626 . . . . 0.0 112.2 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.91 -4.02 36.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.778 0.704 . . . . 0.0 112.257 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.31 -4.33 38.59 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 27.0 t-20 47.64 106.75 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.765 1.626 . . . . 0.0 114.989 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -53.04 -21.59 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -67.58 -10.21 49.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.586 0.754 . . . . 0.0 111.51 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.84 9.47 13.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.756 0.822 . . . . 0.0 110.664 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.61 -156.54 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 109.132 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -67.1 -8.64 32.28 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.23 -139.2 18.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.85 -0.82 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.842 0.857 . . . . 0.0 113.054 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.83 26.05 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.052 0.541 . . . . 0.0 111.347 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.7 m -66.08 -1.64 3.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.415 0.686 . . . . 0.0 111.296 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.95 167.76 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.024 0.929 . . . . 0.0 111.249 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.41 174.41 10.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.398 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -142.22 166.37 24.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 110.348 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.04 7.24 0.41 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -149.96 14.36 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.2 179.11 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.73 0.776 . . . . 0.0 110.853 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.08 152.7 32.71 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 mm -131.34 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.59 138.09 8.74 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.34 128.39 74.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.61 144.9 51.06 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.569 0.348 . . . . 0.0 111.037 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 62.3 Cg_endo -80.35 172.25 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 125.262 3.975 . . . . 0.0 110.99 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 68.4 Cg_endo . . . . . 0 N--CA 1.458 -0.578 0 C-N-CA 123.336 2.691 . . . . 0.0 113.039 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.49 126.51 28.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.95 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.27 126.61 31.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.249 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.14 -172.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 110.777 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -123.58 152.5 41.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.696 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.44 133.33 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -113.68 148.21 36.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.102 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.0 mt -127.03 157.91 38.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -145.05 160.36 41.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -173.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.08 -145.44 0.2 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.6 0.36 . . . . 0.0 110.88 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -58.91 -9.95 2.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.61 -30.92 61.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.082 0.855 . . . . 0.0 110.054 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -69.89 -33.08 71.73 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -72.54 -22.93 60.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.672 0.789 . . . . 0.0 111.808 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.283 0.365 . . . . 0.0 111.053 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.12 -7.37 3.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.523 0.729 . . . . 0.0 110.731 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 7.42 44.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.596 0.617 . . . . 0.0 112.152 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.8 p -142.75 144.68 30.78 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-N 117.825 0.812 . . . . 0.0 110.193 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.63 -16.14 13.32 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.097 2.531 . . . . 0.0 111.722 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -164.81 158.67 17.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.124 0.42 . . . . 0.0 111.585 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.457 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 155.01 26.16 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 123.615 0.766 . . . . 0.0 111.238 177.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.21 152.34 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.802 3.001 . . . . 0.0 110.857 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -162.92 -176.9 5.16 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.355 0.662 . . . . 0.0 109.659 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -148.12 159.39 43.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.709 0.29 . . . . 0.0 111.564 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 155.49 11.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 174.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.57 -28.69 56.32 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.007 -0.702 . . . . 0.0 110.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -137.16 167.39 21.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.171 0.988 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.46 -54.71 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.71 -32.51 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -66.8 -21.74 66.04 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 121.473 -0.767 . . . . 0.0 111.118 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.81 -44.15 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -37.4 66.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 35' ' ' LEU . 39.9 mt -73.74 -16.68 61.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 -25.79 17.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.928 0.394 . . . . 0.0 110.174 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.37 -48.81 76.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -69.08 -15.98 63.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.056 0.542 . . . . 0.0 111.289 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -71.52 -46.9 58.39 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.921 0.328 . . . . 0.0 111.524 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -92.88 -19.3 21.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.253 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -118.25 77.21 12.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.681 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.89 -16.62 56.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.009 2.472 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.89 2.22 7.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.696 0.798 . . . . 0.0 111.41 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.69 -6.62 7.43 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.707 0.803 . . . . 0.0 111.021 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -62.07 -22.91 66.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.84 0.456 . . . . 0.0 111.978 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.74 25.35 8.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.058 0.543 . . . . 0.0 109.817 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.7 t -126.57 -8.51 4.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.459 1.104 . . . . 0.0 109.07 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.29 -19.17 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.113 0.965 . . . . 0.0 109.18 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.94 161.05 32.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.023 0.44 . . . . 0.0 110.907 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.9 133.24 35.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.367 0.667 . . . . 0.0 109.997 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 124.992 1.317 . . . . 0.0 110.556 175.863 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.8 mt . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.7 mm . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.869 0.366 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -117.71 124.88 49.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.6 mt -121.35 148.18 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.213 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.9 mt -130.08 162.71 28.17 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.175 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.401 HG12 ' CG2' ' A' ' 74' ' ' ILE . 35.6 mm -135.31 108.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.22 10.24 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.949 0.5 . . . . 0.0 111.74 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.69 -3.05 39.09 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.874 0.75 . . . . 0.0 112.386 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -77.05 0.37 21.6 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.29 97.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.838 1.255 . . . . 0.0 114.202 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.401 ' CG2' HG12 ' A' ' 69' ' ' ILE . 26.7 pt -50.38 -20.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -64.03 -16.88 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.575 0.625 . . . . 0.0 111.878 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -110.99 6.9 21.35 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.492 0.717 . . . . 0.0 110.579 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.03 -157.34 0.76 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.788 0.835 . . . . 0.0 109.399 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -73.56 -0.54 15.49 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.97 -137.11 20.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.87 -2.48 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.837 0.855 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.68 21.62 7.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.345 0.521 . . . . 0.0 111.421 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 82' ' ' THR . 89.3 m -65.61 -0.9 2.28 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.779 0.832 . . . . 0.0 112.261 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt 60.38 164.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.231 1.012 . . . . 0.0 110.918 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.4 mt -138.45 169.98 16.83 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.697 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 4.5 mptt -136.49 167.36 21.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.03 0.932 . . . . 0.0 111.475 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.84 7.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.685 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.7 t -152.05 16.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -69.76 -179.97 1.98 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.592 0.71 . . . . 0.0 110.365 174.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -155.32 152.57 29.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mm -127.45 154.55 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.08 127.41 2.77 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.21 132.36 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.79 146.41 60.1 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.174 0.59 . . . . 0.0 110.683 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 98.3 Cg_endo -78.43 173.19 14.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.78 3.653 . . . . 0.0 110.252 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.2 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.191 2.594 . . . . 0.0 112.893 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.37 131.82 50.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.35 129.56 35.14 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.03 -173.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.179 0.592 . . . . 0.0 110.422 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -127.43 157.2 40.64 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.345 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -136.69 128.03 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 47.3 mtmt -113.71 139.96 48.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.766 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.97 160.55 16.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.63 159.64 42.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.84 -151.79 0.17 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.379 0.272 . . . . 0.0 110.719 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -56.11 -11.97 1.33 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.36 -30.71 69.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.877 0.762 . . . . 0.0 109.92 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.45 -33.39 69.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.601 0.76 . . . . 0.0 110.35 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -70.6 -32.13 69.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 122.845 0.458 . . . . 0.0 111.653 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.82 -23.74 25.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.683 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.09 -17.49 37.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.321 0.248 . . . . 0.0 110.351 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.06 2.74 58.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.2 p -143.77 149.39 46.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.61 0.764 . . . . 0.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.56 -26.69 11.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.954 2.436 . . . . 0.0 110.952 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.66 163.23 19.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.987 0.515 . . . . 0.0 110.185 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.09 156.72 24.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.967 0.507 . . . . 0.0 110.766 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.34 156.01 36.98 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.1 2.533 . . . . 0.0 110.287 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.4 mt -163.61 -175.39 4.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.958 0.903 . . . . 0.0 108.782 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -146.55 160.48 42.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 111.275 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.02 150.93 6.63 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.93 -24.18 41.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.647 0.723 . . . . 0.0 110.275 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -134.98 171.48 14.36 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.282 1.033 . . . . 0.0 109.826 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HD21 ' A' ' 84' ' ' LEU . 46.4 t -56.42 -45.5 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.13 -35.54 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.94 -22.92 64.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.737 0.699 . . . . 0.0 111.008 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.04 -44.13 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -32.03 73.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.201 0.2 . . . . 0.0 111.373 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.8 -18.43 60.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -86.23 -30.96 21.96 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.966 0.412 . . . . 0.0 110.025 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.94 -46.8 89.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.1 p -70.96 -15.2 62.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.075 0.55 . . . . 0.0 111.771 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.18 -40.89 70.97 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.301 0.5 . . . . 0.0 112.14 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -101.92 -18.55 15.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.175 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -117.13 75.04 7.72 Favored Pre-proline 0 N--CA 1.454 -0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.115 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.2 -16.62 56.0 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.892 2.395 . . . . 0.0 110.382 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 0.08 6.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.042 0.937 . . . . 0.0 111.65 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.4 mt -125.52 -4.85 7.14 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.868 0.867 . . . . 0.0 110.825 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.6 tttt -62.35 -23.98 67.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.65 0.38 . . . . 0.0 112.013 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.7 28.64 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.718 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.7 -10.08 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.45 1.1 . . . . 0.0 109.123 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.7 mt -121.49 -18.65 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.972 0.909 . . . . 0.0 108.936 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.13 163.16 29.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.43 0.634 . . . . 0.0 111.147 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.42 169.33 17.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.512 1.125 . . . . 0.0 109.646 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 tttt . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 124.952 1.301 . . . . 0.0 109.235 -176.056 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 CA--C 1.52 -0.182 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.7 mm . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.85 125.06 53.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.0 mt -123.04 147.56 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.786 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 33.9 mt -130.76 158.02 41.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.566 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.32 108.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 m120 54.12 10.42 0.29 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.211 0.605 . . . . 0.0 111.835 -170.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.29 33.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.913 0.768 . . . . 0.0 112.615 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.97 -0.1 23.13 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.9 t-20 50.73 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 113.767 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.1 pt -49.99 -21.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -63.21 -15.61 57.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -115.75 9.73 15.23 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.464 0.706 . . . . 0.0 110.608 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.6 mt -123.19 -154.52 0.61 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.872 0.869 . . . . 0.0 109.069 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.59 -14.73 61.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.609 0.764 . . . . 0.0 111.774 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.61 -137.99 15.85 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.16 4.95 0.11 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.818 0.847 . . . . 0.0 113.242 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -131.62 27.38 4.68 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.453 0.701 . . . . 0.0 111.155 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 82' ' ' THR . 94.8 m -62.96 -1.01 0.78 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt 53.33 83.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.671 0.748 . . . . 0.0 112.643 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.402 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.98 170.67 0.61 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.036 1.334 . . . . 0.0 111.417 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 38.0 mtmm -140.45 166.36 24.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.043 0.937 . . . . 0.0 110.65 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -62.6 4.65 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -151.91 15.51 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.383 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 34.0 m-20 -66.3 175.11 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.703 0.764 . . . . 0.0 111.933 174.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.94 150.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.985 0.914 . . . . 0.0 109.103 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -133.81 155.51 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.84 133.88 6.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.6 mt -117.94 129.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.46 146.77 59.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.41 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.02 171.22 18.37 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.852 3.035 . . . . 0.0 110.673 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 C-N-CA 123.777 2.985 . . . . 0.0 113.067 177.439 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.25 128.62 36.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.99 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.8 129.85 35.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 110.09 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 m -140.11 -175.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.348 0.594 . . . . 0.0 110.458 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -119.97 156.42 30.88 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.52 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.93 123.84 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -108.39 152.23 24.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.27 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -127.22 156.46 41.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -143.62 158.35 43.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -150.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.53 0.332 . . . . 0.0 110.95 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -55.95 -11.17 0.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.41 -30.66 67.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.271 0.942 . . . . 0.0 110.028 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -68.89 -38.75 79.83 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.234 0.613 . . . . 0.0 109.705 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.54 -37.43 79.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.648 0.779 . . . . 0.0 111.286 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.13 -0.5 19.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.086 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.85 -6.01 4.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.519 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.33 35.31 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.152 0.882 . . . . 0.0 113.028 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.5 p -141.22 144.46 34.6 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 118.077 0.939 . . . . 0.0 110.472 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.47 -24.73 8.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.284 2.656 . . . . 0.0 111.574 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -167.41 162.72 14.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 23' ' ' LEU . 2.5 pt? -161.03 155.58 19.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.239 0.616 . . . . 0.0 110.659 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.35 154.33 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.261 2.64 . . . . 0.0 110.62 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -161.86 -177.55 5.9 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.797 0.839 . . . . 0.0 108.885 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -147.54 160.48 42.58 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.009 0.433 . . . . 0.0 111.774 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.72 158.16 16.31 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.23 -25.76 39.44 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.937 -0.743 . . . . 0.0 109.466 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -138.1 165.95 25.35 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.638 1.175 . . . . 0.0 109.225 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.9 t -45.56 -54.3 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.93 -32.26 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -68.19 -21.58 64.87 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.595 -0.69 . . . . 0.0 111.34 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.48 -45.79 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.45 -36.99 64.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.64 0.776 . . . . 0.0 111.573 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 35' ' ' LEU . 43.3 mt -74.32 -17.66 60.81 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -87.7 -32.53 19.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.78 -50.63 72.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.8 p -71.05 -14.37 62.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.46 0.704 . . . . 0.0 111.815 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.88 -37.22 70.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 118.339 0.518 . . . . 0.0 112.166 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -103.7 -19.31 14.36 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.37 75.16 11.74 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 123.97 0.908 . . . . 0.0 108.963 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.08 -17.99 61.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.113 2.542 . . . . 0.0 110.087 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 1.21 5.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.089 0.955 . . . . 0.0 111.277 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.72 -5.71 6.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.675 0.79 . . . . 0.0 111.249 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.34 -24.05 67.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.096 -0.378 . . . . 0.0 112.005 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.96 24.58 10.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.46 0.704 . . . . 0.0 109.635 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.49 -6.78 5.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 C-N-CA 124.592 1.157 . . . . 0.0 109.006 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.63 -21.55 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.73 0.812 . . . . 0.0 109.217 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -131.08 163.55 27.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.898 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.92 157.97 35.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.997 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.4 tttt . . . . . 0 N--CA 1.451 -0.407 0 C-N-CA 124.002 0.921 . . . . 0.0 112.525 -174.011 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.6 mt . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -123.27 129.15 50.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.32 146.23 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 mt -130.65 163.51 27.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.5 0.32 . . . . 0.0 110.45 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.4 mm -134.77 106.74 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 54.45 8.81 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.984 0.514 . . . . 0.0 112.119 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.94 -3.76 35.86 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.666 0.65 . . . . 0.0 112.317 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -74.39 -1.69 22.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 50.75 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 113.55 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.0 pt -49.68 -21.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -63.46 -13.98 46.09 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -113.73 7.85 17.3 Favored 'General case' 0 N--CA 1.46 0.044 0 C-N-CA 123.3 0.64 . . . . 0.0 110.73 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.88 -156.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.225 1.01 . . . . 0.0 108.948 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.41 -2.32 18.95 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.66 21.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.28 -2.32 0.45 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.892 0.877 . . . . 0.0 112.703 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -124.63 24.57 7.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.172 0.589 . . . . 0.0 111.256 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' THR . 88.9 m -65.59 -1.62 2.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.324 0.65 . . . . 0.0 111.293 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.62 168.02 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 110.558 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.7 mt -138.15 172.66 12.59 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.626 0.77 . . . . 0.0 110.008 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -140.74 167.77 21.38 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.933 0.893 . . . . 0.0 109.818 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.37 8.71 0.29 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t -150.65 15.79 0.78 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.135 0.493 . . . . 0.0 110.035 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.59 -179.83 2.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.693 0.759 . . . . 0.0 110.28 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -154.26 152.89 30.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.42 155.84 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.91 7.1 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 mt -122.52 127.6 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mp -131.79 144.82 54.85 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.272 0.629 . . . . 0.0 110.361 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.75 172.36 11.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 124.634 3.556 . . . . 0.0 109.869 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.451 -0.983 0 C-N-CA 123.099 2.533 . . . . 0.0 111.008 172.808 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.33 131.34 47.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.36 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.27 133.39 38.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -143.11 -171.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.175 0.512 . . . . 0.0 110.777 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -131.16 156.98 44.37 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.782 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.0 t -128.45 137.53 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.85 138.65 52.58 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.877 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -111.75 160.53 17.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -145.79 158.61 43.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.68 -147.09 0.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.461 0.305 . . . . 0.0 111.318 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -57.16 -8.69 0.74 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.86 -31.75 59.43 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.345 0.975 . . . . 0.0 109.771 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -71.46 -32.65 68.54 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.092 0.557 . . . . 0.0 109.888 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -68.34 -35.41 77.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.718 0.407 . . . . 0.0 110.19 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.27 -27.23 38.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.42 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.61 -17.86 27.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.781 0.432 . . . . 0.0 110.944 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.14 4.88 69.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.2 p -144.19 145.31 29.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.656 0.782 . . . . 0.0 109.658 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.08 -25.43 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.047 2.498 . . . . 0.0 110.823 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.86 161.65 23.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.444 0.298 . . . . 0.0 111.265 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.99 155.18 23.88 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.526 0.73 . . . . 0.0 111.759 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.4 150.68 19.74 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.001 3.134 . . . . 0.0 111.386 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 36' ' ' SER . 9.8 mt -160.96 -174.63 4.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.159 0.984 . . . . 0.0 109.655 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -147.95 163.39 36.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.33 154.39 9.09 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.17 -23.92 43.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.475 0.637 . . . . 0.0 109.848 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -140.12 172.92 12.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.162 0.985 . . . . 0.0 109.767 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.85 -49.56 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -62.01 -31.53 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.83 -20.9 63.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.553 -0.717 . . . . 0.0 110.856 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.19 -42.08 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.98 -40.95 77.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.866 0.866 . . . . 0.0 111.499 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.3 -15.63 60.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.661 0.267 . . . . 0.0 111.245 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . 2.2 m -93.61 -23.01 18.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.456 1.102 . . . . 0.0 110.712 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -70.57 -51.3 29.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -66.47 -13.33 60.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.824 0.45 . . . . 0.0 111.048 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.62 -44.74 70.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.485 0.314 . . . . 0.0 111.671 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -98.34 -17.73 18.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.077 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -117.86 75.99 10.69 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 109.454 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.62 -16.93 57.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.724 2.283 . . . . 0.0 110.506 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.7 0.36 9.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.009 0.923 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.7 -5.04 8.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.825 0.85 . . . . 0.0 110.886 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.36 -23.32 66.95 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.57 27.76 8.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.992 0.517 . . . . 0.0 109.659 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.5 -38.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -85.05 -24.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -130.5 165.7 22.12 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.038 0.535 . . . . 0.0 111.035 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -87.51 142.76 27.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt . . . . . 0 CA--C 1.533 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 111.838 179.265 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.9 mt . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -125.49 123.86 40.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -111.9 135.67 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -122.13 161.28 23.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -125.54 111.61 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 56.02 10.13 0.55 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.203 0.601 . . . . 0.0 112.154 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.38 15.31 9.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.335 0.493 . . . . 0.0 111.971 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -123.66 93.74 4.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.683 1.193 . . . . 0.0 109.438 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -39.15 109.73 0.12 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.749 1.62 . . . . 0.0 111.961 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 pt -50.03 -23.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.22 -8.36 12.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.898 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -121.76 8.21 9.98 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.386 1.074 . . . . 0.0 110.644 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.78 -153.89 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.538 1.135 . . . . 0.0 108.659 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.53 -15.37 60.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.54 0.736 . . . . 0.0 111.864 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 89.3 -142.56 16.85 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.0 5.27 0.06 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.881 0.873 . . . . 0.0 112.895 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.7 mt-10 -130.51 26.92 5.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.606 0.639 . . . . 0.0 111.587 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.436 ' O ' HG22 ' A' ' 82' ' ' THR . 88.7 m -63.47 -0.13 0.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.603 0.761 . . . . 0.0 112.838 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt 52.61 79.67 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.505 0.669 . . . . 0.0 112.777 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.45 165.25 1.14 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.942 1.297 . . . . 0.0 111.107 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -133.77 167.42 20.57 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.205 1.002 . . . . 0.0 109.558 -178.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.98 5.98 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -153.76 19.58 0.53 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.812 -0.555 . . . . 0.0 110.175 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.73 178.22 3.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.758 0.79 . . . . 0.0 110.468 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.05 151.52 31.22 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.83 150.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.63 130.33 5.95 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.52 128.38 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.62 147.72 65.71 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 122.451 0.3 . . . . 0.0 110.642 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 67.7 Cg_endo -79.61 175.23 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.9 3.733 . . . . 0.0 110.244 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 C-N-CA 122.826 2.35 . . . . 0.0 110.727 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.72 131.98 50.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 130.24 35.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.29 -173.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 110.54 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -127.76 157.52 40.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 169.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.8 127.47 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -108.49 152.34 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.494 0.717 . . . . 0.0 109.5 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.78 156.71 43.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.56 159.77 42.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.11 -148.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.504 0.322 . . . . 0.0 111.219 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.14 -9.99 0.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.63 -31.89 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.292 0.951 . . . . 0.0 109.724 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.08 -35.83 74.49 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.322 0.649 . . . . 0.0 110.071 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -68.22 -33.59 74.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.885 0.874 . . . . 0.0 110.723 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -2.74 40.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.875 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.0 -5.83 3.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.533 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.17 11.22 44.92 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.659 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.0 p -141.54 144.21 32.65 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 118.276 1.038 . . . . 0.0 110.571 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 -20.13 11.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.425 2.75 . . . . 0.0 111.62 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.12 162.02 19.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.65 0.38 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.91 155.24 24.19 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.235 0.614 . . . . 0.0 111.247 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.27 154.03 28.21 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.244 2.629 . . . . 0.0 110.09 172.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -163.75 -176.04 4.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.948 0.899 . . . . 0.0 109.253 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.26 161.66 40.5 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.69 155.76 10.32 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -79.09 -24.99 43.08 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.529 0.664 . . . . 0.0 110.047 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -140.61 172.5 12.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.944 0.898 . . . . 0.0 109.733 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 84' ' ' LEU . 41.7 t -55.72 -43.89 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.47 -35.01 74.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.98 -21.44 65.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.696 -0.628 . . . . 0.0 110.638 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -86.23 -45.27 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.71 -29.54 70.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 119.546 -0.264 . . . . 0.0 111.389 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -74.44 -19.12 60.52 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.098 0.408 . . . . 0.0 111.928 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.86 -31.13 20.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.077 0.465 . . . . 0.0 109.876 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.65 -48.87 79.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.412 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 73.5 p -71.44 -13.97 62.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.404 0.681 . . . . 0.0 112.11 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.65 -38.6 70.68 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.284 0.493 . . . . 0.0 111.769 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -104.34 -17.66 14.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.331 0.394 . . . . 0.0 111.575 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -117.4 75.8 9.1 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.44 -17.68 60.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.052 2.502 . . . . 0.0 110.224 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 0.25 6.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.974 0.91 . . . . 0.0 111.568 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.8 -6.83 7.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.903 0.881 . . . . 0.0 110.937 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 82.0 tttt -65.38 -23.37 66.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.431 0.292 . . . . 0.0 111.621 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -118.96 27.67 8.74 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.078 0.551 . . . . 0.0 109.894 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.94 -35.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 123.849 0.86 . . . . 0.0 108.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG13 ' A' ' 65' ' ' ILE . 96.8 mt -88.11 -24.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.37 163.27 30.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.689 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.11 147.57 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.688 0.795 . . . . 0.0 109.409 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.5 tttt . . . . . 0 N--CA 1.453 -0.324 0 C-N-CA 124.75 1.22 . . . . 0.0 110.756 175.214 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 48' ' ' ILE . 18.1 mm . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -121.14 126.23 49.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.75 143.03 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.4 mt -125.93 159.87 31.46 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.4 mm -130.93 107.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 54.38 11.2 0.38 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.192 0.597 . . . . 0.0 111.604 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.86 39.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.861 0.743 . . . . 0.0 112.596 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.44 -1.33 26.52 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.06 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.97 1.308 . . . . 0.0 113.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.62 -21.33 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.725 -0.609 . . . . 0.0 112.177 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.54 -11.53 25.07 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.291 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.37 9.95 11.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.443 0.697 . . . . 0.0 110.79 175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.7 -155.49 0.67 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.216 1.006 . . . . 0.0 109.436 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.13 -5.57 18.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.74 0.416 . . . . 0.0 111.965 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.19 -141.16 22.05 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.82 5.82 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 113.079 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.4 mt-10 -130.38 25.53 5.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.406 0.682 . . . . 0.0 111.308 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 82' ' ' THR . 90.5 m -62.26 0.97 0.37 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.986 0.914 . . . . 0.0 113.168 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.7 mt 51.77 84.27 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -58.63 171.56 0.61 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.963 1.305 . . . . 0.0 111.422 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.82 166.74 23.82 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.187 0.995 . . . . 0.0 110.877 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.57 4.6 0.24 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -151.96 15.58 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.992 -0.443 . . . . 0.0 110.363 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.2 m-20 -66.99 177.76 1.62 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.541 0.686 . . . . 0.0 111.593 174.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -149.4 151.28 33.78 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.05 0.94 . . . . 0.0 108.786 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.41 157.81 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.72 133.18 5.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.62 130.43 66.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.21 146.48 56.43 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 122.858 0.463 . . . . 0.0 110.911 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.93 166.77 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.437 3.425 . . . . 0.0 110.755 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo . . . . . 0 N--CA 1.457 -0.672 0 C-N-CA 124.286 3.324 . . . . 0.0 113.267 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 131.14 48.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.04 132.92 37.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 m -142.1 -174.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.226 0.536 . . . . 0.0 111.022 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -126.67 155.77 42.09 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -137.77 128.07 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -113.9 138.61 50.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.903 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.74 161.12 15.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -145.87 158.88 43.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.78 -147.66 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.421 0.288 . . . . 0.0 111.239 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.93 -11.38 1.44 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.56 -31.06 64.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.193 0.906 . . . . 0.0 110.084 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -70.26 -33.32 71.46 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.047 0.539 . . . . 0.0 109.922 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.22 -31.84 69.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.881 0.472 . . . . 0.0 111.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.05 -23.1 22.64 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.611 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.69 -18.56 34.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.707 0.23 . . . . 0.0 110.841 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.37 62.65 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.2 p -144.4 145.85 30.61 Favored Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.833 0.853 . . . . 0.0 109.727 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.92 -26.03 11.46 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.114 2.543 . . . . 0.0 110.953 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -164.95 163.85 20.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 110.095 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -162.58 157.78 19.09 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.081 0.553 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.3 155.0 28.68 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.145 2.564 . . . . 0.0 110.136 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.5 mt -161.25 -176.64 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.046 0.938 . . . . 0.0 108.678 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -147.72 157.77 43.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 111.452 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.82 148.77 5.8 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -77.71 -24.97 49.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.783 0.791 . . . . 0.0 110.452 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.03 170.84 15.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.946 0.898 . . . . 0.0 109.939 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.7 -45.28 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -33.92 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -69.87 -20.98 63.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.359 0.527 . . . . 0.0 111.537 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.86 -40.58 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.23 -33.31 75.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.875 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.76 -18.73 60.94 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.87 0.304 . . . . 0.0 110.936 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -26.75 20.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.923 0.889 . . . . 0.0 110.729 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -67.75 -51.28 50.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 76.3 p -67.48 -13.37 61.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.119 0.568 . . . . 0.0 111.634 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.76 -39.43 80.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -106.26 -17.38 14.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -116.58 73.08 5.63 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.969 . . . . 0.0 108.98 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -64.14 -17.18 58.76 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.904 2.403 . . . . 0.0 110.444 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -1.07 9.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.006 0.922 . . . . 0.0 111.434 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 -4.73 8.99 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.889 0.875 . . . . 0.0 110.906 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.3 -22.68 66.87 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.15 28.91 6.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.8 t -125.48 -41.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.04 -24.69 10.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -130.0 167.46 18.22 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.231 0.612 . . . . 0.0 109.903 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.07 146.84 23.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.6 tttt . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 124.814 1.246 . . . . 0.0 112.044 178.897 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -118.4 126.43 52.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.578 ' C ' HD22 ' A' ' 68' ' ' LEU . 29.5 mt -124.67 136.61 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.756 0.789 . . . . 0.0 110.141 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -126.18 152.9 45.38 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.966 -172.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 74' ' ' ILE . 37.8 mm -124.17 100.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 64.55 0.92 1.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.189 0.995 . . . . 0.0 110.475 -172.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.81 -0.0 19.8 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 17.9 p30 -75.83 -4.13 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.8 t30 49.06 93.83 0.01 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.181 1.392 . . . . 0.0 113.782 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 69' ' ' ILE . 15.6 pt -49.2 -22.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -67.09 -10.88 54.73 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.888 0.875 . . . . 0.0 112.402 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -118.21 6.97 11.99 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.29 0.636 . . . . 0.0 110.348 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.0 mt -123.81 -154.94 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.158 0.983 . . . . 0.0 109.587 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.26 -4.49 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -132.6 19.24 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.76 -0.97 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.297 1.039 . . . . 0.0 113.61 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.35 25.81 5.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.641 0.655 . . . . 0.0 111.523 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 82' ' ' THR . 67.0 m -64.99 2.71 0.68 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.1 mt 51.95 85.0 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.77 168.9 1.55 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.915 1.286 . . . . 0.0 110.718 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -139.91 167.87 21.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.056 0.942 . . . . 0.0 110.21 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.04 5.96 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -153.08 16.8 0.56 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.316 0.507 . . . . 0.0 110.381 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 178.57 1.92 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.758 0.79 . . . . 0.0 111.202 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.81 151.54 34.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.039 0.935 . . . . 0.0 108.502 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.5 152.0 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.72 131.95 5.84 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.5 mt -118.08 131.77 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.54 148.31 66.93 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.8 0.44 . . . . 0.0 110.362 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.21 174.02 13.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.322 3.348 . . . . 0.0 110.316 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.455 -0.784 0 C-N-CA 122.852 2.368 . . . . 0.0 110.365 173.804 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.1 mtp . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.6 127.71 32.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.06 126.53 30.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.242 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.33 -175.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.939 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -117.68 154.39 31.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.251 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.15 119.46 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.08 151.13 22.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.557 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -129.76 155.69 45.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -144.17 157.56 44.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.15 -152.5 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.243 0.217 . . . . 0.0 110.627 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -53.47 -14.85 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.04 -30.48 70.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.075 0.852 . . . . 0.0 110.029 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -70.7 -37.28 73.55 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.015 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -37.99 76.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.094 0.558 . . . . 0.0 111.656 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.76 -1.03 20.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.231 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.85 -7.64 5.55 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.039 0.936 . . . . 0.0 110.307 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 12.9 50.72 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.32 0.962 . . . . 0.0 112.76 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.7 p -142.01 141.86 23.08 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 118.06 0.93 . . . . 0.0 110.929 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.51 -20.91 13.58 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.585 2.857 . . . . 0.0 111.164 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.79 161.97 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.712 0.405 . . . . 0.0 110.424 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.73 156.1 27.96 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.145 0.578 . . . . 0.0 110.861 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.42 153.0 23.71 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.271 2.647 . . . . 0.0 110.299 172.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.4 mt -163.71 -179.42 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.18 0.992 . . . . 0.0 108.865 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -148.19 158.83 44.31 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.36 157.27 13.81 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.63 -26.9 50.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.037 -0.684 . . . . 0.0 109.911 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -137.59 166.59 23.53 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.032 0.933 . . . . 0.0 109.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -46.75 -49.19 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.799 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.44 -34.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.52 -20.95 65.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.567 -0.708 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.53 -45.24 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.54 -24.63 67.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -79.05 -18.58 53.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 122.048 -0.407 . . . . 0.0 112.078 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.9 -28.98 22.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 110.196 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.14 -48.61 79.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -71.65 -17.22 62.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.258 0.623 . . . . 0.0 111.925 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.22 -39.61 78.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 117.995 0.362 . . . . 0.0 111.828 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -102.38 -18.32 15.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.442 0.464 . . . . 0.0 111.247 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -117.53 74.9 8.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.743 . . . . 0.0 109.117 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.56 -17.4 59.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.81 2.34 . . . . 0.0 110.356 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.36 1.51 6.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.22 1.008 . . . . 0.0 111.29 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.91 -6.24 6.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.5 0.72 . . . . 0.0 111.529 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.6 ttpt -64.25 -27.81 69.3 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.048 -0.408 . . . . 0.0 111.92 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -115.76 26.63 9.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 110.397 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.78 -12.22 3.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.284 1.034 . . . . 0.0 109.128 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.17 -19.85 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 109.692 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.52 162.56 30.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.28 138.68 34.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.106 0.562 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 N--CA 1.451 -0.404 0 C-N-CA 125.293 1.437 . . . . 0.0 111.151 175.977 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 mt . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mm . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -125.38 122.4 36.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 mm -108.51 144.99 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -128.82 162.37 27.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.692 0.397 . . . . 0.0 110.349 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -133.53 105.74 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.82 8.78 0.24 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.234 0.614 . . . . 0.0 111.792 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.88 33.07 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.825 0.726 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -72.47 -2.18 18.62 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.04 97.35 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.804 1.242 . . . . 0.0 113.748 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.61 -20.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -62.78 -14.67 47.93 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.273 0.488 . . . . 0.0 112.113 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -112.59 6.85 18.59 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.303 0.641 . . . . 0.0 110.685 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.8 mt -123.81 -156.1 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.144 0.978 . . . . 0.0 109.604 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.57 -15.66 63.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.894 0.878 . . . . 0.0 112.345 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -139.41 15.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.75 -2.09 0.49 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 112.793 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -125.89 25.5 6.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.567 0.622 . . . . 0.0 111.595 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.7 m -66.29 -2.09 4.05 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.096 0.558 . . . . 0.0 111.491 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.98 166.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 110.332 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.3 mt -137.21 175.59 9.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.63 0.772 . . . . 0.0 110.414 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.3 mttt -141.64 167.39 22.28 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.748 0.819 . . . . 0.0 110.877 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.17 7.26 0.77 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.6 t -150.38 13.8 0.76 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.359 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.98 -179.5 1.51 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.498 0.666 . . . . 0.0 110.632 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -152.54 153.33 33.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mm -131.16 158.2 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.62 140.52 9.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.84 126.92 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.43 147.56 66.61 Favored Pre-proline 0 N--CA 1.452 -0.326 0 O-C-N 123.224 0.328 . . . . 0.0 110.689 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 88.4 Cg_endo -76.8 174.02 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.812 3.674 . . . . 0.0 110.749 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.6 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 123.234 2.623 . . . . 0.0 110.431 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.03 132.42 52.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.38 130.81 35.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.05 -173.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.282 0.563 . . . . 0.0 110.504 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -128.12 157.98 39.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.384 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.51 131.2 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -115.16 137.95 51.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.353 0.661 . . . . 0.0 109.532 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -110.26 160.01 16.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -145.05 159.17 43.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -152.63 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.313 0.245 . . . . 0.0 110.756 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -53.77 -14.06 0.85 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.59 -30.6 70.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.111 0.869 . . . . 0.0 109.844 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.57 -36.58 73.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.454 0.702 . . . . 0.0 109.967 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -40.52 81.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.73 0.412 . . . . 0.0 110.995 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.18 -27.43 59.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.792 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.31 -18.23 39.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.214 -0.303 . . . . 0.0 110.56 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.26 3.09 64.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.9 p -145.25 149.54 41.83 Favored Pre-proline 0 C--O 1.232 0.133 0 C-N-CA 123.642 0.777 . . . . 0.0 109.822 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.78 -24.65 11.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.182 2.588 . . . . 0.0 110.946 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -164.87 163.23 21.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.53 0.332 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 23' ' ' LEU . 2.4 pt? -160.42 155.33 20.85 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 123.487 0.715 . . . . 0.0 110.724 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 154.01 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.16 2.573 . . . . 0.0 110.29 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -161.3 -174.39 4.28 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.038 0.935 . . . . 0.0 108.889 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -148.86 161.09 42.55 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.761 0.315 . . . . 0.0 111.749 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.19 155.93 9.85 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.08 -24.03 43.77 Favored 'General case' 0 C--O 1.23 0.056 0 O-C-N 122.091 -0.652 . . . . 0.0 109.97 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.51 172.92 12.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.727 0.811 . . . . 0.0 109.659 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.42 -43.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.76 -36.01 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.65 -22.03 64.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.424 0.556 . . . . 0.0 111.055 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.2 t -86.64 -46.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.43 -29.4 70.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.444 0.298 . . . . 0.0 111.58 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 35' ' ' LEU . 32.7 mt -75.18 -16.45 60.5 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -88.67 -30.99 18.73 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 109.979 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.95 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.429 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 70.5 p -70.2 -15.64 62.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.237 0.615 . . . . 0.0 111.769 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.81 -38.53 73.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.324 0.511 . . . . 0.0 111.847 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -104.49 -18.25 14.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.138 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -116.86 75.5 7.35 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 124.115 0.966 . . . . 0.0 108.884 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -64.7 -16.55 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.042 2.495 . . . . 0.0 110.47 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -0.9 10.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.819 0.848 . . . . 0.0 111.486 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.53 -5.09 8.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.967 0.907 . . . . 0.0 110.958 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 76.9 tttt -63.63 -24.69 67.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.85 31.54 5.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.34 0.59 . . . . 0.0 109.46 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.23 -41.03 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.05 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.61 163.94 26.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.493 0.664 . . . . 0.0 110.989 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.83 172.13 12.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.2 tttt . . . . . 0 N--CA 1.452 -0.374 0 C-N-CA 124.366 1.067 . . . . 0.0 108.905 -177.42 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.341 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mm . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.64 126.63 42.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.2 145.22 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.7 mt -129.16 159.49 35.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.9 mm -130.71 108.24 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 55.33 10.5 0.46 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.198 0.599 . . . . 0.0 111.333 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.28 -2.1 40.3 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.15 0.881 . . . . 0.0 112.424 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -81.14 1.65 30.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.57 101.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.84 1.256 . . . . 0.0 114.079 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.5 -26.41 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.964 -0.46 . . . . 0.0 112.214 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -60.87 -11.61 8.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -122.91 13.38 9.84 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.491 0.716 . . . . 0.0 111.278 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.04 -84.91 0.66 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.697 0.399 . . . . 0.0 110.558 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -144.35 1.64 1.08 Allowed 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 118.481 0.582 . . . . 0.0 111.772 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.67 -141.29 28.29 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.4 1.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -128.63 25.38 5.7 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.602 0.637 . . . . 0.0 111.834 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 82' ' ' THR . 91.4 m -63.71 0.81 0.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.9 mt 51.66 84.85 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.76 170.42 1.13 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 111.619 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 64.5 mttp -139.48 167.2 22.62 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.449 1.1 . . . . 0.0 111.657 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.29 4.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 t -153.07 16.03 0.55 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.074 -0.391 . . . . 0.0 110.201 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 6.7 m-20 -67.32 177.36 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.963 0.887 . . . . 0.0 111.351 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -148.07 151.15 35.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.44 1.096 . . . . 0.0 108.55 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.11 153.36 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.19 133.98 7.16 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.46 128.58 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.61 147.45 61.59 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 122.705 0.402 . . . . 0.0 111.006 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -79.41 174.2 12.21 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.052 3.835 . . . . 0.0 110.467 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 59.8 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 123.139 2.559 . . . . 0.0 111.291 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.61 130.95 48.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.39 132.58 39.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.27 -173.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.18 0.592 . . . . 0.0 110.14 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.01 158.41 38.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.3 t -130.05 138.12 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.75 152.29 37.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt -128.49 155.58 44.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.03 159.22 42.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.73 -146.18 0.27 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.432 0.293 . . . . 0.0 111.17 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -56.69 -10.68 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.05 -30.52 61.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.342 0.974 . . . . 0.0 110.125 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -70.39 -33.49 71.47 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.076 0.55 . . . . 0.0 109.6 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -72.01 -21.98 61.47 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.468 0.707 . . . . 0.0 111.718 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 1.98 56.7 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.288 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.27 -7.54 2.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.326 0.65 . . . . 0.0 110.709 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.4 9.0 48.23 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.337 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 p -141.26 144.75 35.56 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.056 0.928 . . . . 0.0 110.39 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.22 -22.4 9.77 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.319 2.68 . . . . 0.0 111.574 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.07 160.82 14.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.517 0.327 . . . . 0.0 110.639 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.64 154.42 23.07 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -178.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.06 152.65 24.58 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.684 2.923 . . . . 0.0 110.976 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.9 mt -163.6 -173.17 3.18 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.994 0.518 . . . . 0.0 110.284 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -148.36 160.64 42.81 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 111.099 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.2 149.48 6.15 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -81.24 -24.8 37.11 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 117.708 0.754 . . . . 0.0 110.388 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -132.22 170.82 14.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.245 1.018 . . . . 0.0 109.227 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.68 -48.33 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.51 -32.32 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.628 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.77 -22.61 64.28 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.654 -0.654 . . . . 0.0 110.703 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.65 -45.03 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -38.79 71.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.121 0.968 . . . . 0.0 111.821 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 mt -74.22 -14.34 60.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.91 -26.21 16.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 174.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -64.09 -49.65 71.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.3 p -68.3 -14.25 62.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.902 0.481 . . . . 0.0 111.484 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.96 -44.98 64.92 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.089 0.404 . . . . 0.0 111.397 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -95.44 -17.84 21.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -118.69 76.57 13.83 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 123.859 0.864 . . . . 0.0 109.666 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -17.19 57.96 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.102 2.535 . . . . 0.0 111.03 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.44 2.02 8.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.334 0.654 . . . . 0.0 111.358 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.0 -7.08 8.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.556 0.743 . . . . 0.0 110.718 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.09 -24.2 67.61 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.891 0.477 . . . . 0.0 112.198 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -121.17 28.57 7.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.938 0.495 . . . . 0.0 109.989 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.3 -36.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.272 1.029 . . . . 0.0 108.244 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.05 -25.4 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.607 0.763 . . . . 0.0 109.187 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.24 161.84 30.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.992 0.517 . . . . 0.0 110.791 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.81 141.41 31.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.3 tttt . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.064 1.346 . . . . 0.0 110.994 177.475 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 mm . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.077 0.465 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -128.98 126.58 39.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.81 145.99 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.53 160.76 32.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.99 0.516 . . . . 0.0 109.642 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.13 105.58 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 55.07 8.61 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.039 0.536 . . . . 0.0 111.856 -169.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.88 -3.88 32.03 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.066 0.841 . . . . 0.0 112.419 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -76.4 -0.15 21.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 49.33 99.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 114.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.07 -21.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.62 -11.67 12.53 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -119.58 9.02 11.37 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.755 0.822 . . . . 0.0 111.541 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.73 -156.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.059 0.944 . . . . 0.0 109.485 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.89 -5.67 22.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.39 -139.44 20.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.82 2.08 0.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.896 0.878 . . . . 0.0 113.132 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -129.22 25.87 5.47 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.398 0.545 . . . . 0.0 111.553 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 82' ' ' THR . 88.9 m -62.16 -0.57 0.55 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.762 0.825 . . . . 0.0 112.991 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.29 83.51 0.06 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.72 170.89 0.72 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.039 1.335 . . . . 0.0 111.896 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -138.36 167.88 20.95 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.27 1.028 . . . . 0.0 110.404 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -64.94 7.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.8 t -152.86 17.21 0.58 Allowed 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.889 -0.507 . . . . 0.0 110.599 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.72 -179.34 2.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.199 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.42 155.26 36.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.386 0.674 . . . . 0.0 109.576 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 mm -125.79 155.13 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.01 120.95 1.63 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.7 mt -108.97 129.97 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.72 149.04 70.88 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 122.632 0.373 . . . . 0.0 110.763 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 73.1 Cg_endo -78.34 174.75 11.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 125.007 3.804 . . . . 0.0 110.076 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 C-N-CA 122.65 2.233 . . . . 0.0 111.344 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.75 131.91 50.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.437 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.56 130.08 35.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.228 0.537 . . . . 0.0 109.753 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.69 -172.42 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.342 0.592 . . . . 0.0 110.659 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -129.88 155.98 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.903 171.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.83 135.27 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.87 139.12 50.52 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.965 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.7 mm? -110.8 160.13 17.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -145.75 159.98 42.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.62 -147.06 0.22 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.219 0.207 . . . . 0.0 111.094 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -56.47 -12.51 1.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.51 -31.87 65.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.937 0.79 . . . . 0.0 110.006 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -70.92 -32.81 69.84 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.76 -33.55 72.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.337 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.87 -24.71 26.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.265 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 -18.97 33.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.556 0.217 . . . . 0.0 110.677 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 3.17 63.01 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.8 p -144.3 148.45 41.01 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.35 -23.69 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.004 2.47 . . . . 0.0 110.883 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -163.58 162.51 24.41 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.4 0.28 . . . . 0.0 111.39 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.67 154.36 26.6 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.634 0.774 . . . . 0.0 111.515 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.77 151.59 21.92 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.599 2.866 . . . . 0.0 110.649 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.3 mt -162.0 -175.3 4.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.251 0.62 . . . . 0.0 110.04 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -147.74 162.11 39.86 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 111.444 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.14 152.26 7.7 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.51 -26.66 60.13 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.561 0.68 . . . . 0.0 110.467 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -139.9 174.43 10.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 109.897 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.76 -45.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 tp -63.79 -34.64 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.95 -22.6 65.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.466 0.575 . . . . 0.0 110.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.0 -44.76 16.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.38 -29.87 70.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.198 -0.313 . . . . 0.0 111.425 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 35' ' ' LEU . 38.8 mt -74.2 -17.89 60.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.143 -0.348 . . . . 0.0 111.472 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.435 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -91.62 -25.09 19.33 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 175.511 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.7 -49.09 76.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 81.8 p -68.68 -16.51 63.85 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.744 0.418 . . . . 0.0 111.571 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.69 -46.24 66.47 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.207 0.458 . . . . 0.0 111.809 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.0 -18.77 21.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -117.26 76.83 9.29 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.804 0.841 . . . . 0.0 109.881 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.06 -16.86 57.31 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.792 2.328 . . . . 0.0 110.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.01 2.16 7.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.792 0.837 . . . . 0.0 111.287 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.2 mt -126.77 -3.41 6.55 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 75.9 tttt -62.53 -24.46 67.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.464 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 24.2 m-85 -124.17 29.44 6.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.428 0.632 . . . . 0.0 109.422 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.41 -10.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.895 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.44 -18.38 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.835 0.854 . . . . 0.0 109.131 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -132.96 161.12 35.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.793 0.437 . . . . 0.0 110.961 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -69.44 168.63 14.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.72 0.808 . . . . 0.0 110.427 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 33.8 ttmt . . . . . 0 CA--C 1.527 0.095 0 C-N-CA 123.799 0.84 . . . . 0.0 110.579 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.9 mt . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.5 mm . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -118.71 126.43 51.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.26 144.09 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 40.0 mt -128.14 159.45 35.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.73 107.95 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.67 10.75 0.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.26 0.624 . . . . 0.0 111.628 -170.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.49 -3.49 37.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.036 0.827 . . . . 0.0 112.436 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -77.26 -0.64 26.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.7 t-20 51.46 100.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.696 1.198 . . . . 0.0 113.751 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.2 pt -51.3 -21.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -64.32 -11.42 31.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.966 0.506 . . . . 0.0 112.224 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -116.86 8.95 13.7 Favored 'General case' 0 N--CA 1.46 0.038 0 C-N-CA 123.66 0.784 . . . . 0.0 110.77 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.5 -155.63 0.69 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.053 0.941 . . . . 0.0 109.201 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.59 -3.23 17.19 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.74 -140.17 22.24 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.15 3.25 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.993 0.917 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.6 mt-10 -128.34 22.72 6.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.535 0.734 . . . . 0.0 111.513 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 82' ' ' THR . 86.2 m -62.15 0.65 0.39 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.524 1.13 . . . . 0.0 113.333 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.27 85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.778 0.799 . . . . 0.0 112.999 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.34 171.69 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.158 1.383 . . . . 0.0 111.409 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.41 166.28 24.97 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.428 1.091 . . . . 0.0 110.88 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.3 5.25 0.28 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 t -152.7 16.6 0.59 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 117.883 0.311 . . . . 0.0 110.503 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.0 m-20 -67.44 177.57 1.88 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.878 0.847 . . . . 0.0 111.344 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.18 151.48 34.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.192 0.997 . . . . 0.0 108.526 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.52 154.39 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.39 132.37 6.06 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -115.21 129.22 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.93 144.37 50.11 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 122.654 0.382 . . . . 0.0 110.439 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -80.12 169.09 18.04 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.57 3.513 . . . . 0.0 111.174 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 123.787 2.991 . . . . 0.0 111.055 172.988 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 127.2 30.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.74 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.99 128.38 34.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.6 m -140.65 -172.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.35 0.595 . . . . 0.0 110.677 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -124.87 153.97 41.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.956 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.62 133.02 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -114.59 136.1 53.41 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.443 0.465 . . . . 0.0 109.811 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -107.49 160.34 15.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.94 160.19 41.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.68 -146.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.393 0.277 . . . . 0.0 110.991 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -57.71 -11.59 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.5 mt -72.13 -29.05 63.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.354 0.979 . . . . 0.0 109.922 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.98 -32.01 70.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.144 0.578 . . . . 0.0 109.472 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.17 -23.2 60.4 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 111.249 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 -5.72 52.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.676 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' A' ' 41' ' ' TYR . . . -115.15 -11.34 12.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.164 0.586 . . . . 0.0 110.319 173.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.26 3.01 36.08 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.6 p -143.71 149.51 47.04 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 123.896 0.878 . . . . 0.0 109.548 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.07 -22.9 14.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.829 2.353 . . . . 0.0 110.994 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.48 163.57 22.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.898 0.317 . . . . 0.0 111.547 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.03 153.98 23.34 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.893 0.877 . . . . 0.0 111.298 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.44 151.07 19.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.684 2.923 . . . . 0.0 110.796 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.7 -175.54 4.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 110.002 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -148.58 159.06 44.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.92 0.391 . . . . 0.0 111.736 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.18 154.54 10.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.94 -27.81 57.72 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 117.603 0.701 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -137.62 165.87 25.3 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.026 0.93 . . . . 0.0 109.698 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -46.05 -52.16 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 122.966 0.506 . . . . 0.0 110.196 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.0 -32.45 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -67.98 -21.22 65.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.52 -0.737 . . . . 0.0 111.137 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -45.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -54.77 -37.52 66.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.534 0.734 . . . . 0.0 111.446 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 35' ' ' LEU . 41.7 mt -73.97 -16.8 61.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.44 -26.12 17.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.939 0.399 . . . . 0.0 110.025 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.0 tm? -63.0 -50.24 71.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.406 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 72.1 p -67.51 -16.17 64.05 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.59 -45.57 65.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.852 0.296 . . . . 0.0 111.467 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -93.97 -18.32 22.02 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.247 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 18' ' ' ALA . 9.2 m-30 -118.31 77.42 13.25 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 123.955 0.902 . . . . 0.0 109.909 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.75 -17.58 59.95 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.873 2.382 . . . . 0.0 110.867 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.72 1.78 7.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.539 0.735 . . . . 0.0 111.445 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.8 mt -124.35 -5.83 7.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.704 0.802 . . . . 0.0 110.858 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.2 tttt -65.17 -23.32 67.08 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -124.27 28.06 6.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.43 -39.4 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -82.78 -28.06 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.25 164.08 23.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.891 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -73.9 171.99 12.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.277 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.8 tttt . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.382 1.073 . . . . 0.0 108.676 -178.996 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.853 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -128.38 123.16 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.0 145.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -133.32 159.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.923 0.889 . . . . 0.0 109.21 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.407 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 34.8 mm -130.06 109.25 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 170.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.42 5.88 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.328 0.651 . . . . 0.0 111.996 -169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.18 -2.6 23.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.028 0.823 . . . . 0.0 112.811 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 18.8 p30 -74.64 -3.39 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.42 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 113.421 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -46.89 -23.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -63.34 -19.49 64.67 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -102.64 2.46 36.01 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.87 -153.89 0.57 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.445 1.098 . . . . 0.0 109.675 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.08 -15.03 58.69 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.952 0.901 . . . . 0.0 112.146 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.7 -138.22 16.61 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.18 1.33 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.187 0.995 . . . . 0.0 112.87 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -129.39 25.61 5.44 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.687 0.676 . . . . 0.0 111.625 -175.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -62.04 -8.51 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.79 0.836 . . . . 0.0 112.706 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.47 125.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.689 1.196 . . . . 0.0 112.164 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 4.5 mp -100.4 174.4 6.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.038 1.335 . . . . 0.0 110.422 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -139.91 168.61 19.42 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.752 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -68.04 8.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -151.95 18.28 0.68 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.006 -0.434 . . . . 0.0 109.939 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.01 178.92 2.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.548 0.69 . . . . 0.0 110.585 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.99 149.73 29.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -133.24 151.21 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.4 134.68 7.72 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 108.404 -1.879 . . . . 0.0 108.404 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.01 128.66 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.21 148.19 66.87 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -80.48 174.81 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.934 3.756 . . . . 0.0 109.94 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo . . . . . 0 N--CA 1.453 -0.856 0 C-N-CA 122.695 2.263 . . . . 0.0 111.26 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 132.55 52.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.14 128.11 33.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.32 -172.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 123.376 0.671 . . . . 0.0 110.781 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -129.85 154.78 46.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.617 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.26 136.1 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -118.16 138.14 52.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.037 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.04 160.35 16.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.88 160.38 41.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.65 -146.89 0.23 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.284 0.234 . . . . 0.0 111.085 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -57.49 -10.38 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.96 -30.71 62.66 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.129 0.877 . . . . 0.0 110.06 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -71.76 -32.07 67.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.975 0.51 . . . . 0.0 109.772 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -70.21 -30.79 67.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.0 111.531 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.79 -24.54 22.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.536 -176.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -18.34 35.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 2.11 60.45 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 149.27 45.5 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 123.82 0.848 . . . . 0.0 109.193 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.98 -20.79 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.07 2.513 . . . . 0.0 111.519 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -165.54 162.2 18.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.965 0.348 . . . . 0.0 111.359 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.486 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.02 155.75 26.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.603 0.761 . . . . 0.0 111.582 178.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.62 153.02 20.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.859 3.039 . . . . 0.0 110.846 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.4 mt -162.96 -173.46 3.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.252 0.621 . . . . 0.0 110.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.75 161.78 40.53 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 120.711 0.291 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 154.2 8.39 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -79.94 -30.45 39.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 117.489 0.644 . . . . 0.0 110.117 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -133.34 172.13 13.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.1 0.96 . . . . 0.0 109.589 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.92 -43.24 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -64.15 -34.63 70.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -68.49 -21.71 64.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 121.781 -0.574 . . . . 0.0 110.876 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.77 -44.33 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.71 -29.31 70.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.219 -0.301 . . . . 0.0 111.391 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.83 -13.93 60.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.991 0.359 . . . . 0.0 111.451 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -96.09 -24.05 16.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 109.966 175.056 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.4 -48.65 76.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.0 p -68.72 -17.87 64.13 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.009 0.524 . . . . 0.0 111.427 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.75 -44.24 74.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.155 -0.34 . . . . 0.0 111.725 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -96.2 -18.8 19.81 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.164 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.17 75.53 11.4 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.855 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.49 -16.35 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.734 2.29 . . . . 0.0 110.367 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.59 1.6 7.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.933 0.893 . . . . 0.0 111.587 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -125.38 -4.65 7.25 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.632 0.773 . . . . 0.0 111.176 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.9 ttpt -64.39 -27.84 69.29 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.78 26.21 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.406 0.683 . . . . 0.0 110.039 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 t -129.1 -11.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.972 0.909 . . . . 0.0 109.16 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.8 mt -120.45 -20.21 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.565 0.746 . . . . 0.0 109.174 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.84 159.83 38.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.611 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -70.06 154.19 42.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.636 0.774 . . . . 0.0 110.12 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 123.667 0.787 . . . . 0.0 111.558 -177.094 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.84 126.94 52.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.88 146.9 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.95 161.55 30.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.0 mm -132.37 108.3 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 54.29 10.05 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.286 0.635 . . . . 0.0 111.701 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.58 -2.38 36.67 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.109 0.862 . . . . 0.0 112.586 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -79.75 1.91 24.87 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.39 99.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.77 1.228 . . . . 0.0 114.063 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 pt -50.12 -25.93 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -62.46 -10.01 10.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.313 0.645 . . . . 0.0 112.581 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -122.43 12.66 10.13 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.595 0.758 . . . . 0.0 111.105 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.14 -83.94 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.906 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -144.25 2.7 1.15 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.629 0.65 . . . . 0.0 111.558 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.35 -142.58 30.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.67 6.28 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.45 20.25 5.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.269 0.627 . . . . 0.0 111.301 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.6 m -61.35 -8.16 3.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.7 mt 61.32 132.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.956 1.302 . . . . 0.0 112.537 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.78 176.44 5.14 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.137 0.975 . . . . 0.0 110.319 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.6 mttt -144.4 166.28 25.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.141 0.977 . . . . 0.0 110.716 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.31 6.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -153.61 16.59 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.175 -0.328 . . . . 0.0 110.376 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 4.4 m-20 -67.55 176.6 2.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.844 0.83 . . . . 0.0 111.097 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.58 151.06 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.75 151.36 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.83 6.69 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -114.9 129.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.32 145.63 54.66 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 122.827 0.451 . . . . 0.0 110.102 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.84 170.84 17.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.108 3.206 . . . . 0.0 110.307 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.456 -0.683 0 C-N-CA 123.398 2.732 . . . . 0.0 112.356 175.824 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.486 0.66 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.29 142.93 56.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.711 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.58 134.22 35.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.17 -175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.998 0.519 . . . . 0.0 110.392 -173.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -126.79 155.9 42.09 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.48 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.72 117.71 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 123.686 0.794 . . . . 0.0 108.956 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.36 158.81 15.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.873 0.469 . . . . 0.0 109.96 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.8 mt -134.24 152.18 51.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -141.33 158.75 43.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 -148.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.482 0.313 . . . . 0.0 110.693 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -55.33 -14.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -68.91 -30.35 68.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.016 0.825 . . . . 0.0 110.263 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -69.01 -30.97 69.46 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.227 0.611 . . . . 0.0 110.038 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.99 -18.69 58.05 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.694 0.798 . . . . 0.0 111.611 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.91 2.33 56.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.431 0.292 . . . . 0.0 111.042 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.56 -5.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.506 0.722 . . . . 0.0 111.109 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.9 10.31 38.42 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.636 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.8 p -142.9 144.08 27.9 Favored Pre-proline 0 C--N 1.341 0.205 0 CA-C-N 117.893 0.847 . . . . 0.0 110.069 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.42 -20.23 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.39 2.727 . . . . 0.0 111.462 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -165.6 161.31 18.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.209 0.604 . . . . 0.0 110.486 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 153.3 26.97 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 122.645 0.378 . . . . 0.0 110.862 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.79 152.03 32.24 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.469 2.779 . . . . 0.0 109.897 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -161.86 -174.37 4.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -147.33 162.46 38.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.776 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.34 151.91 8.44 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.3 -25.35 46.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -140.46 173.83 11.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.824 1.25 . . . . 0.0 108.961 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -54.87 -51.37 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -59.19 -33.94 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -67.0 -20.71 65.92 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.416 -0.802 . . . . 0.0 111.157 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.43 -45.18 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.29 -38.5 71.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.196 0.999 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 35' ' ' LEU . 48.4 mt -72.85 -16.91 61.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -88.62 -32.06 18.26 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.821 0.344 . . . . 0.0 110.161 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.57 -46.43 90.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 p -73.14 -13.05 61.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.502 0.321 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.84 -42.91 63.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -100.66 -19.07 16.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.37 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -117.97 77.81 12.45 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.627 0.771 . . . . 0.0 108.996 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.96 -15.94 52.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.641 2.228 . . . . 0.0 110.158 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.19 2.22 4.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.492 1.117 . . . . 0.0 111.55 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.1 mt -124.23 -9.8 7.56 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.818 0.847 . . . . 0.0 110.675 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.86 -25.6 67.64 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -123.68 26.92 7.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.103 0.478 . . . . 0.0 109.728 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.13 -10.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 C-N-CA 124.571 1.148 . . . . 0.0 108.658 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.53 -20.55 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.78 0.832 . . . . 0.0 109.326 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.97 159.1 36.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 110.752 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.59 136.78 36.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.416 0.686 . . . . 0.0 109.439 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.7 tttt . . . . . 0 CA--C 1.535 0.38 0 C-N-CA 124.975 1.31 . . . . 0.0 110.891 176.238 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.225 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -121.86 129.39 52.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -124.39 148.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.391 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -129.13 160.14 33.8 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.415 HG12 ' CG2' ' A' ' 74' ' ' ILE . 32.5 mm -132.43 109.79 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 170.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 54.06 11.39 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.059 0.544 . . . . 0.0 111.714 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.19 -1.63 43.82 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.035 0.826 . . . . 0.0 112.509 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -80.29 0.42 32.88 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.43 99.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.623 1.169 . . . . 0.0 113.652 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 69' ' ' ILE . 30.5 pt -51.29 -21.55 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 112.071 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -66.67 -10.42 46.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.516 0.727 . . . . 0.0 112.23 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.56 9.92 11.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.769 0.828 . . . . 0.0 110.211 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.81 -156.27 0.71 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 108.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.73 -2.33 14.3 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.58 -136.77 19.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.61 1.76 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.17 0.988 . . . . 0.0 113.35 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.72 23.57 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.589 0.631 . . . . 0.0 111.917 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 82' ' ' THR . 88.8 m -63.37 0.24 0.73 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.938 0.895 . . . . 0.0 113.354 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt 52.73 85.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.74 171.1 0.95 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.018 1.327 . . . . 0.0 111.364 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -140.72 164.59 29.79 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.643 1.177 . . . . 0.0 109.891 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.01 3.81 0.06 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 t -152.4 18.07 0.63 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 110.013 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.59 177.24 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.696 0.76 . . . . 0.0 110.355 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.39 153.76 37.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -135.16 157.19 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 133.72 5.02 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.96 134.33 61.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.3 144.37 53.19 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.383 0.673 . . . . 0.0 110.29 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 66.6 Cg_endo -80.41 175.26 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.693 3.595 . . . . 0.0 110.187 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 77.1 Cg_endo . . . . . 0 N--CA 1.457 -0.654 0 C-N-CA 123.168 2.578 . . . . 0.0 112.176 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.85 128.02 34.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.109 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.21 128.75 35.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 110.282 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 m -140.18 -175.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.14 0.495 . . . . 0.0 110.643 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.809 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.24 132.36 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -109.73 147.63 32.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.6 mt -126.1 155.53 41.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -143.64 159.55 42.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.37 -147.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.458 0.303 . . . . 0.0 111.033 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -56.13 -13.65 2.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.59 -30.94 66.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.16 0.891 . . . . 0.0 110.072 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.83 -30.13 67.56 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.347 0.659 . . . . 0.0 109.711 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -78.89 -18.66 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.282 0.633 . . . . 0.0 112.133 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -95.28 3.23 54.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.763 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.02 -8.99 3.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.789 0.836 . . . . 0.0 110.673 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 8.25 50.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.6 p -141.35 144.48 34.27 Favored Pre-proline 0 N--CA 1.457 -0.12 0 CA-C-N 118.05 0.925 . . . . 0.0 110.41 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.84 -21.14 12.77 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.244 2.629 . . . . 0.0 111.197 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -164.93 159.6 18.34 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.738 0.415 . . . . 0.0 110.776 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.49 156.15 29.7 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.367 0.667 . . . . 0.0 111.759 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.58 150.24 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.669 2.913 . . . . 0.0 111.741 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.1 mt -160.63 -176.77 5.75 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.257 1.023 . . . . 0.0 109.817 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -149.06 158.16 43.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.06 158.15 15.54 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.75 -26.84 40.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.51 0.655 . . . . 0.0 109.703 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -137.92 165.9 25.39 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.437 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -46.73 -47.89 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.85 -32.48 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -68.92 -20.68 64.23 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.382 0.537 . . . . 0.0 111.439 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.9 t -93.04 -39.63 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.34 -29.26 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.321 0.51 . . . . 0.0 110.921 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.9 mt -76.87 -16.15 59.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.323 0.249 . . . . 0.0 111.221 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' HD22 ' A' ' 25' ' ' LEU . 1.8 m -94.34 -21.45 18.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.879 0.872 . . . . 0.0 110.362 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.4 tm? -67.84 -49.63 61.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.9 p -67.75 -16.03 63.92 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.038 0.535 . . . . 0.0 111.247 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.34 -44.41 75.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -97.7 -18.13 19.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -118.56 76.17 13.12 Favored Pre-proline 0 N--CA 1.455 -0.219 0 C-N-CA 123.385 0.674 . . . . 0.0 109.778 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.42 -17.22 58.88 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.89 2.393 . . . . 0.0 110.444 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.3 1.17 8.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 111.666 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -123.58 -6.38 8.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.487 0.715 . . . . 0.0 111.183 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 35.7 ttpt -63.11 -26.95 69.06 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.547 ' CE2' ' HE2' ' A' ' 51' ' ' LYS . 20.7 m-85 -117.38 27.45 9.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 109.89 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.95 -9.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.407 1.083 . . . . 0.0 108.817 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.78 -20.2 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.118 0.967 . . . . 0.0 109.268 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -131.69 162.76 29.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.695 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -83.98 132.61 34.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.274 0.63 . . . . 0.0 109.988 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HE2' ' CE2' ' A' ' 46' ' ' TYR . 51.6 tttm . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 125.115 1.366 . . . . 0.0 111.976 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 C--O 1.225 -0.217 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.947 0.403 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.24 146.15 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -129.95 163.18 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.715 0.406 . . . . 0.0 110.403 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 mm -134.05 105.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 55.07 7.69 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.195 0.598 . . . . 0.0 111.952 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.14 -4.64 31.73 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.731 0.681 . . . . 0.0 112.175 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -73.12 -2.57 22.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.08 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 113.729 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.72 -20.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -66.01 -10.01 35.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.947 0.499 . . . . 0.0 111.655 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -117.79 8.21 12.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.532 0.733 . . . . 0.0 110.656 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.01 -156.68 0.72 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.269 1.028 . . . . 0.0 109.162 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.0 -3.44 19.54 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -137.62 20.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.12 -0.66 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.91 25.32 5.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.303 0.502 . . . . 0.0 111.349 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.1 m -65.77 -2.29 3.58 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.352 0.661 . . . . 0.0 111.381 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt 60.37 166.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.257 1.023 . . . . 0.0 110.958 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.47 171.55 14.21 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.829 0.852 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -139.96 167.29 22.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.892 0.877 . . . . 0.0 109.86 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -66.97 8.39 0.28 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -151.78 17.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.06 -179.7 2.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.75 0.786 . . . . 0.0 109.993 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -153.54 153.37 32.27 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mm -128.99 156.88 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.49 138.34 8.38 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.01 127.62 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.81 144.87 55.05 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.935 0.494 . . . . 0.0 110.623 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.98 173.13 12.28 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.621 3.547 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 122.911 2.407 . . . . 0.0 111.723 175.117 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.38 31.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.25 128.87 35.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.72 -172.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -125.52 155.48 40.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.76 134.74 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -115.56 137.02 52.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.083 0.553 . . . . 0.0 109.901 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.76 160.62 16.17 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.62 159.07 43.67 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.92 -146.04 0.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.503 0.321 . . . . 0.0 111.101 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -56.66 -12.82 2.02 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -72.41 -31.35 65.44 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.07 0.85 . . . . 0.0 110.018 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -70.9 -31.04 67.56 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.003 0.521 . . . . 0.0 110.168 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.41 -33.12 69.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.783 0.433 . . . . 0.0 111.332 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.55 -23.24 25.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.615 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.5 -19.56 33.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.197 0.199 . . . . 0.0 110.495 174.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.97 1.98 60.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.6 p -144.47 149.95 45.95 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 123.798 0.839 . . . . 0.0 109.575 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 -24.52 11.77 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.776 2.317 . . . . 0.0 110.876 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.95 161.73 22.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.935 0.334 . . . . 0.0 111.395 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.476 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.36 155.74 26.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 111.59 -178.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.22 149.6 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.963 3.109 . . . . 0.0 111.733 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.0 mt -159.99 -177.11 6.08 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.265 1.026 . . . . 0.0 109.432 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -148.47 158.32 44.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 111.71 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.27 158.07 15.6 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.9 -27.39 49.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.355 0.577 . . . . 0.0 109.982 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -138.54 166.24 24.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.185 0.994 . . . . 0.0 109.588 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.62 -47.85 7.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.951 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.24 -32.93 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.91 -21.89 64.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.474 0.579 . . . . 0.0 111.412 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.05 -38.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.29 -30.45 70.87 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.633 -0.667 . . . . 0.0 110.87 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.49 -16.51 59.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.488 0.315 . . . . 0.0 111.386 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.53 ' HB3' HD22 ' A' ' 25' ' ' LEU . 3.5 m -92.53 -23.3 19.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.887 0.875 . . . . 0.0 110.613 176.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -66.91 -50.89 61.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.2 p -67.12 -15.11 63.51 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.965 0.506 . . . . 0.0 111.085 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.74 -44.22 74.26 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -98.29 -17.45 18.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.228 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -117.8 75.3 10.03 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 123.767 0.827 . . . . 0.0 109.665 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.54 -17.39 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 110.415 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.99 1.63 6.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.665 0.786 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.32 -3.59 7.41 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.724 0.81 . . . . 0.0 110.763 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.4 tttt -64.53 -23.69 67.36 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -123.19 27.68 7.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.285 0.564 . . . . 0.0 109.583 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.43 -14.57 3.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 C-N-CA 124.231 1.012 . . . . 0.0 108.832 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.35 -21.27 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.955 0.902 . . . . 0.0 108.938 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.44 160.69 33.29 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.778 0.431 . . . . 0.0 109.889 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -84.03 136.59 33.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.916 0.486 . . . . 0.0 110.099 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 124.957 1.303 . . . . 0.0 111.027 175.473 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -124.75 123.54 40.2 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -109.6 144.97 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.8 mt -128.51 161.41 29.62 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.161 0.584 . . . . 0.0 109.836 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -133.09 107.37 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 170.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 54.86 9.66 0.31 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.24 0.616 . . . . 0.0 111.623 -169.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.14 -4.08 35.51 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 123.899 0.761 . . . . 0.0 112.258 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.72 -1.36 21.54 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 50.81 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.6 1.16 . . . . 0.0 113.994 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.42 -21.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -62.08 -15.6 46.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.917 0.487 . . . . 0.0 112.267 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -113.55 8.02 17.59 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.427 0.691 . . . . 0.0 110.643 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -123.75 -155.61 0.67 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 108.986 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.08 -2.62 19.13 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.937 -0.477 . . . . 0.0 112.012 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.6 -140.17 21.57 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -60.87 -5.43 1.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.444 0.698 . . . . 0.0 112.591 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.82 22.55 12.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.417 0.687 . . . . 0.0 111.944 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 82' ' ' THR . 92.7 m -66.08 0.65 1.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.661 0.784 . . . . 0.0 112.12 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt 59.63 169.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.581 0.753 . . . . 0.0 110.645 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.54 170.76 15.18 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.759 1.224 . . . . 0.0 109.231 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.9 167.26 22.52 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.951 0.9 . . . . 0.0 109.929 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -66.56 7.59 0.32 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -151.92 17.61 0.68 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.211 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.7 178.49 2.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.86 0.838 . . . . 0.0 110.313 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -153.35 149.67 28.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.69 153.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.39 136.35 8.44 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.6 mt -118.31 128.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.57 146.36 60.19 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 122.884 0.473 . . . . 0.0 110.511 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.25 173.46 13.83 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.688 3.592 . . . . 0.0 110.497 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.454 -0.852 0 C-N-CA 122.984 2.456 . . . . 0.0 111.02 175.474 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.99 130.68 46.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -76.99 132.02 38.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -142.25 -172.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.299 0.571 . . . . 0.0 110.593 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -130.35 153.97 48.15 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.254 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.58 137.58 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -117.74 150.01 39.81 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.659 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -127.26 156.78 41.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.29 160.31 41.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.35 -147.63 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.588 0.355 . . . . 0.0 111.108 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -56.86 -10.91 1.19 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.79 -31.58 63.34 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.41 1.005 . . . . 0.0 110.189 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.35 -32.4 71.45 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.086 0.554 . . . . 0.0 109.679 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 111.637 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.8 56.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.18 -7.02 3.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.54 0.736 . . . . 0.0 110.709 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.69 43.9 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.481 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.0 p -142.15 143.98 29.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 117.996 0.898 . . . . 0.0 110.215 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.45 -17.69 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.463 2.775 . . . . 0.0 111.732 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -164.28 160.14 20.71 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.159 -0.338 . . . . 0.0 111.259 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 154.61 25.32 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 123.665 0.786 . . . . 0.0 111.47 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.49 153.0 20.54 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.848 3.032 . . . . 0.0 110.518 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.8 mt -162.95 -174.81 4.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.715 0.406 . . . . 0.0 110.341 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -146.62 160.78 41.73 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 146.69 4.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.52 -25.42 50.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.668 0.734 . . . . 0.0 110.973 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -134.45 170.89 15.07 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 124.097 0.959 . . . . 0.0 109.792 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 84' ' ' LEU . 46.2 t -56.67 -44.35 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.84 -34.64 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -69.94 -23.39 63.19 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.731 -0.606 . . . . 0.0 110.842 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.31 -45.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.12 -30.08 71.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.625 0.37 . . . . 0.0 111.733 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 mt -75.57 -16.81 60.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.149 0.431 . . . . 0.0 111.419 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.414 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -91.25 -25.28 19.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.988 0.423 . . . . 0.0 110.007 175.522 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.453 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.1 tm? -63.88 -50.5 68.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.425 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.5 p -67.51 -15.09 63.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.15 0.58 . . . . 0.0 111.579 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.29 -44.27 68.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.263 0.483 . . . . 0.0 111.377 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -95.85 -17.98 20.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.506 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.48 76.1 12.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.512 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.53 -17.61 60.15 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.118 2.545 . . . . 0.0 111.013 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.66 1.72 9.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.56 0.744 . . . . 0.0 111.257 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.46 -6.14 8.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 111.048 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.3 tttt -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD2' ' HD3' ' A' ' 51' ' ' LYS . 22.2 m-85 -122.77 28.23 7.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.114 0.483 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.57 -37.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.03 -24.58 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.489 0.716 . . . . 0.0 109.125 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.75 160.98 32.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.116 0.566 . . . . 0.0 110.584 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -84.91 138.6 32.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 46' ' ' TYR . 26.8 ttpp . . . . . 0 C--O 1.231 0.099 0 C-N-CA 123.07 0.548 . . . . 0.0 110.002 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.192 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -127.08 126.47 43.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.85 144.83 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 38.7 mt -128.11 160.27 32.51 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.7 mm -130.64 107.76 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.74 9.92 0.32 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.224 0.609 . . . . 0.0 111.704 -170.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.47 34.34 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.504 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.89 0.05 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 49.84 99.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.858 1.263 . . . . 0.0 114.145 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 pt -51.3 -21.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -61.95 -13.06 21.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -117.85 9.68 12.99 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.596 0.759 . . . . 0.0 111.018 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -124.81 -155.94 0.7 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.04 0.936 . . . . 0.0 109.497 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -70.89 -2.83 16.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.77 -138.2 21.19 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.15 0.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.782 0.833 . . . . 0.0 112.689 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.54 23.78 6.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.144 0.578 . . . . 0.0 111.453 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 82' ' ' THR . 84.9 m -62.12 -0.26 0.5 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.916 0.886 . . . . 0.0 113.297 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt 52.56 83.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 30' ' ' VAL . 4.1 mm? -58.08 169.86 0.74 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.924 1.289 . . . . 0.0 110.962 175.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.99 167.75 21.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.371 1.069 . . . . 0.0 109.924 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.48 5.95 0.16 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.1 t -153.48 17.37 0.54 Allowed 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.894 -0.503 . . . . 0.0 110.184 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -69.09 177.06 2.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.559 0.695 . . . . 0.0 111.049 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -149.54 151.47 33.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.29 152.57 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.08 129.95 4.97 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -111.45 130.92 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.05 147.96 64.78 Favored Pre-proline 0 N--CA 1.453 -0.289 0 C-N-CA 122.801 0.44 . . . . 0.0 110.593 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -79.63 174.01 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.637 3.558 . . . . 0.0 110.584 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 123.186 2.591 . . . . 0.0 110.68 174.114 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.6 mtp . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.689 0.757 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.77 131.03 45.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.822 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.52 134.29 38.34 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -142.25 -175.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.168 0.509 . . . . 0.0 110.31 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -118.48 154.94 31.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.225 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.84 124.57 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.9 153.1 25.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.25 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.7 mt -127.02 157.6 39.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.49 159.47 42.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.19 -146.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.53 0.332 . . . . 0.0 111.26 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -56.94 -10.71 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.58 -30.11 61.59 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.258 0.935 . . . . 0.0 110.292 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -71.62 -33.24 68.79 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.303 0.641 . . . . 0.0 109.708 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.09 -23.71 60.56 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.692 0.797 . . . . 0.0 112.04 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.43 1.87 56.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.32 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.8 -6.46 4.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.491 0.717 . . . . 0.0 110.581 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.87 10.42 45.55 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.661 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -140.84 143.89 33.57 Favored Pre-proline 0 N--CA 1.455 -0.196 0 CA-C-N 117.853 0.826 . . . . 0.0 110.288 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.89 -20.87 10.02 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.379 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -166.99 162.81 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.921 0.328 . . . . 0.0 111.242 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.1 155.97 16.28 Favored Pre-proline 0 N--CA 1.456 -0.148 0 C-N-CA 123.632 0.773 . . . . 0.0 110.407 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.28 156.13 33.04 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.054 2.503 . . . . 0.0 110.08 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -161.61 -176.22 5.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.134 0.973 . . . . 0.0 108.85 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -149.63 158.69 44.4 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.867 0.365 . . . . 0.0 111.689 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.62 156.45 13.32 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -77.8 -26.83 49.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.358 0.579 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -139.36 166.34 24.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.605 1.162 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -45.82 -48.61 4.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 tp -62.27 -33.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -68.11 -20.19 64.9 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.604 0.638 . . . . 0.0 111.304 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.41 -43.42 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.29 -27.54 69.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.336 -0.228 . . . . 0.0 111.108 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.07 -18.53 57.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -86.81 -31.22 20.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.8 -48.98 78.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.98 0.512 . . . . 0.0 109.654 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 p -71.64 -15.2 62.23 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.887 0.475 . . . . 0.0 111.405 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.46 -38.55 65.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.249 0.477 . . . . 0.0 111.179 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -23.25 17.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -121.52 79.22 37.85 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 123.899 0.879 . . . . 0.0 109.22 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.82 -17.28 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.022 2.481 . . . . 0.0 110.232 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.41 0.92 7.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.162 0.985 . . . . 0.0 111.374 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.98 -5.53 6.8 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.7 0.8 . . . . 0.0 111.11 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.02 -24.1 67.76 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -122.06 25.31 9.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.303 0.641 . . . . 0.0 109.808 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.04 -9.96 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.228 1.011 . . . . 0.0 108.899 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.23 -19.84 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.778 0.831 . . . . 0.0 109.509 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -130.66 161.05 32.47 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.116 0.484 . . . . 0.0 110.937 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -71.22 152.35 43.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.547 0.739 . . . . 0.0 109.634 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 CA--C 1.53 0.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.567 -178.274 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.911 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.5 mm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -124.15 123.82 41.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.9 144.36 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -127.79 162.18 27.24 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -133.09 105.88 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 55.23 8.4 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.133 0.573 . . . . 0.0 112.137 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.26 -4.84 33.49 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.973 0.797 . . . . 0.0 112.349 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.47 -1.99 20.7 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.49 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 113.808 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -49.8 -21.29 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -63.02 -13.62 37.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -114.52 7.75 16.24 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.491 0.716 . . . . 0.0 110.556 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.73 -154.95 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.025 0.93 . . . . 0.0 109.345 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.2 -13.2 61.74 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.06 0.944 . . . . 0.0 112.3 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 -141.54 18.62 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.38 4.14 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.901 0.88 . . . . 0.0 113.333 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.03 23.15 5.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.177 0.591 . . . . 0.0 111.181 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' THR . 86.5 m -66.49 -1.82 4.0 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.1 mt 60.54 167.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.549 0.74 . . . . 0.0 110.747 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.63 170.53 15.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.761 0.824 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -141.35 166.5 24.59 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.57 1.148 . . . . 0.0 109.888 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.96 -5.55 0.45 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.9 t -143.77 14.87 1.75 Allowed 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.89 179.04 2.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.494 0.664 . . . . 0.0 110.569 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.73 152.63 30.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mm -131.75 155.18 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.94 135.18 5.75 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 172.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.85 127.97 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.8 146.56 62.34 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 122.733 0.413 . . . . 0.0 110.467 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.31 172.71 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.653 3.569 . . . . 0.0 110.353 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 C-N-CA 122.843 2.362 . . . . 0.0 110.592 175.591 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.468 ' CG ' ' N ' ' A' ' 3' ' ' MET . 70.4 t60 57.31 170.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.999 1.319 . . . . 0.0 113.119 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.468 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.7 mtp -146.46 104.39 3.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 132.14 51.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.17 129.39 35.08 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -139.66 -172.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.317 0.579 . . . . 0.0 110.438 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -128.46 158.23 38.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.475 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.0 t -134.4 131.37 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -114.97 137.61 51.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.08 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -111.16 160.88 16.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -145.75 158.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.39 -145.67 0.27 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.543 0.337 . . . . 0.0 111.258 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -56.13 -12.01 1.35 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.7 -31.62 61.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 109.708 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -70.23 -32.42 70.28 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.17 0.588 . . . . 0.0 110.052 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.75 -32.53 71.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.866 0.467 . . . . 0.0 111.651 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 -23.51 23.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.395 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.47 -17.71 35.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.698 0.227 . . . . 0.0 110.722 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.84 3.29 59.27 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 p -143.94 148.71 43.29 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 123.915 0.886 . . . . 0.0 109.792 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.94 -25.55 11.88 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.954 2.436 . . . . 0.0 110.821 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.04 163.0 20.71 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.855 0.462 . . . . 0.0 110.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.5 pt? -159.59 155.72 23.57 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.279 0.632 . . . . 0.0 110.583 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.59 154.85 35.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.23 2.62 . . . . 0.0 110.217 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.6 mt -163.38 -175.31 4.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.197 0.999 . . . . 0.0 108.696 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -145.88 160.21 42.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 111.254 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.8 146.73 5.11 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -78.57 -24.51 45.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.137 -0.625 . . . . 0.0 110.379 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -132.13 171.02 14.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.931 0.892 . . . . 0.0 109.593 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -55.21 -49.12 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.5 -32.73 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -68.61 -21.91 64.46 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.6 -46.07 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.53 -39.93 68.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.469 1.107 . . . . 0.0 111.803 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.3 mt -72.4 -18.24 61.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -88.38 -30.93 19.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.957 0.344 . . . . 0.0 110.409 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.77 -48.97 79.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -70.64 -14.77 62.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.135 0.574 . . . . 0.0 111.824 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 -40.99 71.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.251 0.478 . . . . 0.0 111.964 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.53 -18.32 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.026 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -116.97 75.84 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.949 0.899 . . . . 0.0 109.085 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -64.88 -16.81 57.22 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.887 2.391 . . . . 0.0 110.303 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.31 -0.64 8.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.113 0.965 . . . . 0.0 111.489 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.7 mt -124.86 -5.19 7.49 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 110.96 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.61 -24.17 67.5 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.4 25.08 10.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.165 0.586 . . . . 0.0 109.838 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.55 -15.19 5.52 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 124.296 1.039 . . . . 0.0 108.755 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.16 -21.05 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.783 0.833 . . . . 0.0 109.316 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.86 159.65 35.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.224 0.535 . . . . 0.0 111.446 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.83 135.5 37.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.881 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -75.95 54.19 0.82 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.114 1.366 . . . . 0.0 111.449 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.7 -179.81 17.77 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 55' ' ' LYS . 30.2 m-20 45.56 44.22 9.8 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.709 0.804 . . . . 0.0 111.987 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.5 15.84 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.141 0.976 . . . . 0.0 113.572 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 53' ' ' ASP . 54.8 mtmt -131.69 13.05 4.91 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.071 0.948 . . . . 0.0 110.368 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -150.0 -167.07 2.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 124.317 1.047 . . . . 0.0 109.265 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -117.03 10.78 14.06 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.594 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.5 mm -74.04 134.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.8 mt -133.2 168.4 18.62 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.596 0.759 . . . . 0.0 109.794 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.1 mt -141.0 131.81 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 tp -61.83 143.34 56.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.0 t -57.46 159.38 4.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.98 18.74 55.34 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.7 m -137.79 -5.68 1.72 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.508 0.723 . . . . 0.0 112.023 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.7 mm -91.33 160.6 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.086 0.469 . . . . 0.0 110.588 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -126.35 130.29 50.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -114.8 144.29 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 36.2 mt -128.43 160.23 32.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.83 0.452 . . . . 0.0 109.963 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -132.19 108.43 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 54.86 10.71 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.943 0.497 . . . . 0.0 111.502 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.35 -3.04 43.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.889 0.757 . . . . 0.0 112.637 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.64 -0.95 25.34 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.5 t-20 51.15 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.731 1.212 . . . . 0.0 113.849 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.6 pt -51.47 -21.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.931 -0.48 . . . . 0.0 112.264 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -62.84 -12.21 23.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -118.18 9.4 12.6 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.564 0.746 . . . . 0.0 110.83 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.81 -155.73 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.219 1.008 . . . . 0.0 109.6 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -70.34 -3.79 19.08 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.48 21.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.89 2.29 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 112.773 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.17 23.44 6.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.433 0.693 . . . . 0.0 111.466 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 82' ' ' THR . 87.2 m -61.92 -0.8 0.53 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.119 0.967 . . . . 0.0 113.26 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 mt 53.02 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.83 0.824 . . . . 0.0 113.045 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.05 174.78 0.59 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 111.57 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 55.2 mtpt -140.91 166.23 25.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.182 0.993 . . . . 0.0 110.785 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.38 5.4 0.28 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.1 t -153.04 16.35 0.56 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.861 0.3 . . . . 0.0 110.232 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 11.7 m-20 -68.03 177.94 2.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 111.345 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -149.19 151.95 35.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.07 154.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.74 134.93 7.39 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.7 mt -116.54 129.42 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.29 146.98 63.15 Favored Pre-proline 0 N--CA 1.454 -0.261 0 C-N-CA 122.342 0.257 . . . . 0.0 110.855 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 97.7 Cg_endo -78.01 174.89 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.558 3.505 . . . . 0.0 110.626 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.9 Cg_endo -67.66 169.92 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.775 2.316 . . . . 0.0 110.912 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.75 161.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.104 0.961 . . . . 0.0 110.321 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.5 m 52.74 18.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.728 0.811 . . . . 0.0 112.956 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.18 179.05 45.49 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 117.25 -1.861 . . . . 0.0 110.797 179.494 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.109 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 3' ' ' MET . 35.8 t60 -153.89 170.02 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.24 0.616 . . . . 0.0 109.948 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.429 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 80.1 mtp -139.57 97.51 3.29 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.33 51.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -78.53 133.02 37.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.42 -173.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 0.0 110.403 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -127.75 155.69 43.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.51 125.32 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -105.82 153.67 21.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.074 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.73 155.94 45.79 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.06 159.0 43.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.55 -146.18 0.25 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.523 0.329 . . . . 0.0 110.938 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -56.36 -12.78 1.8 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.83 -30.99 64.47 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.096 0.862 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -69.26 -31.15 69.49 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.286 0.634 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.78 -19.75 58.77 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.74 0.816 . . . . 0.0 112.181 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -93.71 1.69 56.48 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.952 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.14 -9.41 3.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.731 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.62 56.87 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.297 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.3 p -142.35 140.66 19.37 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.977 0.889 . . . . 0.0 110.458 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.37 -16.16 15.44 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.263 2.642 . . . . 0.0 111.396 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.68 159.47 18.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 110.792 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.72 157.1 22.97 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 123.392 0.677 . . . . 0.0 111.19 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.99 154.2 22.55 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.308 2.672 . . . . 0.0 110.517 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.9 mt -161.61 -176.13 5.13 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.567 1.147 . . . . 0.0 108.829 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -148.77 162.27 40.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.66 156.63 10.16 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.48 -24.22 42.48 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.518 0.659 . . . . 0.0 110.001 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -140.57 172.06 13.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.086 0.954 . . . . 0.0 109.85 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 84' ' ' LEU . 43.5 t -56.22 -44.85 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.42 -34.01 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.5 -23.12 63.57 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.8 -0.562 . . . . 0.0 111.179 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.44 -39.8 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.9 -31.62 71.54 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.095 -0.378 . . . . 0.0 111.155 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.56 -20.62 58.51 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.094 0.406 . . . . 0.0 110.697 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -85.55 -26.77 25.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.895 0.878 . . . . 0.0 110.351 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.82 -50.63 61.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.332 0.653 . . . . 0.0 109.452 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.2 p -68.25 -13.49 62.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.696 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.34 -37.93 74.76 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -106.77 -18.02 14.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.452 0.47 . . . . 0.0 111.107 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -116.98 74.06 6.78 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 123.953 0.901 . . . . 0.0 108.744 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.98 -16.91 57.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.748 2.299 . . . . 0.0 110.308 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.08 0.45 7.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.952 0.901 . . . . 0.0 111.525 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 17' ' ' ALA . 91.5 mt -123.41 -4.91 8.28 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.52 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 78.1 tttt -62.36 -23.51 66.83 Favored 'General case' 0 CA--C 1.526 0.041 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.68 26.16 8.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.217 0.607 . . . . 0.0 109.579 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.24 -8.85 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.327 1.051 . . . . 0.0 108.754 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.12 -19.99 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.181 0.992 . . . . 0.0 109.332 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -132.46 162.09 32.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.098 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -78.09 135.47 37.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.292 0.637 . . . . 0.0 109.882 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -74.5 30.45 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.129 1.371 . . . . 0.0 111.487 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.92 0.79 86.36 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 122.076 -0.39 . . . . 0.0 112.391 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -142.06 126.01 17.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.866 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -143.15 4.79 1.45 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.324 0.649 . . . . 0.0 111.985 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -145.88 158.17 43.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.899 0.88 . . . . 0.0 110.01 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.08 1.94 29.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.164 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.05 131.95 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.4 mt -140.13 173.03 11.92 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.564 0.746 . . . . 0.0 110.235 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.1 mt -139.35 127.45 26.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -57.94 133.77 55.77 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' N ' HD13 ' A' ' 61' ' ' LEU . 5.7 t -56.98 162.79 2.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.082 0.468 . . . . 0.0 111.497 -176.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.42 18.88 52.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.8 p -138.5 -5.19 1.59 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.269 0.628 . . . . 0.0 112.096 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.74 159.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 122.9 0.48 . . . . 0.0 110.625 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.81 131.58 53.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.14 143.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.7 mt -127.69 160.62 31.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.73 0.412 . . . . 0.0 110.215 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mm -132.06 108.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 54.52 11.02 0.38 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.997 0.519 . . . . 0.0 111.598 -170.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.73 -3.7 42.3 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.71 0.671 . . . . 0.0 112.259 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -77.07 -0.41 24.6 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.4 t-20 51.23 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.774 1.23 . . . . 0.0 114.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 pt -51.41 -21.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.862 -0.524 . . . . 0.0 112.012 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -62.97 -11.65 20.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.053 0.541 . . . . 0.0 112.256 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.76 9.89 11.5 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.522 0.729 . . . . 0.0 110.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.6 mt -124.62 -155.73 0.68 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.361 1.065 . . . . 0.0 109.269 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -69.6 -4.75 20.58 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.9 -138.54 20.92 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.11 1.18 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.48 26.52 5.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.294 0.638 . . . . 0.0 111.403 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 82' ' ' THR . 85.6 m -62.93 0.42 0.55 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.529 0.731 . . . . 0.0 112.916 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.6 mt 51.82 83.64 0.05 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.42 169.58 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.77 1.228 . . . . 0.0 111.097 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -140.01 166.91 23.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.579 1.152 . . . . 0.0 110.051 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.04 4.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 115.805 1.779 . . . . 0.0 115.805 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -152.81 16.83 0.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.334 0.516 . . . . 0.0 110.576 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.25 177.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.67 0.747 . . . . 0.0 110.886 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.64 153.41 36.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.734 0.814 . . . . 0.0 109.067 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.28 157.01 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.24 134.59 6.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.81 131.12 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.46 145.38 56.23 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 122.658 0.383 . . . . 0.0 111.11 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 70.8 Cg_endo -79.19 171.68 15.86 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.947 3.765 . . . . 0.0 110.554 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 49.8 Cg_endo -66.01 -13.71 41.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.179 2.586 . . . . 0.0 113.368 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -83.5 8.11 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.416 0.553 . . . . 0.0 111.304 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -156.82 177.89 10.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.384 0.274 . . . . 0.0 110.558 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.22 -16.08 0.11 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.505 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 117.378 -1.79 . . . . 0.0 110.867 179.123 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 59.4 t60 -152.68 169.22 23.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.256 0.622 . . . . 0.0 110.193 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.5 mtp -140.61 102.75 4.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 128.66 36.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.035 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 128.49 34.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.401 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.23 -175.8 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 110.451 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -120.35 154.22 35.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.851 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -134.1 124.59 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -113.29 133.34 55.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.222 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -102.56 161.31 13.82 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -145.35 159.03 43.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.35 -148.77 0.2 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.365 0.266 . . . . 0.0 111.359 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -56.29 -12.21 1.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.34 -30.55 66.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.058 0.845 . . . . 0.0 110.002 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -68.44 -32.62 72.77 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.321 0.648 . . . . 0.0 109.964 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.45 -31.9 65.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.796 0.438 . . . . 0.0 111.508 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.98 -26.44 25.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.299 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.78 -18.35 44.46 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.855 0.298 . . . . 0.0 110.436 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.4 2.16 59.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.4 p -144.36 150.3 47.58 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 124.094 0.958 . . . . 0.0 109.653 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.19 -25.0 12.0 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.065 2.51 . . . . 0.0 111.135 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -166.51 163.85 17.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.593 0.235 . . . . 0.0 110.99 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.32 155.73 17.53 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.555 0.742 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.58 155.36 31.61 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.216 2.611 . . . . 0.0 109.844 171.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.2 mt -160.26 -175.44 5.05 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.686 0.794 . . . . 0.0 108.925 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -149.21 158.98 44.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.06 157.1 14.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.57 -25.71 38.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.506 0.653 . . . . 0.0 109.291 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.18 165.96 25.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.502 1.121 . . . . 0.0 109.089 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 t -45.55 -54.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.19 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.12 -32.58 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -66.58 -21.57 66.14 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.634 -0.666 . . . . 0.0 111.169 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.98 -45.04 16.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.11 -36.45 65.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.733 0.813 . . . . 0.0 111.605 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.16 -17.83 60.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -86.22 -33.65 20.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.128 0.422 . . . . 0.0 110.161 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.55 -49.56 75.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.98 0.512 . . . . 0.0 109.624 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.1 p -69.57 -16.55 63.43 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.789 0.436 . . . . 0.0 112.025 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.21 -37.26 72.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 111.945 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.28 -20.27 14.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.784 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.95 74.65 13.24 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.95 0.9 . . . . 0.0 108.837 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.78 -17.22 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.914 2.409 . . . . 0.0 110.054 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.58 1.78 6.1 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 111.563 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -125.11 -6.42 7.21 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.576 0.75 . . . . 0.0 111.36 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 33.2 ttpt -63.34 -26.74 68.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.088 -0.383 . . . . 0.0 111.796 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 m-85 -117.56 27.37 9.1 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.267 0.627 . . . . 0.0 110.067 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.9 -7.47 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.274 1.03 . . . . 0.0 108.99 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.87 -23.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.129 0.972 . . . . 0.0 109.121 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.62 164.62 21.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.801 0.44 . . . . 0.0 110.113 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -75.91 174.42 9.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.436 0.694 . . . . 0.0 110.451 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 34.0 ttmt -119.23 32.36 6.15 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.357 1.063 . . . . 0.0 110.015 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.25 23.44 9.73 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.781 0.705 . . . . 0.0 112.805 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -137.85 132.26 32.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.4 6.21 2.3 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.424 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -142.13 8.98 1.87 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.214 0.606 . . . . 0.0 111.72 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -149.82 -165.66 2.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.04 0.536 . . . . 0.0 109.948 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.06 14.76 7.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 128.55 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.34 167.56 12.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.278 0.631 . . . . 0.0 110.063 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.7 mt -141.41 123.64 14.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.42 132.17 52.89 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.7 t -57.4 161.05 3.63 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 111.245 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.76 18.67 54.63 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.8 m -137.08 -1.87 2.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.379 0.671 . . . . 0.0 111.684 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.31 157.96 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.089 0.556 . . . . 0.0 110.374 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.48 129.22 52.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.98 138.42 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 35.3 mt -125.6 161.62 26.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.472 0.177 . . . . 0.0 110.723 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.2 mm -132.66 106.31 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 171.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 54.84 9.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.266 0.626 . . . . 0.0 112.2 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.91 -4.02 36.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.778 0.704 . . . . 0.0 112.257 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.31 -4.33 38.59 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 27.0 t-20 47.64 106.75 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.765 1.626 . . . . 0.0 114.989 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -53.04 -21.59 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -67.58 -10.21 49.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.586 0.754 . . . . 0.0 111.51 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.84 9.47 13.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.756 0.822 . . . . 0.0 110.664 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.61 -156.54 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 109.132 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -67.1 -8.64 32.28 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.23 -139.2 18.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.85 -0.82 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.842 0.857 . . . . 0.0 113.054 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.83 26.05 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.052 0.541 . . . . 0.0 111.347 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.7 m -66.08 -1.64 3.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.415 0.686 . . . . 0.0 111.296 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.95 167.76 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.024 0.929 . . . . 0.0 111.249 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.41 174.41 10.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.398 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -142.22 166.37 24.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 110.348 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.04 7.24 0.41 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -149.96 14.36 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.2 179.11 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.73 0.776 . . . . 0.0 110.853 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.08 152.7 32.71 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 mm -131.34 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.59 138.09 8.74 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.34 128.39 74.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.61 144.9 51.06 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.569 0.348 . . . . 0.0 111.037 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 62.3 Cg_endo -80.35 172.25 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 125.262 3.975 . . . . 0.0 110.99 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 68.4 Cg_endo -71.65 -13.62 29.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.336 2.691 . . . . 0.0 113.039 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -145.05 140.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 118.489 0.586 . . . . 0.0 109.657 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 t -152.76 171.78 17.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.873 0.469 . . . . 0.0 110.249 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.84 178.32 48.42 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.475 -1.736 . . . . 0.0 110.262 -179.623 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.21 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 66.7 t60 -152.85 168.99 23.93 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.077 0.551 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 88.2 mtp -140.61 105.24 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.49 126.51 28.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.95 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.27 126.61 31.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.249 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.14 -172.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 110.777 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -123.58 152.5 41.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.696 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.44 133.33 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -113.68 148.21 36.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.102 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.0 mt -127.03 157.91 38.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -145.05 160.36 41.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -173.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.08 -145.44 0.2 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.6 0.36 . . . . 0.0 110.88 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -58.91 -9.95 2.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.61 -30.92 61.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.082 0.855 . . . . 0.0 110.054 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -69.89 -33.08 71.73 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -72.54 -22.93 60.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.672 0.789 . . . . 0.0 111.808 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.283 0.365 . . . . 0.0 111.053 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.12 -7.37 3.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.523 0.729 . . . . 0.0 110.731 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 7.42 44.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.596 0.617 . . . . 0.0 112.152 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.8 p -142.75 144.68 30.78 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-N 117.825 0.812 . . . . 0.0 110.193 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.63 -16.14 13.32 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.097 2.531 . . . . 0.0 111.722 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -164.81 158.67 17.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.124 0.42 . . . . 0.0 111.585 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 155.01 26.16 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 123.615 0.766 . . . . 0.0 111.238 177.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.21 152.34 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.802 3.001 . . . . 0.0 110.857 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -162.92 -176.9 5.16 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.355 0.662 . . . . 0.0 109.659 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -148.12 159.39 43.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.709 0.29 . . . . 0.0 111.564 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 155.49 11.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 174.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.57 -28.69 56.32 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.007 -0.702 . . . . 0.0 110.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -137.16 167.39 21.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.171 0.988 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.46 -54.71 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.71 -32.51 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -66.8 -21.74 66.04 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 121.473 -0.767 . . . . 0.0 111.118 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.81 -44.15 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -37.4 66.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 35' ' ' LEU . 39.9 mt -73.74 -16.68 61.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 -25.79 17.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.928 0.394 . . . . 0.0 110.174 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.37 -48.81 76.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -69.08 -15.98 63.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.056 0.542 . . . . 0.0 111.289 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -71.52 -46.9 58.39 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.921 0.328 . . . . 0.0 111.524 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -92.88 -19.3 21.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.253 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -118.25 77.21 12.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.681 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.89 -16.62 56.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.009 2.472 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.89 2.22 7.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.696 0.798 . . . . 0.0 111.41 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.69 -6.62 7.43 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.707 0.803 . . . . 0.0 111.021 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -62.07 -22.91 66.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.84 0.456 . . . . 0.0 111.978 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.74 25.35 8.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.058 0.543 . . . . 0.0 109.817 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.7 t -126.57 -8.51 4.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.459 1.104 . . . . 0.0 109.07 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.29 -19.17 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.113 0.965 . . . . 0.0 109.18 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.94 161.05 32.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.023 0.44 . . . . 0.0 110.907 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.9 133.24 35.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.367 0.667 . . . . 0.0 109.997 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -75.26 47.84 0.39 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.992 1.317 . . . . 0.0 110.556 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.31 1.0 46.76 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.141 0.4 . . . . 0.0 112.423 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -80.4 25.95 0.39 Allowed 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.599 0.759 . . . . 0.0 111.988 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.07 0.29 1.33 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -140.48 11.02 2.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.848 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 t -150.26 -163.5 1.79 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.793 0.806 . . . . 0.0 110.909 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.43 25.03 3.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.352 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.7 mm -119.13 114.53 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.17 0.988 . . . . 0.0 109.649 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.47 171.5 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.168 0.509 . . . . 0.0 111.115 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.8 mt -140.25 125.96 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -58.2 135.69 57.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' N ' HD13 ' A' ' 61' ' ' LEU . 11.3 t -58.92 165.94 2.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.098 0.475 . . . . 0.0 111.176 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.44 20.06 28.25 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.9 m -138.24 -0.84 1.99 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.875 0.87 . . . . 0.0 111.578 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.7 mm -102.12 149.3 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 122.912 0.485 . . . . 0.0 110.025 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -117.71 124.88 49.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.6 mt -121.35 148.18 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.213 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.9 mt -130.08 162.71 28.17 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.175 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.401 HG12 ' CG2' ' A' ' 74' ' ' ILE . 35.6 mm -135.31 108.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.22 10.24 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.949 0.5 . . . . 0.0 111.74 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.69 -3.05 39.09 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.874 0.75 . . . . 0.0 112.386 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -77.05 0.37 21.6 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.29 97.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.838 1.255 . . . . 0.0 114.202 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.401 ' CG2' HG12 ' A' ' 69' ' ' ILE . 26.7 pt -50.38 -20.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -64.03 -16.88 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.575 0.625 . . . . 0.0 111.878 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -110.99 6.9 21.35 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.492 0.717 . . . . 0.0 110.579 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.03 -157.34 0.76 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.788 0.835 . . . . 0.0 109.399 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -73.56 -0.54 15.49 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.97 -137.11 20.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.87 -2.48 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.837 0.855 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.68 21.62 7.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.345 0.521 . . . . 0.0 111.421 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 82' ' ' THR . 89.3 m -65.61 -0.9 2.28 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.779 0.832 . . . . 0.0 112.261 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt 60.38 164.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.231 1.012 . . . . 0.0 110.918 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.4 mt -138.45 169.98 16.83 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.697 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 4.5 mptt -136.49 167.36 21.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.03 0.932 . . . . 0.0 111.475 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.84 7.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.685 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.7 t -152.05 16.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -69.76 -179.97 1.98 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.592 0.71 . . . . 0.0 110.365 174.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -155.32 152.57 29.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mm -127.45 154.55 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.08 127.41 2.77 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.21 132.36 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.79 146.41 60.1 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.174 0.59 . . . . 0.0 110.683 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 98.3 Cg_endo -78.43 173.19 14.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.78 3.653 . . . . 0.0 110.252 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.2 Cg_endo -66.21 -2.46 7.03 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.191 2.594 . . . . 0.0 112.893 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.4 t -66.38 -13.51 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 C-N-CA 122.965 0.506 . . . . 0.0 110.884 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.4 t -157.16 177.0 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.219 -0.301 . . . . 0.0 110.348 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.85 -14.97 0.09 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.961 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.382 -1.788 . . . . 0.0 110.823 179.499 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' CG ' ' N ' ' A' ' 3' ' ' MET . 79.3 t60 -153.02 167.78 28.05 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.977 0.511 . . . . 0.0 110.394 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.438 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 88.1 mtp -141.48 105.09 4.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.37 131.82 50.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.35 129.56 35.14 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.03 -173.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.179 0.592 . . . . 0.0 110.422 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -127.43 157.2 40.64 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.345 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -136.69 128.03 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 47.3 mtmt -113.71 139.96 48.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.766 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.97 160.55 16.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.63 159.64 42.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.84 -151.79 0.17 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.379 0.272 . . . . 0.0 110.719 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -56.11 -11.97 1.33 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.36 -30.71 69.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.877 0.762 . . . . 0.0 109.92 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.45 -33.39 69.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.601 0.76 . . . . 0.0 110.35 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -70.6 -32.13 69.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 122.845 0.458 . . . . 0.0 111.653 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.82 -23.74 25.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.683 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.09 -17.49 37.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.321 0.248 . . . . 0.0 110.351 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.06 2.74 58.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.2 p -143.77 149.39 46.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.61 0.764 . . . . 0.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.56 -26.69 11.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.954 2.436 . . . . 0.0 110.952 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.66 163.23 19.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.987 0.515 . . . . 0.0 110.185 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.09 156.72 24.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.967 0.507 . . . . 0.0 110.766 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.34 156.01 36.98 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.1 2.533 . . . . 0.0 110.287 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.4 mt -163.61 -175.39 4.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.958 0.903 . . . . 0.0 108.782 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -146.55 160.48 42.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 111.275 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.02 150.93 6.63 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.93 -24.18 41.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.647 0.723 . . . . 0.0 110.275 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -134.98 171.48 14.36 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.282 1.033 . . . . 0.0 109.826 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HD21 ' A' ' 84' ' ' LEU . 46.4 t -56.42 -45.5 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.13 -35.54 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.94 -22.92 64.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.737 0.699 . . . . 0.0 111.008 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.04 -44.13 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -32.03 73.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.201 0.2 . . . . 0.0 111.373 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.8 -18.43 60.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -86.23 -30.96 21.96 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.966 0.412 . . . . 0.0 110.025 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.94 -46.8 89.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.1 p -70.96 -15.2 62.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.075 0.55 . . . . 0.0 111.771 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.18 -40.89 70.97 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.301 0.5 . . . . 0.0 112.14 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -101.92 -18.55 15.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.175 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -117.13 75.04 7.72 Favored Pre-proline 0 N--CA 1.454 -0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.115 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.2 -16.62 56.0 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.892 2.395 . . . . 0.0 110.382 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 0.08 6.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.042 0.937 . . . . 0.0 111.65 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.4 mt -125.52 -4.85 7.14 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.868 0.867 . . . . 0.0 110.825 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.6 tttt -62.35 -23.98 67.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.65 0.38 . . . . 0.0 112.013 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.7 28.64 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.718 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.7 -10.08 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.45 1.1 . . . . 0.0 109.123 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.7 mt -121.49 -18.65 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.972 0.909 . . . . 0.0 108.936 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.13 163.16 29.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.43 0.634 . . . . 0.0 111.147 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.42 169.33 17.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.512 1.125 . . . . 0.0 109.646 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -121.42 32.17 6.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.952 1.301 . . . . 0.0 109.235 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.85 -3.87 69.5 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.575 -0.569 . . . . 0.0 113.524 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -144.15 131.05 20.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.064 0.932 . . . . 0.0 109.281 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.13 15.01 8.44 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.056 0.943 . . . . 0.0 111.048 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.75 -0.04 3.9 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.067 0.947 . . . . 0.0 110.564 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 m -146.74 163.95 34.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.521 1.128 . . . . 0.0 110.452 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.85 4.5 29.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.579 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.04 127.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.2 mt -136.18 165.66 25.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.043 0.937 . . . . 0.0 110.097 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -144.33 138.7 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.476 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -58.25 144.68 40.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.04 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.476 ' H ' HD13 ' A' ' 61' ' ' LEU . 5.5 t -58.56 -1.76 0.17 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.87 5.61 9.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.837 1.208 . . . . 0.0 114.574 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.3 m -138.94 -13.88 1.2 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.44 1.12 . . . . 0.0 112.391 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.7 mm -73.12 150.52 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.85 125.06 53.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.0 mt -123.04 147.56 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.786 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 33.9 mt -130.76 158.02 41.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.566 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.32 108.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 m120 54.12 10.42 0.29 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.211 0.605 . . . . 0.0 111.835 -170.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.29 33.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.913 0.768 . . . . 0.0 112.615 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.97 -0.1 23.13 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.9 t-20 50.73 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 113.767 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.1 pt -49.99 -21.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -63.21 -15.61 57.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -115.75 9.73 15.23 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.464 0.706 . . . . 0.0 110.608 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.6 mt -123.19 -154.52 0.61 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.872 0.869 . . . . 0.0 109.069 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.59 -14.73 61.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.609 0.764 . . . . 0.0 111.774 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.61 -137.99 15.85 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.16 4.95 0.11 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.818 0.847 . . . . 0.0 113.242 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -131.62 27.38 4.68 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.453 0.701 . . . . 0.0 111.155 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 82' ' ' THR . 94.8 m -62.96 -1.01 0.78 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt 53.33 83.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.671 0.748 . . . . 0.0 112.643 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.402 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.98 170.67 0.61 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.036 1.334 . . . . 0.0 111.417 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 38.0 mtmm -140.45 166.36 24.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.043 0.937 . . . . 0.0 110.65 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -62.6 4.65 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -151.91 15.51 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.383 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 34.0 m-20 -66.3 175.11 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.703 0.764 . . . . 0.0 111.933 174.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.94 150.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.985 0.914 . . . . 0.0 109.103 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -133.81 155.51 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.84 133.88 6.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.6 mt -117.94 129.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.46 146.77 59.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.41 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.02 171.22 18.37 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.852 3.035 . . . . 0.0 110.673 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.95 0.79 6.64 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.777 2.985 . . . . 0.0 113.067 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.1 m 40.42 26.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.265 1.826 . . . . 0.0 115.037 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.6 t -153.9 3.55 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.615 0.366 . . . . 0.0 111.407 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -172.03 18.32 0.06 OUTLIER Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.701 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.28 -1.844 . . . . 0.0 110.87 -177.476 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 51.1 t60 -153.68 170.58 20.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.368 0.667 . . . . 0.0 110.196 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 83.3 mtp -140.68 100.72 3.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.25 128.62 36.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.99 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.8 129.85 35.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 110.09 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 m -140.11 -175.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.348 0.594 . . . . 0.0 110.458 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -119.97 156.42 30.88 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.52 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.93 123.84 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -108.39 152.23 24.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.27 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -127.22 156.46 41.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -143.62 158.35 43.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -150.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.53 0.332 . . . . 0.0 110.95 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -55.95 -11.17 0.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.41 -30.66 67.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.271 0.942 . . . . 0.0 110.028 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -68.89 -38.75 79.83 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.234 0.613 . . . . 0.0 109.705 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.54 -37.43 79.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.648 0.779 . . . . 0.0 111.286 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.13 -0.5 19.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.086 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.85 -6.01 4.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.519 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.33 35.31 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.152 0.882 . . . . 0.0 113.028 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.5 p -141.22 144.46 34.6 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 118.077 0.939 . . . . 0.0 110.472 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.47 -24.73 8.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.284 2.656 . . . . 0.0 111.574 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -167.41 162.72 14.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 23' ' ' LEU . 2.5 pt? -161.03 155.58 19.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.239 0.616 . . . . 0.0 110.659 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.35 154.33 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.261 2.64 . . . . 0.0 110.62 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -161.86 -177.55 5.9 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.797 0.839 . . . . 0.0 108.885 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -147.54 160.48 42.58 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.009 0.433 . . . . 0.0 111.774 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.72 158.16 16.31 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.23 -25.76 39.44 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.937 -0.743 . . . . 0.0 109.466 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -138.1 165.95 25.35 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.638 1.175 . . . . 0.0 109.225 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.9 t -45.56 -54.3 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.93 -32.26 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -68.19 -21.58 64.87 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.595 -0.69 . . . . 0.0 111.34 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.48 -45.79 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.45 -36.99 64.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.64 0.776 . . . . 0.0 111.573 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 35' ' ' LEU . 43.3 mt -74.32 -17.66 60.81 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -87.7 -32.53 19.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.78 -50.63 72.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.8 p -71.05 -14.37 62.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.46 0.704 . . . . 0.0 111.815 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.88 -37.22 70.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 118.339 0.518 . . . . 0.0 112.166 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -103.7 -19.31 14.36 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.37 75.16 11.74 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 123.97 0.908 . . . . 0.0 108.963 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.08 -17.99 61.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.113 2.542 . . . . 0.0 110.087 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 1.21 5.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.089 0.955 . . . . 0.0 111.277 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.72 -5.71 6.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.675 0.79 . . . . 0.0 111.249 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.34 -24.05 67.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.096 -0.378 . . . . 0.0 112.005 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.96 24.58 10.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.46 0.704 . . . . 0.0 109.635 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.49 -6.78 5.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 C-N-CA 124.592 1.157 . . . . 0.0 109.006 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.63 -21.55 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.73 0.812 . . . . 0.0 109.217 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -131.08 163.55 27.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.898 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.92 157.97 35.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.997 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -89.49 22.65 2.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.002 0.921 . . . . 0.0 112.525 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.12 -176.95 44.31 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-O 121.947 0.748 . . . . 0.0 113.913 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -146.43 147.91 31.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 0.0 107.62 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.2 -10.01 55.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -143.93 -0.74 1.01 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.237 0.926 . . . . 0.0 113.208 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 t -157.07 -157.69 0.7 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 110.616 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -127.9 11.6 6.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.891 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.66 119.8 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.81 164.48 10.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.291 0.637 . . . . 0.0 111.669 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.6 mt -139.49 129.01 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.72 130.79 48.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.8 t -54.31 153.52 5.3 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.882 0.372 . . . . 0.0 111.099 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 13.54 66.1 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.608 -0.551 . . . . 0.0 112.801 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.55 -6.4 1.34 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.912 0.856 . . . . 0.0 112.465 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm -82.19 159.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.663 0.785 . . . . 0.0 110.257 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -123.27 129.15 50.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.32 146.23 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 mt -130.65 163.51 27.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.5 0.32 . . . . 0.0 110.45 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.4 mm -134.77 106.74 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 54.45 8.81 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.984 0.514 . . . . 0.0 112.119 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.94 -3.76 35.86 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.666 0.65 . . . . 0.0 112.317 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -74.39 -1.69 22.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 50.75 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 113.55 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.0 pt -49.68 -21.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -63.46 -13.98 46.09 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -113.73 7.85 17.3 Favored 'General case' 0 N--CA 1.46 0.044 0 C-N-CA 123.3 0.64 . . . . 0.0 110.73 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.88 -156.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.225 1.01 . . . . 0.0 108.948 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.41 -2.32 18.95 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.66 21.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.28 -2.32 0.45 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.892 0.877 . . . . 0.0 112.703 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -124.63 24.57 7.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.172 0.589 . . . . 0.0 111.256 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' THR . 88.9 m -65.59 -1.62 2.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.324 0.65 . . . . 0.0 111.293 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.62 168.02 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 110.558 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.7 mt -138.15 172.66 12.59 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.626 0.77 . . . . 0.0 110.008 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -140.74 167.77 21.38 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.933 0.893 . . . . 0.0 109.818 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.37 8.71 0.29 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t -150.65 15.79 0.78 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.135 0.493 . . . . 0.0 110.035 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.59 -179.83 2.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.693 0.759 . . . . 0.0 110.28 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -154.26 152.89 30.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.42 155.84 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.91 7.1 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 mt -122.52 127.6 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mp -131.79 144.82 54.85 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.272 0.629 . . . . 0.0 110.361 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.75 172.36 11.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 124.634 3.556 . . . . 0.0 109.869 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.38 176.3 5.84 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.099 2.533 . . . . 0.0 111.008 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.27 16.5 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.974 0.51 . . . . 0.0 110.808 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -150.9 13.15 0.7 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.323 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.04 179.24 46.45 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.938 -1.479 . . . . 0.0 111.428 179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.442 ' CG ' ' N ' ' A' ' 3' ' ' MET . 47.8 t60 -153.87 170.17 21.65 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.338 0.655 . . . . 0.0 110.234 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.442 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 82.2 mtp -140.34 99.81 3.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.33 131.34 47.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.36 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.27 133.39 38.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -143.11 -171.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.175 0.512 . . . . 0.0 110.777 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -131.16 156.98 44.37 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.782 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.0 t -128.45 137.53 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.85 138.65 52.58 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.877 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -111.75 160.53 17.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -145.79 158.61 43.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.68 -147.09 0.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.461 0.305 . . . . 0.0 111.318 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -57.16 -8.69 0.74 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.86 -31.75 59.43 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.345 0.975 . . . . 0.0 109.771 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -71.46 -32.65 68.54 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.092 0.557 . . . . 0.0 109.888 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -68.34 -35.41 77.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.718 0.407 . . . . 0.0 110.19 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.27 -27.23 38.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.42 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.61 -17.86 27.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.781 0.432 . . . . 0.0 110.944 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.14 4.88 69.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.2 p -144.19 145.31 29.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.656 0.782 . . . . 0.0 109.658 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.08 -25.43 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.047 2.498 . . . . 0.0 110.823 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.86 161.65 23.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.444 0.298 . . . . 0.0 111.265 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.99 155.18 23.88 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.526 0.73 . . . . 0.0 111.759 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.4 150.68 19.74 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.001 3.134 . . . . 0.0 111.386 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 36' ' ' SER . 9.8 mt -160.96 -174.63 4.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.159 0.984 . . . . 0.0 109.655 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -147.95 163.39 36.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.33 154.39 9.09 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.17 -23.92 43.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.475 0.637 . . . . 0.0 109.848 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -140.12 172.92 12.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.162 0.985 . . . . 0.0 109.767 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.85 -49.56 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -62.01 -31.53 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.83 -20.9 63.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.553 -0.717 . . . . 0.0 110.856 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.19 -42.08 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.98 -40.95 77.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.866 0.866 . . . . 0.0 111.499 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.3 -15.63 60.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.661 0.267 . . . . 0.0 111.245 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . 2.2 m -93.61 -23.01 18.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.456 1.102 . . . . 0.0 110.712 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -70.57 -51.3 29.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -66.47 -13.33 60.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.824 0.45 . . . . 0.0 111.048 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.62 -44.74 70.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.485 0.314 . . . . 0.0 111.671 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -98.34 -17.73 18.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.077 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -117.86 75.99 10.69 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 109.454 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.62 -16.93 57.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.724 2.283 . . . . 0.0 110.506 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.7 0.36 9.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.009 0.923 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.7 -5.04 8.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.825 0.85 . . . . 0.0 110.886 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.36 -23.32 66.95 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.57 27.76 8.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.992 0.517 . . . . 0.0 109.659 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.5 -38.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -85.05 -24.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -130.5 165.7 22.12 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.038 0.535 . . . . 0.0 111.035 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -87.51 142.76 27.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -73.41 39.05 0.1 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 111.838 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -17.88 65.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.709 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -150.0 113.72 5.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.063 0.931 . . . . 0.0 109.851 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.14 2.79 37.88 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -139.78 8.87 2.37 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.8 m -142.1 165.04 28.54 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.495 0.664 . . . . 0.0 111.518 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -77.78 -5.32 50.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.859 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 58' ' ' ILE . 4.7 mp -72.75 126.39 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.8 mt -143.34 173.63 11.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.938 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.9 mt -139.06 123.19 19.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 127.5 31.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 t -55.45 147.77 16.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.62 17.21 45.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.719 0.676 . . . . 0.0 111.573 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.1 m -134.99 -7.92 2.35 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.779 -176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 mm -90.09 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.004 0.522 . . . . 0.0 110.456 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -125.49 123.86 40.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -111.9 135.67 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -122.13 161.28 23.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -125.54 111.61 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 56.02 10.13 0.55 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.203 0.601 . . . . 0.0 112.154 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.38 15.31 9.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.335 0.493 . . . . 0.0 111.971 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -123.66 93.74 4.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.683 1.193 . . . . 0.0 109.438 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -39.15 109.73 0.12 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.749 1.62 . . . . 0.0 111.961 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 pt -50.03 -23.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.22 -8.36 12.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.898 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -121.76 8.21 9.98 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.386 1.074 . . . . 0.0 110.644 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.78 -153.89 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.538 1.135 . . . . 0.0 108.659 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.53 -15.37 60.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.54 0.736 . . . . 0.0 111.864 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 89.3 -142.56 16.85 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.0 5.27 0.06 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.881 0.873 . . . . 0.0 112.895 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.7 mt-10 -130.51 26.92 5.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.606 0.639 . . . . 0.0 111.587 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.436 ' O ' HG22 ' A' ' 82' ' ' THR . 88.7 m -63.47 -0.13 0.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.603 0.761 . . . . 0.0 112.838 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt 52.61 79.67 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.505 0.669 . . . . 0.0 112.777 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.45 165.25 1.14 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.942 1.297 . . . . 0.0 111.107 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -133.77 167.42 20.57 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.205 1.002 . . . . 0.0 109.558 -178.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.98 5.98 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -153.76 19.58 0.53 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.812 -0.555 . . . . 0.0 110.175 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.73 178.22 3.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.758 0.79 . . . . 0.0 110.468 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.05 151.52 31.22 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.83 150.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.63 130.33 5.95 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.52 128.38 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.62 147.72 65.71 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 122.451 0.3 . . . . 0.0 110.642 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 67.7 Cg_endo -79.61 175.23 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.9 3.733 . . . . 0.0 110.244 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo -67.22 170.89 12.36 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.826 2.35 . . . . 0.0 110.727 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.8 151.38 20.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.367 0.667 . . . . 0.0 109.467 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -153.22 175.85 12.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.969 0.508 . . . . 0.0 110.141 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.32 -15.85 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.184 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 117.168 -1.907 . . . . 0.0 110.62 178.943 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 3' ' ' MET . 68.2 t60 -152.64 168.25 26.24 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.812 0.445 . . . . 0.0 110.267 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.441 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.9 mtp -140.48 103.66 4.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.72 131.98 50.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 130.24 35.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.29 -173.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 110.54 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -127.76 157.52 40.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 169.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.8 127.47 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -108.49 152.34 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.494 0.717 . . . . 0.0 109.5 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.78 156.71 43.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.56 159.77 42.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.11 -148.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.504 0.322 . . . . 0.0 111.219 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.14 -9.99 0.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.63 -31.89 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.292 0.951 . . . . 0.0 109.724 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.08 -35.83 74.49 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.322 0.649 . . . . 0.0 110.071 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -68.22 -33.59 74.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.885 0.874 . . . . 0.0 110.723 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -2.74 40.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.875 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.0 -5.83 3.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.533 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.17 11.22 44.92 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.659 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.0 p -141.54 144.21 32.65 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 118.276 1.038 . . . . 0.0 110.571 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 -20.13 11.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.425 2.75 . . . . 0.0 111.62 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.12 162.02 19.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.65 0.38 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.91 155.24 24.19 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.235 0.614 . . . . 0.0 111.247 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.27 154.03 28.21 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.244 2.629 . . . . 0.0 110.09 172.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -163.75 -176.04 4.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.948 0.899 . . . . 0.0 109.253 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.26 161.66 40.5 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.69 155.76 10.32 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -79.09 -24.99 43.08 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.529 0.664 . . . . 0.0 110.047 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -140.61 172.5 12.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.944 0.898 . . . . 0.0 109.733 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 84' ' ' LEU . 41.7 t -55.72 -43.89 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.47 -35.01 74.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.98 -21.44 65.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.696 -0.628 . . . . 0.0 110.638 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -86.23 -45.27 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.71 -29.54 70.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 119.546 -0.264 . . . . 0.0 111.389 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -74.44 -19.12 60.52 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.098 0.408 . . . . 0.0 111.928 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.86 -31.13 20.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.077 0.465 . . . . 0.0 109.876 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.65 -48.87 79.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.412 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 73.5 p -71.44 -13.97 62.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.404 0.681 . . . . 0.0 112.11 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.65 -38.6 70.68 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.284 0.493 . . . . 0.0 111.769 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -104.34 -17.66 14.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.331 0.394 . . . . 0.0 111.575 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -117.4 75.8 9.1 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.44 -17.68 60.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.052 2.502 . . . . 0.0 110.224 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 0.25 6.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.974 0.91 . . . . 0.0 111.568 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.8 -6.83 7.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.903 0.881 . . . . 0.0 110.937 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 82.0 tttt -65.38 -23.37 66.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.431 0.292 . . . . 0.0 111.621 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -118.96 27.67 8.74 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.078 0.551 . . . . 0.0 109.894 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.94 -35.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 123.849 0.86 . . . . 0.0 108.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG13 ' A' ' 65' ' ' ILE . 96.8 mt -88.11 -24.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.37 163.27 30.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.689 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.11 147.57 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.688 0.795 . . . . 0.0 109.409 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -75.22 36.76 0.12 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.75 1.22 . . . . 0.0 110.756 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.86 29.66 6.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.307 0.956 . . . . 0.0 112.354 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -130.13 20.24 5.37 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.546 0.738 . . . . 0.0 112.313 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.07 -1.55 4.35 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -141.4 8.83 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.902 0.881 . . . . 0.0 111.124 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -144.49 -170.04 3.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.797 0.839 . . . . 0.0 109.875 -176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -131.05 24.14 4.92 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.3 mm -124.0 116.5 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.143 0.977 . . . . 0.0 109.723 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.5 mt -84.24 175.05 9.68 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.297 0.57 . . . . 0.0 111.065 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -141.87 131.04 23.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -57.51 141.29 48.26 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.421 ' H ' HD13 ' A' ' 61' ' ' LEU . 5.5 t -59.14 -2.39 0.27 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.06 7.11 15.32 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.373 0.987 . . . . 0.0 114.537 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -139.19 -14.77 1.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.254 1.027 . . . . 0.0 112.39 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 48' ' ' ILE . 18.1 mm -71.01 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.259 0.624 . . . . 0.0 109.741 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -121.14 126.23 49.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.75 143.03 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.4 mt -125.93 159.87 31.46 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.4 mm -130.93 107.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 54.38 11.2 0.38 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.192 0.597 . . . . 0.0 111.604 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.86 39.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.861 0.743 . . . . 0.0 112.596 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.44 -1.33 26.52 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.06 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.97 1.308 . . . . 0.0 113.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.62 -21.33 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.725 -0.609 . . . . 0.0 112.177 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.54 -11.53 25.07 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.291 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.37 9.95 11.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.443 0.697 . . . . 0.0 110.79 175.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.7 -155.49 0.67 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.216 1.006 . . . . 0.0 109.436 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.13 -5.57 18.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.74 0.416 . . . . 0.0 111.965 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.19 -141.16 22.05 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.82 5.82 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 113.079 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.4 mt-10 -130.38 25.53 5.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.406 0.682 . . . . 0.0 111.308 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 82' ' ' THR . 90.5 m -62.26 0.97 0.37 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.986 0.914 . . . . 0.0 113.168 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.7 mt 51.77 84.27 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -58.63 171.56 0.61 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.963 1.305 . . . . 0.0 111.422 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.82 166.74 23.82 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.187 0.995 . . . . 0.0 110.877 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.57 4.6 0.24 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -151.96 15.58 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.992 -0.443 . . . . 0.0 110.363 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.2 m-20 -66.99 177.76 1.62 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.541 0.686 . . . . 0.0 111.593 174.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -149.4 151.28 33.78 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.05 0.94 . . . . 0.0 108.786 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.41 157.81 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.72 133.18 5.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.62 130.43 66.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.21 146.48 56.43 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 122.858 0.463 . . . . 0.0 110.911 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.93 166.77 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.437 3.425 . . . . 0.0 110.755 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -72.87 5.46 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.286 3.324 . . . . 0.0 113.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.01 14.1 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.385 0.674 . . . . 0.0 112.42 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 t -157.43 176.92 12.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.6 10.24 0.7 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.61 -1.661 . . . . 0.0 110.747 -179.674 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.443 ' CG ' ' N ' ' A' ' 3' ' ' MET . 68.1 t60 -153.13 169.06 23.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.025 0.53 . . . . 0.0 110.376 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.443 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.5 mtp -141.73 104.28 4.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 131.14 48.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.04 132.92 37.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 m -142.1 -174.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.226 0.536 . . . . 0.0 111.022 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -126.67 155.77 42.09 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -137.77 128.07 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -113.9 138.61 50.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.903 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.74 161.12 15.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -145.87 158.88 43.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.78 -147.66 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.421 0.288 . . . . 0.0 111.239 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.93 -11.38 1.44 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.56 -31.06 64.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.193 0.906 . . . . 0.0 110.084 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -70.26 -33.32 71.46 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.047 0.539 . . . . 0.0 109.922 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.22 -31.84 69.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.881 0.472 . . . . 0.0 111.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.05 -23.1 22.64 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.611 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.69 -18.56 34.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.707 0.23 . . . . 0.0 110.841 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.37 62.65 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.2 p -144.4 145.85 30.61 Favored Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.833 0.853 . . . . 0.0 109.727 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.92 -26.03 11.46 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.114 2.543 . . . . 0.0 110.953 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -164.95 163.85 20.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 110.095 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -162.58 157.78 19.09 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.081 0.553 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.3 155.0 28.68 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.145 2.564 . . . . 0.0 110.136 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.5 mt -161.25 -176.64 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.046 0.938 . . . . 0.0 108.678 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -147.72 157.77 43.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 111.452 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.82 148.77 5.8 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -77.71 -24.97 49.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.783 0.791 . . . . 0.0 110.452 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.03 170.84 15.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.946 0.898 . . . . 0.0 109.939 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.7 -45.28 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -33.92 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -69.87 -20.98 63.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.359 0.527 . . . . 0.0 111.537 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.86 -40.58 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.23 -33.31 75.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.875 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.76 -18.73 60.94 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.87 0.304 . . . . 0.0 110.936 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -26.75 20.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.923 0.889 . . . . 0.0 110.729 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -67.75 -51.28 50.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 76.3 p -67.48 -13.37 61.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.119 0.568 . . . . 0.0 111.634 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.76 -39.43 80.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -106.26 -17.38 14.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -116.58 73.08 5.63 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.969 . . . . 0.0 108.98 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -64.14 -17.18 58.76 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.904 2.403 . . . . 0.0 110.444 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -1.07 9.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.006 0.922 . . . . 0.0 111.434 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 -4.73 8.99 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.889 0.875 . . . . 0.0 110.906 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.3 -22.68 66.87 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.15 28.91 6.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.8 t -125.48 -41.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.04 -24.69 10.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -130.0 167.46 18.22 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.231 0.612 . . . . 0.0 109.903 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.07 146.84 23.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -72.76 35.35 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.814 1.246 . . . . 0.0 112.044 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.12 26.0 2.2 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.403 1.001 . . . . 0.0 112.435 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.88 21.94 6.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.812 0.845 . . . . 0.0 111.659 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.59 -5.17 14.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.12 10.88 1.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.071 0.949 . . . . 0.0 110.916 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -144.05 -166.3 2.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.914 0.885 . . . . 0.0 109.701 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.93 24.53 4.27 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.427 0.691 . . . . 0.0 109.484 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mm -124.22 116.86 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.19 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.97 175.16 10.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.541 0.736 . . . . 0.0 111.123 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.79 122.74 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.56 123.47 17.48 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.5 t -58.98 136.6 57.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.83 81.7 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 m -84.0 -17.83 39.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.375 0.67 . . . . 0.0 111.439 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.53 151.08 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.64 0.776 . . . . 0.0 109.829 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -118.4 126.43 52.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.578 ' C ' HD22 ' A' ' 68' ' ' LEU . 29.5 mt -124.67 136.61 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.756 0.789 . . . . 0.0 110.141 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -126.18 152.9 45.38 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.966 -172.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 74' ' ' ILE . 37.8 mm -124.17 100.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 64.55 0.92 1.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.189 0.995 . . . . 0.0 110.475 -172.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.81 -0.0 19.8 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 17.9 p30 -75.83 -4.13 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.8 t30 49.06 93.83 0.01 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.181 1.392 . . . . 0.0 113.782 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 69' ' ' ILE . 15.6 pt -49.2 -22.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -67.09 -10.88 54.73 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.888 0.875 . . . . 0.0 112.402 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -118.21 6.97 11.99 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.29 0.636 . . . . 0.0 110.348 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.0 mt -123.81 -154.94 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.158 0.983 . . . . 0.0 109.587 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.26 -4.49 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -132.6 19.24 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.76 -0.97 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.297 1.039 . . . . 0.0 113.61 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.35 25.81 5.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.641 0.655 . . . . 0.0 111.523 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 82' ' ' THR . 67.0 m -64.99 2.71 0.68 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.1 mt 51.95 85.0 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.77 168.9 1.55 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.915 1.286 . . . . 0.0 110.718 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -139.91 167.87 21.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.056 0.942 . . . . 0.0 110.21 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.04 5.96 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -153.08 16.8 0.56 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.316 0.507 . . . . 0.0 110.381 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 178.57 1.92 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.758 0.79 . . . . 0.0 111.202 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.81 151.54 34.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.039 0.935 . . . . 0.0 108.502 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.5 152.0 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.72 131.95 5.84 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.5 mt -118.08 131.77 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.54 148.31 66.93 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.8 0.44 . . . . 0.0 110.362 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.21 174.02 13.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.322 3.348 . . . . 0.0 110.316 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.24 160.76 46.07 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.852 2.368 . . . . 0.0 110.365 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.1 m -137.75 7.75 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.731 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -159.36 174.41 14.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.464 0.173 . . . . 0.0 110.68 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.28 -15.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.825 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.46 -1.744 . . . . 0.0 111.114 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.08 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 3' ' ' MET . 63.1 t60 -152.56 169.98 21.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.031 0.533 . . . . 0.0 110.063 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.456 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.1 mtp -140.96 103.21 4.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.6 127.71 32.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.06 126.53 30.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.242 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.33 -175.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.939 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -117.68 154.39 31.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.251 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.15 119.46 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.08 151.13 22.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.557 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -129.76 155.69 45.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -144.17 157.56 44.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.15 -152.5 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.243 0.217 . . . . 0.0 110.627 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -53.47 -14.85 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.04 -30.48 70.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.075 0.852 . . . . 0.0 110.029 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -70.7 -37.28 73.55 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.015 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -37.99 76.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.094 0.558 . . . . 0.0 111.656 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.76 -1.03 20.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.231 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.85 -7.64 5.55 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.039 0.936 . . . . 0.0 110.307 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 12.9 50.72 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.32 0.962 . . . . 0.0 112.76 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.7 p -142.01 141.86 23.08 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 118.06 0.93 . . . . 0.0 110.929 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.51 -20.91 13.58 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.585 2.857 . . . . 0.0 111.164 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.79 161.97 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.712 0.405 . . . . 0.0 110.424 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.73 156.1 27.96 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.145 0.578 . . . . 0.0 110.861 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.42 153.0 23.71 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.271 2.647 . . . . 0.0 110.299 172.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.4 mt -163.71 -179.42 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.18 0.992 . . . . 0.0 108.865 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -148.19 158.83 44.31 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.36 157.27 13.81 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.63 -26.9 50.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.037 -0.684 . . . . 0.0 109.911 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -137.59 166.59 23.53 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.032 0.933 . . . . 0.0 109.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -46.75 -49.19 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.799 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.44 -34.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.52 -20.95 65.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.567 -0.708 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.53 -45.24 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.54 -24.63 67.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -79.05 -18.58 53.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 122.048 -0.407 . . . . 0.0 112.078 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.9 -28.98 22.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 110.196 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.14 -48.61 79.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -71.65 -17.22 62.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.258 0.623 . . . . 0.0 111.925 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.22 -39.61 78.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 117.995 0.362 . . . . 0.0 111.828 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -102.38 -18.32 15.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.442 0.464 . . . . 0.0 111.247 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -117.53 74.9 8.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.743 . . . . 0.0 109.117 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.56 -17.4 59.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.81 2.34 . . . . 0.0 110.356 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.36 1.51 6.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.22 1.008 . . . . 0.0 111.29 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.91 -6.24 6.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.5 0.72 . . . . 0.0 111.529 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.6 ttpt -64.25 -27.81 69.3 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.048 -0.408 . . . . 0.0 111.92 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -115.76 26.63 9.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 110.397 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.78 -12.22 3.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.284 1.034 . . . . 0.0 109.128 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.17 -19.85 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 109.692 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.52 162.56 30.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.28 138.68 34.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.106 0.562 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.09 35.0 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.293 1.437 . . . . 0.0 111.151 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.59 26.32 5.91 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 124.133 0.873 . . . . 0.0 112.858 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -138.39 131.34 29.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.178 0.514 . . . . 0.0 110.026 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.96 4.24 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.364 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -141.82 4.27 1.69 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.109 0.564 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -145.91 -173.02 4.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.717 0.807 . . . . 0.0 109.531 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.71 15.17 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.815 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.5 mm -79.1 127.16 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.22 169.39 8.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.806 0.442 . . . . 0.0 110.196 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 mt -140.5 122.37 15.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -56.33 130.12 43.27 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.412 ' N ' HD13 ' A' ' 61' ' ' LEU . 17.9 t -56.1 155.45 6.49 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-O 121.039 0.447 . . . . 0.0 111.515 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.71 17.08 59.34 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -134.61 -5.96 2.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.694 0.798 . . . . 0.0 111.705 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.78 159.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.94 0.496 . . . . 0.0 109.88 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -125.38 122.4 36.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 mm -108.51 144.99 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -128.82 162.37 27.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.692 0.397 . . . . 0.0 110.349 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -133.53 105.74 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.82 8.78 0.24 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.234 0.614 . . . . 0.0 111.792 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.88 33.07 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.825 0.726 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -72.47 -2.18 18.62 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.04 97.35 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.804 1.242 . . . . 0.0 113.748 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.61 -20.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -62.78 -14.67 47.93 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.273 0.488 . . . . 0.0 112.113 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -112.59 6.85 18.59 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.303 0.641 . . . . 0.0 110.685 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.8 mt -123.81 -156.1 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.144 0.978 . . . . 0.0 109.604 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.57 -15.66 63.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.894 0.878 . . . . 0.0 112.345 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -139.41 15.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.75 -2.09 0.49 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 112.793 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -125.89 25.5 6.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.567 0.622 . . . . 0.0 111.595 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.7 m -66.29 -2.09 4.05 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.096 0.558 . . . . 0.0 111.491 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.98 166.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 110.332 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.3 mt -137.21 175.59 9.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.63 0.772 . . . . 0.0 110.414 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.3 mttt -141.64 167.39 22.28 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.748 0.819 . . . . 0.0 110.877 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.17 7.26 0.77 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.6 t -150.38 13.8 0.76 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.359 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.98 -179.5 1.51 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.498 0.666 . . . . 0.0 110.632 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -152.54 153.33 33.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mm -131.16 158.2 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.62 140.52 9.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.84 126.92 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.43 147.56 66.61 Favored Pre-proline 0 N--CA 1.452 -0.326 0 O-C-N 123.224 0.328 . . . . 0.0 110.689 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 88.4 Cg_endo -76.8 174.02 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.812 3.674 . . . . 0.0 110.749 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.6 Cg_endo -67.99 166.66 23.99 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.234 2.623 . . . . 0.0 110.431 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.65 -11.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.0 p -160.13 4.59 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.043 0.838 . . . . 0.0 113.068 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.5 47.44 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.241 -1.866 . . . . 0.0 110.755 -179.88 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.442 ' CG ' ' N ' ' A' ' 3' ' ' MET . 53.5 t60 -153.68 169.11 24.1 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.981 0.512 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.442 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.0 mtp -139.88 101.11 4.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.03 132.42 52.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.38 130.81 35.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.05 -173.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.282 0.563 . . . . 0.0 110.504 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -128.12 157.98 39.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.384 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.51 131.2 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -115.16 137.95 51.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.353 0.661 . . . . 0.0 109.532 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -110.26 160.01 16.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -145.05 159.17 43.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -152.63 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.313 0.245 . . . . 0.0 110.756 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -53.77 -14.06 0.85 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.59 -30.6 70.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.111 0.869 . . . . 0.0 109.844 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.57 -36.58 73.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.454 0.702 . . . . 0.0 109.967 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -40.52 81.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.73 0.412 . . . . 0.0 110.995 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.18 -27.43 59.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.792 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.31 -18.23 39.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.214 -0.303 . . . . 0.0 110.56 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.26 3.09 64.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.9 p -145.25 149.54 41.83 Favored Pre-proline 0 C--O 1.232 0.133 0 C-N-CA 123.642 0.777 . . . . 0.0 109.822 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.78 -24.65 11.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.182 2.588 . . . . 0.0 110.946 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -164.87 163.23 21.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.53 0.332 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 23' ' ' LEU . 2.4 pt? -160.42 155.33 20.85 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 123.487 0.715 . . . . 0.0 110.724 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 154.01 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.16 2.573 . . . . 0.0 110.29 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -161.3 -174.39 4.28 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.038 0.935 . . . . 0.0 108.889 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -148.86 161.09 42.55 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.761 0.315 . . . . 0.0 111.749 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.19 155.93 9.85 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.08 -24.03 43.77 Favored 'General case' 0 C--O 1.23 0.056 0 O-C-N 122.091 -0.652 . . . . 0.0 109.97 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.51 172.92 12.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.727 0.811 . . . . 0.0 109.659 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.42 -43.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.76 -36.01 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.65 -22.03 64.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.424 0.556 . . . . 0.0 111.055 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.2 t -86.64 -46.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.43 -29.4 70.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.444 0.298 . . . . 0.0 111.58 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 35' ' ' LEU . 32.7 mt -75.18 -16.45 60.5 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -88.67 -30.99 18.73 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 109.979 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.95 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.429 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 70.5 p -70.2 -15.64 62.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.237 0.615 . . . . 0.0 111.769 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.81 -38.53 73.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.324 0.511 . . . . 0.0 111.847 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -104.49 -18.25 14.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.138 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -116.86 75.5 7.35 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 124.115 0.966 . . . . 0.0 108.884 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -64.7 -16.55 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.042 2.495 . . . . 0.0 110.47 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -0.9 10.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.819 0.848 . . . . 0.0 111.486 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.53 -5.09 8.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.967 0.907 . . . . 0.0 110.958 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 76.9 tttt -63.63 -24.69 67.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.85 31.54 5.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.34 0.59 . . . . 0.0 109.46 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.23 -41.03 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.05 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.61 163.94 26.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.493 0.664 . . . . 0.0 110.989 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.83 172.13 12.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -121.49 35.06 4.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.366 1.067 . . . . 0.0 108.905 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.3 -7.96 64.76 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.758 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -146.35 130.14 17.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.608 0.704 . . . . 0.0 109.107 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.02 16.24 10.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.741 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -134.88 7.55 3.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.696 0.798 . . . . 0.0 110.716 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m -148.89 164.92 33.07 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.496 1.118 . . . . 0.0 110.015 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.23 3.29 31.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.65 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -65.34 127.27 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.46 169.91 16.78 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.717 0.807 . . . . 0.0 110.218 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.8 mt -144.3 133.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 62' ' ' CYS . 2.0 tt -57.99 127.82 34.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.413 ' N ' HD23 ' A' ' 61' ' ' LEU . 49.6 t -54.75 144.17 23.09 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.301 0.572 . . . . 0.0 111.34 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.33 15.65 16.88 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.968 0.794 . . . . 0.0 112.019 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.1 m -135.77 -8.96 2.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.266 0.626 . . . . 0.0 111.988 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mm -87.36 159.77 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.0 110.326 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.64 126.63 42.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.2 145.22 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.7 mt -129.16 159.49 35.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.9 mm -130.71 108.24 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 55.33 10.5 0.46 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.198 0.599 . . . . 0.0 111.333 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.28 -2.1 40.3 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.15 0.881 . . . . 0.0 112.424 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -81.14 1.65 30.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.57 101.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.84 1.256 . . . . 0.0 114.079 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.5 -26.41 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.964 -0.46 . . . . 0.0 112.214 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -60.87 -11.61 8.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -122.91 13.38 9.84 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.491 0.716 . . . . 0.0 111.278 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.04 -84.91 0.66 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.697 0.399 . . . . 0.0 110.558 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -144.35 1.64 1.08 Allowed 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 118.481 0.582 . . . . 0.0 111.772 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.67 -141.29 28.29 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.4 1.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -128.63 25.38 5.7 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.602 0.637 . . . . 0.0 111.834 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 82' ' ' THR . 91.4 m -63.71 0.81 0.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.9 mt 51.66 84.85 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.76 170.42 1.13 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 111.619 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 64.5 mttp -139.48 167.2 22.62 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.449 1.1 . . . . 0.0 111.657 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.29 4.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 t -153.07 16.03 0.55 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.074 -0.391 . . . . 0.0 110.201 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 6.7 m-20 -67.32 177.36 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.963 0.887 . . . . 0.0 111.351 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -148.07 151.15 35.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.44 1.096 . . . . 0.0 108.55 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.11 153.36 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.19 133.98 7.16 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.46 128.58 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.61 147.45 61.59 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 122.705 0.402 . . . . 0.0 111.006 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -79.41 174.2 12.21 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.052 3.835 . . . . 0.0 110.467 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 59.8 Cg_endo -68.88 172.3 12.01 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.139 2.559 . . . . 0.0 111.291 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 p 43.8 31.95 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.542 1.537 . . . . 0.0 113.053 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 t -154.87 174.2 15.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.069 -0.395 . . . . 0.0 110.713 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -162.73 14.93 0.12 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.717 -0.491 . . . . 0.0 112.352 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.434 -1.759 . . . . 0.0 110.773 -179.135 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 69.4 t60 -154.05 168.71 25.53 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.25 0.62 . . . . 0.0 110.43 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.9 mtp -142.43 104.36 4.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.61 130.95 48.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.39 132.58 39.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.27 -173.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.18 0.592 . . . . 0.0 110.14 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.01 158.41 38.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.3 t -130.05 138.12 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.75 152.29 37.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt -128.49 155.58 44.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.03 159.22 42.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.73 -146.18 0.27 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.432 0.293 . . . . 0.0 111.17 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -56.69 -10.68 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.05 -30.52 61.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.342 0.974 . . . . 0.0 110.125 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -70.39 -33.49 71.47 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.076 0.55 . . . . 0.0 109.6 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -72.01 -21.98 61.47 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.468 0.707 . . . . 0.0 111.718 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 1.98 56.7 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.288 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.27 -7.54 2.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.326 0.65 . . . . 0.0 110.709 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.4 9.0 48.23 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.337 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 p -141.26 144.75 35.56 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.056 0.928 . . . . 0.0 110.39 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.22 -22.4 9.77 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.319 2.68 . . . . 0.0 111.574 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.07 160.82 14.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.517 0.327 . . . . 0.0 110.639 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.64 154.42 23.07 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -178.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.06 152.65 24.58 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.684 2.923 . . . . 0.0 110.976 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.9 mt -163.6 -173.17 3.18 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.994 0.518 . . . . 0.0 110.284 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -148.36 160.64 42.81 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 111.099 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.2 149.48 6.15 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -81.24 -24.8 37.11 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 117.708 0.754 . . . . 0.0 110.388 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -132.22 170.82 14.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.245 1.018 . . . . 0.0 109.227 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.68 -48.33 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.51 -32.32 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.628 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.77 -22.61 64.28 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.654 -0.654 . . . . 0.0 110.703 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.65 -45.03 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -38.79 71.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.121 0.968 . . . . 0.0 111.821 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 mt -74.22 -14.34 60.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.91 -26.21 16.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 174.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -64.09 -49.65 71.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.3 p -68.3 -14.25 62.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.902 0.481 . . . . 0.0 111.484 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.96 -44.98 64.92 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.089 0.404 . . . . 0.0 111.397 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -95.44 -17.84 21.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -118.69 76.57 13.83 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 123.859 0.864 . . . . 0.0 109.666 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -17.19 57.96 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.102 2.535 . . . . 0.0 111.03 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.44 2.02 8.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.334 0.654 . . . . 0.0 111.358 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.0 -7.08 8.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.556 0.743 . . . . 0.0 110.718 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.09 -24.2 67.61 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.891 0.477 . . . . 0.0 112.198 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -121.17 28.57 7.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.938 0.495 . . . . 0.0 109.989 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.3 -36.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.272 1.029 . . . . 0.0 108.244 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.05 -25.4 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.607 0.763 . . . . 0.0 109.187 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.24 161.84 30.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.992 0.517 . . . . 0.0 110.791 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.81 141.41 31.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.49 43.84 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.064 1.346 . . . . 0.0 110.994 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.78 -21.36 69.22 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.491 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -151.33 117.85 5.71 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.798 0.809 . . . . 0.0 110.175 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -88.48 0.8 55.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.6 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -137.2 7.89 2.91 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.607 -0.683 . . . . 0.0 112.676 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -143.52 166.16 25.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -1.59 21.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 58' ' ' ILE . 4.6 mp -77.05 127.0 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.1 mt -138.86 168.77 19.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.13 122.79 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 125.43 21.32 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.2 t -53.18 146.54 11.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.069 0.461 . . . . 0.0 111.086 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.61 16.85 43.16 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.923 0.773 . . . . 0.0 111.584 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -134.26 -9.98 2.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.46 0.704 . . . . 0.0 111.495 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.24 161.03 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 122.871 0.468 . . . . 0.0 110.202 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -128.98 126.58 39.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.81 145.99 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.53 160.76 32.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.99 0.516 . . . . 0.0 109.642 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.13 105.58 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 55.07 8.61 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.039 0.536 . . . . 0.0 111.856 -169.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.88 -3.88 32.03 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.066 0.841 . . . . 0.0 112.419 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -76.4 -0.15 21.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 49.33 99.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 114.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.07 -21.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.62 -11.67 12.53 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -119.58 9.02 11.37 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.755 0.822 . . . . 0.0 111.541 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.73 -156.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.059 0.944 . . . . 0.0 109.485 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.89 -5.67 22.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.39 -139.44 20.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.82 2.08 0.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.896 0.878 . . . . 0.0 113.132 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -129.22 25.87 5.47 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.398 0.545 . . . . 0.0 111.553 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 82' ' ' THR . 88.9 m -62.16 -0.57 0.55 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.762 0.825 . . . . 0.0 112.991 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.29 83.51 0.06 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.72 170.89 0.72 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.039 1.335 . . . . 0.0 111.896 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -138.36 167.88 20.95 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.27 1.028 . . . . 0.0 110.404 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -64.94 7.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.8 t -152.86 17.21 0.58 Allowed 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.889 -0.507 . . . . 0.0 110.599 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.72 -179.34 2.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.199 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.42 155.26 36.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.386 0.674 . . . . 0.0 109.576 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 mm -125.79 155.13 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.01 120.95 1.63 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.7 mt -108.97 129.97 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.72 149.04 70.88 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 122.632 0.373 . . . . 0.0 110.763 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 73.1 Cg_endo -78.34 174.75 11.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 125.007 3.804 . . . . 0.0 110.076 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 45.9 Cg_endo -65.17 157.56 56.82 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.65 2.233 . . . . 0.0 111.344 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.2 m -142.67 172.94 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.658 1.183 . . . . 0.0 110.053 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -142.41 165.55 27.12 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 110.649 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.54 -15.01 0.15 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-O 119.895 -0.392 . . . . 0.0 112.395 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 CA-C-O 117.313 -1.826 . . . . 0.0 110.692 178.59 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 3' ' ' MET . 51.1 t60 -153.09 169.57 22.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.435 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.6 mtp -139.5 100.69 4.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.75 131.91 50.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.437 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.56 130.08 35.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.228 0.537 . . . . 0.0 109.753 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.69 -172.42 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.342 0.592 . . . . 0.0 110.659 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -129.88 155.98 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.903 171.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.83 135.27 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.87 139.12 50.52 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.965 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.7 mm? -110.8 160.13 17.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -145.75 159.98 42.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.62 -147.06 0.22 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.219 0.207 . . . . 0.0 111.094 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -56.47 -12.51 1.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.51 -31.87 65.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.937 0.79 . . . . 0.0 110.006 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -70.92 -32.81 69.84 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.76 -33.55 72.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.337 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.87 -24.71 26.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.265 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 -18.97 33.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.556 0.217 . . . . 0.0 110.677 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 3.17 63.01 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.8 p -144.3 148.45 41.01 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.35 -23.69 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.004 2.47 . . . . 0.0 110.883 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -163.58 162.51 24.41 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.4 0.28 . . . . 0.0 111.39 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.67 154.36 26.6 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.634 0.774 . . . . 0.0 111.515 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.77 151.59 21.92 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.599 2.866 . . . . 0.0 110.649 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.3 mt -162.0 -175.3 4.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.251 0.62 . . . . 0.0 110.04 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -147.74 162.11 39.86 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 111.444 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.14 152.26 7.7 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.51 -26.66 60.13 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.561 0.68 . . . . 0.0 110.467 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -139.9 174.43 10.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 109.897 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.76 -45.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 tp -63.79 -34.64 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.95 -22.6 65.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.466 0.575 . . . . 0.0 110.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.0 -44.76 16.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.38 -29.87 70.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.198 -0.313 . . . . 0.0 111.425 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 35' ' ' LEU . 38.8 mt -74.2 -17.89 60.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.143 -0.348 . . . . 0.0 111.472 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.435 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -91.62 -25.09 19.33 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 175.511 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.7 -49.09 76.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 81.8 p -68.68 -16.51 63.85 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.744 0.418 . . . . 0.0 111.571 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.69 -46.24 66.47 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.207 0.458 . . . . 0.0 111.809 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.0 -18.77 21.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -117.26 76.83 9.29 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.804 0.841 . . . . 0.0 109.881 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.06 -16.86 57.31 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.792 2.328 . . . . 0.0 110.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.01 2.16 7.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.792 0.837 . . . . 0.0 111.287 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.2 mt -126.77 -3.41 6.55 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 75.9 tttt -62.53 -24.46 67.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.464 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 24.2 m-85 -124.17 29.44 6.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.428 0.632 . . . . 0.0 109.422 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.41 -10.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.895 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.44 -18.38 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.835 0.854 . . . . 0.0 109.131 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -132.96 161.12 35.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.793 0.437 . . . . 0.0 110.961 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -69.44 168.63 14.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.72 0.808 . . . . 0.0 110.427 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 33.8 ttmt -114.18 28.04 9.05 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.799 0.84 . . . . 0.0 110.579 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.18 3.21 78.23 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -141.13 124.75 16.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.38 11.4 3.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.473 0.709 . . . . 0.0 110.953 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -138.87 6.3 2.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -147.58 159.22 44.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.784 0.833 . . . . 0.0 110.155 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.46 1.52 28.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.448 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.19 131.74 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.0 mt -139.55 171.99 13.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.499 0.72 . . . . 0.0 110.107 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.9 mt -141.18 135.46 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -58.24 142.23 48.35 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.458 ' H ' HD13 ' A' ' 61' ' ' LEU . 4.5 t -58.54 -2.31 0.2 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.19 3.84 7.24 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.808 1.194 . . . . 0.0 114.749 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 m -137.23 -4.37 1.9 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.35 1.075 . . . . 0.0 111.894 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.5 mm -81.61 159.9 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.328 0.651 . . . . 0.0 109.375 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -118.71 126.43 51.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.26 144.09 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 40.0 mt -128.14 159.45 35.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.73 107.95 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.67 10.75 0.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.26 0.624 . . . . 0.0 111.628 -170.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.49 -3.49 37.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.036 0.827 . . . . 0.0 112.436 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -77.26 -0.64 26.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.7 t-20 51.46 100.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.696 1.198 . . . . 0.0 113.751 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.2 pt -51.3 -21.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -64.32 -11.42 31.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.966 0.506 . . . . 0.0 112.224 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -116.86 8.95 13.7 Favored 'General case' 0 N--CA 1.46 0.038 0 C-N-CA 123.66 0.784 . . . . 0.0 110.77 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.5 -155.63 0.69 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.053 0.941 . . . . 0.0 109.201 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.59 -3.23 17.19 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.74 -140.17 22.24 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.15 3.25 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.993 0.917 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.6 mt-10 -128.34 22.72 6.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.535 0.734 . . . . 0.0 111.513 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.442 ' O ' HG22 ' A' ' 82' ' ' THR . 86.2 m -62.15 0.65 0.39 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.524 1.13 . . . . 0.0 113.333 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.27 85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.778 0.799 . . . . 0.0 112.999 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.34 171.69 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.158 1.383 . . . . 0.0 111.409 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.41 166.28 24.97 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.428 1.091 . . . . 0.0 110.88 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.3 5.25 0.28 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 t -152.7 16.6 0.59 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 117.883 0.311 . . . . 0.0 110.503 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.0 m-20 -67.44 177.57 1.88 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.878 0.847 . . . . 0.0 111.344 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.18 151.48 34.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.192 0.997 . . . . 0.0 108.526 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.52 154.39 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.39 132.37 6.06 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -115.21 129.22 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.93 144.37 50.11 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 122.654 0.382 . . . . 0.0 110.439 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -80.12 169.09 18.04 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.57 3.513 . . . . 0.0 111.174 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.16 -179.24 3.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.787 2.991 . . . . 0.0 111.055 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.84 154.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.2 0.6 . . . . 0.0 109.806 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.3 t -147.94 17.35 1.11 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.813 0.339 . . . . 0.0 111.545 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.11 16.99 0.53 Allowed Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.872 -0.517 . . . . 0.0 112.198 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 CA-C-O 117.23 -1.872 . . . . 0.0 111.125 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 64.8 t60 -152.6 169.25 23.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.007 0.523 . . . . 0.0 110.384 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.2 mtp -140.46 104.64 4.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 127.2 30.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.74 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.99 128.38 34.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.6 m -140.65 -172.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.35 0.595 . . . . 0.0 110.677 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -124.87 153.97 41.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.956 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.62 133.02 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -114.59 136.1 53.41 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.443 0.465 . . . . 0.0 109.811 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -107.49 160.34 15.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.94 160.19 41.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.68 -146.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.393 0.277 . . . . 0.0 110.991 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -57.71 -11.59 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.5 mt -72.13 -29.05 63.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.354 0.979 . . . . 0.0 109.922 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.98 -32.01 70.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.144 0.578 . . . . 0.0 109.472 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.17 -23.2 60.4 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 111.249 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 -5.72 52.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.676 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' A' ' 41' ' ' TYR . . . -115.15 -11.34 12.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.164 0.586 . . . . 0.0 110.319 173.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.26 3.01 36.08 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.6 p -143.71 149.51 47.04 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 123.896 0.878 . . . . 0.0 109.548 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.07 -22.9 14.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.829 2.353 . . . . 0.0 110.994 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.48 163.57 22.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.898 0.317 . . . . 0.0 111.547 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.03 153.98 23.34 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.893 0.877 . . . . 0.0 111.298 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.44 151.07 19.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.684 2.923 . . . . 0.0 110.796 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.7 -175.54 4.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 110.002 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -148.58 159.06 44.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.92 0.391 . . . . 0.0 111.736 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.18 154.54 10.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.94 -27.81 57.72 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 117.603 0.701 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -137.62 165.87 25.3 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.026 0.93 . . . . 0.0 109.698 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -46.05 -52.16 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 122.966 0.506 . . . . 0.0 110.196 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.0 -32.45 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -67.98 -21.22 65.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.52 -0.737 . . . . 0.0 111.137 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -45.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -54.77 -37.52 66.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.534 0.734 . . . . 0.0 111.446 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 35' ' ' LEU . 41.7 mt -73.97 -16.8 61.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.44 -26.12 17.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.939 0.399 . . . . 0.0 110.025 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.0 tm? -63.0 -50.24 71.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.406 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 72.1 p -67.51 -16.17 64.05 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.59 -45.57 65.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.852 0.296 . . . . 0.0 111.467 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -93.97 -18.32 22.02 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.247 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 18' ' ' ALA . 9.2 m-30 -118.31 77.42 13.25 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 123.955 0.902 . . . . 0.0 109.909 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.75 -17.58 59.95 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.873 2.382 . . . . 0.0 110.867 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.72 1.78 7.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.539 0.735 . . . . 0.0 111.445 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.8 mt -124.35 -5.83 7.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.704 0.802 . . . . 0.0 110.858 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.2 tttt -65.17 -23.32 67.08 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -124.27 28.06 6.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.43 -39.4 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -82.78 -28.06 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.25 164.08 23.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.891 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -73.9 171.99 12.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.277 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -125.03 64.42 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.382 1.073 . . . . 0.0 108.676 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.16 11.93 5.83 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.265 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.15 143.52 57.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.666 0.746 . . . . 0.0 110.943 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.68 45.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.376 1.47 . . . . 0.0 110.94 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 56.33 47.38 19.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.222 0.609 . . . . 0.0 110.62 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -139.95 165.63 26.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.634 1.173 . . . . 0.0 110.854 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.12 -2.51 37.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.66 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.53 129.7 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -136.11 176.21 8.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.361 0.664 . . . . 0.0 110.534 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.18 126.59 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.0 tp -57.7 136.13 56.83 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.68 151.98 23.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.859 0.362 . . . . 0.0 110.42 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.94 17.4 36.84 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.579 0.609 . . . . 0.0 111.981 -174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -138.59 -8.73 1.44 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.063 0.545 . . . . 0.0 112.403 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.5 mm -85.31 157.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 110.854 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -128.38 123.16 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.0 145.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -133.32 159.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.923 0.889 . . . . 0.0 109.21 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.407 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 34.8 mm -130.06 109.25 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 170.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.42 5.88 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.328 0.651 . . . . 0.0 111.996 -169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.18 -2.6 23.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.028 0.823 . . . . 0.0 112.811 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 18.8 p30 -74.64 -3.39 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.42 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 113.421 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -46.89 -23.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -63.34 -19.49 64.67 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -102.64 2.46 36.01 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.87 -153.89 0.57 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.445 1.098 . . . . 0.0 109.675 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.08 -15.03 58.69 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.952 0.901 . . . . 0.0 112.146 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.7 -138.22 16.61 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.18 1.33 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.187 0.995 . . . . 0.0 112.87 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -129.39 25.61 5.44 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.687 0.676 . . . . 0.0 111.625 -175.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -62.04 -8.51 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.79 0.836 . . . . 0.0 112.706 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.47 125.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.689 1.196 . . . . 0.0 112.164 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 4.5 mp -100.4 174.4 6.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.038 1.335 . . . . 0.0 110.422 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -139.91 168.61 19.42 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.752 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -68.04 8.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -151.95 18.28 0.68 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.006 -0.434 . . . . 0.0 109.939 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.01 178.92 2.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.548 0.69 . . . . 0.0 110.585 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.99 149.73 29.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -133.24 151.21 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.4 134.68 7.72 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 108.404 -1.879 . . . . 0.0 108.404 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.01 128.66 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.21 148.19 66.87 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -80.48 174.81 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.934 3.756 . . . . 0.0 109.94 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo -66.83 169.08 15.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.695 2.263 . . . . 0.0 111.26 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.5 t -142.45 149.41 19.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.671 0.788 . . . . 0.0 109.02 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -152.02 170.74 19.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.538 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.15 -179.75 48.4 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 117.494 -1.726 . . . . 0.0 110.817 -179.649 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.215 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 62.2 t60 -154.15 168.7 25.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.06 0.544 . . . . 0.0 110.193 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.4 mtp -139.82 101.48 4.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 132.55 52.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.14 128.11 33.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.32 -172.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 123.376 0.671 . . . . 0.0 110.781 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -129.85 154.78 46.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.617 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.26 136.1 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -118.16 138.14 52.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.037 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.04 160.35 16.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.88 160.38 41.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.65 -146.89 0.23 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.284 0.234 . . . . 0.0 111.085 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -57.49 -10.38 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.96 -30.71 62.66 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.129 0.877 . . . . 0.0 110.06 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -71.76 -32.07 67.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.975 0.51 . . . . 0.0 109.772 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -70.21 -30.79 67.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.0 111.531 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.79 -24.54 22.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.536 -176.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -18.34 35.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 2.11 60.45 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 149.27 45.5 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 123.82 0.848 . . . . 0.0 109.193 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.98 -20.79 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.07 2.513 . . . . 0.0 111.519 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -165.54 162.2 18.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.965 0.348 . . . . 0.0 111.359 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.486 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.02 155.75 26.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.603 0.761 . . . . 0.0 111.582 178.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.62 153.02 20.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.859 3.039 . . . . 0.0 110.846 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.4 mt -162.96 -173.46 3.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.252 0.621 . . . . 0.0 110.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.75 161.78 40.53 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 120.711 0.291 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 154.2 8.39 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -79.94 -30.45 39.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 117.489 0.644 . . . . 0.0 110.117 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -133.34 172.13 13.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.1 0.96 . . . . 0.0 109.589 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.92 -43.24 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -64.15 -34.63 70.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -68.49 -21.71 64.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 121.781 -0.574 . . . . 0.0 110.876 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.77 -44.33 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.71 -29.31 70.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.219 -0.301 . . . . 0.0 111.391 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.83 -13.93 60.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.991 0.359 . . . . 0.0 111.451 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -96.09 -24.05 16.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 109.966 175.056 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.4 -48.65 76.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.0 p -68.72 -17.87 64.13 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.009 0.524 . . . . 0.0 111.427 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.75 -44.24 74.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.155 -0.34 . . . . 0.0 111.725 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -96.2 -18.8 19.81 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.164 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.17 75.53 11.4 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.855 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.49 -16.35 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.734 2.29 . . . . 0.0 110.367 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.59 1.6 7.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.933 0.893 . . . . 0.0 111.587 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -125.38 -4.65 7.25 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.632 0.773 . . . . 0.0 111.176 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.9 ttpt -64.39 -27.84 69.29 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.78 26.21 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.406 0.683 . . . . 0.0 110.039 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 t -129.1 -11.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.972 0.909 . . . . 0.0 109.16 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.8 mt -120.45 -20.21 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.565 0.746 . . . . 0.0 109.174 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.84 159.83 38.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.611 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -70.06 154.19 42.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.636 0.774 . . . . 0.0 110.12 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.08 30.16 0.78 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.667 0.787 . . . . 0.0 111.558 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.35 178.72 43.22 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 44.83 48.62 9.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.829 0.852 . . . . 0.0 112.159 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.4 13.97 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.4 1.08 . . . . 0.0 113.87 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.65 7.38 3.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.466 0.706 . . . . 0.0 111.428 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -146.68 166.81 25.46 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.476 0.71 . . . . 0.0 110.499 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.27 1.17 38.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.4 mm -68.43 131.96 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.4 mt -136.41 171.38 14.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.584 0.754 . . . . 0.0 110.046 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -139.22 134.24 40.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -58.33 143.62 44.3 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.427 ' H ' HD13 ' A' ' 61' ' ' LEU . 4.6 t -57.63 -2.26 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.63 5.14 6.31 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.771 1.176 . . . . 0.0 114.932 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.3 m -139.03 -4.73 1.51 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.497 1.149 . . . . 0.0 111.928 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mm -80.58 160.3 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.84 126.94 52.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.88 146.9 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.95 161.55 30.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.0 mm -132.37 108.3 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 54.29 10.05 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.286 0.635 . . . . 0.0 111.701 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.58 -2.38 36.67 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.109 0.862 . . . . 0.0 112.586 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -79.75 1.91 24.87 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.39 99.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.77 1.228 . . . . 0.0 114.063 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 pt -50.12 -25.93 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -62.46 -10.01 10.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.313 0.645 . . . . 0.0 112.581 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -122.43 12.66 10.13 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.595 0.758 . . . . 0.0 111.105 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.14 -83.94 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.906 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -144.25 2.7 1.15 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.629 0.65 . . . . 0.0 111.558 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.35 -142.58 30.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.67 6.28 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.45 20.25 5.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.269 0.627 . . . . 0.0 111.301 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.6 m -61.35 -8.16 3.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.7 mt 61.32 132.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.956 1.302 . . . . 0.0 112.537 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.78 176.44 5.14 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.137 0.975 . . . . 0.0 110.319 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.6 mttt -144.4 166.28 25.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.141 0.977 . . . . 0.0 110.716 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.31 6.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -153.61 16.59 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.175 -0.328 . . . . 0.0 110.376 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 4.4 m-20 -67.55 176.6 2.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.844 0.83 . . . . 0.0 111.097 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.58 151.06 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.75 151.36 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.83 6.69 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -114.9 129.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.32 145.63 54.66 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 122.827 0.451 . . . . 0.0 110.102 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.84 170.84 17.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.108 3.206 . . . . 0.0 110.307 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.2 -7.64 21.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.398 2.732 . . . . 0.0 112.356 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.57 146.73 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 122.847 0.459 . . . . 0.0 110.013 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.6 t -153.6 171.42 18.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.678 0.391 . . . . 0.0 110.139 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.37 15.53 0.09 OUTLIER Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.73 -0.483 . . . . 0.0 112.318 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.3 -1.834 . . . . 0.0 111.148 -178.706 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.65 20.6 0.4 Allowed 'General case' 0 C--O 1.23 0.045 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp 54.96 85.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.486 0.66 . . . . 0.0 110.938 -169.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.29 142.93 56.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.711 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.58 134.22 35.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.17 -175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.998 0.519 . . . . 0.0 110.392 -173.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -126.79 155.9 42.09 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.48 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.72 117.71 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 123.686 0.794 . . . . 0.0 108.956 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.36 158.81 15.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.873 0.469 . . . . 0.0 109.96 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.8 mt -134.24 152.18 51.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -141.33 158.75 43.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 -148.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.482 0.313 . . . . 0.0 110.693 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -55.33 -14.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -68.91 -30.35 68.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.016 0.825 . . . . 0.0 110.263 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -69.01 -30.97 69.46 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.227 0.611 . . . . 0.0 110.038 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.99 -18.69 58.05 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.694 0.798 . . . . 0.0 111.611 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.91 2.33 56.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.431 0.292 . . . . 0.0 111.042 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.56 -5.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.506 0.722 . . . . 0.0 111.109 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.9 10.31 38.42 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.636 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.8 p -142.9 144.08 27.9 Favored Pre-proline 0 C--N 1.341 0.205 0 CA-C-N 117.893 0.847 . . . . 0.0 110.069 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.42 -20.23 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.39 2.727 . . . . 0.0 111.462 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -165.6 161.31 18.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.209 0.604 . . . . 0.0 110.486 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 153.3 26.97 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 122.645 0.378 . . . . 0.0 110.862 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.79 152.03 32.24 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.469 2.779 . . . . 0.0 109.897 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -161.86 -174.37 4.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -147.33 162.46 38.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.776 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.34 151.91 8.44 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.3 -25.35 46.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -140.46 173.83 11.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.824 1.25 . . . . 0.0 108.961 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -54.87 -51.37 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -59.19 -33.94 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -67.0 -20.71 65.92 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.416 -0.802 . . . . 0.0 111.157 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.43 -45.18 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.29 -38.5 71.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.196 0.999 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 35' ' ' LEU . 48.4 mt -72.85 -16.91 61.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -88.62 -32.06 18.26 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.821 0.344 . . . . 0.0 110.161 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.57 -46.43 90.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 p -73.14 -13.05 61.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.502 0.321 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.84 -42.91 63.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -100.66 -19.07 16.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.37 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -117.97 77.81 12.45 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.627 0.771 . . . . 0.0 108.996 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.96 -15.94 52.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.641 2.228 . . . . 0.0 110.158 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.19 2.22 4.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.492 1.117 . . . . 0.0 111.55 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.1 mt -124.23 -9.8 7.56 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.818 0.847 . . . . 0.0 110.675 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.86 -25.6 67.64 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -123.68 26.92 7.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.103 0.478 . . . . 0.0 109.728 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.13 -10.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 C-N-CA 124.571 1.148 . . . . 0.0 108.658 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.53 -20.55 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.78 0.832 . . . . 0.0 109.326 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.97 159.1 36.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 110.752 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 52' ' ' GLY . 25.4 mt-10 -79.59 136.78 36.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.416 0.686 . . . . 0.0 109.439 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -73.65 32.63 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.975 1.31 . . . . 0.0 110.891 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -91.05 31.3 5.72 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.175 0.893 . . . . 0.0 111.971 -174.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -125.24 17.75 8.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 111.884 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.98 3.01 2.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -139.17 3.84 2.2 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.25 1.02 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -141.38 -167.38 2.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.802 0.841 . . . . 0.0 110.2 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.79 22.73 4.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.109 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.3 mm -125.75 115.3 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.116 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.21 170.93 15.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.222 0.609 . . . . 0.0 110.646 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.27 134.03 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.01 144.43 56.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.8 t -61.0 169.65 1.88 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.153 0.501 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.97 21.07 13.84 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -137.76 -0.75 2.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.854 0.862 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.97 151.42 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.132 0.573 . . . . 0.0 110.117 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -121.86 129.39 52.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -124.39 148.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.391 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -129.13 160.14 33.8 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.415 HG12 ' CG2' ' A' ' 74' ' ' ILE . 32.5 mm -132.43 109.79 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 170.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 54.06 11.39 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.059 0.544 . . . . 0.0 111.714 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.19 -1.63 43.82 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.035 0.826 . . . . 0.0 112.509 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -80.29 0.42 32.88 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.43 99.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.623 1.169 . . . . 0.0 113.652 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 69' ' ' ILE . 30.5 pt -51.29 -21.55 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 112.071 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -66.67 -10.42 46.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.516 0.727 . . . . 0.0 112.23 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.56 9.92 11.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.769 0.828 . . . . 0.0 110.211 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.81 -156.27 0.71 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 108.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.73 -2.33 14.3 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.58 -136.77 19.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.61 1.76 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.17 0.988 . . . . 0.0 113.35 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.72 23.57 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.589 0.631 . . . . 0.0 111.917 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 82' ' ' THR . 88.8 m -63.37 0.24 0.73 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.938 0.895 . . . . 0.0 113.354 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt 52.73 85.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.74 171.1 0.95 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.018 1.327 . . . . 0.0 111.364 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -140.72 164.59 29.79 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.643 1.177 . . . . 0.0 109.891 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.01 3.81 0.06 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 t -152.4 18.07 0.63 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 110.013 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.59 177.24 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.696 0.76 . . . . 0.0 110.355 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.39 153.76 37.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -135.16 157.19 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 133.72 5.02 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.96 134.33 61.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.3 144.37 53.19 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.383 0.673 . . . . 0.0 110.29 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 66.6 Cg_endo -80.41 175.26 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.693 3.595 . . . . 0.0 110.187 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 77.1 Cg_endo -72.18 5.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.168 2.578 . . . . 0.0 112.176 174.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t 43.64 38.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.569 1.148 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.3 m 49.96 17.43 0.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.78 11.17 0.03 OUTLIER Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.15 0.886 . . . . 0.0 114.956 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.493 -1.726 . . . . 0.0 111.346 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 3' ' ' MET . 52.4 t60 -154.92 170.01 22.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.447 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.5 mtp -140.07 101.33 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.85 128.02 34.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.109 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.21 128.75 35.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 110.282 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 m -140.18 -175.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.14 0.495 . . . . 0.0 110.643 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.809 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.24 132.36 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -109.73 147.63 32.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.6 mt -126.1 155.53 41.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -143.64 159.55 42.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.37 -147.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.458 0.303 . . . . 0.0 111.033 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -56.13 -13.65 2.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.59 -30.94 66.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.16 0.891 . . . . 0.0 110.072 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.83 -30.13 67.56 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.347 0.659 . . . . 0.0 109.711 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -78.89 -18.66 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.282 0.633 . . . . 0.0 112.133 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -95.28 3.23 54.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.763 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.02 -8.99 3.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.789 0.836 . . . . 0.0 110.673 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 8.25 50.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.6 p -141.35 144.48 34.27 Favored Pre-proline 0 N--CA 1.457 -0.12 0 CA-C-N 118.05 0.925 . . . . 0.0 110.41 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.84 -21.14 12.77 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.244 2.629 . . . . 0.0 111.197 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -164.93 159.6 18.34 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.738 0.415 . . . . 0.0 110.776 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.49 156.15 29.7 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.367 0.667 . . . . 0.0 111.759 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.58 150.24 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.669 2.913 . . . . 0.0 111.741 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.1 mt -160.63 -176.77 5.75 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.257 1.023 . . . . 0.0 109.817 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -149.06 158.16 43.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.06 158.15 15.54 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.75 -26.84 40.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.51 0.655 . . . . 0.0 109.703 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -137.92 165.9 25.39 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.437 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -46.73 -47.89 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.85 -32.48 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -68.92 -20.68 64.23 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.382 0.537 . . . . 0.0 111.439 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.9 t -93.04 -39.63 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.34 -29.26 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.321 0.51 . . . . 0.0 110.921 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.9 mt -76.87 -16.15 59.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.323 0.249 . . . . 0.0 111.221 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' HD22 ' A' ' 25' ' ' LEU . 1.8 m -94.34 -21.45 18.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.879 0.872 . . . . 0.0 110.362 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.4 tm? -67.84 -49.63 61.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.9 p -67.75 -16.03 63.92 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.038 0.535 . . . . 0.0 111.247 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.34 -44.41 75.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -97.7 -18.13 19.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -118.56 76.17 13.12 Favored Pre-proline 0 N--CA 1.455 -0.219 0 C-N-CA 123.385 0.674 . . . . 0.0 109.778 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.42 -17.22 58.88 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.89 2.393 . . . . 0.0 110.444 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.3 1.17 8.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 111.666 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -123.58 -6.38 8.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.487 0.715 . . . . 0.0 111.183 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 35.7 ttpt -63.11 -26.95 69.06 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.547 ' CE2' ' HE2' ' A' ' 51' ' ' LYS . 20.7 m-85 -117.38 27.45 9.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 109.89 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.95 -9.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.407 1.083 . . . . 0.0 108.817 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.78 -20.2 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.118 0.967 . . . . 0.0 109.268 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -131.69 162.76 29.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.695 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -83.98 132.61 34.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.274 0.63 . . . . 0.0 109.988 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HE2' ' CE2' ' A' ' 46' ' ' TYR . 51.6 tttm -70.95 41.86 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.115 1.366 . . . . 0.0 111.976 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.45 -2.0 77.22 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -79.58 22.57 0.45 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.848 0.859 . . . . 0.0 112.249 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -66.9 -5.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.98 -0.45 . . . . 0.0 111.958 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -138.17 3.28 2.39 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.166 0.986 . . . . 0.0 111.191 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m -142.05 -169.4 2.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.185 0.994 . . . . 0.0 110.245 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -131.45 23.72 4.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.778 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.01 116.31 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.145 0.978 . . . . 0.0 109.872 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.33 171.32 15.05 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.225 0.61 . . . . 0.0 110.984 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -140.65 125.26 18.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -57.29 131.28 49.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.428 ' N ' HD13 ' A' ' 61' ' ' LEU . 14.6 t -57.16 160.03 4.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.783 0.433 . . . . 0.0 111.635 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.12 18.29 55.85 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.5 m -136.38 -1.55 2.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.595 0.758 . . . . 0.0 111.657 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.96 157.45 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 122.918 0.487 . . . . 0.0 110.458 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.24 146.15 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -129.95 163.18 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.715 0.406 . . . . 0.0 110.403 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 mm -134.05 105.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 55.07 7.69 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.195 0.598 . . . . 0.0 111.952 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.14 -4.64 31.73 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.731 0.681 . . . . 0.0 112.175 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -73.12 -2.57 22.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.08 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 113.729 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.72 -20.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -66.01 -10.01 35.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.947 0.499 . . . . 0.0 111.655 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -117.79 8.21 12.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.532 0.733 . . . . 0.0 110.656 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.01 -156.68 0.72 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.269 1.028 . . . . 0.0 109.162 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.0 -3.44 19.54 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -137.62 20.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.12 -0.66 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.91 25.32 5.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.303 0.502 . . . . 0.0 111.349 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.1 m -65.77 -2.29 3.58 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.352 0.661 . . . . 0.0 111.381 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt 60.37 166.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.257 1.023 . . . . 0.0 110.958 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.47 171.55 14.21 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.829 0.852 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -139.96 167.29 22.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.892 0.877 . . . . 0.0 109.86 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -66.97 8.39 0.28 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -151.78 17.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.06 -179.7 2.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.75 0.786 . . . . 0.0 109.993 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -153.54 153.37 32.27 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mm -128.99 156.88 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.49 138.34 8.38 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.01 127.62 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.81 144.87 55.05 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.935 0.494 . . . . 0.0 110.623 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.98 173.13 12.28 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.621 3.547 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.13 -8.61 24.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.911 2.407 . . . . 0.0 111.723 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 p 44.78 19.84 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.618 1.967 . . . . 0.0 114.603 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -161.22 -32.94 0.05 Allowed 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.559 -0.713 . . . . 0.0 111.996 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.81 -21.47 1.63 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.219 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 CA-C-O 117.403 -1.776 . . . . 0.0 110.938 179.275 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.2 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.439 ' CG ' ' N ' ' A' ' 3' ' ' MET . 54.4 t60 -153.59 169.86 22.22 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.124 0.57 . . . . 0.0 110.123 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.439 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.2 mtp -140.46 101.0 4.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.38 31.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.25 128.87 35.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.72 -172.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -125.52 155.48 40.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.76 134.74 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -115.56 137.02 52.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.083 0.553 . . . . 0.0 109.901 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.76 160.62 16.17 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.62 159.07 43.67 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.92 -146.04 0.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.503 0.321 . . . . 0.0 111.101 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -56.66 -12.82 2.02 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -72.41 -31.35 65.44 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.07 0.85 . . . . 0.0 110.018 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -70.9 -31.04 67.56 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.003 0.521 . . . . 0.0 110.168 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.41 -33.12 69.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.783 0.433 . . . . 0.0 111.332 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.55 -23.24 25.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.615 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.5 -19.56 33.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.197 0.199 . . . . 0.0 110.495 174.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.97 1.98 60.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.6 p -144.47 149.95 45.95 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 123.798 0.839 . . . . 0.0 109.575 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 -24.52 11.77 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.776 2.317 . . . . 0.0 110.876 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.95 161.73 22.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.935 0.334 . . . . 0.0 111.395 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.476 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.36 155.74 26.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 111.59 -178.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.22 149.6 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.963 3.109 . . . . 0.0 111.733 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.0 mt -159.99 -177.11 6.08 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.265 1.026 . . . . 0.0 109.432 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -148.47 158.32 44.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 111.71 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.27 158.07 15.6 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.9 -27.39 49.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.355 0.577 . . . . 0.0 109.982 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -138.54 166.24 24.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.185 0.994 . . . . 0.0 109.588 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.62 -47.85 7.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.951 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.24 -32.93 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.91 -21.89 64.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.474 0.579 . . . . 0.0 111.412 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.05 -38.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.29 -30.45 70.87 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.633 -0.667 . . . . 0.0 110.87 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.49 -16.51 59.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.488 0.315 . . . . 0.0 111.386 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.53 ' HB3' HD22 ' A' ' 25' ' ' LEU . 3.5 m -92.53 -23.3 19.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.887 0.875 . . . . 0.0 110.613 176.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -66.91 -50.89 61.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.2 p -67.12 -15.11 63.51 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.965 0.506 . . . . 0.0 111.085 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.74 -44.22 74.26 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -98.29 -17.45 18.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.228 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -117.8 75.3 10.03 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 123.767 0.827 . . . . 0.0 109.665 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.54 -17.39 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 110.415 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.99 1.63 6.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.665 0.786 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.32 -3.59 7.41 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.724 0.81 . . . . 0.0 110.763 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.4 tttt -64.53 -23.69 67.36 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -123.19 27.68 7.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.285 0.564 . . . . 0.0 109.583 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.43 -14.57 3.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 C-N-CA 124.231 1.012 . . . . 0.0 108.832 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.35 -21.27 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.955 0.902 . . . . 0.0 108.938 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.44 160.69 33.29 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.778 0.431 . . . . 0.0 109.889 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -84.03 136.59 33.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.916 0.486 . . . . 0.0 110.099 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.61 38.49 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.957 1.303 . . . . 0.0 111.027 175.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.9 21.78 9.08 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 123.818 0.723 . . . . 0.0 112.378 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -138.52 131.73 30.09 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.379 0.609 . . . . 0.0 110.0 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -137.54 4.07 2.59 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.114 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -142.82 3.86 1.45 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.325 0.65 . . . . 0.0 111.621 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.6 m -145.09 -166.55 2.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.672 0.789 . . . . 0.0 109.498 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.78 19.09 6.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 111.179 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 58' ' ' ILE . 4.3 mp -85.64 129.65 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -115.54 166.13 12.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.98 0.912 . . . . 0.0 109.816 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.56 121.55 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -56.84 128.0 34.5 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.417 ' N ' HD13 ' A' ' 61' ' ' LEU . 23.8 t -54.68 149.53 10.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.161 0.505 . . . . 0.0 111.4 -175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.78 16.53 56.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.5 m -133.64 -6.47 2.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.487 0.715 . . . . 0.0 111.506 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 mm -90.61 157.6 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.979 0.511 . . . . 0.0 110.128 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -124.75 123.54 40.2 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -109.6 144.97 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.8 mt -128.51 161.41 29.62 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.161 0.584 . . . . 0.0 109.836 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -133.09 107.37 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 170.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 54.86 9.66 0.31 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.24 0.616 . . . . 0.0 111.623 -169.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.14 -4.08 35.51 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 123.899 0.761 . . . . 0.0 112.258 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.72 -1.36 21.54 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 50.81 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.6 1.16 . . . . 0.0 113.994 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.42 -21.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -62.08 -15.6 46.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.917 0.487 . . . . 0.0 112.267 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -113.55 8.02 17.59 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.427 0.691 . . . . 0.0 110.643 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -123.75 -155.61 0.67 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 108.986 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.08 -2.62 19.13 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.937 -0.477 . . . . 0.0 112.012 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.6 -140.17 21.57 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -60.87 -5.43 1.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.444 0.698 . . . . 0.0 112.591 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.82 22.55 12.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.417 0.687 . . . . 0.0 111.944 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 82' ' ' THR . 92.7 m -66.08 0.65 1.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.661 0.784 . . . . 0.0 112.12 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt 59.63 169.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.581 0.753 . . . . 0.0 110.645 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.54 170.76 15.18 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.759 1.224 . . . . 0.0 109.231 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.9 167.26 22.52 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.951 0.9 . . . . 0.0 109.929 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -66.56 7.59 0.32 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -151.92 17.61 0.68 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.211 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.7 178.49 2.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.86 0.838 . . . . 0.0 110.313 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -153.35 149.67 28.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.69 153.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.39 136.35 8.44 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.6 mt -118.31 128.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.57 146.36 60.19 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 122.884 0.473 . . . . 0.0 110.511 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.25 173.46 13.83 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.688 3.592 . . . . 0.0 110.497 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.05 167.58 21.36 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.984 2.456 . . . . 0.0 111.02 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.25 6.66 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.352 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -160.17 177.26 10.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.073 -0.392 . . . . 0.0 110.471 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.49 -16.69 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.028 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 CA-C-O 117.52 -1.711 . . . . 0.0 110.734 178.981 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' CG ' ' N ' ' A' ' 3' ' ' MET . 72.0 t60 -153.17 168.62 25.33 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.012 0.525 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.438 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.4 mtp -142.05 104.87 4.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 174.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.99 130.68 46.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -76.99 132.02 38.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -142.25 -172.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.299 0.571 . . . . 0.0 110.593 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -130.35 153.97 48.15 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.254 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.58 137.58 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -117.74 150.01 39.81 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.659 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -127.26 156.78 41.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.29 160.31 41.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.35 -147.63 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.588 0.355 . . . . 0.0 111.108 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -56.86 -10.91 1.19 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.79 -31.58 63.34 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.41 1.005 . . . . 0.0 110.189 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.35 -32.4 71.45 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.086 0.554 . . . . 0.0 109.679 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 111.637 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.8 56.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.18 -7.02 3.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.54 0.736 . . . . 0.0 110.709 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.69 43.9 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.481 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.0 p -142.15 143.98 29.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 117.996 0.898 . . . . 0.0 110.215 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.45 -17.69 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.463 2.775 . . . . 0.0 111.732 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -164.28 160.14 20.71 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.159 -0.338 . . . . 0.0 111.259 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 154.61 25.32 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 123.665 0.786 . . . . 0.0 111.47 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.49 153.0 20.54 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.848 3.032 . . . . 0.0 110.518 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.8 mt -162.95 -174.81 4.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.715 0.406 . . . . 0.0 110.341 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -146.62 160.78 41.73 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 146.69 4.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.52 -25.42 50.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.668 0.734 . . . . 0.0 110.973 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -134.45 170.89 15.07 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 124.097 0.959 . . . . 0.0 109.792 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 84' ' ' LEU . 46.2 t -56.67 -44.35 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.84 -34.64 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -69.94 -23.39 63.19 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.731 -0.606 . . . . 0.0 110.842 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.31 -45.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.12 -30.08 71.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.625 0.37 . . . . 0.0 111.733 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 mt -75.57 -16.81 60.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.149 0.431 . . . . 0.0 111.419 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.414 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -91.25 -25.28 19.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.988 0.423 . . . . 0.0 110.007 175.522 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.453 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.1 tm? -63.88 -50.5 68.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.425 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.5 p -67.51 -15.09 63.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.15 0.58 . . . . 0.0 111.579 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.29 -44.27 68.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.263 0.483 . . . . 0.0 111.377 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -95.85 -17.98 20.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.506 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.48 76.1 12.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.512 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.53 -17.61 60.15 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.118 2.545 . . . . 0.0 111.013 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.66 1.72 9.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.56 0.744 . . . . 0.0 111.257 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.46 -6.14 8.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 111.048 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.3 tttt -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD2' ' HD3' ' A' ' 51' ' ' LYS . 22.2 m-85 -122.77 28.23 7.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.114 0.483 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.57 -37.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.03 -24.58 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.489 0.716 . . . . 0.0 109.125 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.75 160.98 32.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.116 0.566 . . . . 0.0 110.584 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -84.91 138.6 32.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 46' ' ' TYR . 26.8 ttpp -80.09 60.06 3.49 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.07 0.548 . . . . 0.0 110.002 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.04 -3.54 70.03 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.907 -175.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -146.15 131.58 18.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -118.39 13.14 13.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.869 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.16 3.37 2.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.343 0.657 . . . . 0.0 111.23 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m -149.25 165.02 33.15 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.058 0.943 . . . . 0.0 110.404 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.12 3.09 24.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.603 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.55 127.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -141.29 172.46 12.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.729 0.811 . . . . 0.0 110.099 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.5 mt -140.5 125.44 19.21 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.97 122.85 14.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.98 133.32 54.78 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.53 0.332 . . . . 0.0 110.745 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.18 -13.06 72.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m -89.73 -18.91 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.097 0.559 . . . . 0.0 111.881 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.48 159.24 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 110.276 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -127.08 126.47 43.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.85 144.83 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 38.7 mt -128.11 160.27 32.51 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.7 mm -130.64 107.76 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.74 9.92 0.32 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.224 0.609 . . . . 0.0 111.704 -170.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.47 34.34 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.504 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.89 0.05 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 49.84 99.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.858 1.263 . . . . 0.0 114.145 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 pt -51.3 -21.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -61.95 -13.06 21.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -117.85 9.68 12.99 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.596 0.759 . . . . 0.0 111.018 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -124.81 -155.94 0.7 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.04 0.936 . . . . 0.0 109.497 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -70.89 -2.83 16.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.77 -138.2 21.19 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.15 0.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.782 0.833 . . . . 0.0 112.689 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.54 23.78 6.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.144 0.578 . . . . 0.0 111.453 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 82' ' ' THR . 84.9 m -62.12 -0.26 0.5 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.916 0.886 . . . . 0.0 113.297 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt 52.56 83.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 30' ' ' VAL . 4.1 mm? -58.08 169.86 0.74 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.924 1.289 . . . . 0.0 110.962 175.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.99 167.75 21.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.371 1.069 . . . . 0.0 109.924 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.48 5.95 0.16 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.1 t -153.48 17.37 0.54 Allowed 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.894 -0.503 . . . . 0.0 110.184 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -69.09 177.06 2.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.559 0.695 . . . . 0.0 111.049 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -149.54 151.47 33.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.29 152.57 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.08 129.95 4.97 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -111.45 130.92 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.05 147.96 64.78 Favored Pre-proline 0 N--CA 1.453 -0.289 0 C-N-CA 122.801 0.44 . . . . 0.0 110.593 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -79.63 174.01 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.637 3.558 . . . . 0.0 110.584 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.51 168.77 17.24 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.186 2.591 . . . . 0.0 110.68 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.54 154.35 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 123.087 0.555 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.8 p -147.89 2.29 0.69 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.22 -16.59 0.15 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.261 0 CA-C-O 117.7 -1.611 . . . . 0.0 110.814 179.161 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.242 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.39 21.69 0.55 Allowed 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.6 mtp 47.81 84.22 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.087 0.955 . . . . 0.0 110.896 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.77 131.03 45.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.822 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.52 134.29 38.34 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -142.25 -175.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.168 0.509 . . . . 0.0 110.31 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -118.48 154.94 31.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.225 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.84 124.57 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.9 153.1 25.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.25 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.7 mt -127.02 157.6 39.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.49 159.47 42.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.19 -146.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.53 0.332 . . . . 0.0 111.26 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -56.94 -10.71 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.58 -30.11 61.59 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.258 0.935 . . . . 0.0 110.292 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -71.62 -33.24 68.79 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.303 0.641 . . . . 0.0 109.708 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.09 -23.71 60.56 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.692 0.797 . . . . 0.0 112.04 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.43 1.87 56.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.32 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.8 -6.46 4.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.491 0.717 . . . . 0.0 110.581 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.87 10.42 45.55 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.661 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -140.84 143.89 33.57 Favored Pre-proline 0 N--CA 1.455 -0.196 0 CA-C-N 117.853 0.826 . . . . 0.0 110.288 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.89 -20.87 10.02 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.379 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -166.99 162.81 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.921 0.328 . . . . 0.0 111.242 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.1 155.97 16.28 Favored Pre-proline 0 N--CA 1.456 -0.148 0 C-N-CA 123.632 0.773 . . . . 0.0 110.407 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.28 156.13 33.04 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.054 2.503 . . . . 0.0 110.08 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -161.61 -176.22 5.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.134 0.973 . . . . 0.0 108.85 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -149.63 158.69 44.4 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.867 0.365 . . . . 0.0 111.689 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.62 156.45 13.32 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -77.8 -26.83 49.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.358 0.579 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -139.36 166.34 24.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.605 1.162 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -45.82 -48.61 4.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 tp -62.27 -33.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -68.11 -20.19 64.9 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.604 0.638 . . . . 0.0 111.304 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.41 -43.42 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.29 -27.54 69.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.336 -0.228 . . . . 0.0 111.108 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.07 -18.53 57.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -86.81 -31.22 20.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.8 -48.98 78.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.98 0.512 . . . . 0.0 109.654 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 p -71.64 -15.2 62.23 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.887 0.475 . . . . 0.0 111.405 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.46 -38.55 65.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.249 0.477 . . . . 0.0 111.179 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -23.25 17.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -121.52 79.22 37.85 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 123.899 0.879 . . . . 0.0 109.22 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.82 -17.28 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.022 2.481 . . . . 0.0 110.232 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.41 0.92 7.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.162 0.985 . . . . 0.0 111.374 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.98 -5.53 6.8 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.7 0.8 . . . . 0.0 111.11 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.02 -24.1 67.76 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -122.06 25.31 9.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.303 0.641 . . . . 0.0 109.808 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.04 -9.96 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.228 1.011 . . . . 0.0 108.899 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.23 -19.84 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.778 0.831 . . . . 0.0 109.509 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -130.66 161.05 32.47 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.116 0.484 . . . . 0.0 110.937 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -71.22 152.35 43.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.547 0.739 . . . . 0.0 109.634 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -87.66 24.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.567 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.03 174.65 42.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 44.75 41.24 4.85 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.662 0.785 . . . . 0.0 112.071 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.97 15.46 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -131.33 7.62 4.59 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.674 0.789 . . . . 0.0 110.822 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.5 m -145.63 168.18 21.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.268 1.027 . . . . 0.0 110.447 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.44 0.53 37.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.0 mm -71.04 130.82 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.3 mt -137.96 168.73 19.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.792 0.837 . . . . 0.0 109.999 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -142.29 132.63 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.81 141.98 56.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.09 159.81 11.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.96 19.44 54.42 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 123.589 0.614 . . . . 0.0 111.746 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.0 p -140.66 -5.5 1.19 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.192 0.597 . . . . 0.0 112.344 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.5 mm -90.79 159.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.073 0.549 . . . . 0.0 110.33 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -124.15 123.82 41.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.9 144.36 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -127.79 162.18 27.24 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -133.09 105.88 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 55.23 8.4 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.133 0.573 . . . . 0.0 112.137 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.26 -4.84 33.49 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.973 0.797 . . . . 0.0 112.349 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.47 -1.99 20.7 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.49 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 113.808 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -49.8 -21.29 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -63.02 -13.62 37.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -114.52 7.75 16.24 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.491 0.716 . . . . 0.0 110.556 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.73 -154.95 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.025 0.93 . . . . 0.0 109.345 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.2 -13.2 61.74 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.06 0.944 . . . . 0.0 112.3 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 -141.54 18.62 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.38 4.14 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.901 0.88 . . . . 0.0 113.333 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.03 23.15 5.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.177 0.591 . . . . 0.0 111.181 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' THR . 86.5 m -66.49 -1.82 4.0 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.1 mt 60.54 167.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.549 0.74 . . . . 0.0 110.747 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.63 170.53 15.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.761 0.824 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -141.35 166.5 24.59 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.57 1.148 . . . . 0.0 109.888 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.96 -5.55 0.45 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.9 t -143.77 14.87 1.75 Allowed 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.89 179.04 2.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.494 0.664 . . . . 0.0 110.569 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.73 152.63 30.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mm -131.75 155.18 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.94 135.18 5.75 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 172.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.85 127.97 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.8 146.56 62.34 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 122.733 0.413 . . . . 0.0 110.467 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.31 172.71 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.653 3.569 . . . . 0.0 110.353 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.08 159.09 53.71 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.843 2.362 . . . . 0.0 110.592 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -143.23 161.56 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 110.15 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.1 m 54.14 -171.52 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.002 0.921 . . . . 0.0 112.821 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.61 179.74 47.46 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.195 -1.892 . . . . 0.0 110.98 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 132.14 51.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.17 129.39 35.08 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -139.66 -172.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.317 0.579 . . . . 0.0 110.438 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -128.46 158.23 38.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.475 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.0 t -134.4 131.37 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -114.97 137.61 51.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.08 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -111.16 160.88 16.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -145.75 158.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.39 -145.67 0.27 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.543 0.337 . . . . 0.0 111.258 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -56.13 -12.01 1.35 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.7 -31.62 61.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 109.708 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -70.23 -32.42 70.28 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.17 0.588 . . . . 0.0 110.052 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.75 -32.53 71.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.866 0.467 . . . . 0.0 111.651 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 -23.51 23.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.395 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.47 -17.71 35.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.698 0.227 . . . . 0.0 110.722 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.84 3.29 59.27 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 p -143.94 148.71 43.29 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 123.915 0.886 . . . . 0.0 109.792 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.94 -25.55 11.88 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.954 2.436 . . . . 0.0 110.821 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.04 163.0 20.71 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.855 0.462 . . . . 0.0 110.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.5 pt? -159.59 155.72 23.57 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.279 0.632 . . . . 0.0 110.583 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.59 154.85 35.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.23 2.62 . . . . 0.0 110.217 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.6 mt -163.38 -175.31 4.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.197 0.999 . . . . 0.0 108.696 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -145.88 160.21 42.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 111.254 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.8 146.73 5.11 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -78.57 -24.51 45.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.137 -0.625 . . . . 0.0 110.379 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -132.13 171.02 14.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.931 0.892 . . . . 0.0 109.593 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -55.21 -49.12 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.5 -32.73 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -68.61 -21.91 64.46 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.6 -46.07 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.53 -39.93 68.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.469 1.107 . . . . 0.0 111.803 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.3 mt -72.4 -18.24 61.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -88.38 -30.93 19.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.957 0.344 . . . . 0.0 110.409 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.77 -48.97 79.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -70.64 -14.77 62.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.135 0.574 . . . . 0.0 111.824 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 -40.99 71.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.251 0.478 . . . . 0.0 111.964 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.53 -18.32 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.026 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -116.97 75.84 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.949 0.899 . . . . 0.0 109.085 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -64.88 -16.81 57.22 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.887 2.391 . . . . 0.0 110.303 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.31 -0.64 8.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.113 0.965 . . . . 0.0 111.489 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.7 mt -124.86 -5.19 7.49 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 110.96 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.61 -24.17 67.5 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.4 25.08 10.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.165 0.586 . . . . 0.0 109.838 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.55 -15.19 5.52 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 124.296 1.039 . . . . 0.0 108.755 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.16 -21.05 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.783 0.833 . . . . 0.0 109.316 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.86 159.65 35.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.224 0.535 . . . . 0.0 111.446 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.83 135.5 37.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.881 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.5 tttt . . . . . 0 N--CA 1.453 -0.296 0 C-N-CA 125.114 1.366 . . . . 0.0 111.449 178.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.1 mt . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.04 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.086 0.469 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -126.35 130.29 50.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -114.8 144.29 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 36.2 mt -128.43 160.23 32.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.83 0.452 . . . . 0.0 109.963 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -132.19 108.43 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 54.86 10.71 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.943 0.497 . . . . 0.0 111.502 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.35 -3.04 43.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.889 0.757 . . . . 0.0 112.637 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.64 -0.95 25.34 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.5 t-20 51.15 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.731 1.212 . . . . 0.0 113.849 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.6 pt -51.47 -21.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.931 -0.48 . . . . 0.0 112.264 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -62.84 -12.21 23.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -118.18 9.4 12.6 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.564 0.746 . . . . 0.0 110.83 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.81 -155.73 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.219 1.008 . . . . 0.0 109.6 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -70.34 -3.79 19.08 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.48 21.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.89 2.29 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 112.773 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.17 23.44 6.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.433 0.693 . . . . 0.0 111.466 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' THR . 87.2 m -61.92 -0.8 0.53 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.119 0.967 . . . . 0.0 113.26 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 mt 53.02 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.83 0.824 . . . . 0.0 113.045 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.05 174.78 0.59 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 111.57 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 55.2 mtpt -140.91 166.23 25.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.182 0.993 . . . . 0.0 110.785 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.38 5.4 0.28 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.1 t -153.04 16.35 0.56 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.861 0.3 . . . . 0.0 110.232 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 11.7 m-20 -68.03 177.94 2.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 111.345 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -149.19 151.95 35.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.07 154.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.74 134.93 7.39 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.7 mt -116.54 129.42 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.29 146.98 63.15 Favored Pre-proline 0 N--CA 1.454 -0.261 0 C-N-CA 122.342 0.257 . . . . 0.0 110.855 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 97.7 Cg_endo -78.01 174.89 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.558 3.505 . . . . 0.0 110.626 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.9 Cg_endo . . . . . 0 N--CA 1.454 -0.829 0 C-N-CA 122.775 2.316 . . . . 0.0 110.912 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.1 mtp . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.33 51.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -78.53 133.02 37.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.42 -173.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 0.0 110.403 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -127.75 155.69 43.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.51 125.32 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -105.82 153.67 21.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.074 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.73 155.94 45.79 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.06 159.0 43.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.55 -146.18 0.25 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.523 0.329 . . . . 0.0 110.938 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -56.36 -12.78 1.8 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.83 -30.99 64.47 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.096 0.862 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -69.26 -31.15 69.49 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.286 0.634 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.78 -19.75 58.77 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.74 0.816 . . . . 0.0 112.181 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -93.71 1.69 56.48 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.952 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.14 -9.41 3.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.731 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.62 56.87 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.297 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.3 p -142.35 140.66 19.37 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.977 0.889 . . . . 0.0 110.458 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.37 -16.16 15.44 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.263 2.642 . . . . 0.0 111.396 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.68 159.47 18.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 110.792 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.72 157.1 22.97 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 123.392 0.677 . . . . 0.0 111.19 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.99 154.2 22.55 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.308 2.672 . . . . 0.0 110.517 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.9 mt -161.61 -176.13 5.13 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.567 1.147 . . . . 0.0 108.829 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -148.77 162.27 40.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.66 156.63 10.16 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.48 -24.22 42.48 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.518 0.659 . . . . 0.0 110.001 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -140.57 172.06 13.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.086 0.954 . . . . 0.0 109.85 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 84' ' ' LEU . 43.5 t -56.22 -44.85 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.42 -34.01 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.5 -23.12 63.57 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.8 -0.562 . . . . 0.0 111.179 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.44 -39.8 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.9 -31.62 71.54 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.095 -0.378 . . . . 0.0 111.155 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.56 -20.62 58.51 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.094 0.406 . . . . 0.0 110.697 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -85.55 -26.77 25.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.895 0.878 . . . . 0.0 110.351 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.82 -50.63 61.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.332 0.653 . . . . 0.0 109.452 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.2 p -68.25 -13.49 62.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.696 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.34 -37.93 74.76 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -106.77 -18.02 14.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.452 0.47 . . . . 0.0 111.107 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -116.98 74.06 6.78 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 123.953 0.901 . . . . 0.0 108.744 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.98 -16.91 57.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.748 2.299 . . . . 0.0 110.308 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.08 0.45 7.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.952 0.901 . . . . 0.0 111.525 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 17' ' ' ALA . 91.5 mt -123.41 -4.91 8.28 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.52 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 78.1 tttt -62.36 -23.51 66.83 Favored 'General case' 0 CA--C 1.526 0.041 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.68 26.16 8.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.217 0.607 . . . . 0.0 109.579 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.24 -8.85 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.327 1.051 . . . . 0.0 108.754 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.12 -19.99 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.181 0.992 . . . . 0.0 109.332 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -132.46 162.09 32.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.098 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -78.09 135.47 37.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.292 0.637 . . . . 0.0 109.882 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.9 tttt . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 125.129 1.371 . . . . 0.0 111.487 177.582 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--O 1.226 -0.163 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.7 mm . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.057 0.456 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.81 131.58 53.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.14 143.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.7 mt -127.69 160.62 31.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.73 0.412 . . . . 0.0 110.215 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mm -132.06 108.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 54.52 11.02 0.38 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.997 0.519 . . . . 0.0 111.598 -170.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.73 -3.7 42.3 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.71 0.671 . . . . 0.0 112.259 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -77.07 -0.41 24.6 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.4 t-20 51.23 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.774 1.23 . . . . 0.0 114.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 pt -51.41 -21.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.862 -0.524 . . . . 0.0 112.012 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -62.97 -11.65 20.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.053 0.541 . . . . 0.0 112.256 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.76 9.89 11.5 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.522 0.729 . . . . 0.0 110.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.6 mt -124.62 -155.73 0.68 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.361 1.065 . . . . 0.0 109.269 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -69.6 -4.75 20.58 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.9 -138.54 20.92 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.11 1.18 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.48 26.52 5.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.294 0.638 . . . . 0.0 111.403 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 82' ' ' THR . 85.6 m -62.93 0.42 0.55 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.529 0.731 . . . . 0.0 112.916 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.6 mt 51.82 83.64 0.05 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.42 169.58 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.77 1.228 . . . . 0.0 111.097 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -140.01 166.91 23.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.579 1.152 . . . . 0.0 110.051 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.04 4.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 115.805 1.779 . . . . 0.0 115.805 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -152.81 16.83 0.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.334 0.516 . . . . 0.0 110.576 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.25 177.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.67 0.747 . . . . 0.0 110.886 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.64 153.41 36.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.734 0.814 . . . . 0.0 109.067 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.28 157.01 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.24 134.59 6.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.81 131.12 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.46 145.38 56.23 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 122.658 0.383 . . . . 0.0 111.11 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 70.8 Cg_endo -79.19 171.68 15.86 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.947 3.765 . . . . 0.0 110.554 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 49.8 Cg_endo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 123.179 2.586 . . . . 0.0 113.368 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 128.66 36.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.035 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 128.49 34.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.401 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.23 -175.8 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 110.451 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -120.35 154.22 35.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.851 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -134.1 124.59 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -113.29 133.34 55.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.222 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -102.56 161.31 13.82 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -145.35 159.03 43.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.35 -148.77 0.2 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.365 0.266 . . . . 0.0 111.359 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -56.29 -12.21 1.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.34 -30.55 66.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.058 0.845 . . . . 0.0 110.002 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -68.44 -32.62 72.77 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.321 0.648 . . . . 0.0 109.964 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.45 -31.9 65.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.796 0.438 . . . . 0.0 111.508 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.98 -26.44 25.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.299 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.78 -18.35 44.46 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.855 0.298 . . . . 0.0 110.436 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.4 2.16 59.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.4 p -144.36 150.3 47.58 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 124.094 0.958 . . . . 0.0 109.653 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.19 -25.0 12.0 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.065 2.51 . . . . 0.0 111.135 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -166.51 163.85 17.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.593 0.235 . . . . 0.0 110.99 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.32 155.73 17.53 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.555 0.742 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.58 155.36 31.61 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.216 2.611 . . . . 0.0 109.844 171.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.2 mt -160.26 -175.44 5.05 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.686 0.794 . . . . 0.0 108.925 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -149.21 158.98 44.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.06 157.1 14.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.57 -25.71 38.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.506 0.653 . . . . 0.0 109.291 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.18 165.96 25.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.502 1.121 . . . . 0.0 109.089 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 t -45.55 -54.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.19 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.12 -32.58 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -66.58 -21.57 66.14 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.634 -0.666 . . . . 0.0 111.169 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.98 -45.04 16.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.11 -36.45 65.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.733 0.813 . . . . 0.0 111.605 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.16 -17.83 60.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -86.22 -33.65 20.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.128 0.422 . . . . 0.0 110.161 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.55 -49.56 75.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.98 0.512 . . . . 0.0 109.624 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.1 p -69.57 -16.55 63.43 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.789 0.436 . . . . 0.0 112.025 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.21 -37.26 72.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 111.945 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.28 -20.27 14.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.784 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.95 74.65 13.24 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.95 0.9 . . . . 0.0 108.837 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.78 -17.22 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.914 2.409 . . . . 0.0 110.054 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.58 1.78 6.1 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 111.563 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -125.11 -6.42 7.21 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.576 0.75 . . . . 0.0 111.36 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 33.2 ttpt -63.34 -26.74 68.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.088 -0.383 . . . . 0.0 111.796 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 m-85 -117.56 27.37 9.1 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.267 0.627 . . . . 0.0 110.067 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.9 -7.47 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.274 1.03 . . . . 0.0 108.99 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.87 -23.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.129 0.972 . . . . 0.0 109.121 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.62 164.62 21.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.801 0.44 . . . . 0.0 110.113 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -75.91 174.42 9.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.436 0.694 . . . . 0.0 110.451 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 34.0 ttmt . . . . . 0 CA--C 1.532 0.262 0 C-N-CA 124.357 1.063 . . . . 0.0 110.015 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.226 -0.176 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.009 0.433 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.48 129.22 52.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.98 138.42 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 35.3 mt -125.6 161.62 26.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.472 0.177 . . . . 0.0 110.723 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.2 mm -132.66 106.31 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 171.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 54.84 9.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.266 0.626 . . . . 0.0 112.2 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.91 -4.02 36.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.778 0.704 . . . . 0.0 112.257 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.31 -4.33 38.59 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 27.0 t-20 47.64 106.75 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.765 1.626 . . . . 0.0 114.989 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -53.04 -21.59 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -67.58 -10.21 49.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.586 0.754 . . . . 0.0 111.51 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.84 9.47 13.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.756 0.822 . . . . 0.0 110.664 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.61 -156.54 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 109.132 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -67.1 -8.64 32.28 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.23 -139.2 18.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.85 -0.82 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.842 0.857 . . . . 0.0 113.054 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.83 26.05 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.052 0.541 . . . . 0.0 111.347 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.7 m -66.08 -1.64 3.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.415 0.686 . . . . 0.0 111.296 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.95 167.76 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.024 0.929 . . . . 0.0 111.249 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.41 174.41 10.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.398 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -142.22 166.37 24.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 110.348 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.04 7.24 0.41 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -149.96 14.36 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.2 179.11 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.73 0.776 . . . . 0.0 110.853 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.08 152.7 32.71 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 mm -131.34 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.59 138.09 8.74 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.34 128.39 74.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.61 144.9 51.06 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.569 0.348 . . . . 0.0 111.037 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 62.3 Cg_endo -80.35 172.25 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 125.262 3.975 . . . . 0.0 110.99 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 68.4 Cg_endo . . . . . 0 N--CA 1.458 -0.578 0 C-N-CA 123.336 2.691 . . . . 0.0 113.039 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.49 126.51 28.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.95 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.27 126.61 31.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.249 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.14 -172.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 110.777 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -123.58 152.5 41.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.696 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.44 133.33 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -113.68 148.21 36.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.102 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.0 mt -127.03 157.91 38.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -145.05 160.36 41.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -173.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.08 -145.44 0.2 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.6 0.36 . . . . 0.0 110.88 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -58.91 -9.95 2.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.61 -30.92 61.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.082 0.855 . . . . 0.0 110.054 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -69.89 -33.08 71.73 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -72.54 -22.93 60.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.672 0.789 . . . . 0.0 111.808 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.283 0.365 . . . . 0.0 111.053 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.12 -7.37 3.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.523 0.729 . . . . 0.0 110.731 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 7.42 44.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.596 0.617 . . . . 0.0 112.152 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.8 p -142.75 144.68 30.78 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-N 117.825 0.812 . . . . 0.0 110.193 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.63 -16.14 13.32 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.097 2.531 . . . . 0.0 111.722 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -164.81 158.67 17.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.124 0.42 . . . . 0.0 111.585 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 155.01 26.16 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 123.615 0.766 . . . . 0.0 111.238 177.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.21 152.34 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.802 3.001 . . . . 0.0 110.857 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -162.92 -176.9 5.16 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.355 0.662 . . . . 0.0 109.659 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -148.12 159.39 43.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.709 0.29 . . . . 0.0 111.564 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 155.49 11.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 174.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.57 -28.69 56.32 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.007 -0.702 . . . . 0.0 110.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -137.16 167.39 21.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.171 0.988 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.46 -54.71 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.71 -32.51 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -66.8 -21.74 66.04 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 121.473 -0.767 . . . . 0.0 111.118 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.81 -44.15 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -37.4 66.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 35' ' ' LEU . 39.9 mt -73.74 -16.68 61.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 -25.79 17.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.928 0.394 . . . . 0.0 110.174 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.37 -48.81 76.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -69.08 -15.98 63.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.056 0.542 . . . . 0.0 111.289 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -71.52 -46.9 58.39 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.921 0.328 . . . . 0.0 111.524 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -92.88 -19.3 21.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.253 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -118.25 77.21 12.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.681 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.89 -16.62 56.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.009 2.472 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.89 2.22 7.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.696 0.798 . . . . 0.0 111.41 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.69 -6.62 7.43 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.707 0.803 . . . . 0.0 111.021 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -62.07 -22.91 66.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.84 0.456 . . . . 0.0 111.978 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.74 25.35 8.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.058 0.543 . . . . 0.0 109.817 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.7 t -126.57 -8.51 4.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.459 1.104 . . . . 0.0 109.07 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.29 -19.17 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.113 0.965 . . . . 0.0 109.18 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.94 161.05 32.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.023 0.44 . . . . 0.0 110.907 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.9 133.24 35.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.367 0.667 . . . . 0.0 109.997 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 124.992 1.317 . . . . 0.0 110.556 175.863 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.8 mt . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.7 mm . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 120.869 0.366 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -117.71 124.88 49.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.6 mt -121.35 148.18 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.213 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.9 mt -130.08 162.71 28.17 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.175 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.401 HG12 ' CG2' ' A' ' 74' ' ' ILE . 35.6 mm -135.31 108.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.22 10.24 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.949 0.5 . . . . 0.0 111.74 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.69 -3.05 39.09 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.874 0.75 . . . . 0.0 112.386 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -77.05 0.37 21.6 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.29 97.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.838 1.255 . . . . 0.0 114.202 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.401 ' CG2' HG12 ' A' ' 69' ' ' ILE . 26.7 pt -50.38 -20.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -64.03 -16.88 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.575 0.625 . . . . 0.0 111.878 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -110.99 6.9 21.35 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.492 0.717 . . . . 0.0 110.579 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.03 -157.34 0.76 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.788 0.835 . . . . 0.0 109.399 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -73.56 -0.54 15.49 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.97 -137.11 20.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.87 -2.48 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.837 0.855 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.68 21.62 7.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.345 0.521 . . . . 0.0 111.421 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 82' ' ' THR . 89.3 m -65.61 -0.9 2.28 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.779 0.832 . . . . 0.0 112.261 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt 60.38 164.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.231 1.012 . . . . 0.0 110.918 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.4 mt -138.45 169.98 16.83 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.697 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 4.5 mptt -136.49 167.36 21.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.03 0.932 . . . . 0.0 111.475 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.84 7.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.685 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.7 t -152.05 16.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -69.76 -179.97 1.98 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.592 0.71 . . . . 0.0 110.365 174.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -155.32 152.57 29.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mm -127.45 154.55 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.08 127.41 2.77 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.21 132.36 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.79 146.41 60.1 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.174 0.59 . . . . 0.0 110.683 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 98.3 Cg_endo -78.43 173.19 14.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.78 3.653 . . . . 0.0 110.252 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.2 Cg_endo . . . . . 0 N--CA 1.458 -0.591 0 C-N-CA 123.191 2.594 . . . . 0.0 112.893 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.37 131.82 50.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.35 129.56 35.14 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.03 -173.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.179 0.592 . . . . 0.0 110.422 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -127.43 157.2 40.64 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.345 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -136.69 128.03 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 47.3 mtmt -113.71 139.96 48.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.766 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.97 160.55 16.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.63 159.64 42.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.84 -151.79 0.17 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.379 0.272 . . . . 0.0 110.719 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -56.11 -11.97 1.33 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.36 -30.71 69.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.877 0.762 . . . . 0.0 109.92 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.45 -33.39 69.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.601 0.76 . . . . 0.0 110.35 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -70.6 -32.13 69.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 122.845 0.458 . . . . 0.0 111.653 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.82 -23.74 25.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.683 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.09 -17.49 37.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.321 0.248 . . . . 0.0 110.351 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.06 2.74 58.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.2 p -143.77 149.39 46.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.61 0.764 . . . . 0.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.56 -26.69 11.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.954 2.436 . . . . 0.0 110.952 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.66 163.23 19.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.987 0.515 . . . . 0.0 110.185 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.09 156.72 24.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.967 0.507 . . . . 0.0 110.766 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.34 156.01 36.98 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.1 2.533 . . . . 0.0 110.287 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.4 mt -163.61 -175.39 4.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.958 0.903 . . . . 0.0 108.782 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -146.55 160.48 42.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 111.275 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.02 150.93 6.63 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.93 -24.18 41.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.647 0.723 . . . . 0.0 110.275 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -134.98 171.48 14.36 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.282 1.033 . . . . 0.0 109.826 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HD21 ' A' ' 84' ' ' LEU . 46.4 t -56.42 -45.5 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.13 -35.54 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.94 -22.92 64.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.737 0.699 . . . . 0.0 111.008 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.04 -44.13 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -32.03 73.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.201 0.2 . . . . 0.0 111.373 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.8 -18.43 60.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -86.23 -30.96 21.96 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.966 0.412 . . . . 0.0 110.025 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.94 -46.8 89.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.1 p -70.96 -15.2 62.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.075 0.55 . . . . 0.0 111.771 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.18 -40.89 70.97 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.301 0.5 . . . . 0.0 112.14 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -101.92 -18.55 15.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.175 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -117.13 75.04 7.72 Favored Pre-proline 0 N--CA 1.454 -0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.115 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.2 -16.62 56.0 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.892 2.395 . . . . 0.0 110.382 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 0.08 6.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.042 0.937 . . . . 0.0 111.65 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.4 mt -125.52 -4.85 7.14 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.868 0.867 . . . . 0.0 110.825 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.6 tttt -62.35 -23.98 67.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.65 0.38 . . . . 0.0 112.013 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.7 28.64 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.718 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.7 -10.08 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.45 1.1 . . . . 0.0 109.123 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.7 mt -121.49 -18.65 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.972 0.909 . . . . 0.0 108.936 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.13 163.16 29.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.43 0.634 . . . . 0.0 111.147 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.42 169.33 17.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.512 1.125 . . . . 0.0 109.646 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 tttt . . . . . 0 N--CA 1.45 -0.456 0 C-N-CA 124.952 1.301 . . . . 0.0 109.235 -176.056 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 CA--C 1.52 -0.182 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.7 mm . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.85 125.06 53.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.0 mt -123.04 147.56 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.786 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 33.9 mt -130.76 158.02 41.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.566 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.32 108.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 m120 54.12 10.42 0.29 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.211 0.605 . . . . 0.0 111.835 -170.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.29 33.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.913 0.768 . . . . 0.0 112.615 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.97 -0.1 23.13 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.9 t-20 50.73 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 113.767 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.1 pt -49.99 -21.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -63.21 -15.61 57.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -115.75 9.73 15.23 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.464 0.706 . . . . 0.0 110.608 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.6 mt -123.19 -154.52 0.61 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.872 0.869 . . . . 0.0 109.069 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.59 -14.73 61.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.609 0.764 . . . . 0.0 111.774 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.61 -137.99 15.85 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.16 4.95 0.11 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.818 0.847 . . . . 0.0 113.242 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -131.62 27.38 4.68 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.453 0.701 . . . . 0.0 111.155 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 82' ' ' THR . 94.8 m -62.96 -1.01 0.78 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt 53.33 83.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.671 0.748 . . . . 0.0 112.643 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.402 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.98 170.67 0.61 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.036 1.334 . . . . 0.0 111.417 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 38.0 mtmm -140.45 166.36 24.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.043 0.937 . . . . 0.0 110.65 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -62.6 4.65 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -151.91 15.51 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.383 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 34.0 m-20 -66.3 175.11 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.703 0.764 . . . . 0.0 111.933 174.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.94 150.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.985 0.914 . . . . 0.0 109.103 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -133.81 155.51 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.84 133.88 6.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.6 mt -117.94 129.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.46 146.77 59.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.41 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.02 171.22 18.37 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.852 3.035 . . . . 0.0 110.673 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 C-N-CA 123.777 2.985 . . . . 0.0 113.067 177.439 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.25 128.62 36.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.99 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.8 129.85 35.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 110.09 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 m -140.11 -175.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.348 0.594 . . . . 0.0 110.458 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -119.97 156.42 30.88 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.52 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.93 123.84 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -108.39 152.23 24.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.27 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -127.22 156.46 41.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -143.62 158.35 43.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -150.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.53 0.332 . . . . 0.0 110.95 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -55.95 -11.17 0.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.41 -30.66 67.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.271 0.942 . . . . 0.0 110.028 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -68.89 -38.75 79.83 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.234 0.613 . . . . 0.0 109.705 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.54 -37.43 79.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.648 0.779 . . . . 0.0 111.286 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.13 -0.5 19.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.086 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.85 -6.01 4.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.519 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.33 35.31 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.152 0.882 . . . . 0.0 113.028 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.5 p -141.22 144.46 34.6 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 118.077 0.939 . . . . 0.0 110.472 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.47 -24.73 8.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.284 2.656 . . . . 0.0 111.574 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -167.41 162.72 14.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.5 pt? -161.03 155.58 19.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.239 0.616 . . . . 0.0 110.659 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.35 154.33 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.261 2.64 . . . . 0.0 110.62 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -161.86 -177.55 5.9 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.797 0.839 . . . . 0.0 108.885 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -147.54 160.48 42.58 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.009 0.433 . . . . 0.0 111.774 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.72 158.16 16.31 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.23 -25.76 39.44 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.937 -0.743 . . . . 0.0 109.466 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -138.1 165.95 25.35 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.638 1.175 . . . . 0.0 109.225 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.9 t -45.56 -54.3 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.93 -32.26 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -68.19 -21.58 64.87 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.595 -0.69 . . . . 0.0 111.34 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.48 -45.79 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.45 -36.99 64.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.64 0.776 . . . . 0.0 111.573 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 35' ' ' LEU . 43.3 mt -74.32 -17.66 60.81 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -87.7 -32.53 19.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.78 -50.63 72.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.8 p -71.05 -14.37 62.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.46 0.704 . . . . 0.0 111.815 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.88 -37.22 70.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 118.339 0.518 . . . . 0.0 112.166 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -103.7 -19.31 14.36 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.37 75.16 11.74 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 123.97 0.908 . . . . 0.0 108.963 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.08 -17.99 61.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.113 2.542 . . . . 0.0 110.087 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 1.21 5.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.089 0.955 . . . . 0.0 111.277 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.72 -5.71 6.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.675 0.79 . . . . 0.0 111.249 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.34 -24.05 67.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.096 -0.378 . . . . 0.0 112.005 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.96 24.58 10.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.46 0.704 . . . . 0.0 109.635 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.49 -6.78 5.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 C-N-CA 124.592 1.157 . . . . 0.0 109.006 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.63 -21.55 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.73 0.812 . . . . 0.0 109.217 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -131.08 163.55 27.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.898 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.92 157.97 35.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.997 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.4 tttt . . . . . 0 N--CA 1.451 -0.407 0 C-N-CA 124.002 0.921 . . . . 0.0 112.525 -174.011 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.6 mt . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -123.27 129.15 50.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.32 146.23 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 mt -130.65 163.51 27.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.5 0.32 . . . . 0.0 110.45 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.4 mm -134.77 106.74 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 54.45 8.81 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.984 0.514 . . . . 0.0 112.119 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.94 -3.76 35.86 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.666 0.65 . . . . 0.0 112.317 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -74.39 -1.69 22.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 50.75 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 113.55 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.0 pt -49.68 -21.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -63.46 -13.98 46.09 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -113.73 7.85 17.3 Favored 'General case' 0 N--CA 1.46 0.044 0 C-N-CA 123.3 0.64 . . . . 0.0 110.73 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.88 -156.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.225 1.01 . . . . 0.0 108.948 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.41 -2.32 18.95 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.66 21.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.28 -2.32 0.45 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.892 0.877 . . . . 0.0 112.703 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -124.63 24.57 7.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.172 0.589 . . . . 0.0 111.256 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' THR . 88.9 m -65.59 -1.62 2.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.324 0.65 . . . . 0.0 111.293 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.62 168.02 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 110.558 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.7 mt -138.15 172.66 12.59 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.626 0.77 . . . . 0.0 110.008 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -140.74 167.77 21.38 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.933 0.893 . . . . 0.0 109.818 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.37 8.71 0.29 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t -150.65 15.79 0.78 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.135 0.493 . . . . 0.0 110.035 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.59 -179.83 2.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.693 0.759 . . . . 0.0 110.28 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -154.26 152.89 30.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.42 155.84 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.91 7.1 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 mt -122.52 127.6 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mp -131.79 144.82 54.85 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.272 0.629 . . . . 0.0 110.361 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.75 172.36 11.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 124.634 3.556 . . . . 0.0 109.869 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.451 -0.983 0 C-N-CA 123.099 2.533 . . . . 0.0 111.008 172.808 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.2 mtp . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.33 131.34 47.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.36 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.27 133.39 38.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -143.11 -171.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.175 0.512 . . . . 0.0 110.777 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -131.16 156.98 44.37 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.782 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.0 t -128.45 137.53 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.85 138.65 52.58 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.877 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -111.75 160.53 17.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -145.79 158.61 43.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.68 -147.09 0.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.461 0.305 . . . . 0.0 111.318 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -57.16 -8.69 0.74 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.86 -31.75 59.43 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.345 0.975 . . . . 0.0 109.771 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -71.46 -32.65 68.54 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.092 0.557 . . . . 0.0 109.888 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -68.34 -35.41 77.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.718 0.407 . . . . 0.0 110.19 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.27 -27.23 38.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.42 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.61 -17.86 27.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.781 0.432 . . . . 0.0 110.944 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.14 4.88 69.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.2 p -144.19 145.31 29.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.656 0.782 . . . . 0.0 109.658 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.08 -25.43 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.047 2.498 . . . . 0.0 110.823 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.86 161.65 23.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.444 0.298 . . . . 0.0 111.265 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.99 155.18 23.88 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.526 0.73 . . . . 0.0 111.759 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.4 150.68 19.74 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.001 3.134 . . . . 0.0 111.386 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 36' ' ' SER . 9.8 mt -160.96 -174.63 4.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.159 0.984 . . . . 0.0 109.655 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -147.95 163.39 36.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.33 154.39 9.09 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.17 -23.92 43.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.475 0.637 . . . . 0.0 109.848 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -140.12 172.92 12.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.162 0.985 . . . . 0.0 109.767 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.85 -49.56 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -62.01 -31.53 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.83 -20.9 63.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.553 -0.717 . . . . 0.0 110.856 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.19 -42.08 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.98 -40.95 77.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.866 0.866 . . . . 0.0 111.499 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.3 -15.63 60.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.661 0.267 . . . . 0.0 111.245 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . 2.2 m -93.61 -23.01 18.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.456 1.102 . . . . 0.0 110.712 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -70.57 -51.3 29.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -66.47 -13.33 60.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.824 0.45 . . . . 0.0 111.048 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.62 -44.74 70.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.485 0.314 . . . . 0.0 111.671 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -98.34 -17.73 18.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.077 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -117.86 75.99 10.69 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 109.454 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.62 -16.93 57.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.724 2.283 . . . . 0.0 110.506 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.7 0.36 9.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.009 0.923 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.7 -5.04 8.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.825 0.85 . . . . 0.0 110.886 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.36 -23.32 66.95 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.57 27.76 8.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.992 0.517 . . . . 0.0 109.659 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.5 -38.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -85.05 -24.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -130.5 165.7 22.12 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.038 0.535 . . . . 0.0 111.035 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -87.51 142.76 27.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt . . . . . 0 CA--C 1.533 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 111.838 179.265 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.9 mt . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.99 0.424 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -125.49 123.86 40.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -111.9 135.67 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -122.13 161.28 23.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -125.54 111.61 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 56.02 10.13 0.55 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.203 0.601 . . . . 0.0 112.154 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.38 15.31 9.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.335 0.493 . . . . 0.0 111.971 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -123.66 93.74 4.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.683 1.193 . . . . 0.0 109.438 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -39.15 109.73 0.12 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.749 1.62 . . . . 0.0 111.961 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 pt -50.03 -23.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.22 -8.36 12.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.898 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -121.76 8.21 9.98 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.386 1.074 . . . . 0.0 110.644 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.78 -153.89 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.538 1.135 . . . . 0.0 108.659 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.53 -15.37 60.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.54 0.736 . . . . 0.0 111.864 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 89.3 -142.56 16.85 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.0 5.27 0.06 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.881 0.873 . . . . 0.0 112.895 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.7 mt-10 -130.51 26.92 5.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.606 0.639 . . . . 0.0 111.587 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 82' ' ' THR . 88.7 m -63.47 -0.13 0.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.603 0.761 . . . . 0.0 112.838 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt 52.61 79.67 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.505 0.669 . . . . 0.0 112.777 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.45 165.25 1.14 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.942 1.297 . . . . 0.0 111.107 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -133.77 167.42 20.57 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.205 1.002 . . . . 0.0 109.558 -178.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.98 5.98 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -153.76 19.58 0.53 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.812 -0.555 . . . . 0.0 110.175 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.73 178.22 3.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.758 0.79 . . . . 0.0 110.468 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.05 151.52 31.22 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.83 150.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.63 130.33 5.95 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.52 128.38 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.62 147.72 65.71 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 122.451 0.3 . . . . 0.0 110.642 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 67.7 Cg_endo -79.61 175.23 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.9 3.733 . . . . 0.0 110.244 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 C-N-CA 122.826 2.35 . . . . 0.0 110.727 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.72 131.98 50.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 130.24 35.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.29 -173.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 110.54 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -127.76 157.52 40.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 169.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.8 127.47 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -108.49 152.34 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.494 0.717 . . . . 0.0 109.5 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.78 156.71 43.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.56 159.77 42.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.11 -148.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.504 0.322 . . . . 0.0 111.219 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.14 -9.99 0.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.63 -31.89 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.292 0.951 . . . . 0.0 109.724 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.08 -35.83 74.49 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.322 0.649 . . . . 0.0 110.071 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -68.22 -33.59 74.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.885 0.874 . . . . 0.0 110.723 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -2.74 40.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.875 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.0 -5.83 3.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.533 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.17 11.22 44.92 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.659 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.0 p -141.54 144.21 32.65 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 118.276 1.038 . . . . 0.0 110.571 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 -20.13 11.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.425 2.75 . . . . 0.0 111.62 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.12 162.02 19.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.65 0.38 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.91 155.24 24.19 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.235 0.614 . . . . 0.0 111.247 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.27 154.03 28.21 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.244 2.629 . . . . 0.0 110.09 172.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -163.75 -176.04 4.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.948 0.899 . . . . 0.0 109.253 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.26 161.66 40.5 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.69 155.76 10.32 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -79.09 -24.99 43.08 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.529 0.664 . . . . 0.0 110.047 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -140.61 172.5 12.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.944 0.898 . . . . 0.0 109.733 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 84' ' ' LEU . 41.7 t -55.72 -43.89 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.47 -35.01 74.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.98 -21.44 65.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.696 -0.628 . . . . 0.0 110.638 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -86.23 -45.27 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.71 -29.54 70.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 119.546 -0.264 . . . . 0.0 111.389 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -74.44 -19.12 60.52 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.098 0.408 . . . . 0.0 111.928 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.86 -31.13 20.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.077 0.465 . . . . 0.0 109.876 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.65 -48.87 79.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.412 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 73.5 p -71.44 -13.97 62.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.404 0.681 . . . . 0.0 112.11 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.65 -38.6 70.68 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.284 0.493 . . . . 0.0 111.769 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -104.34 -17.66 14.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.331 0.394 . . . . 0.0 111.575 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -117.4 75.8 9.1 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.44 -17.68 60.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.052 2.502 . . . . 0.0 110.224 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 0.25 6.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.974 0.91 . . . . 0.0 111.568 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.8 -6.83 7.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.903 0.881 . . . . 0.0 110.937 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 82.0 tttt -65.38 -23.37 66.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.431 0.292 . . . . 0.0 111.621 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -118.96 27.67 8.74 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.078 0.551 . . . . 0.0 109.894 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.94 -35.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 123.849 0.86 . . . . 0.0 108.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG13 ' A' ' 65' ' ' ILE . 96.8 mt -88.11 -24.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.37 163.27 30.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.689 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.11 147.57 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.688 0.795 . . . . 0.0 109.409 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.5 tttt . . . . . 0 N--CA 1.453 -0.324 0 C-N-CA 124.75 1.22 . . . . 0.0 110.756 175.214 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 61' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 48' ' ' ILE . 18.1 mm . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -121.14 126.23 49.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.75 143.03 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.4 mt -125.93 159.87 31.46 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.4 mm -130.93 107.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 54.38 11.2 0.38 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.192 0.597 . . . . 0.0 111.604 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.86 39.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.861 0.743 . . . . 0.0 112.596 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.44 -1.33 26.52 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.06 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.97 1.308 . . . . 0.0 113.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.62 -21.33 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.725 -0.609 . . . . 0.0 112.177 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.54 -11.53 25.07 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.291 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.37 9.95 11.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.443 0.697 . . . . 0.0 110.79 175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.7 -155.49 0.67 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.216 1.006 . . . . 0.0 109.436 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.13 -5.57 18.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.74 0.416 . . . . 0.0 111.965 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.19 -141.16 22.05 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.82 5.82 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 113.079 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.4 mt-10 -130.38 25.53 5.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.406 0.682 . . . . 0.0 111.308 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 82' ' ' THR . 90.5 m -62.26 0.97 0.37 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.986 0.914 . . . . 0.0 113.168 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.7 mt 51.77 84.27 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -58.63 171.56 0.61 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.963 1.305 . . . . 0.0 111.422 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.82 166.74 23.82 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.187 0.995 . . . . 0.0 110.877 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.57 4.6 0.24 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -151.96 15.58 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.992 -0.443 . . . . 0.0 110.363 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.2 m-20 -66.99 177.76 1.62 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.541 0.686 . . . . 0.0 111.593 174.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -149.4 151.28 33.78 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.05 0.94 . . . . 0.0 108.786 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.41 157.81 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.72 133.18 5.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.62 130.43 66.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.21 146.48 56.43 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 122.858 0.463 . . . . 0.0 110.911 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.93 166.77 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.437 3.425 . . . . 0.0 110.755 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo . . . . . 0 N--CA 1.457 -0.672 0 C-N-CA 124.286 3.324 . . . . 0.0 113.267 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 131.14 48.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.04 132.92 37.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 m -142.1 -174.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.226 0.536 . . . . 0.0 111.022 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -126.67 155.77 42.09 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -137.77 128.07 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -113.9 138.61 50.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.903 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.74 161.12 15.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -145.87 158.88 43.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.78 -147.66 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.421 0.288 . . . . 0.0 111.239 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.93 -11.38 1.44 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.56 -31.06 64.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.193 0.906 . . . . 0.0 110.084 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -70.26 -33.32 71.46 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.047 0.539 . . . . 0.0 109.922 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.22 -31.84 69.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.881 0.472 . . . . 0.0 111.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.05 -23.1 22.64 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.611 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.69 -18.56 34.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.707 0.23 . . . . 0.0 110.841 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.37 62.65 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.2 p -144.4 145.85 30.61 Favored Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.833 0.853 . . . . 0.0 109.727 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.92 -26.03 11.46 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.114 2.543 . . . . 0.0 110.953 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -164.95 163.85 20.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 110.095 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -162.58 157.78 19.09 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.081 0.553 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.3 155.0 28.68 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.145 2.564 . . . . 0.0 110.136 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.5 mt -161.25 -176.64 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.046 0.938 . . . . 0.0 108.678 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -147.72 157.77 43.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 111.452 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.82 148.77 5.8 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -77.71 -24.97 49.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.783 0.791 . . . . 0.0 110.452 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.03 170.84 15.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.946 0.898 . . . . 0.0 109.939 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.7 -45.28 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -33.92 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -69.87 -20.98 63.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.359 0.527 . . . . 0.0 111.537 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.86 -40.58 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.23 -33.31 75.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.875 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.76 -18.73 60.94 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.87 0.304 . . . . 0.0 110.936 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -26.75 20.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.923 0.889 . . . . 0.0 110.729 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -67.75 -51.28 50.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 76.3 p -67.48 -13.37 61.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.119 0.568 . . . . 0.0 111.634 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.76 -39.43 80.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -106.26 -17.38 14.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -116.58 73.08 5.63 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.969 . . . . 0.0 108.98 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -64.14 -17.18 58.76 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.904 2.403 . . . . 0.0 110.444 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -1.07 9.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.006 0.922 . . . . 0.0 111.434 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 -4.73 8.99 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.889 0.875 . . . . 0.0 110.906 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.3 -22.68 66.87 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.15 28.91 6.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.8 t -125.48 -41.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.04 -24.69 10.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -130.0 167.46 18.22 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.231 0.612 . . . . 0.0 109.903 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.07 146.84 23.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.6 tttt . . . . . 0 CA--C 1.536 0.428 0 C-N-CA 124.814 1.246 . . . . 0.0 112.044 178.897 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.0 mm . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -118.4 126.43 52.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.578 ' C ' HD22 ' A' ' 68' ' ' LEU . 29.5 mt -124.67 136.61 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.756 0.789 . . . . 0.0 110.141 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -126.18 152.9 45.38 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.966 -172.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 74' ' ' ILE . 37.8 mm -124.17 100.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 64.55 0.92 1.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.189 0.995 . . . . 0.0 110.475 -172.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.81 -0.0 19.8 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 17.9 p30 -75.83 -4.13 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 49.06 93.83 0.01 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.181 1.392 . . . . 0.0 113.782 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 69' ' ' ILE . 15.6 pt -49.2 -22.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -67.09 -10.88 54.73 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.888 0.875 . . . . 0.0 112.402 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -118.21 6.97 11.99 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.29 0.636 . . . . 0.0 110.348 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.0 mt -123.81 -154.94 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.158 0.983 . . . . 0.0 109.587 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.26 -4.49 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -132.6 19.24 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.76 -0.97 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.297 1.039 . . . . 0.0 113.61 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.35 25.81 5.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.641 0.655 . . . . 0.0 111.523 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 82' ' ' THR . 67.0 m -64.99 2.71 0.68 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.1 mt 51.95 85.0 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.77 168.9 1.55 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.915 1.286 . . . . 0.0 110.718 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -139.91 167.87 21.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.056 0.942 . . . . 0.0 110.21 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.04 5.96 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -153.08 16.8 0.56 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.316 0.507 . . . . 0.0 110.381 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 178.57 1.92 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.758 0.79 . . . . 0.0 111.202 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.81 151.54 34.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.039 0.935 . . . . 0.0 108.502 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.5 152.0 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.72 131.95 5.84 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.5 mt -118.08 131.77 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.54 148.31 66.93 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.8 0.44 . . . . 0.0 110.362 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.21 174.02 13.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.322 3.348 . . . . 0.0 110.316 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.455 -0.784 0 C-N-CA 122.852 2.368 . . . . 0.0 110.365 173.804 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.1 mtp . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.6 127.71 32.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.06 126.53 30.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.242 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.33 -175.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.939 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -117.68 154.39 31.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.251 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.15 119.46 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.08 151.13 22.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.557 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -129.76 155.69 45.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -144.17 157.56 44.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.15 -152.5 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.243 0.217 . . . . 0.0 110.627 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -53.47 -14.85 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.04 -30.48 70.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.075 0.852 . . . . 0.0 110.029 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -70.7 -37.28 73.55 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.015 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -37.99 76.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.094 0.558 . . . . 0.0 111.656 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.76 -1.03 20.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.231 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.85 -7.64 5.55 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.039 0.936 . . . . 0.0 110.307 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 12.9 50.72 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.32 0.962 . . . . 0.0 112.76 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.7 p -142.01 141.86 23.08 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 118.06 0.93 . . . . 0.0 110.929 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.51 -20.91 13.58 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.585 2.857 . . . . 0.0 111.164 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.79 161.97 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.712 0.405 . . . . 0.0 110.424 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.73 156.1 27.96 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.145 0.578 . . . . 0.0 110.861 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.42 153.0 23.71 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.271 2.647 . . . . 0.0 110.299 172.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.4 mt -163.71 -179.42 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.18 0.992 . . . . 0.0 108.865 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -148.19 158.83 44.31 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.36 157.27 13.81 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.63 -26.9 50.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.037 -0.684 . . . . 0.0 109.911 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -137.59 166.59 23.53 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.032 0.933 . . . . 0.0 109.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -46.75 -49.19 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.799 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.44 -34.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.52 -20.95 65.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.567 -0.708 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.53 -45.24 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.54 -24.63 67.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -79.05 -18.58 53.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 122.048 -0.407 . . . . 0.0 112.078 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.9 -28.98 22.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 110.196 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.14 -48.61 79.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -71.65 -17.22 62.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.258 0.623 . . . . 0.0 111.925 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.22 -39.61 78.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 117.995 0.362 . . . . 0.0 111.828 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -102.38 -18.32 15.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.442 0.464 . . . . 0.0 111.247 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -117.53 74.9 8.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.743 . . . . 0.0 109.117 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.56 -17.4 59.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.81 2.34 . . . . 0.0 110.356 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.36 1.51 6.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.22 1.008 . . . . 0.0 111.29 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.91 -6.24 6.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.5 0.72 . . . . 0.0 111.529 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.6 ttpt -64.25 -27.81 69.3 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.048 -0.408 . . . . 0.0 111.92 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -115.76 26.63 9.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 110.397 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.78 -12.22 3.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.284 1.034 . . . . 0.0 109.128 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.17 -19.85 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 109.692 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.52 162.56 30.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.28 138.68 34.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.106 0.562 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.3 tttt . . . . . 0 N--CA 1.451 -0.404 0 C-N-CA 125.293 1.437 . . . . 0.0 111.151 175.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 mt . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mm . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -125.38 122.4 36.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 mm -108.51 144.99 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -128.82 162.37 27.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.692 0.397 . . . . 0.0 110.349 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -133.53 105.74 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.82 8.78 0.24 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.234 0.614 . . . . 0.0 111.792 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.88 33.07 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.825 0.726 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -72.47 -2.18 18.62 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.04 97.35 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.804 1.242 . . . . 0.0 113.748 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.61 -20.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -62.78 -14.67 47.93 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.273 0.488 . . . . 0.0 112.113 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -112.59 6.85 18.59 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.303 0.641 . . . . 0.0 110.685 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.8 mt -123.81 -156.1 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.144 0.978 . . . . 0.0 109.604 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.57 -15.66 63.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.894 0.878 . . . . 0.0 112.345 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -139.41 15.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.75 -2.09 0.49 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 112.793 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -125.89 25.5 6.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.567 0.622 . . . . 0.0 111.595 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.7 m -66.29 -2.09 4.05 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.096 0.558 . . . . 0.0 111.491 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.98 166.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 110.332 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.3 mt -137.21 175.59 9.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.63 0.772 . . . . 0.0 110.414 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.3 mttt -141.64 167.39 22.28 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.748 0.819 . . . . 0.0 110.877 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.17 7.26 0.77 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.6 t -150.38 13.8 0.76 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.359 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.98 -179.5 1.51 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.498 0.666 . . . . 0.0 110.632 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -152.54 153.33 33.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mm -131.16 158.2 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.62 140.52 9.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.84 126.92 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.43 147.56 66.61 Favored Pre-proline 0 N--CA 1.452 -0.326 0 O-C-N 123.224 0.328 . . . . 0.0 110.689 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 88.4 Cg_endo -76.8 174.02 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.812 3.674 . . . . 0.0 110.749 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.6 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 123.234 2.623 . . . . 0.0 110.431 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.03 132.42 52.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.38 130.81 35.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.05 -173.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.282 0.563 . . . . 0.0 110.504 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -128.12 157.98 39.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.384 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.51 131.2 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -115.16 137.95 51.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.353 0.661 . . . . 0.0 109.532 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -110.26 160.01 16.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -145.05 159.17 43.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -152.63 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.313 0.245 . . . . 0.0 110.756 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -53.77 -14.06 0.85 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.59 -30.6 70.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.111 0.869 . . . . 0.0 109.844 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.57 -36.58 73.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.454 0.702 . . . . 0.0 109.967 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -40.52 81.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.73 0.412 . . . . 0.0 110.995 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.18 -27.43 59.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.792 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.31 -18.23 39.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.214 -0.303 . . . . 0.0 110.56 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.26 3.09 64.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.9 p -145.25 149.54 41.83 Favored Pre-proline 0 C--O 1.232 0.133 0 C-N-CA 123.642 0.777 . . . . 0.0 109.822 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.78 -24.65 11.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.182 2.588 . . . . 0.0 110.946 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -164.87 163.23 21.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.53 0.332 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.4 pt? -160.42 155.33 20.85 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 123.487 0.715 . . . . 0.0 110.724 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 154.01 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.16 2.573 . . . . 0.0 110.29 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -161.3 -174.39 4.28 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.038 0.935 . . . . 0.0 108.889 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -148.86 161.09 42.55 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.761 0.315 . . . . 0.0 111.749 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.19 155.93 9.85 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.08 -24.03 43.77 Favored 'General case' 0 C--O 1.23 0.056 0 O-C-N 122.091 -0.652 . . . . 0.0 109.97 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.51 172.92 12.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.727 0.811 . . . . 0.0 109.659 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.42 -43.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.76 -36.01 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.65 -22.03 64.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.424 0.556 . . . . 0.0 111.055 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.2 t -86.64 -46.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.43 -29.4 70.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.444 0.298 . . . . 0.0 111.58 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 35' ' ' LEU . 32.7 mt -75.18 -16.45 60.5 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -88.67 -30.99 18.73 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 109.979 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.95 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.429 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 70.5 p -70.2 -15.64 62.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.237 0.615 . . . . 0.0 111.769 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.81 -38.53 73.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.324 0.511 . . . . 0.0 111.847 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -104.49 -18.25 14.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.138 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -116.86 75.5 7.35 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 124.115 0.966 . . . . 0.0 108.884 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -64.7 -16.55 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.042 2.495 . . . . 0.0 110.47 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -0.9 10.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.819 0.848 . . . . 0.0 111.486 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.53 -5.09 8.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.967 0.907 . . . . 0.0 110.958 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 76.9 tttt -63.63 -24.69 67.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.85 31.54 5.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.34 0.59 . . . . 0.0 109.46 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.23 -41.03 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.05 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.61 163.94 26.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.493 0.664 . . . . 0.0 110.989 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.83 172.13 12.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.2 tttt . . . . . 0 N--CA 1.452 -0.374 0 C-N-CA 124.366 1.067 . . . . 0.0 108.905 -177.42 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.341 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mm . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.64 126.63 42.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.2 145.22 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.7 mt -129.16 159.49 35.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.9 mm -130.71 108.24 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 55.33 10.5 0.46 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.198 0.599 . . . . 0.0 111.333 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.28 -2.1 40.3 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.15 0.881 . . . . 0.0 112.424 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -81.14 1.65 30.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.57 101.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.84 1.256 . . . . 0.0 114.079 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.5 -26.41 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.964 -0.46 . . . . 0.0 112.214 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -60.87 -11.61 8.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -122.91 13.38 9.84 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.491 0.716 . . . . 0.0 111.278 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.04 -84.91 0.66 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.697 0.399 . . . . 0.0 110.558 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -144.35 1.64 1.08 Allowed 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 118.481 0.582 . . . . 0.0 111.772 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.67 -141.29 28.29 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.4 1.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -128.63 25.38 5.7 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.602 0.637 . . . . 0.0 111.834 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' THR . 91.4 m -63.71 0.81 0.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.9 mt 51.66 84.85 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.76 170.42 1.13 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 111.619 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 64.5 mttp -139.48 167.2 22.62 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.449 1.1 . . . . 0.0 111.657 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.29 4.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 t -153.07 16.03 0.55 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.074 -0.391 . . . . 0.0 110.201 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 6.7 m-20 -67.32 177.36 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.963 0.887 . . . . 0.0 111.351 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -148.07 151.15 35.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.44 1.096 . . . . 0.0 108.55 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.11 153.36 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.19 133.98 7.16 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.46 128.58 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.61 147.45 61.59 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 122.705 0.402 . . . . 0.0 111.006 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -79.41 174.2 12.21 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.052 3.835 . . . . 0.0 110.467 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 59.8 Cg_endo . . . . . 0 N--CA 1.454 -0.843 0 C-N-CA 123.139 2.559 . . . . 0.0 111.291 175.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.61 130.95 48.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.39 132.58 39.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.27 -173.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.18 0.592 . . . . 0.0 110.14 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.01 158.41 38.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.3 t -130.05 138.12 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.75 152.29 37.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt -128.49 155.58 44.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.03 159.22 42.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.73 -146.18 0.27 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.432 0.293 . . . . 0.0 111.17 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -56.69 -10.68 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.05 -30.52 61.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.342 0.974 . . . . 0.0 110.125 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -70.39 -33.49 71.47 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.076 0.55 . . . . 0.0 109.6 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -72.01 -21.98 61.47 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.468 0.707 . . . . 0.0 111.718 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 1.98 56.7 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.288 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.27 -7.54 2.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.326 0.65 . . . . 0.0 110.709 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.4 9.0 48.23 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.337 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 p -141.26 144.75 35.56 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.056 0.928 . . . . 0.0 110.39 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.22 -22.4 9.77 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.319 2.68 . . . . 0.0 111.574 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.07 160.82 14.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.517 0.327 . . . . 0.0 110.639 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.64 154.42 23.07 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -178.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.06 152.65 24.58 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.684 2.923 . . . . 0.0 110.976 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.9 mt -163.6 -173.17 3.18 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.994 0.518 . . . . 0.0 110.284 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -148.36 160.64 42.81 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 111.099 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.2 149.48 6.15 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -81.24 -24.8 37.11 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 117.708 0.754 . . . . 0.0 110.388 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -132.22 170.82 14.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.245 1.018 . . . . 0.0 109.227 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.68 -48.33 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.51 -32.32 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.628 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.77 -22.61 64.28 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.654 -0.654 . . . . 0.0 110.703 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.65 -45.03 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -38.79 71.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.121 0.968 . . . . 0.0 111.821 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 mt -74.22 -14.34 60.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.91 -26.21 16.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 174.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -64.09 -49.65 71.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.3 p -68.3 -14.25 62.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.902 0.481 . . . . 0.0 111.484 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.96 -44.98 64.92 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.089 0.404 . . . . 0.0 111.397 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -95.44 -17.84 21.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -118.69 76.57 13.83 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 123.859 0.864 . . . . 0.0 109.666 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -17.19 57.96 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.102 2.535 . . . . 0.0 111.03 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.44 2.02 8.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.334 0.654 . . . . 0.0 111.358 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.0 -7.08 8.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.556 0.743 . . . . 0.0 110.718 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.09 -24.2 67.61 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.891 0.477 . . . . 0.0 112.198 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -121.17 28.57 7.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.938 0.495 . . . . 0.0 109.989 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.3 -36.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.272 1.029 . . . . 0.0 108.244 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.05 -25.4 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.607 0.763 . . . . 0.0 109.187 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.24 161.84 30.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.992 0.517 . . . . 0.0 110.791 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.81 141.41 31.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.3 tttt . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.064 1.346 . . . . 0.0 110.994 177.475 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 mm . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.077 0.465 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -128.98 126.58 39.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.81 145.99 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.53 160.76 32.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.99 0.516 . . . . 0.0 109.642 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.13 105.58 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 55.07 8.61 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.039 0.536 . . . . 0.0 111.856 -169.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.88 -3.88 32.03 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.066 0.841 . . . . 0.0 112.419 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -76.4 -0.15 21.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 49.33 99.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 114.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.07 -21.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.62 -11.67 12.53 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -119.58 9.02 11.37 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.755 0.822 . . . . 0.0 111.541 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.73 -156.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.059 0.944 . . . . 0.0 109.485 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.89 -5.67 22.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.39 -139.44 20.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.82 2.08 0.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.896 0.878 . . . . 0.0 113.132 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -129.22 25.87 5.47 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.398 0.545 . . . . 0.0 111.553 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 82' ' ' THR . 88.9 m -62.16 -0.57 0.55 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.762 0.825 . . . . 0.0 112.991 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.29 83.51 0.06 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.72 170.89 0.72 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.039 1.335 . . . . 0.0 111.896 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -138.36 167.88 20.95 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.27 1.028 . . . . 0.0 110.404 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -64.94 7.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.8 t -152.86 17.21 0.58 Allowed 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.889 -0.507 . . . . 0.0 110.599 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.72 -179.34 2.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.199 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.42 155.26 36.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.386 0.674 . . . . 0.0 109.576 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 mm -125.79 155.13 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.01 120.95 1.63 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.7 mt -108.97 129.97 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.72 149.04 70.88 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 122.632 0.373 . . . . 0.0 110.763 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 73.1 Cg_endo -78.34 174.75 11.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 125.007 3.804 . . . . 0.0 110.076 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 45.9 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 C-N-CA 122.65 2.233 . . . . 0.0 111.344 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.75 131.91 50.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.437 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.56 130.08 35.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.228 0.537 . . . . 0.0 109.753 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.69 -172.42 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.342 0.592 . . . . 0.0 110.659 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -129.88 155.98 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.903 171.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.83 135.27 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.87 139.12 50.52 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.965 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.7 mm? -110.8 160.13 17.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -145.75 159.98 42.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.62 -147.06 0.22 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.219 0.207 . . . . 0.0 111.094 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -56.47 -12.51 1.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.51 -31.87 65.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.937 0.79 . . . . 0.0 110.006 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -70.92 -32.81 69.84 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.76 -33.55 72.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.337 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.87 -24.71 26.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.265 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 -18.97 33.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.556 0.217 . . . . 0.0 110.677 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 3.17 63.01 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.8 p -144.3 148.45 41.01 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.35 -23.69 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.004 2.47 . . . . 0.0 110.883 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -163.58 162.51 24.41 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.4 0.28 . . . . 0.0 111.39 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.67 154.36 26.6 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.634 0.774 . . . . 0.0 111.515 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.77 151.59 21.92 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.599 2.866 . . . . 0.0 110.649 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.3 mt -162.0 -175.3 4.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.251 0.62 . . . . 0.0 110.04 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -147.74 162.11 39.86 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 111.444 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.14 152.26 7.7 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.51 -26.66 60.13 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.561 0.68 . . . . 0.0 110.467 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -139.9 174.43 10.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 109.897 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.76 -45.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 tp -63.79 -34.64 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.95 -22.6 65.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.466 0.575 . . . . 0.0 110.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.0 -44.76 16.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.38 -29.87 70.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.198 -0.313 . . . . 0.0 111.425 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 35' ' ' LEU . 38.8 mt -74.2 -17.89 60.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.143 -0.348 . . . . 0.0 111.472 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.435 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -91.62 -25.09 19.33 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 175.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.7 -49.09 76.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 81.8 p -68.68 -16.51 63.85 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.744 0.418 . . . . 0.0 111.571 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.69 -46.24 66.47 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.207 0.458 . . . . 0.0 111.809 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.0 -18.77 21.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -117.26 76.83 9.29 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.804 0.841 . . . . 0.0 109.881 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.06 -16.86 57.31 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.792 2.328 . . . . 0.0 110.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.01 2.16 7.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.792 0.837 . . . . 0.0 111.287 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.2 mt -126.77 -3.41 6.55 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 75.9 tttt -62.53 -24.46 67.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.464 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 24.2 m-85 -124.17 29.44 6.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.428 0.632 . . . . 0.0 109.422 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.41 -10.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.895 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.44 -18.38 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.835 0.854 . . . . 0.0 109.131 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -132.96 161.12 35.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.793 0.437 . . . . 0.0 110.961 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -69.44 168.63 14.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.72 0.808 . . . . 0.0 110.427 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 33.8 ttmt . . . . . 0 CA--C 1.527 0.095 0 C-N-CA 123.799 0.84 . . . . 0.0 110.579 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.9 mt . . . . . 0 CA--C 1.52 -0.173 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.5 mm . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -118.71 126.43 51.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.26 144.09 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 40.0 mt -128.14 159.45 35.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.73 107.95 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.67 10.75 0.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.26 0.624 . . . . 0.0 111.628 -170.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.49 -3.49 37.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.036 0.827 . . . . 0.0 112.436 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -77.26 -0.64 26.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.7 t-20 51.46 100.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.696 1.198 . . . . 0.0 113.751 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.2 pt -51.3 -21.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -64.32 -11.42 31.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.966 0.506 . . . . 0.0 112.224 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -116.86 8.95 13.7 Favored 'General case' 0 N--CA 1.46 0.038 0 C-N-CA 123.66 0.784 . . . . 0.0 110.77 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.5 -155.63 0.69 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.053 0.941 . . . . 0.0 109.201 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.59 -3.23 17.19 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.74 -140.17 22.24 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.15 3.25 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.993 0.917 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.6 mt-10 -128.34 22.72 6.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.535 0.734 . . . . 0.0 111.513 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 82' ' ' THR . 86.2 m -62.15 0.65 0.39 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.524 1.13 . . . . 0.0 113.333 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.27 85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.778 0.799 . . . . 0.0 112.999 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.34 171.69 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.158 1.383 . . . . 0.0 111.409 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.41 166.28 24.97 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.428 1.091 . . . . 0.0 110.88 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.3 5.25 0.28 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 t -152.7 16.6 0.59 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 117.883 0.311 . . . . 0.0 110.503 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.0 m-20 -67.44 177.57 1.88 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.878 0.847 . . . . 0.0 111.344 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.18 151.48 34.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.192 0.997 . . . . 0.0 108.526 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.52 154.39 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.39 132.37 6.06 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -115.21 129.22 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.93 144.37 50.11 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 122.654 0.382 . . . . 0.0 110.439 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -80.12 169.09 18.04 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.57 3.513 . . . . 0.0 111.174 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo . . . . . 0 N--CA 1.455 -0.774 0 C-N-CA 123.787 2.991 . . . . 0.0 111.055 172.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 127.2 30.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.74 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.99 128.38 34.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.6 m -140.65 -172.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.35 0.595 . . . . 0.0 110.677 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -124.87 153.97 41.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.956 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.62 133.02 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -114.59 136.1 53.41 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.443 0.465 . . . . 0.0 109.811 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -107.49 160.34 15.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.94 160.19 41.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.68 -146.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.393 0.277 . . . . 0.0 110.991 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -57.71 -11.59 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.5 mt -72.13 -29.05 63.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.354 0.979 . . . . 0.0 109.922 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.98 -32.01 70.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.144 0.578 . . . . 0.0 109.472 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.17 -23.2 60.4 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 111.249 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 -5.72 52.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.676 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' A' ' 41' ' ' TYR . . . -115.15 -11.34 12.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.164 0.586 . . . . 0.0 110.319 173.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.26 3.01 36.08 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.6 p -143.71 149.51 47.04 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 123.896 0.878 . . . . 0.0 109.548 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.07 -22.9 14.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.829 2.353 . . . . 0.0 110.994 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.48 163.57 22.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.898 0.317 . . . . 0.0 111.547 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.03 153.98 23.34 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.893 0.877 . . . . 0.0 111.298 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.44 151.07 19.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.684 2.923 . . . . 0.0 110.796 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.7 -175.54 4.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 110.002 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -148.58 159.06 44.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.92 0.391 . . . . 0.0 111.736 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.18 154.54 10.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.94 -27.81 57.72 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 117.603 0.701 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -137.62 165.87 25.3 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.026 0.93 . . . . 0.0 109.698 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -46.05 -52.16 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 122.966 0.506 . . . . 0.0 110.196 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.0 -32.45 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -67.98 -21.22 65.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.52 -0.737 . . . . 0.0 111.137 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -45.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -54.77 -37.52 66.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.534 0.734 . . . . 0.0 111.446 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 35' ' ' LEU . 41.7 mt -73.97 -16.8 61.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.44 -26.12 17.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.939 0.399 . . . . 0.0 110.025 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.0 tm? -63.0 -50.24 71.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.406 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 72.1 p -67.51 -16.17 64.05 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.59 -45.57 65.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.852 0.296 . . . . 0.0 111.467 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -93.97 -18.32 22.02 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.247 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 18' ' ' ALA . 9.2 m-30 -118.31 77.42 13.25 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 123.955 0.902 . . . . 0.0 109.909 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.75 -17.58 59.95 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.873 2.382 . . . . 0.0 110.867 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.72 1.78 7.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.539 0.735 . . . . 0.0 111.445 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.8 mt -124.35 -5.83 7.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.704 0.802 . . . . 0.0 110.858 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.2 tttt -65.17 -23.32 67.08 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -124.27 28.06 6.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.43 -39.4 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -82.78 -28.06 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.25 164.08 23.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.891 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -73.9 171.99 12.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.277 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.8 tttt . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 124.382 1.073 . . . . 0.0 108.676 -178.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt . . . . . 0 CA--C 1.52 -0.193 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.853 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.915 0.388 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -128.38 123.16 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.0 145.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -133.32 159.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.923 0.889 . . . . 0.0 109.21 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.407 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 34.8 mm -130.06 109.25 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 170.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.42 5.88 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.328 0.651 . . . . 0.0 111.996 -169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.18 -2.6 23.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.028 0.823 . . . . 0.0 112.811 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 18.8 p30 -74.64 -3.39 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.42 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 113.421 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -46.89 -23.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -63.34 -19.49 64.67 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -102.64 2.46 36.01 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.87 -153.89 0.57 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.445 1.098 . . . . 0.0 109.675 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.08 -15.03 58.69 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.952 0.901 . . . . 0.0 112.146 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.7 -138.22 16.61 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.18 1.33 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.187 0.995 . . . . 0.0 112.87 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -129.39 25.61 5.44 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.687 0.676 . . . . 0.0 111.625 -175.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -62.04 -8.51 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.79 0.836 . . . . 0.0 112.706 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.47 125.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.689 1.196 . . . . 0.0 112.164 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.5 mp -100.4 174.4 6.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.038 1.335 . . . . 0.0 110.422 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -139.91 168.61 19.42 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.752 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -68.04 8.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -151.95 18.28 0.68 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.006 -0.434 . . . . 0.0 109.939 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.01 178.92 2.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.548 0.69 . . . . 0.0 110.585 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.99 149.73 29.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -133.24 151.21 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.4 134.68 7.72 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 108.404 -1.879 . . . . 0.0 108.404 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.01 128.66 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.21 148.19 66.87 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -80.48 174.81 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.934 3.756 . . . . 0.0 109.94 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo . . . . . 0 N--CA 1.453 -0.856 0 C-N-CA 122.695 2.263 . . . . 0.0 111.26 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 132.55 52.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.14 128.11 33.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.32 -172.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 123.376 0.671 . . . . 0.0 110.781 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -129.85 154.78 46.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.617 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.26 136.1 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -118.16 138.14 52.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.037 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.04 160.35 16.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.88 160.38 41.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.65 -146.89 0.23 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.284 0.234 . . . . 0.0 111.085 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -57.49 -10.38 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.96 -30.71 62.66 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.129 0.877 . . . . 0.0 110.06 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -71.76 -32.07 67.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.975 0.51 . . . . 0.0 109.772 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -70.21 -30.79 67.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.0 111.531 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.79 -24.54 22.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.536 -176.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -18.34 35.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 2.11 60.45 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 149.27 45.5 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 123.82 0.848 . . . . 0.0 109.193 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.98 -20.79 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.07 2.513 . . . . 0.0 111.519 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -165.54 162.2 18.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.965 0.348 . . . . 0.0 111.359 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.02 155.75 26.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.603 0.761 . . . . 0.0 111.582 178.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.62 153.02 20.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.859 3.039 . . . . 0.0 110.846 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.4 mt -162.96 -173.46 3.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.252 0.621 . . . . 0.0 110.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.75 161.78 40.53 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 120.711 0.291 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 154.2 8.39 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -79.94 -30.45 39.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 117.489 0.644 . . . . 0.0 110.117 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -133.34 172.13 13.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.1 0.96 . . . . 0.0 109.589 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.92 -43.24 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -64.15 -34.63 70.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -68.49 -21.71 64.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 121.781 -0.574 . . . . 0.0 110.876 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.77 -44.33 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.71 -29.31 70.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.219 -0.301 . . . . 0.0 111.391 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.83 -13.93 60.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.991 0.359 . . . . 0.0 111.451 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -96.09 -24.05 16.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 109.966 175.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.4 -48.65 76.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.0 p -68.72 -17.87 64.13 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.009 0.524 . . . . 0.0 111.427 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.75 -44.24 74.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.155 -0.34 . . . . 0.0 111.725 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -96.2 -18.8 19.81 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.164 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.17 75.53 11.4 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.855 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.49 -16.35 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.734 2.29 . . . . 0.0 110.367 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.59 1.6 7.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.933 0.893 . . . . 0.0 111.587 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -125.38 -4.65 7.25 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.632 0.773 . . . . 0.0 111.176 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.9 ttpt -64.39 -27.84 69.29 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.78 26.21 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.406 0.683 . . . . 0.0 110.039 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 t -129.1 -11.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.972 0.909 . . . . 0.0 109.16 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.8 mt -120.45 -20.21 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.565 0.746 . . . . 0.0 109.174 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.84 159.83 38.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.611 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -70.06 154.19 42.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.636 0.774 . . . . 0.0 110.12 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 123.667 0.787 . . . . 0.0 111.558 -177.094 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.84 126.94 52.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.88 146.9 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.95 161.55 30.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.0 mm -132.37 108.3 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 54.29 10.05 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.286 0.635 . . . . 0.0 111.701 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.58 -2.38 36.67 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.109 0.862 . . . . 0.0 112.586 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -79.75 1.91 24.87 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.39 99.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.77 1.228 . . . . 0.0 114.063 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 pt -50.12 -25.93 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -62.46 -10.01 10.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.313 0.645 . . . . 0.0 112.581 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -122.43 12.66 10.13 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.595 0.758 . . . . 0.0 111.105 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.14 -83.94 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.906 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -144.25 2.7 1.15 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.629 0.65 . . . . 0.0 111.558 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.35 -142.58 30.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.67 6.28 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.45 20.25 5.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.269 0.627 . . . . 0.0 111.301 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.6 m -61.35 -8.16 3.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.7 mt 61.32 132.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.956 1.302 . . . . 0.0 112.537 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.78 176.44 5.14 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.137 0.975 . . . . 0.0 110.319 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.6 mttt -144.4 166.28 25.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.141 0.977 . . . . 0.0 110.716 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.31 6.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -153.61 16.59 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.175 -0.328 . . . . 0.0 110.376 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 4.4 m-20 -67.55 176.6 2.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.844 0.83 . . . . 0.0 111.097 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.58 151.06 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.75 151.36 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.83 6.69 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -114.9 129.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.32 145.63 54.66 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 122.827 0.451 . . . . 0.0 110.102 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.84 170.84 17.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.108 3.206 . . . . 0.0 110.307 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.456 -0.683 0 C-N-CA 123.398 2.732 . . . . 0.0 112.356 175.824 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.486 0.66 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.29 142.93 56.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.711 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.58 134.22 35.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.17 -175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.998 0.519 . . . . 0.0 110.392 -173.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -126.79 155.9 42.09 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.48 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.72 117.71 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 123.686 0.794 . . . . 0.0 108.956 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.36 158.81 15.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.873 0.469 . . . . 0.0 109.96 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.8 mt -134.24 152.18 51.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -141.33 158.75 43.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 -148.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.482 0.313 . . . . 0.0 110.693 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -55.33 -14.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -68.91 -30.35 68.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.016 0.825 . . . . 0.0 110.263 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -69.01 -30.97 69.46 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.227 0.611 . . . . 0.0 110.038 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.99 -18.69 58.05 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.694 0.798 . . . . 0.0 111.611 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.91 2.33 56.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.431 0.292 . . . . 0.0 111.042 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.56 -5.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.506 0.722 . . . . 0.0 111.109 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.9 10.31 38.42 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.636 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.8 p -142.9 144.08 27.9 Favored Pre-proline 0 C--N 1.341 0.205 0 CA-C-N 117.893 0.847 . . . . 0.0 110.069 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.42 -20.23 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.39 2.727 . . . . 0.0 111.462 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -165.6 161.31 18.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.209 0.604 . . . . 0.0 110.486 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 153.3 26.97 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 122.645 0.378 . . . . 0.0 110.862 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.79 152.03 32.24 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.469 2.779 . . . . 0.0 109.897 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -161.86 -174.37 4.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -147.33 162.46 38.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.776 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.34 151.91 8.44 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.3 -25.35 46.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -140.46 173.83 11.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.824 1.25 . . . . 0.0 108.961 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -54.87 -51.37 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -59.19 -33.94 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -67.0 -20.71 65.92 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.416 -0.802 . . . . 0.0 111.157 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.43 -45.18 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.29 -38.5 71.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.196 0.999 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 35' ' ' LEU . 48.4 mt -72.85 -16.91 61.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -88.62 -32.06 18.26 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.821 0.344 . . . . 0.0 110.161 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.57 -46.43 90.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 p -73.14 -13.05 61.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.502 0.321 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.84 -42.91 63.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -100.66 -19.07 16.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.37 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -117.97 77.81 12.45 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.627 0.771 . . . . 0.0 108.996 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.96 -15.94 52.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.641 2.228 . . . . 0.0 110.158 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.19 2.22 4.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.492 1.117 . . . . 0.0 111.55 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.1 mt -124.23 -9.8 7.56 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.818 0.847 . . . . 0.0 110.675 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.86 -25.6 67.64 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -123.68 26.92 7.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.103 0.478 . . . . 0.0 109.728 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.13 -10.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 C-N-CA 124.571 1.148 . . . . 0.0 108.658 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.53 -20.55 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.78 0.832 . . . . 0.0 109.326 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.97 159.1 36.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 110.752 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -79.59 136.78 36.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.416 0.686 . . . . 0.0 109.439 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.7 tttt . . . . . 0 CA--C 1.535 0.38 0 C-N-CA 124.975 1.31 . . . . 0.0 110.891 176.238 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 CA--C 1.521 -0.158 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.225 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -121.86 129.39 52.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -124.39 148.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.391 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -129.13 160.14 33.8 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.415 HG12 ' CG2' ' A' ' 74' ' ' ILE . 32.5 mm -132.43 109.79 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 170.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 54.06 11.39 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.059 0.544 . . . . 0.0 111.714 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.19 -1.63 43.82 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.035 0.826 . . . . 0.0 112.509 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -80.29 0.42 32.88 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.43 99.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.623 1.169 . . . . 0.0 113.652 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 69' ' ' ILE . 30.5 pt -51.29 -21.55 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 112.071 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -66.67 -10.42 46.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.516 0.727 . . . . 0.0 112.23 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.56 9.92 11.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.769 0.828 . . . . 0.0 110.211 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.81 -156.27 0.71 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 108.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.73 -2.33 14.3 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.58 -136.77 19.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.61 1.76 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.17 0.988 . . . . 0.0 113.35 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.72 23.57 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.589 0.631 . . . . 0.0 111.917 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' THR . 88.8 m -63.37 0.24 0.73 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.938 0.895 . . . . 0.0 113.354 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt 52.73 85.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.74 171.1 0.95 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.018 1.327 . . . . 0.0 111.364 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -140.72 164.59 29.79 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.643 1.177 . . . . 0.0 109.891 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.01 3.81 0.06 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 t -152.4 18.07 0.63 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 110.013 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.59 177.24 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.696 0.76 . . . . 0.0 110.355 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.39 153.76 37.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -135.16 157.19 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 133.72 5.02 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.96 134.33 61.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.3 144.37 53.19 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.383 0.673 . . . . 0.0 110.29 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 66.6 Cg_endo -80.41 175.26 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.693 3.595 . . . . 0.0 110.187 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 77.1 Cg_endo . . . . . 0 N--CA 1.457 -0.654 0 C-N-CA 123.168 2.578 . . . . 0.0 112.176 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.85 128.02 34.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.109 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.21 128.75 35.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 110.282 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 m -140.18 -175.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.14 0.495 . . . . 0.0 110.643 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.809 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.24 132.36 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -109.73 147.63 32.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.6 mt -126.1 155.53 41.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -143.64 159.55 42.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.37 -147.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.458 0.303 . . . . 0.0 111.033 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -56.13 -13.65 2.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.59 -30.94 66.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.16 0.891 . . . . 0.0 110.072 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.83 -30.13 67.56 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.347 0.659 . . . . 0.0 109.711 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -78.89 -18.66 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.282 0.633 . . . . 0.0 112.133 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -95.28 3.23 54.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.763 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.02 -8.99 3.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.789 0.836 . . . . 0.0 110.673 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 8.25 50.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.6 p -141.35 144.48 34.27 Favored Pre-proline 0 N--CA 1.457 -0.12 0 CA-C-N 118.05 0.925 . . . . 0.0 110.41 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.84 -21.14 12.77 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.244 2.629 . . . . 0.0 111.197 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -164.93 159.6 18.34 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.738 0.415 . . . . 0.0 110.776 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.49 156.15 29.7 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.367 0.667 . . . . 0.0 111.759 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.58 150.24 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.669 2.913 . . . . 0.0 111.741 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.1 mt -160.63 -176.77 5.75 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.257 1.023 . . . . 0.0 109.817 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -149.06 158.16 43.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.06 158.15 15.54 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.75 -26.84 40.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.51 0.655 . . . . 0.0 109.703 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -137.92 165.9 25.39 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.437 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -46.73 -47.89 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.85 -32.48 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -68.92 -20.68 64.23 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.382 0.537 . . . . 0.0 111.439 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.9 t -93.04 -39.63 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.34 -29.26 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.321 0.51 . . . . 0.0 110.921 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.9 mt -76.87 -16.15 59.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.323 0.249 . . . . 0.0 111.221 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' HD22 ' A' ' 25' ' ' LEU . 1.8 m -94.34 -21.45 18.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.879 0.872 . . . . 0.0 110.362 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.4 tm? -67.84 -49.63 61.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.9 p -67.75 -16.03 63.92 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.038 0.535 . . . . 0.0 111.247 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.34 -44.41 75.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -97.7 -18.13 19.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -118.56 76.17 13.12 Favored Pre-proline 0 N--CA 1.455 -0.219 0 C-N-CA 123.385 0.674 . . . . 0.0 109.778 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.42 -17.22 58.88 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.89 2.393 . . . . 0.0 110.444 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.3 1.17 8.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 111.666 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -123.58 -6.38 8.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.487 0.715 . . . . 0.0 111.183 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 35.7 ttpt -63.11 -26.95 69.06 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.547 ' CE2' ' HE2' ' A' ' 51' ' ' LYS . 20.7 m-85 -117.38 27.45 9.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 109.89 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.95 -9.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.407 1.083 . . . . 0.0 108.817 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.78 -20.2 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.118 0.967 . . . . 0.0 109.268 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -131.69 162.76 29.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.695 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -83.98 132.61 34.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.274 0.63 . . . . 0.0 109.988 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HE2' ' CE2' ' A' ' 46' ' ' TYR . 51.6 tttm . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 125.115 1.366 . . . . 0.0 111.976 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 C--O 1.225 -0.217 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.947 0.403 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.24 146.15 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -129.95 163.18 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.715 0.406 . . . . 0.0 110.403 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 mm -134.05 105.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 55.07 7.69 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.195 0.598 . . . . 0.0 111.952 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.14 -4.64 31.73 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.731 0.681 . . . . 0.0 112.175 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -73.12 -2.57 22.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.08 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 113.729 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.72 -20.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -66.01 -10.01 35.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.947 0.499 . . . . 0.0 111.655 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -117.79 8.21 12.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.532 0.733 . . . . 0.0 110.656 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.01 -156.68 0.72 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.269 1.028 . . . . 0.0 109.162 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.0 -3.44 19.54 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -137.62 20.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.12 -0.66 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.91 25.32 5.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.303 0.502 . . . . 0.0 111.349 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.1 m -65.77 -2.29 3.58 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.352 0.661 . . . . 0.0 111.381 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt 60.37 166.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.257 1.023 . . . . 0.0 110.958 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.47 171.55 14.21 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.829 0.852 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -139.96 167.29 22.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.892 0.877 . . . . 0.0 109.86 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -66.97 8.39 0.28 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -151.78 17.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.06 -179.7 2.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.75 0.786 . . . . 0.0 109.993 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -153.54 153.37 32.27 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mm -128.99 156.88 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.49 138.34 8.38 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.01 127.62 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.81 144.87 55.05 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.935 0.494 . . . . 0.0 110.623 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.98 173.13 12.28 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.621 3.547 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 C-N-CA 122.911 2.407 . . . . 0.0 111.723 175.117 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.38 31.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.25 128.87 35.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.72 -172.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -125.52 155.48 40.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.76 134.74 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -115.56 137.02 52.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.083 0.553 . . . . 0.0 109.901 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.76 160.62 16.17 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.62 159.07 43.67 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.92 -146.04 0.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.503 0.321 . . . . 0.0 111.101 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -56.66 -12.82 2.02 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -72.41 -31.35 65.44 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.07 0.85 . . . . 0.0 110.018 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -70.9 -31.04 67.56 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.003 0.521 . . . . 0.0 110.168 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.41 -33.12 69.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.783 0.433 . . . . 0.0 111.332 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.55 -23.24 25.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.615 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.5 -19.56 33.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.197 0.199 . . . . 0.0 110.495 174.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.97 1.98 60.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.6 p -144.47 149.95 45.95 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 123.798 0.839 . . . . 0.0 109.575 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 -24.52 11.77 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.776 2.317 . . . . 0.0 110.876 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.95 161.73 22.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.935 0.334 . . . . 0.0 111.395 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.36 155.74 26.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 111.59 -178.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.22 149.6 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.963 3.109 . . . . 0.0 111.733 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.0 mt -159.99 -177.11 6.08 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.265 1.026 . . . . 0.0 109.432 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -148.47 158.32 44.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 111.71 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.27 158.07 15.6 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.9 -27.39 49.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.355 0.577 . . . . 0.0 109.982 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -138.54 166.24 24.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.185 0.994 . . . . 0.0 109.588 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.62 -47.85 7.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.951 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.24 -32.93 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.91 -21.89 64.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.474 0.579 . . . . 0.0 111.412 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.05 -38.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.29 -30.45 70.87 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.633 -0.667 . . . . 0.0 110.87 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.49 -16.51 59.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.488 0.315 . . . . 0.0 111.386 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.53 ' HB3' HD22 ' A' ' 25' ' ' LEU . 3.5 m -92.53 -23.3 19.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.887 0.875 . . . . 0.0 110.613 176.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -66.91 -50.89 61.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.2 p -67.12 -15.11 63.51 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.965 0.506 . . . . 0.0 111.085 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.74 -44.22 74.26 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -98.29 -17.45 18.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.228 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -117.8 75.3 10.03 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 123.767 0.827 . . . . 0.0 109.665 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.54 -17.39 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 110.415 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.99 1.63 6.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.665 0.786 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.32 -3.59 7.41 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.724 0.81 . . . . 0.0 110.763 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.4 tttt -64.53 -23.69 67.36 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -123.19 27.68 7.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.285 0.564 . . . . 0.0 109.583 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.43 -14.57 3.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 C-N-CA 124.231 1.012 . . . . 0.0 108.832 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.35 -21.27 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.955 0.902 . . . . 0.0 108.938 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.44 160.69 33.29 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.778 0.431 . . . . 0.0 109.889 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -84.03 136.59 33.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.916 0.486 . . . . 0.0 110.099 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 124.957 1.303 . . . . 0.0 111.027 175.473 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -124.75 123.54 40.2 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -109.6 144.97 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.8 mt -128.51 161.41 29.62 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.161 0.584 . . . . 0.0 109.836 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -133.09 107.37 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 170.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 54.86 9.66 0.31 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.24 0.616 . . . . 0.0 111.623 -169.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.14 -4.08 35.51 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 123.899 0.761 . . . . 0.0 112.258 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.72 -1.36 21.54 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 50.81 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.6 1.16 . . . . 0.0 113.994 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.42 -21.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -62.08 -15.6 46.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.917 0.487 . . . . 0.0 112.267 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -113.55 8.02 17.59 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.427 0.691 . . . . 0.0 110.643 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -123.75 -155.61 0.67 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 108.986 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.08 -2.62 19.13 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.937 -0.477 . . . . 0.0 112.012 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.6 -140.17 21.57 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -60.87 -5.43 1.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.444 0.698 . . . . 0.0 112.591 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.82 22.55 12.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.417 0.687 . . . . 0.0 111.944 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 82' ' ' THR . 92.7 m -66.08 0.65 1.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.661 0.784 . . . . 0.0 112.12 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt 59.63 169.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.581 0.753 . . . . 0.0 110.645 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.54 170.76 15.18 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.759 1.224 . . . . 0.0 109.231 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.9 167.26 22.52 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.951 0.9 . . . . 0.0 109.929 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -66.56 7.59 0.32 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -151.92 17.61 0.68 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.211 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.7 178.49 2.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.86 0.838 . . . . 0.0 110.313 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -153.35 149.67 28.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.69 153.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.39 136.35 8.44 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.6 mt -118.31 128.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.57 146.36 60.19 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 122.884 0.473 . . . . 0.0 110.511 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.25 173.46 13.83 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.688 3.592 . . . . 0.0 110.497 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.454 -0.852 0 C-N-CA 122.984 2.456 . . . . 0.0 111.02 175.474 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.99 130.68 46.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -76.99 132.02 38.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -142.25 -172.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.299 0.571 . . . . 0.0 110.593 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -130.35 153.97 48.15 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.254 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.58 137.58 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -117.74 150.01 39.81 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.659 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -127.26 156.78 41.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.29 160.31 41.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.35 -147.63 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.588 0.355 . . . . 0.0 111.108 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -56.86 -10.91 1.19 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.79 -31.58 63.34 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.41 1.005 . . . . 0.0 110.189 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.35 -32.4 71.45 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.086 0.554 . . . . 0.0 109.679 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 111.637 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.8 56.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.18 -7.02 3.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.54 0.736 . . . . 0.0 110.709 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.69 43.9 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.481 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.0 p -142.15 143.98 29.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 117.996 0.898 . . . . 0.0 110.215 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.45 -17.69 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.463 2.775 . . . . 0.0 111.732 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -164.28 160.14 20.71 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.159 -0.338 . . . . 0.0 111.259 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.484 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 154.61 25.32 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 123.665 0.786 . . . . 0.0 111.47 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.49 153.0 20.54 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.848 3.032 . . . . 0.0 110.518 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.8 mt -162.95 -174.81 4.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.715 0.406 . . . . 0.0 110.341 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -146.62 160.78 41.73 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 146.69 4.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.52 -25.42 50.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.668 0.734 . . . . 0.0 110.973 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -134.45 170.89 15.07 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 124.097 0.959 . . . . 0.0 109.792 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 84' ' ' LEU . 46.2 t -56.67 -44.35 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.84 -34.64 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -69.94 -23.39 63.19 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.731 -0.606 . . . . 0.0 110.842 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.31 -45.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.12 -30.08 71.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.625 0.37 . . . . 0.0 111.733 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 mt -75.57 -16.81 60.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.149 0.431 . . . . 0.0 111.419 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.414 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -91.25 -25.28 19.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.988 0.423 . . . . 0.0 110.007 175.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.453 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.1 tm? -63.88 -50.5 68.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.425 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.5 p -67.51 -15.09 63.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.15 0.58 . . . . 0.0 111.579 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.29 -44.27 68.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.263 0.483 . . . . 0.0 111.377 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -95.85 -17.98 20.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.506 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.48 76.1 12.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.512 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.53 -17.61 60.15 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.118 2.545 . . . . 0.0 111.013 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.66 1.72 9.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.56 0.744 . . . . 0.0 111.257 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.46 -6.14 8.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 111.048 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.3 tttt -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD2' ' HD3' ' A' ' 51' ' ' LYS . 22.2 m-85 -122.77 28.23 7.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.114 0.483 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.57 -37.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.03 -24.58 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.489 0.716 . . . . 0.0 109.125 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.75 160.98 32.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.116 0.566 . . . . 0.0 110.584 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -84.91 138.6 32.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 46' ' ' TYR . 26.8 ttpp . . . . . 0 C--O 1.231 0.099 0 C-N-CA 123.07 0.548 . . . . 0.0 110.002 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.226 -0.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.192 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 mm . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.944 0.402 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -127.08 126.47 43.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.85 144.83 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 38.7 mt -128.11 160.27 32.51 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.7 mm -130.64 107.76 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.74 9.92 0.32 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.224 0.609 . . . . 0.0 111.704 -170.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.47 34.34 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.504 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.89 0.05 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 49.84 99.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.858 1.263 . . . . 0.0 114.145 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 pt -51.3 -21.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -61.95 -13.06 21.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -117.85 9.68 12.99 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.596 0.759 . . . . 0.0 111.018 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -124.81 -155.94 0.7 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.04 0.936 . . . . 0.0 109.497 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -70.89 -2.83 16.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.77 -138.2 21.19 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.15 0.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.782 0.833 . . . . 0.0 112.689 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.54 23.78 6.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.144 0.578 . . . . 0.0 111.453 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 82' ' ' THR . 84.9 m -62.12 -0.26 0.5 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.916 0.886 . . . . 0.0 113.297 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt 52.56 83.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 30' ' ' VAL . 4.1 mm? -58.08 169.86 0.74 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.924 1.289 . . . . 0.0 110.962 175.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.99 167.75 21.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.371 1.069 . . . . 0.0 109.924 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.48 5.95 0.16 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.1 t -153.48 17.37 0.54 Allowed 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.894 -0.503 . . . . 0.0 110.184 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -69.09 177.06 2.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.559 0.695 . . . . 0.0 111.049 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -149.54 151.47 33.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.29 152.57 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.08 129.95 4.97 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -111.45 130.92 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.05 147.96 64.78 Favored Pre-proline 0 N--CA 1.453 -0.289 0 C-N-CA 122.801 0.44 . . . . 0.0 110.593 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -79.63 174.01 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.637 3.558 . . . . 0.0 110.584 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 C-N-CA 123.186 2.591 . . . . 0.0 110.68 174.114 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.6 mtp . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 121.689 0.757 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.77 131.03 45.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.822 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.52 134.29 38.34 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -142.25 -175.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.168 0.509 . . . . 0.0 110.31 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -118.48 154.94 31.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.225 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.84 124.57 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.9 153.1 25.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.25 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.7 mt -127.02 157.6 39.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.49 159.47 42.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.19 -146.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.53 0.332 . . . . 0.0 111.26 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -56.94 -10.71 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.58 -30.11 61.59 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.258 0.935 . . . . 0.0 110.292 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -71.62 -33.24 68.79 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.303 0.641 . . . . 0.0 109.708 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.09 -23.71 60.56 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.692 0.797 . . . . 0.0 112.04 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.43 1.87 56.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.32 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.8 -6.46 4.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.491 0.717 . . . . 0.0 110.581 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.87 10.42 45.55 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.661 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -140.84 143.89 33.57 Favored Pre-proline 0 N--CA 1.455 -0.196 0 CA-C-N 117.853 0.826 . . . . 0.0 110.288 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.89 -20.87 10.02 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.379 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -166.99 162.81 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.921 0.328 . . . . 0.0 111.242 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.1 155.97 16.28 Favored Pre-proline 0 N--CA 1.456 -0.148 0 C-N-CA 123.632 0.773 . . . . 0.0 110.407 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.28 156.13 33.04 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.054 2.503 . . . . 0.0 110.08 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -161.61 -176.22 5.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.134 0.973 . . . . 0.0 108.85 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -149.63 158.69 44.4 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.867 0.365 . . . . 0.0 111.689 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.62 156.45 13.32 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -77.8 -26.83 49.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.358 0.579 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -139.36 166.34 24.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.605 1.162 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -45.82 -48.61 4.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 tp -62.27 -33.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -68.11 -20.19 64.9 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.604 0.638 . . . . 0.0 111.304 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.41 -43.42 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.29 -27.54 69.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.336 -0.228 . . . . 0.0 111.108 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.07 -18.53 57.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -86.81 -31.22 20.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.8 -48.98 78.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.98 0.512 . . . . 0.0 109.654 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 p -71.64 -15.2 62.23 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.887 0.475 . . . . 0.0 111.405 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.46 -38.55 65.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.249 0.477 . . . . 0.0 111.179 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -23.25 17.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -121.52 79.22 37.85 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 123.899 0.879 . . . . 0.0 109.22 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.82 -17.28 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.022 2.481 . . . . 0.0 110.232 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.41 0.92 7.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.162 0.985 . . . . 0.0 111.374 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.98 -5.53 6.8 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.7 0.8 . . . . 0.0 111.11 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.02 -24.1 67.76 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -122.06 25.31 9.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.303 0.641 . . . . 0.0 109.808 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.04 -9.96 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.228 1.011 . . . . 0.0 108.899 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.23 -19.84 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.778 0.831 . . . . 0.0 109.509 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -130.66 161.05 32.47 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.116 0.484 . . . . 0.0 110.937 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -71.22 152.35 43.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.547 0.739 . . . . 0.0 109.634 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 CA--C 1.53 0.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.567 -178.274 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 CA--C 1.521 -0.172 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.911 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.5 mm . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.873 0.368 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -124.15 123.82 41.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.9 144.36 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -127.79 162.18 27.24 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -133.09 105.88 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 55.23 8.4 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.133 0.573 . . . . 0.0 112.137 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.26 -4.84 33.49 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.973 0.797 . . . . 0.0 112.349 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.47 -1.99 20.7 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.49 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 113.808 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -49.8 -21.29 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -63.02 -13.62 37.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -114.52 7.75 16.24 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.491 0.716 . . . . 0.0 110.556 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.73 -154.95 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.025 0.93 . . . . 0.0 109.345 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.2 -13.2 61.74 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.06 0.944 . . . . 0.0 112.3 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 -141.54 18.62 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.38 4.14 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.901 0.88 . . . . 0.0 113.333 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.03 23.15 5.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.177 0.591 . . . . 0.0 111.181 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 82' ' ' THR . 86.5 m -66.49 -1.82 4.0 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.1 mt 60.54 167.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.549 0.74 . . . . 0.0 110.747 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.63 170.53 15.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.761 0.824 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -141.35 166.5 24.59 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.57 1.148 . . . . 0.0 109.888 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.96 -5.55 0.45 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.9 t -143.77 14.87 1.75 Allowed 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.89 179.04 2.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.494 0.664 . . . . 0.0 110.569 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.73 152.63 30.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mm -131.75 155.18 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.94 135.18 5.75 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 172.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.85 127.97 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.8 146.56 62.34 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 122.733 0.413 . . . . 0.0 110.467 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.31 172.71 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.653 3.569 . . . . 0.0 110.353 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 C-N-CA 122.843 2.362 . . . . 0.0 110.592 175.591 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.468 ' CG ' ' N ' ' A' ' 3' ' ' MET . 70.4 t60 57.31 170.91 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.999 1.319 . . . . 0.0 113.119 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.468 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.7 mtp -146.46 104.39 3.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 132.14 51.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.17 129.39 35.08 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.3 m -139.66 -172.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.317 0.579 . . . . 0.0 110.438 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -128.46 158.23 38.91 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.475 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.0 t -134.4 131.37 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -114.97 137.61 51.8 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.08 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -111.16 160.88 16.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -145.75 158.22 43.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.39 -145.67 0.27 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.543 0.337 . . . . 0.0 111.258 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -56.13 -12.01 1.35 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.7 -31.62 61.92 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 119.229 0.922 . . . . 0.0 109.708 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -70.23 -32.42 70.28 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 123.17 0.588 . . . . 0.0 110.052 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.75 -32.53 71.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.866 0.467 . . . . 0.0 111.651 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 -23.51 23.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.395 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.47 -17.71 35.69 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.698 0.227 . . . . 0.0 110.722 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.84 3.29 59.27 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 p -143.94 148.71 43.29 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 123.915 0.886 . . . . 0.0 109.792 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.94 -25.55 11.88 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.954 2.436 . . . . 0.0 110.821 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.04 163.0 20.71 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 122.855 0.462 . . . . 0.0 110.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.5 pt? -159.59 155.72 23.57 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.279 0.632 . . . . 0.0 110.583 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.59 154.85 35.48 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.23 2.62 . . . . 0.0 110.217 172.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.6 mt -163.38 -175.31 4.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.197 0.999 . . . . 0.0 108.696 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -145.88 160.21 42.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 111.254 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.8 146.73 5.11 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -78.57 -24.51 45.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.137 -0.625 . . . . 0.0 110.379 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -132.13 171.02 14.17 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.931 0.892 . . . . 0.0 109.593 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -55.21 -49.12 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.5 -32.73 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -68.61 -21.91 64.46 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.457 -0.777 . . . . 0.0 111.049 -177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -85.6 -46.07 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.53 -39.93 68.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.469 1.107 . . . . 0.0 111.803 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.3 mt -72.4 -18.24 61.74 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -88.38 -30.93 19.14 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.957 0.344 . . . . 0.0 110.409 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.77 -48.97 79.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.5 p -70.64 -14.77 62.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.135 0.574 . . . . 0.0 111.824 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -70.99 -40.99 71.54 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 118.251 0.478 . . . . 0.0 111.964 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.53 -18.32 16.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.026 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -116.97 75.84 7.77 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.949 0.899 . . . . 0.0 109.085 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -64.88 -16.81 57.22 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.887 2.391 . . . . 0.0 110.303 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.31 -0.64 8.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.113 0.965 . . . . 0.0 111.489 175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.7 mt -124.86 -5.19 7.49 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 110.96 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.61 -24.17 67.5 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -120.4 25.08 10.03 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.165 0.586 . . . . 0.0 109.838 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.1 t -123.55 -15.19 5.52 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 C-N-CA 124.296 1.039 . . . . 0.0 108.755 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.16 -21.05 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.783 0.833 . . . . 0.0 109.316 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.86 159.65 35.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.224 0.535 . . . . 0.0 111.446 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.83 135.5 37.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.881 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -75.95 54.19 0.82 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.114 1.366 . . . . 0.0 111.449 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -116.7 -179.81 17.77 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 55' ' ' LYS . 30.2 m-20 45.56 44.22 9.8 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.709 0.804 . . . . 0.0 111.987 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.5 15.84 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.141 0.976 . . . . 0.0 113.572 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 53' ' ' ASP . 54.8 mtmt -131.69 13.05 4.91 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.071 0.948 . . . . 0.0 110.368 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -150.0 -167.07 2.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 124.317 1.047 . . . . 0.0 109.265 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -117.03 10.78 14.06 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.594 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.5 mm -74.04 134.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.8 mt -133.2 168.4 18.62 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.596 0.759 . . . . 0.0 109.794 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.1 mt -141.0 131.81 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 15.8 tp -61.83 143.34 56.48 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.0 t -57.46 159.38 4.91 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.881 0.372 . . . . 0.0 110.454 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -99.98 18.74 55.34 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.7 m -137.79 -5.68 1.72 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.508 0.723 . . . . 0.0 112.023 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.7 mm -91.33 160.6 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.086 0.469 . . . . 0.0 110.588 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -126.35 130.29 50.48 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 170.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -114.8 144.29 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 36.2 mt -128.43 160.23 32.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.83 0.452 . . . . 0.0 109.963 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.3 mm -132.19 108.43 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 171.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 54.86 10.71 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.943 0.497 . . . . 0.0 111.502 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.35 -3.04 43.29 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.889 0.757 . . . . 0.0 112.637 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -76.64 -0.95 25.34 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.5 t-20 51.15 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.731 1.212 . . . . 0.0 113.849 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.6 pt -51.47 -21.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.931 -0.48 . . . . 0.0 112.264 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -62.84 -12.21 23.2 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -118.18 9.4 12.6 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.564 0.746 . . . . 0.0 110.83 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.81 -155.73 0.69 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.219 1.008 . . . . 0.0 109.6 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -70.34 -3.79 19.08 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.48 21.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.89 2.29 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.763 0.825 . . . . 0.0 112.773 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -128.17 23.44 6.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.433 0.693 . . . . 0.0 111.466 -174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' THR . 87.2 m -61.92 -0.8 0.53 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.119 0.967 . . . . 0.0 113.26 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 mt 53.02 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.83 0.824 . . . . 0.0 113.045 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.05 174.78 0.59 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 111.57 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 55.2 mtpt -140.91 166.23 25.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.182 0.993 . . . . 0.0 110.785 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.38 5.4 0.28 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.1 t -153.04 16.35 0.56 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.861 0.3 . . . . 0.0 110.232 173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 11.7 m-20 -68.03 177.94 2.01 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 111.345 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -149.19 151.95 35.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.07 154.26 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.74 134.93 7.39 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.7 mt -116.54 129.42 73.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.29 146.98 63.15 Favored Pre-proline 0 N--CA 1.454 -0.261 0 C-N-CA 122.342 0.257 . . . . 0.0 110.855 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 97.7 Cg_endo -78.01 174.89 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.558 3.505 . . . . 0.0 110.626 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.9 Cg_endo -67.66 169.92 14.93 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.775 2.316 . . . . 0.0 110.912 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m -137.75 161.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.104 0.961 . . . . 0.0 110.321 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.5 m 52.74 18.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.728 0.811 . . . . 0.0 112.956 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.18 179.05 45.49 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 117.25 -1.861 . . . . 0.0 110.797 179.494 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.109 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 3' ' ' MET . 35.8 t60 -153.89 170.02 22.02 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.24 0.616 . . . . 0.0 109.948 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.429 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 80.1 mtp -139.57 97.51 3.29 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.98 132.33 51.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -78.53 133.02 37.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.42 -173.57 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 0.0 110.403 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -127.75 155.69 43.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 172.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.6 t -138.51 125.32 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -105.82 153.67 21.59 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.074 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.73 155.94 45.79 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.06 159.0 43.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -174.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.55 -146.18 0.25 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.523 0.329 . . . . 0.0 110.938 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -56.36 -12.78 1.8 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.1 mt -72.83 -30.99 64.47 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 119.096 0.862 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -69.26 -31.15 69.49 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 123.286 0.634 . . . . 0.0 109.754 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -75.78 -19.75 58.77 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.74 0.816 . . . . 0.0 112.181 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -93.71 1.69 56.48 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.952 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.14 -9.41 3.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.731 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.89 9.62 56.87 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.297 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.3 p -142.35 140.66 19.37 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 117.977 0.889 . . . . 0.0 110.458 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.37 -16.16 15.44 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.263 2.642 . . . . 0.0 111.396 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -164.68 159.47 18.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 110.792 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.72 157.1 22.97 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 123.392 0.677 . . . . 0.0 111.19 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.99 154.2 22.55 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.308 2.672 . . . . 0.0 110.517 171.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.9 mt -161.61 -176.13 5.13 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.567 1.147 . . . . 0.0 108.829 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.9 m -148.77 162.27 40.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.66 156.63 10.16 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.48 -24.22 42.48 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 117.518 0.659 . . . . 0.0 110.001 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -140.57 172.06 13.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.086 0.954 . . . . 0.0 109.85 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.403 HG22 HD21 ' A' ' 84' ' ' LEU . 43.5 t -56.22 -44.85 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.42 -34.01 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.5 -23.12 63.57 Favored 'General case' 0 C--O 1.231 0.11 0 O-C-N 121.8 -0.562 . . . . 0.0 111.179 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.0 t -88.44 -39.8 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.3 mt -67.9 -31.62 71.54 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.095 -0.378 . . . . 0.0 111.155 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.3 mt -75.56 -20.62 58.51 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.094 0.406 . . . . 0.0 110.697 176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -85.55 -26.77 25.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.895 0.878 . . . . 0.0 110.351 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.82 -50.63 61.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.332 0.653 . . . . 0.0 109.452 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.2 p -68.25 -13.49 62.29 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.225 0.61 . . . . 0.0 111.696 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.34 -37.93 74.76 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -106.77 -18.02 14.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.452 0.47 . . . . 0.0 111.107 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -116.98 74.06 6.78 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 123.953 0.901 . . . . 0.0 108.744 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.98 -16.91 57.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.748 2.299 . . . . 0.0 110.308 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.08 0.45 7.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.952 0.901 . . . . 0.0 111.525 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 17' ' ' ALA . 91.5 mt -123.41 -4.91 8.28 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.658 0.783 . . . . 0.0 110.52 175.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 78.1 tttt -62.36 -23.51 66.83 Favored 'General case' 0 CA--C 1.526 0.041 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -122.68 26.16 8.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.217 0.607 . . . . 0.0 109.579 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.24 -8.85 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 124.327 1.051 . . . . 0.0 108.754 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 95.4 mt -122.12 -19.99 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.181 0.992 . . . . 0.0 109.332 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -132.46 162.09 32.05 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.098 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -78.09 135.47 37.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.292 0.637 . . . . 0.0 109.882 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -74.5 30.45 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.129 1.371 . . . . 0.0 111.487 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.92 0.79 86.36 Favored Glycine 0 CA--C 1.524 0.636 0 O-C-N 122.076 -0.39 . . . . 0.0 112.391 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -142.06 126.01 17.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -132.32 15.31 4.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.866 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -143.15 4.79 1.45 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.324 0.649 . . . . 0.0 111.985 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -145.88 158.17 43.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.899 0.88 . . . . 0.0 110.01 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.08 1.94 29.42 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.164 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mm -72.05 131.95 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.4 mt -140.13 173.03 11.92 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.564 0.746 . . . . 0.0 110.235 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.1 mt -139.35 127.45 26.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -57.94 133.77 55.77 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' N ' HD13 ' A' ' 61' ' ' LEU . 5.7 t -56.98 162.79 2.28 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.082 0.468 . . . . 0.0 111.497 -176.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.42 18.88 52.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.8 p -138.5 -5.19 1.59 Allowed 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.269 0.628 . . . . 0.0 112.096 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.7 mm -93.74 159.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 122.9 0.48 . . . . 0.0 110.625 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.81 131.58 53.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.7 mm -117.14 143.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.7 mt -127.69 160.62 31.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.73 0.412 . . . . 0.0 110.215 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mm -132.06 108.41 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 54.52 11.02 0.38 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.997 0.519 . . . . 0.0 111.598 -170.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.73 -3.7 42.3 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.71 0.671 . . . . 0.0 112.259 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -77.07 -0.41 24.6 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -173.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.4 t-20 51.23 100.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.774 1.23 . . . . 0.0 114.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.5 pt -51.41 -21.62 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 121.862 -0.524 . . . . 0.0 112.012 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -62.97 -11.65 20.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.053 0.541 . . . . 0.0 112.256 177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.76 9.89 11.5 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.522 0.729 . . . . 0.0 110.797 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.6 mt -124.62 -155.73 0.68 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.361 1.065 . . . . 0.0 109.269 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -69.6 -4.75 20.58 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.9 -138.54 20.92 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.11 1.18 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -129.48 26.52 5.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.294 0.638 . . . . 0.0 111.403 -176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 82' ' ' THR . 85.6 m -62.93 0.42 0.55 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.529 0.731 . . . . 0.0 112.916 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.6 mt 51.82 83.64 0.05 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.42 169.58 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.77 1.228 . . . . 0.0 111.097 176.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -140.01 166.91 23.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 124.579 1.152 . . . . 0.0 110.051 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.04 4.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 115.805 1.779 . . . . 0.0 115.805 -172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -152.81 16.83 0.58 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 118.334 0.516 . . . . 0.0 110.576 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.25 177.44 2.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.67 0.747 . . . . 0.0 110.886 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.64 153.41 36.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.734 0.814 . . . . 0.0 109.067 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.28 157.01 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.24 134.59 6.19 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.81 131.12 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.46 145.38 56.23 Favored Pre-proline 0 N--CA 1.454 -0.256 0 C-N-CA 122.658 0.383 . . . . 0.0 111.11 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 70.8 Cg_endo -79.19 171.68 15.86 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.947 3.765 . . . . 0.0 110.554 177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 49.8 Cg_endo -66.01 -13.71 41.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.179 2.586 . . . . 0.0 113.368 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -83.5 8.11 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.416 0.553 . . . . 0.0 111.304 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -156.82 177.89 10.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.384 0.274 . . . . 0.0 110.558 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.22 -16.08 0.11 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.505 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 117.378 -1.79 . . . . 0.0 110.867 179.123 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 59.4 t60 -152.68 169.22 23.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.256 0.622 . . . . 0.0 110.193 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.5 mtp -140.61 102.75 4.38 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 128.66 36.77 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.035 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -77.58 128.49 34.23 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.401 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.7 m -138.23 -175.8 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.275 0.56 . . . . 0.0 110.451 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -120.35 154.22 35.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.851 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.1 t -134.1 124.59 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -113.29 133.34 55.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.222 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -102.56 161.31 13.82 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -145.35 159.03 43.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.35 -148.77 0.2 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.365 0.266 . . . . 0.0 111.359 -174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -56.29 -12.21 1.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.34 -30.55 66.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.058 0.845 . . . . 0.0 110.002 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -68.44 -32.62 72.77 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.321 0.648 . . . . 0.0 109.964 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.45 -31.9 65.83 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.796 0.438 . . . . 0.0 111.508 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.98 -26.44 25.47 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.299 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.78 -18.35 44.46 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.855 0.298 . . . . 0.0 110.436 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.4 2.16 59.02 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.4 p -144.36 150.3 47.58 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 124.094 0.958 . . . . 0.0 109.653 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.19 -25.0 12.0 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.065 2.51 . . . . 0.0 111.135 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -166.51 163.85 17.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.593 0.235 . . . . 0.0 110.99 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.32 155.73 17.53 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 123.555 0.742 . . . . 0.0 110.38 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.58 155.36 31.61 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.216 2.611 . . . . 0.0 109.844 171.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.2 mt -160.26 -175.44 5.05 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.686 0.794 . . . . 0.0 108.925 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -149.21 158.98 44.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.944 0.402 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.06 157.1 14.77 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -80.57 -25.71 38.37 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 117.506 0.653 . . . . 0.0 109.291 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -138.18 165.96 25.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.502 1.121 . . . . 0.0 109.089 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.2 t -45.55 -54.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.19 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.12 -32.58 44.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -66.58 -21.57 66.14 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.634 -0.666 . . . . 0.0 111.169 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.0 t -86.98 -45.04 16.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.11 -36.45 65.72 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.733 0.813 . . . . 0.0 111.605 177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -75.16 -17.83 60.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -86.22 -33.65 20.68 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.128 0.422 . . . . 0.0 110.161 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.55 -49.56 75.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.98 0.512 . . . . 0.0 109.624 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.467 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.1 p -69.57 -16.55 63.43 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.789 0.436 . . . . 0.0 112.025 178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.21 -37.26 72.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.387 0.54 . . . . 0.0 111.945 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.28 -20.27 14.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.784 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -118.95 74.65 13.24 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 123.95 0.9 . . . . 0.0 108.837 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -63.78 -17.22 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.914 2.409 . . . . 0.0 110.054 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.58 1.78 6.1 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.237 1.015 . . . . 0.0 111.563 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -125.11 -6.42 7.21 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.576 0.75 . . . . 0.0 111.36 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 33.2 ttpt -63.34 -26.74 68.9 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.088 -0.383 . . . . 0.0 111.796 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 23.0 m-85 -117.56 27.37 9.1 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.267 0.627 . . . . 0.0 110.067 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.9 -7.47 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.274 1.03 . . . . 0.0 108.99 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.5 mt -123.87 -23.55 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 124.129 0.972 . . . . 0.0 109.121 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -127.62 164.62 21.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.801 0.44 . . . . 0.0 110.113 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -75.91 174.42 9.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.436 0.694 . . . . 0.0 110.451 176.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 34.0 ttmt -119.23 32.36 6.15 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.357 1.063 . . . . 0.0 110.015 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.25 23.44 9.73 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.781 0.705 . . . . 0.0 112.805 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -137.85 132.26 32.29 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -139.4 6.21 2.3 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.424 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -142.13 8.98 1.87 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.214 0.606 . . . . 0.0 111.72 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.3 t -149.82 -165.66 2.34 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 123.04 0.536 . . . . 0.0 109.948 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.06 14.76 7.9 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.31 128.55 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.8 mt -121.34 167.56 12.62 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.278 0.631 . . . . 0.0 110.063 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.7 mt -141.41 123.64 14.4 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.42 132.17 52.89 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.7 t -57.4 161.05 3.63 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.156 0.503 . . . . 0.0 111.245 -176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.76 18.67 54.63 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.8 m -137.08 -1.87 2.12 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.379 0.671 . . . . 0.0 111.684 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.5 mm -100.31 157.96 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 123.089 0.556 . . . . 0.0 110.374 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.48 129.22 52.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.98 138.42 47.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 35.3 mt -125.6 161.62 26.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.472 0.177 . . . . 0.0 110.723 -175.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.2 mm -132.66 106.31 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 171.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 54.84 9.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.266 0.626 . . . . 0.0 112.2 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.91 -4.02 36.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.778 0.704 . . . . 0.0 112.257 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -75.31 -4.33 38.59 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 27.0 t-20 47.64 106.75 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.765 1.626 . . . . 0.0 114.989 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -53.04 -21.59 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -67.58 -10.21 49.85 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.586 0.754 . . . . 0.0 111.51 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -116.84 9.47 13.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.756 0.822 . . . . 0.0 110.664 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.61 -156.54 0.76 Allowed 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 109.132 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -67.1 -8.64 32.28 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.23 -139.2 18.07 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.85 -0.82 0.22 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.842 0.857 . . . . 0.0 113.054 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -127.83 26.05 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.052 0.541 . . . . 0.0 111.347 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 86.7 m -66.08 -1.64 3.35 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.415 0.686 . . . . 0.0 111.296 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.95 167.76 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.024 0.929 . . . . 0.0 111.249 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.6 mt -138.41 174.41 10.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.449 0.7 . . . . 0.0 110.398 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -142.22 166.37 24.87 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 110.348 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.04 7.24 0.41 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.7 t -149.96 14.36 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.2 179.11 1.65 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.73 0.776 . . . . 0.0 110.853 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.08 152.7 32.71 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 mm -131.34 153.39 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.59 138.09 8.74 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.1 mt -123.34 128.39 74.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.61 144.9 51.06 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.569 0.348 . . . . 0.0 111.037 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 62.3 Cg_endo -80.35 172.25 13.88 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 125.262 3.975 . . . . 0.0 110.99 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 68.4 Cg_endo -71.65 -13.62 29.92 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.336 2.691 . . . . 0.0 113.039 178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -145.05 140.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 118.489 0.586 . . . . 0.0 109.657 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 t -152.76 171.78 17.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.873 0.469 . . . . 0.0 110.249 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.84 178.32 48.42 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.475 -1.736 . . . . 0.0 110.262 -179.623 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.21 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 66.7 t60 -152.85 168.99 23.93 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.077 0.551 . . . . 0.0 110.256 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 88.2 mtp -140.61 105.24 4.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.49 126.51 28.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.95 -174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.27 126.61 31.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.249 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.14 -172.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 110.777 -177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -123.58 152.5 41.81 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.696 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.1 t -126.44 133.33 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -113.68 148.21 36.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.102 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.0 mt -127.03 157.91 38.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -145.05 160.36 41.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -173.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.08 -145.44 0.2 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.6 0.36 . . . . 0.0 110.88 -175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -58.91 -9.95 2.17 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.61 -30.92 61.84 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.082 0.855 . . . . 0.0 110.054 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -69.89 -33.08 71.73 Favored 'General case' 0 C--N 1.338 0.084 0 C-N-CA 123.377 0.671 . . . . 0.0 109.546 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -72.54 -22.93 60.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 123.672 0.789 . . . . 0.0 111.808 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 123.283 0.365 . . . . 0.0 111.053 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.12 -7.37 3.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.523 0.729 . . . . 0.0 110.731 176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 7.42 44.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.596 0.617 . . . . 0.0 112.152 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.8 p -142.75 144.68 30.78 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-N 117.825 0.812 . . . . 0.0 110.193 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.63 -16.14 13.32 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.097 2.531 . . . . 0.0 111.722 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -164.81 158.67 17.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.124 0.42 . . . . 0.0 111.585 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 155.01 26.16 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 123.615 0.766 . . . . 0.0 111.238 177.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -81.21 152.34 18.3 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.802 3.001 . . . . 0.0 110.857 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -162.92 -176.9 5.16 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.355 0.662 . . . . 0.0 109.659 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -148.12 159.39 43.98 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.709 0.29 . . . . 0.0 111.564 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.87 155.49 11.52 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 174.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -76.57 -28.69 56.32 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.007 -0.702 . . . . 0.0 110.274 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -137.16 167.39 21.64 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.171 0.988 . . . . 0.0 109.412 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.46 -54.71 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.198 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.71 -32.51 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -66.8 -21.74 66.04 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 121.473 -0.767 . . . . 0.0 111.118 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.81 -44.15 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -54.81 -37.4 66.07 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 35' ' ' LEU . 39.9 mt -73.74 -16.68 61.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 -25.79 17.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.928 0.394 . . . . 0.0 110.174 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.37 -48.81 76.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.9 p -69.08 -15.98 63.57 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.056 0.542 . . . . 0.0 111.289 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -71.52 -46.9 58.39 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.921 0.328 . . . . 0.0 111.524 -177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -92.88 -19.3 21.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.253 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -118.25 77.21 12.89 Favored Pre-proline 0 N--CA 1.454 -0.228 0 C-N-CA 123.568 0.747 . . . . 0.0 109.681 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.89 -16.62 56.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.009 2.472 . . . . 0.0 110.838 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.89 2.22 7.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.696 0.798 . . . . 0.0 111.41 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.69 -6.62 7.43 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.707 0.803 . . . . 0.0 111.021 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -62.07 -22.91 66.15 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.84 0.456 . . . . 0.0 111.978 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.74 25.35 8.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.058 0.543 . . . . 0.0 109.817 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.7 t -126.57 -8.51 4.91 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.459 1.104 . . . . 0.0 109.07 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.29 -19.17 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.113 0.965 . . . . 0.0 109.18 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -130.94 161.05 32.74 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.023 0.44 . . . . 0.0 110.907 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.9 133.24 35.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.367 0.667 . . . . 0.0 109.997 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -75.26 47.84 0.39 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.992 1.317 . . . . 0.0 110.556 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.31 1.0 46.76 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.141 0.4 . . . . 0.0 112.423 -174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -80.4 25.95 0.39 Allowed 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.599 0.759 . . . . 0.0 111.988 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.07 0.29 1.33 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -140.48 11.02 2.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.967 0.907 . . . . 0.0 111.848 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 t -150.26 -163.5 1.79 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.793 0.806 . . . . 0.0 110.909 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -134.43 25.03 3.79 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.352 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.7 mm -119.13 114.53 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.17 0.988 . . . . 0.0 109.649 -174.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -78.47 171.5 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.168 0.509 . . . . 0.0 111.115 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.8 mt -140.25 125.96 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -58.2 135.69 57.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' N ' HD13 ' A' ' 61' ' ' LEU . 11.3 t -58.92 165.94 2.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.098 0.475 . . . . 0.0 111.176 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.44 20.06 28.25 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.9 m -138.24 -0.84 1.99 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.875 0.87 . . . . 0.0 111.578 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.7 mm -102.12 149.3 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 122.912 0.485 . . . . 0.0 110.025 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -117.71 124.88 49.57 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 69.6 mt -121.35 148.18 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.213 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.9 mt -130.08 162.71 28.17 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.175 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.401 HG12 ' CG2' ' A' ' 74' ' ' ILE . 35.6 mm -135.31 108.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.22 10.24 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.949 0.5 . . . . 0.0 111.74 -170.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.69 -3.05 39.09 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.874 0.75 . . . . 0.0 112.386 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -77.05 0.37 21.6 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.29 97.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.838 1.255 . . . . 0.0 114.202 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.401 ' CG2' HG12 ' A' ' 69' ' ' ILE . 26.7 pt -50.38 -20.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -64.03 -16.88 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.575 0.625 . . . . 0.0 111.878 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -110.99 6.9 21.35 Favored 'General case' 0 CA--C 1.527 0.059 0 C-N-CA 123.492 0.717 . . . . 0.0 110.579 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -124.03 -157.34 0.76 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.788 0.835 . . . . 0.0 109.399 -178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -73.56 -0.54 15.49 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.97 -137.11 20.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.87 -2.48 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.837 0.855 . . . . 0.0 112.754 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.68 21.62 7.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.345 0.521 . . . . 0.0 111.421 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 82' ' ' THR . 89.3 m -65.61 -0.9 2.28 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.779 0.832 . . . . 0.0 112.261 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.2 mt 60.38 164.97 0.07 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.231 1.012 . . . . 0.0 110.918 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.4 mt -138.45 169.98 16.83 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.668 0.787 . . . . 0.0 110.697 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 4.5 mptt -136.49 167.36 21.51 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.03 0.932 . . . . 0.0 111.475 -178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -68.84 7.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.9 -1.045 . . . . 0.0 113.685 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.7 t -152.05 16.3 0.65 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -69.76 -179.97 1.98 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.592 0.71 . . . . 0.0 110.365 174.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -155.32 152.57 29.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.9 mm -127.45 154.55 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.08 127.41 2.77 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 173.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.7 mt -119.21 132.36 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.79 146.41 60.1 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 123.174 0.59 . . . . 0.0 110.683 -175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 98.3 Cg_endo -78.43 173.19 14.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.78 3.653 . . . . 0.0 110.252 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.2 Cg_endo -66.21 -2.46 7.03 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.191 2.594 . . . . 0.0 112.893 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.4 t -66.38 -13.51 16.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 C-N-CA 122.965 0.506 . . . . 0.0 110.884 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.4 t -157.16 177.0 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.219 -0.301 . . . . 0.0 110.348 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 164.85 -14.97 0.09 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.961 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.382 -1.788 . . . . 0.0 110.823 179.499 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.191 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' CG ' ' N ' ' A' ' 3' ' ' MET . 79.3 t60 -153.02 167.78 28.05 Favored 'General case' 0 N--CA 1.457 -0.086 0 C-N-CA 122.977 0.511 . . . . 0.0 110.394 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.438 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 88.1 mtp -141.48 105.09 4.7 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.37 131.82 50.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.35 129.56 35.14 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.03 -173.51 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.179 0.592 . . . . 0.0 110.422 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -127.43 157.2 40.64 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.345 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -136.69 128.03 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 47.3 mtmt -113.71 139.96 48.65 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.766 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.97 160.55 16.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -145.63 159.64 42.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.84 -151.79 0.17 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.379 0.272 . . . . 0.0 110.719 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -56.11 -11.97 1.33 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.36 -30.71 69.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.877 0.762 . . . . 0.0 109.92 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.45 -33.39 69.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.601 0.76 . . . . 0.0 110.35 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -70.6 -32.13 69.37 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 122.845 0.458 . . . . 0.0 111.653 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.82 -23.74 25.24 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.683 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.09 -17.49 37.22 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.321 0.248 . . . . 0.0 110.351 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.06 2.74 58.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.2 p -143.77 149.39 46.4 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.61 0.764 . . . . 0.0 109.836 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.56 -26.69 11.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.954 2.436 . . . . 0.0 110.952 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -165.66 163.23 19.17 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.987 0.515 . . . . 0.0 110.185 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.09 156.72 24.13 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.967 0.507 . . . . 0.0 110.766 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.34 156.01 36.98 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 123.1 2.533 . . . . 0.0 110.287 171.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.4 mt -163.61 -175.39 4.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.958 0.903 . . . . 0.0 108.782 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -146.55 160.48 42.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 111.275 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.02 150.93 6.63 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.93 -24.18 41.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.647 0.723 . . . . 0.0 110.275 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -134.98 171.48 14.36 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.282 1.033 . . . . 0.0 109.826 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.402 HG22 HD21 ' A' ' 84' ' ' LEU . 46.4 t -56.42 -45.5 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.13 -35.54 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -68.94 -22.92 64.1 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.737 0.699 . . . . 0.0 111.008 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.04 -44.13 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.38 -32.03 73.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.201 0.2 . . . . 0.0 111.373 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.8 -18.43 60.96 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -86.23 -30.96 21.96 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.966 0.412 . . . . 0.0 110.025 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.94 -46.8 89.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.42 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 68.1 p -70.96 -15.2 62.57 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.075 0.55 . . . . 0.0 111.771 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -71.18 -40.89 70.97 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.301 0.5 . . . . 0.0 112.14 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -101.92 -18.55 15.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.175 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -117.13 75.04 7.72 Favored Pre-proline 0 N--CA 1.454 -0.255 0 C-N-CA 123.956 0.902 . . . . 0.0 109.115 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.2 -16.62 56.0 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.892 2.395 . . . . 0.0 110.382 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.23 0.08 6.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.042 0.937 . . . . 0.0 111.65 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.4 mt -125.52 -4.85 7.14 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.868 0.867 . . . . 0.0 110.825 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.6 tttt -62.35 -23.98 67.09 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.65 0.38 . . . . 0.0 112.013 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -124.7 28.64 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.206 0.527 . . . . 0.0 109.718 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.7 -10.08 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.45 1.1 . . . . 0.0 109.123 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 92.7 mt -121.49 -18.65 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.972 0.909 . . . . 0.0 108.936 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -133.13 163.16 29.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.43 0.634 . . . . 0.0 111.147 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -73.42 169.33 17.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.512 1.125 . . . . 0.0 109.646 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -121.42 32.17 6.01 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.952 1.301 . . . . 0.0 109.235 -176.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.85 -3.87 69.5 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 119.575 -0.569 . . . . 0.0 113.524 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -144.15 131.05 20.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.064 0.932 . . . . 0.0 109.281 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -125.13 15.01 8.44 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 124.056 0.943 . . . . 0.0 111.048 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -131.75 -0.04 3.9 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.067 0.947 . . . . 0.0 110.564 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.6 m -146.74 163.95 34.34 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.521 1.128 . . . . 0.0 110.452 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -83.85 4.5 29.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.579 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.04 127.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.2 mt -136.18 165.66 25.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.043 0.937 . . . . 0.0 110.097 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -144.33 138.7 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.476 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -58.25 144.68 40.16 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.476 ' H ' HD13 ' A' ' 61' ' ' LEU . 5.5 t -58.56 -1.76 0.17 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.87 5.61 9.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.837 1.208 . . . . 0.0 114.574 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.3 m -138.94 -13.88 1.2 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.44 1.12 . . . . 0.0 112.391 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.7 mm -73.12 150.52 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -110.85 125.06 53.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.0 mt -123.04 147.56 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.786 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 33.9 mt -130.76 158.02 41.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.566 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.8 mm -129.32 108.86 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 170.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.2 m120 54.12 10.42 0.29 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.211 0.605 . . . . 0.0 111.835 -170.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.97 -4.29 33.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.913 0.768 . . . . 0.0 112.615 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.97 -0.1 23.13 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.9 t-20 50.73 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 113.767 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.1 pt -49.99 -21.26 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -63.21 -15.61 57.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -115.75 9.73 15.23 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.464 0.706 . . . . 0.0 110.608 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 73.6 mt -123.19 -154.52 0.61 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.872 0.869 . . . . 0.0 109.069 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -65.59 -14.73 61.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.609 0.764 . . . . 0.0 111.774 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.61 -137.99 15.85 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.16 4.95 0.11 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.818 0.847 . . . . 0.0 113.242 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -131.62 27.38 4.68 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.453 0.701 . . . . 0.0 111.155 -175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 82' ' ' THR . 94.8 m -62.96 -1.01 0.78 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 mt 53.33 83.2 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.671 0.748 . . . . 0.0 112.643 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.402 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -57.98 170.67 0.61 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.036 1.334 . . . . 0.0 111.417 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.415 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 38.0 mtmm -140.45 166.36 24.94 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.043 0.937 . . . . 0.0 110.65 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -62.6 4.65 0.15 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -151.91 15.51 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 0.0 110.383 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 34.0 m-20 -66.3 175.11 2.31 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.703 0.764 . . . . 0.0 111.933 174.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -147.94 150.99 35.06 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.985 0.914 . . . . 0.0 109.103 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -133.81 155.51 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.84 133.88 6.29 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.6 mt -117.94 129.71 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.46 146.77 59.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 123.14 0.576 . . . . 0.0 110.41 -176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.02 171.22 18.37 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.852 3.035 . . . . 0.0 110.673 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.95 0.79 6.64 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.777 2.985 . . . . 0.0 113.067 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.1 m 40.42 26.15 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 126.265 1.826 . . . . 0.0 115.037 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.6 t -153.9 3.55 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.615 0.366 . . . . 0.0 111.407 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -172.03 18.32 0.06 OUTLIER Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.701 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.28 -1.844 . . . . 0.0 110.87 -177.476 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 51.1 t60 -153.68 170.58 20.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.368 0.667 . . . . 0.0 110.196 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 83.3 mtp -140.68 100.72 3.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.25 128.62 36.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.99 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.8 129.85 35.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.101 0.476 . . . . 0.0 110.09 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 m -140.11 -175.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.348 0.594 . . . . 0.0 110.458 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -119.97 156.42 30.88 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.52 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.7 t -134.93 123.84 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -108.39 152.23 24.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.27 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.2 mt -127.22 156.46 41.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -143.62 158.35 43.73 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -150.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.53 0.332 . . . . 0.0 110.95 -173.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -55.95 -11.17 0.95 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.4 mt -70.41 -30.66 67.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.271 0.942 . . . . 0.0 110.028 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttt-85 -68.89 -38.75 79.83 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.234 0.613 . . . . 0.0 109.705 176.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.54 -37.43 79.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.648 0.779 . . . . 0.0 111.286 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.13 -0.5 19.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.086 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.85 -6.01 4.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.014 0.926 . . . . 0.0 110.519 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.33 35.31 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.152 0.882 . . . . 0.0 113.028 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.5 p -141.22 144.46 34.6 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 118.077 0.939 . . . . 0.0 110.472 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.47 -24.73 8.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.284 2.656 . . . . 0.0 111.574 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -167.41 162.72 14.79 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.48 0.312 . . . . 0.0 110.829 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.5 pt? -161.03 155.58 19.78 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 123.239 0.616 . . . . 0.0 110.659 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.35 154.33 31.88 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.261 2.64 . . . . 0.0 110.62 173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -161.86 -177.55 5.9 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.797 0.839 . . . . 0.0 108.885 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -147.54 160.48 42.58 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.009 0.433 . . . . 0.0 111.774 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.72 158.16 16.31 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -80.23 -25.76 39.44 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.937 -0.743 . . . . 0.0 109.466 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -138.1 165.95 25.35 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.638 1.175 . . . . 0.0 109.225 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.9 t -45.56 -54.3 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.069 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 tp -57.93 -32.26 43.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -68.19 -21.58 64.87 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 121.595 -0.69 . . . . 0.0 111.34 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.5 t -86.48 -45.79 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.45 -36.99 64.66 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.64 0.776 . . . . 0.0 111.573 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 35' ' ' LEU . 43.3 mt -74.32 -17.66 60.81 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -87.7 -32.53 19.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.934 0.397 . . . . 0.0 110.232 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.78 -50.63 72.6 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.8 p -71.05 -14.37 62.31 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.46 0.704 . . . . 0.0 111.815 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.88 -37.22 70.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 118.339 0.518 . . . . 0.0 112.166 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -103.7 -19.31 14.36 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.953 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.37 75.16 11.74 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 123.97 0.908 . . . . 0.0 108.963 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -64.08 -17.99 61.87 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.113 2.542 . . . . 0.0 110.087 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.69 1.21 5.6 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.089 0.955 . . . . 0.0 111.277 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -125.72 -5.71 6.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.675 0.79 . . . . 0.0 111.249 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.34 -24.05 67.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 122.096 -0.378 . . . . 0.0 112.005 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -119.96 24.58 10.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.46 0.704 . . . . 0.0 109.635 178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.49 -6.78 5.05 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.153 0 C-N-CA 124.592 1.157 . . . . 0.0 109.006 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 91.5 mt -123.63 -21.55 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.73 0.812 . . . . 0.0 109.217 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -131.08 163.55 27.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.354 0.597 . . . . 0.0 110.898 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.92 157.97 35.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.389 -0.823 . . . . 0.0 108.997 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -89.49 22.65 2.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.002 0.921 . . . . 0.0 112.525 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.12 -176.95 44.31 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-O 121.947 0.748 . . . . 0.0 113.913 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -146.43 147.91 31.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 0.0 107.62 173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.2 -10.01 55.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -143.93 -0.74 1.01 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.237 0.926 . . . . 0.0 113.208 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 t -157.07 -157.69 0.7 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.433 0.635 . . . . 0.0 110.616 -175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -127.9 11.6 6.63 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.891 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.66 119.8 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.81 164.48 10.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.291 0.637 . . . . 0.0 111.669 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.6 mt -139.49 129.01 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.72 130.79 48.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 42.8 t -54.31 153.52 5.3 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.882 0.372 . . . . 0.0 111.099 -176.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.27 13.54 66.1 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 119.608 -0.551 . . . . 0.0 112.801 -173.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.55 -6.4 1.34 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.912 0.856 . . . . 0.0 112.465 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.1 mm -82.19 159.67 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.663 0.785 . . . . 0.0 110.257 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -123.27 129.15 50.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.9 mm -117.32 146.23 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 mt -130.65 163.51 27.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.5 0.32 . . . . 0.0 110.45 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.4 mm -134.77 106.74 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 54.45 8.81 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.984 0.514 . . . . 0.0 112.119 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.94 -3.76 35.86 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 123.666 0.65 . . . . 0.0 112.317 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -74.39 -1.69 22.12 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 50.75 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 113.55 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.0 pt -49.68 -21.25 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 -63.46 -13.98 46.09 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -113.73 7.85 17.3 Favored 'General case' 0 N--CA 1.46 0.044 0 C-N-CA 123.3 0.64 . . . . 0.0 110.73 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.4 mt -123.88 -156.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.225 1.01 . . . . 0.0 108.948 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -72.41 -2.32 18.95 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.7 -139.66 21.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.28 -2.32 0.45 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.892 0.877 . . . . 0.0 112.703 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -124.63 24.57 7.77 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.172 0.589 . . . . 0.0 111.256 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' THR . 88.9 m -65.59 -1.62 2.81 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.324 0.65 . . . . 0.0 111.293 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.5 mt 59.62 168.02 0.07 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.947 0.899 . . . . 0.0 110.558 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.7 mt -138.15 172.66 12.59 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.626 0.77 . . . . 0.0 110.008 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -140.74 167.77 21.38 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.933 0.893 . . . . 0.0 109.818 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.37 8.71 0.29 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t -150.65 15.79 0.78 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.135 0.493 . . . . 0.0 110.035 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.59 -179.83 2.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.693 0.759 . . . . 0.0 110.28 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -154.26 152.89 30.84 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.42 155.84 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.91 7.1 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 mt -122.52 127.6 75.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mp -131.79 144.82 54.85 Favored Pre-proline 0 N--CA 1.456 -0.169 0 C-N-CA 123.272 0.629 . . . . 0.0 110.361 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.75 172.36 11.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 124.634 3.556 . . . . 0.0 109.869 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.38 176.3 5.84 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.099 2.533 . . . . 0.0 111.008 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.27 16.5 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.974 0.51 . . . . 0.0 110.808 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.3 t -150.9 13.15 0.7 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.323 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.04 179.24 46.45 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.938 -1.479 . . . . 0.0 111.428 179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.442 ' CG ' ' N ' ' A' ' 3' ' ' MET . 47.8 t60 -153.87 170.17 21.65 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.338 0.655 . . . . 0.0 110.234 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.442 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 82.2 mtp -140.34 99.81 3.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.33 131.34 47.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.36 -174.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -77.27 133.39 38.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.115 0.483 . . . . 0.0 109.977 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.5 m -143.11 -171.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.175 0.512 . . . . 0.0 110.777 -174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -131.16 156.98 44.37 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.782 170.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.0 t -128.45 137.53 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -118.85 138.65 52.58 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.877 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -111.75 160.53 17.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -145.79 158.61 43.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.68 -147.09 0.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.461 0.305 . . . . 0.0 111.318 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -57.16 -8.69 0.74 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -75.86 -31.75 59.43 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.345 0.975 . . . . 0.0 109.771 176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -71.46 -32.65 68.54 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.092 0.557 . . . . 0.0 109.888 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -68.34 -35.41 77.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.718 0.407 . . . . 0.0 110.19 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.27 -27.23 38.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.42 -174.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.61 -17.86 27.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.781 0.432 . . . . 0.0 110.944 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.14 4.88 69.44 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.2 p -144.19 145.31 29.17 Favored Pre-proline 0 N--CA 1.455 -0.2 0 C-N-CA 123.656 0.782 . . . . 0.0 109.658 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -75.08 -25.43 11.75 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.047 2.498 . . . . 0.0 110.823 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.86 161.65 23.18 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.444 0.298 . . . . 0.0 111.265 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.99 155.18 23.88 Favored Pre-proline 0 CA--C 1.529 0.169 0 C-N-CA 123.526 0.73 . . . . 0.0 111.759 -178.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.4 150.68 19.74 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.001 3.134 . . . . 0.0 111.386 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 36' ' ' SER . 9.8 mt -160.96 -174.63 4.49 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.159 0.984 . . . . 0.0 109.655 178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 m -147.95 163.39 36.99 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.33 154.39 9.09 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.17 -23.92 43.59 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.475 0.637 . . . . 0.0 109.848 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -140.12 172.92 12.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.162 0.985 . . . . 0.0 109.767 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 36.9 t -54.85 -49.56 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -62.01 -31.53 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.83 -20.9 63.41 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.553 -0.717 . . . . 0.0 110.856 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -89.19 -42.08 14.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 mp -56.98 -40.95 77.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.866 0.866 . . . . 0.0 111.499 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -74.3 -15.63 60.96 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.661 0.267 . . . . 0.0 111.245 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' HD22 ' A' ' 25' ' ' LEU . 2.2 m -93.61 -23.01 18.44 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.456 1.102 . . . . 0.0 110.712 176.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.44 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -70.57 -51.3 29.4 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.419 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -66.47 -13.33 60.68 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.824 0.45 . . . . 0.0 111.048 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.62 -44.74 70.05 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 122.485 0.314 . . . . 0.0 111.671 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -98.34 -17.73 18.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.077 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -117.86 75.99 10.69 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.831 0.852 . . . . 0.0 109.454 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -64.62 -16.93 57.78 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.724 2.283 . . . . 0.0 110.506 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.7 0.36 9.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.009 0.923 . . . . 0.0 111.641 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.7 -5.04 8.12 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.825 0.85 . . . . 0.0 110.886 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.36 -23.32 66.95 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -121.57 27.76 8.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.992 0.517 . . . . 0.0 109.659 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.5 -38.22 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.4 mt -85.05 -24.96 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.726 0.81 . . . . 0.0 109.158 174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -130.5 165.7 22.12 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.038 0.535 . . . . 0.0 111.035 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -87.51 142.76 27.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -73.41 39.05 0.1 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 111.838 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.59 -17.88 65.15 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.709 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -150.0 113.72 5.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.063 0.931 . . . . 0.0 109.851 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -84.14 2.79 37.88 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -139.78 8.87 2.37 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.8 m -142.1 165.04 28.54 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.495 0.664 . . . . 0.0 111.518 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -77.78 -5.32 50.36 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.859 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.456 ' H ' HD12 ' A' ' 58' ' ' ILE . 4.7 mp -72.75 126.39 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.8 mt -143.34 173.63 11.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.938 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.9 mt -139.06 123.19 19.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 127.5 31.51 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 t -55.45 147.77 16.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 110.88 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.62 17.21 45.96 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.719 0.676 . . . . 0.0 111.573 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.1 m -134.99 -7.92 2.35 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.813 0.845 . . . . 0.0 111.779 -176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.8 mm -90.09 156.86 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 123.004 0.522 . . . . 0.0 110.456 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -125.49 123.86 40.11 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -111.9 135.67 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -122.13 161.28 23.42 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 38.6 mm -125.54 111.61 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 56.02 10.13 0.55 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.203 0.601 . . . . 0.0 112.154 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.38 15.31 9.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.335 0.493 . . . . 0.0 111.971 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -123.66 93.74 4.03 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.683 1.193 . . . . 0.0 109.438 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -39.15 109.73 0.12 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.749 1.62 . . . . 0.0 111.961 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 pt -50.03 -23.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -64.22 -8.36 12.28 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.14 0.576 . . . . 0.0 111.898 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -121.76 8.21 9.98 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.386 1.074 . . . . 0.0 110.644 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -121.78 -153.89 0.57 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.538 1.135 . . . . 0.0 108.659 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.53 -15.37 60.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.54 0.736 . . . . 0.0 111.864 -178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 89.3 -142.56 16.85 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -175.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.0 5.27 0.06 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.881 0.873 . . . . 0.0 112.895 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.7 mt-10 -130.51 26.92 5.05 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.606 0.639 . . . . 0.0 111.587 -175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 82' ' ' THR . 88.7 m -63.47 -0.13 0.84 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.603 0.761 . . . . 0.0 112.838 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt 52.61 79.67 0.11 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.505 0.669 . . . . 0.0 112.777 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -56.45 165.25 1.14 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.942 1.297 . . . . 0.0 111.107 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -133.77 167.42 20.57 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.205 1.002 . . . . 0.0 109.558 -178.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.98 5.98 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -171.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -153.76 19.58 0.53 Allowed 'General case' 0 C--N 1.332 -0.17 0 O-C-N 121.812 -0.555 . . . . 0.0 110.175 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.73 178.22 3.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.758 0.79 . . . . 0.0 110.468 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.05 151.52 31.22 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -174.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.83 150.4 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.63 130.33 5.95 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.5 mt -113.52 128.38 70.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.62 147.72 65.71 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 122.451 0.3 . . . . 0.0 110.642 -177.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 67.7 Cg_endo -79.61 175.23 10.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 124.9 3.733 . . . . 0.0 110.244 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo -67.22 170.89 12.36 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.826 2.35 . . . . 0.0 110.727 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.8 151.38 20.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.367 0.667 . . . . 0.0 109.467 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 t -153.22 175.85 12.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 122.969 0.508 . . . . 0.0 110.141 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.32 -15.85 0.05 OUTLIER Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.48 -0.622 . . . . 0.0 113.184 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 117.168 -1.907 . . . . 0.0 110.62 178.943 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 3' ' ' MET . 68.2 t60 -152.64 168.25 26.24 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.812 0.445 . . . . 0.0 110.267 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.441 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.9 mtp -140.48 103.66 4.6 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 174.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.72 131.98 50.75 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 130.24 35.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.29 -173.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.232 0.539 . . . . 0.0 110.54 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -127.76 157.52 40.15 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 169.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.3 t -136.8 127.47 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -108.49 152.34 24.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.494 0.717 . . . . 0.0 109.5 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.78 156.71 43.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -144.56 159.77 42.23 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 -174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.11 -148.63 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.504 0.322 . . . . 0.0 111.219 -174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.14 -9.99 0.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.63 -31.89 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.292 0.951 . . . . 0.0 109.724 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.08 -35.83 74.49 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.322 0.649 . . . . 0.0 110.071 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -68.22 -33.59 74.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.885 0.874 . . . . 0.0 110.723 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -2.74 40.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.875 -174.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.0 -5.83 3.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.533 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.17 11.22 44.92 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 119.22 -0.767 . . . . 0.0 112.659 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.0 p -141.54 144.21 32.65 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 118.276 1.038 . . . . 0.0 110.571 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.04 -20.13 11.75 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.425 2.75 . . . . 0.0 111.62 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.12 162.02 19.92 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 122.65 0.38 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.91 155.24 24.19 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.235 0.614 . . . . 0.0 111.247 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.27 154.03 28.21 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.244 2.629 . . . . 0.0 110.09 172.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -163.75 -176.04 4.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.948 0.899 . . . . 0.0 109.253 177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.26 161.66 40.5 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.69 155.76 10.32 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -79.09 -24.99 43.08 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.529 0.664 . . . . 0.0 110.047 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -140.61 172.5 12.62 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.944 0.898 . . . . 0.0 109.733 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 84' ' ' LEU . 41.7 t -55.72 -43.89 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.47 -35.01 74.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.98 -21.44 65.06 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.696 -0.628 . . . . 0.0 110.638 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 94.7 t -86.23 -45.27 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.71 -29.54 70.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 119.546 -0.264 . . . . 0.0 111.389 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.0 mt -74.44 -19.12 60.52 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.098 0.408 . . . . 0.0 111.928 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.86 -31.13 20.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.077 0.465 . . . . 0.0 109.876 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.65 -48.87 79.97 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.412 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 73.5 p -71.44 -13.97 62.0 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.404 0.681 . . . . 0.0 112.11 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -71.65 -38.6 70.68 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.284 0.493 . . . . 0.0 111.769 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -104.34 -17.66 14.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 123.331 0.394 . . . . 0.0 111.575 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -117.4 75.8 9.1 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.44 -17.68 60.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.052 2.502 . . . . 0.0 110.224 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 0.25 6.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.974 0.91 . . . . 0.0 111.568 175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.8 -6.83 7.34 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.903 0.881 . . . . 0.0 110.937 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 82.0 tttt -65.38 -23.37 66.96 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.431 0.292 . . . . 0.0 111.621 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -118.96 27.67 8.74 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 123.078 0.551 . . . . 0.0 109.894 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.94 -35.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.219 0 C-N-CA 123.849 0.86 . . . . 0.0 108.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.407 ' HA ' HG13 ' A' ' 65' ' ' ILE . 96.8 mt -88.11 -24.81 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 173.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -134.37 163.27 30.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.162 0.506 . . . . 0.0 110.689 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -78.11 147.57 34.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.688 0.795 . . . . 0.0 109.409 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -75.22 36.76 0.12 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.75 1.22 . . . . 0.0 110.756 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.86 29.66 6.26 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.307 0.956 . . . . 0.0 112.354 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -130.13 20.24 5.37 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.546 0.738 . . . . 0.0 112.313 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.07 -1.55 4.35 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -141.4 8.83 2.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.902 0.881 . . . . 0.0 111.124 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -144.49 -170.04 3.28 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.797 0.839 . . . . 0.0 109.875 -176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -131.05 24.14 4.92 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.3 mm -124.0 116.5 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 124.143 0.977 . . . . 0.0 109.723 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.5 mt -84.24 175.05 9.68 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.297 0.57 . . . . 0.0 111.065 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -141.87 131.04 23.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -57.51 141.29 48.26 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.421 ' H ' HD13 ' A' ' 61' ' ' LEU . 5.5 t -59.14 -2.39 0.27 Allowed 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -173.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.06 7.11 15.32 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.373 0.987 . . . . 0.0 114.537 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 79.8 p -139.19 -14.77 1.13 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.254 1.027 . . . . 0.0 112.39 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 48' ' ' ILE . 18.1 mm -71.01 158.95 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.259 0.624 . . . . 0.0 109.741 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -121.14 126.23 49.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.7 mm -113.75 143.03 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.4 mt -125.93 159.87 31.46 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.4 mm -130.93 107.48 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 54.38 11.2 0.38 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.192 0.597 . . . . 0.0 111.604 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.86 39.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.861 0.743 . . . . 0.0 112.596 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -76.44 -1.33 26.52 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 51.06 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.97 1.308 . . . . 0.0 113.84 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.62 -21.33 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 121.725 -0.609 . . . . 0.0 112.177 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -63.54 -11.53 25.07 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.175 0.59 . . . . 0.0 112.291 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -119.37 9.95 11.77 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.443 0.697 . . . . 0.0 110.79 175.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.3 mt -124.7 -155.49 0.67 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.216 1.006 . . . . 0.0 109.436 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -68.13 -5.57 18.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.74 0.416 . . . . 0.0 111.965 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 81.19 -141.16 22.05 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.82 5.82 0.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 113.079 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' GLY . 38.4 mt-10 -130.38 25.53 5.14 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.406 0.682 . . . . 0.0 111.308 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 82' ' ' THR . 90.5 m -62.26 0.97 0.37 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.986 0.914 . . . . 0.0 113.168 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.7 mt 51.77 84.27 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 30' ' ' VAL . 4.2 mm? -58.63 171.56 0.61 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.963 1.305 . . . . 0.0 111.422 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.82 166.74 23.82 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.187 0.995 . . . . 0.0 110.877 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -63.57 4.6 0.24 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.0 t -151.96 15.58 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.992 -0.443 . . . . 0.0 110.363 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.2 m-20 -66.99 177.76 1.62 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.541 0.686 . . . . 0.0 111.593 174.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -149.4 151.28 33.78 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.05 0.94 . . . . 0.0 108.786 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.2 mt -133.41 157.81 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.72 133.18 5.43 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.62 130.43 66.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.21 146.48 56.43 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 122.858 0.463 . . . . 0.0 110.911 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -81.93 166.77 16.75 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.437 3.425 . . . . 0.0 110.755 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -72.87 5.46 2.96 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.286 3.324 . . . . 0.0 113.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.01 14.1 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.385 0.674 . . . . 0.0 112.42 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.2 t -157.43 176.92 12.04 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.997 0.427 . . . . 0.0 111.314 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.6 10.24 0.7 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.61 -1.661 . . . . 0.0 110.747 -179.674 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.443 ' CG ' ' N ' ' A' ' 3' ' ' MET . 68.1 t60 -153.13 169.06 23.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.025 0.53 . . . . 0.0 110.376 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.443 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.5 mtp -141.73 104.28 4.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.47 131.14 48.17 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.04 132.92 37.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.6 m -142.1 -174.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.226 0.536 . . . . 0.0 111.022 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -126.67 155.77 42.09 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -137.77 128.07 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -113.9 138.61 50.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.903 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.74 161.12 15.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -145.87 158.88 43.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.78 -147.66 0.21 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.421 0.288 . . . . 0.0 111.239 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -56.93 -11.38 1.44 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.56 -31.06 64.95 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.193 0.906 . . . . 0.0 110.084 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -70.26 -33.32 71.46 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.047 0.539 . . . . 0.0 109.922 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -70.22 -31.84 69.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.881 0.472 . . . . 0.0 111.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.05 -23.1 22.64 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.611 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.69 -18.56 34.91 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.707 0.23 . . . . 0.0 110.841 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.37 62.65 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.2 p -144.4 145.85 30.61 Favored Pre-proline 0 C--O 1.232 0.169 0 C-N-CA 123.833 0.853 . . . . 0.0 109.727 -177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.92 -26.03 11.46 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.114 2.543 . . . . 0.0 110.953 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -164.95 163.85 20.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 110.095 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -162.58 157.78 19.09 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.081 0.553 . . . . 0.0 111.128 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.3 155.0 28.68 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.145 2.564 . . . . 0.0 110.136 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 25' ' ' LEU . 8.5 mt -161.25 -176.64 5.53 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 124.046 0.938 . . . . 0.0 108.678 176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -147.72 157.77 43.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 111.452 177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.82 148.77 5.8 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -77.71 -24.97 49.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.783 0.791 . . . . 0.0 110.452 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -134.03 170.84 15.04 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.946 0.898 . . . . 0.0 109.939 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.2 t -54.7 -45.28 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.93 -33.92 63.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -69.87 -20.98 63.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.359 0.527 . . . . 0.0 111.537 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.86 -40.58 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.063 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.23 -33.31 75.47 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 122.191 -0.318 . . . . 0.0 110.875 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.76 -18.73 60.94 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.87 0.304 . . . . 0.0 110.936 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 m -90.16 -26.75 20.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.923 0.889 . . . . 0.0 110.729 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -67.75 -51.28 50.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 76.3 p -67.48 -13.37 61.98 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.119 0.568 . . . . 0.0 111.634 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.76 -39.43 80.26 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -106.26 -17.38 14.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.19 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -116.58 73.08 5.63 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.124 0.969 . . . . 0.0 108.98 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -64.14 -17.18 58.76 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.904 2.403 . . . . 0.0 110.444 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -1.07 9.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.006 0.922 . . . . 0.0 111.434 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.1 mt -122.1 -4.73 8.99 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.889 0.875 . . . . 0.0 110.906 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.5 tttt -65.3 -22.68 66.87 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -123.15 28.91 6.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.8 t -125.48 -41.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.04 -24.69 10.65 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -130.0 167.46 18.22 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.231 0.612 . . . . 0.0 109.903 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -93.07 146.84 23.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -72.76 35.35 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.814 1.246 . . . . 0.0 112.044 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.12 26.0 2.2 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.403 1.001 . . . . 0.0 112.435 -177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -127.88 21.94 6.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.812 0.845 . . . . 0.0 111.659 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.59 -5.17 14.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.12 10.88 1.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.071 0.949 . . . . 0.0 110.916 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -144.05 -166.3 2.33 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.914 0.885 . . . . 0.0 109.701 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.93 24.53 4.27 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.427 0.691 . . . . 0.0 109.484 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mm -124.22 116.86 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.19 -175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.97 175.16 10.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.541 0.736 . . . . 0.0 111.123 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -140.79 122.74 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.56 123.47 17.48 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 21.5 t -58.98 136.6 57.98 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.83 81.7 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 75.2 m -84.0 -17.83 39.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.375 0.67 . . . . 0.0 111.439 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.53 151.08 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.64 0.776 . . . . 0.0 109.829 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -118.4 126.43 52.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.578 ' C ' HD22 ' A' ' 68' ' ' LEU . 29.5 mt -124.67 136.61 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 121.756 0.789 . . . . 0.0 110.141 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.578 HD22 ' C ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -126.18 152.9 45.38 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.966 -172.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.436 HG12 ' CG2' ' A' ' 74' ' ' ILE . 37.8 mm -124.17 100.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 172.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 64.55 0.92 1.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.189 0.995 . . . . 0.0 110.475 -172.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.81 -0.0 19.8 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.146 0.879 . . . . 0.0 112.253 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 17.9 p30 -75.83 -4.13 39.01 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 49.06 93.83 0.01 OUTLIER 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.181 1.392 . . . . 0.0 113.782 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.436 ' CG2' HG12 ' A' ' 69' ' ' ILE . 15.6 pt -49.2 -22.78 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.9 mtp85 -67.09 -10.88 54.73 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.888 0.875 . . . . 0.0 112.402 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -118.21 6.97 11.99 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.29 0.636 . . . . 0.0 110.348 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.0 mt -123.81 -154.94 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.158 0.983 . . . . 0.0 109.587 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.26 -4.49 10.75 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -132.6 19.24 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.76 -0.97 0.12 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.297 1.039 . . . . 0.0 113.61 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.35 25.81 5.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.641 0.655 . . . . 0.0 111.523 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 82' ' ' THR . 67.0 m -64.99 2.71 0.68 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.1 mt 51.95 85.0 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.77 168.9 1.55 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.915 1.286 . . . . 0.0 110.718 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -139.91 167.87 21.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 124.056 0.942 . . . . 0.0 110.21 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.04 5.96 0.21 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.7 t -153.08 16.8 0.56 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.316 0.507 . . . . 0.0 110.381 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.39 178.57 1.92 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.758 0.79 . . . . 0.0 111.202 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.81 151.54 34.96 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.039 0.935 . . . . 0.0 108.502 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.1 mt -134.5 152.0 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.72 131.95 5.84 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.5 mt -118.08 131.77 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.54 148.31 66.93 Favored Pre-proline 0 N--CA 1.453 -0.277 0 C-N-CA 122.8 0.44 . . . . 0.0 110.362 -177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.21 174.02 13.04 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 124.322 3.348 . . . . 0.0 110.316 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.24 160.76 46.07 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.852 2.368 . . . . 0.0 110.365 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 20.1 m -137.75 7.75 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.731 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -159.36 174.41 14.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.464 0.173 . . . . 0.0 110.68 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.28 -15.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.825 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 117.46 -1.744 . . . . 0.0 111.114 178.501 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.08 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 3' ' ' MET . 63.1 t60 -152.56 169.98 21.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.031 0.533 . . . . 0.0 110.063 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.456 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.1 mtp -140.96 103.21 4.43 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.6 127.71 32.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 -174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -78.06 126.53 30.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.242 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.33 -175.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.939 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -117.68 154.39 31.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.251 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -133.15 119.46 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -101.08 151.13 22.18 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.557 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.0 mt -129.76 155.69 45.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -144.17 157.56 44.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 49.15 -152.5 0.13 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.243 0.217 . . . . 0.0 110.627 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -53.47 -14.85 0.88 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -67.04 -30.48 70.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.075 0.852 . . . . 0.0 110.029 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt-85 -70.7 -37.28 73.55 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.344 0.657 . . . . 0.0 110.015 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.71 -37.99 76.77 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.094 0.558 . . . . 0.0 111.656 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.76 -1.03 20.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.231 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.85 -7.64 5.55 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.039 0.936 . . . . 0.0 110.307 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 12.9 50.72 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.32 0.962 . . . . 0.0 112.76 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.7 p -142.01 141.86 23.08 Favored Pre-proline 0 C--O 1.231 0.131 0 CA-C-N 118.06 0.93 . . . . 0.0 110.929 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.51 -20.91 13.58 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.585 2.857 . . . . 0.0 111.164 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -162.79 161.97 26.38 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.712 0.405 . . . . 0.0 110.424 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.73 156.1 27.96 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.145 0.578 . . . . 0.0 110.861 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.42 153.0 23.71 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.271 2.647 . . . . 0.0 110.299 172.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.4 mt -163.71 -179.42 6.37 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.18 0.992 . . . . 0.0 108.865 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 m -148.19 158.83 44.31 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.36 157.27 13.81 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -77.63 -26.9 50.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.037 -0.684 . . . . 0.0 109.911 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -137.59 166.59 23.53 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.032 0.933 . . . . 0.0 109.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.5 t -46.75 -49.19 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.799 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.44 -34.35 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.52 -20.95 65.5 Favored 'General case' 0 N--CA 1.457 -0.087 0 O-C-N 121.567 -0.708 . . . . 0.0 111.14 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.53 -45.24 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.54 -24.63 67.89 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -79.05 -18.58 53.24 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 122.048 -0.407 . . . . 0.0 112.078 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -86.9 -28.98 22.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 110.196 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.14 -48.61 79.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.5 p -71.65 -17.22 62.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.258 0.623 . . . . 0.0 111.925 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.22 -39.61 78.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 117.995 0.362 . . . . 0.0 111.828 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -102.38 -18.32 15.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 123.442 0.464 . . . . 0.0 111.247 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -117.53 74.9 8.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 123.559 0.743 . . . . 0.0 109.117 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.56 -17.4 59.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.81 2.34 . . . . 0.0 110.356 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.36 1.51 6.15 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.22 1.008 . . . . 0.0 111.29 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.6 mt -125.91 -6.24 6.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.5 0.72 . . . . 0.0 111.529 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.6 ttpt -64.25 -27.81 69.3 Favored 'General case' 0 N--CA 1.456 -0.165 0 O-C-N 122.048 -0.408 . . . . 0.0 111.92 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -115.76 26.63 9.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 110.397 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.78 -12.22 3.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.284 1.034 . . . . 0.0 109.128 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.17 -19.85 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 123.647 0.779 . . . . 0.0 109.692 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.52 162.56 30.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.28 138.68 34.52 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.106 0.562 . . . . 0.0 110.248 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -75.09 35.0 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.293 1.437 . . . . 0.0 111.151 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.59 26.32 5.91 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 124.133 0.873 . . . . 0.0 112.858 -173.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -138.39 131.34 29.74 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.178 0.514 . . . . 0.0 110.026 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -138.96 4.24 2.27 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.364 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -141.82 4.27 1.69 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.109 0.564 . . . . 0.0 111.324 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.9 m -145.91 -173.02 4.04 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.717 0.807 . . . . 0.0 109.531 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -121.71 15.17 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.815 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.5 mm -79.1 127.16 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.1 mt -113.22 169.39 8.98 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.806 0.442 . . . . 0.0 110.196 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 mt -140.5 122.37 15.21 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -56.33 130.12 43.27 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.412 ' N ' HD13 ' A' ' 61' ' ' LEU . 17.9 t -56.1 155.45 6.49 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-O 121.039 0.447 . . . . 0.0 111.515 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.71 17.08 59.34 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 71.2 m -134.61 -5.96 2.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.694 0.798 . . . . 0.0 111.705 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mm -93.78 159.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.94 0.496 . . . . 0.0 109.88 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -125.38 122.4 36.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 mm -108.51 144.99 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.0 mt -128.82 162.37 27.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.692 0.397 . . . . 0.0 110.349 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.3 mm -133.53 105.74 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 54.82 8.78 0.24 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.234 0.614 . . . . 0.0 111.792 -169.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.47 -4.88 33.07 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.825 0.726 . . . . 0.0 112.289 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -72.47 -2.18 18.62 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.04 97.35 0.01 OUTLIER 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.804 1.242 . . . . 0.0 113.748 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.7 pt -49.61 -20.61 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -62.78 -14.67 47.93 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.273 0.488 . . . . 0.0 112.113 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -112.59 6.85 18.59 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.303 0.641 . . . . 0.0 110.685 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.8 mt -123.81 -156.1 0.69 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.144 0.978 . . . . 0.0 109.604 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -66.57 -15.66 63.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.894 0.878 . . . . 0.0 112.345 -176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.6 -139.41 15.44 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.75 -2.09 0.49 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.097 0.959 . . . . 0.0 112.793 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -125.89 25.5 6.81 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.567 0.622 . . . . 0.0 111.595 -176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 85.7 m -66.29 -2.09 4.05 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.096 0.558 . . . . 0.0 111.491 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 20.6 mt 60.98 166.09 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.968 0.907 . . . . 0.0 110.332 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.3 mt -137.21 175.59 9.48 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.63 0.772 . . . . 0.0 110.414 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.3 mttt -141.64 167.39 22.28 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.748 0.819 . . . . 0.0 110.877 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -69.17 7.26 0.77 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.6 t -150.38 13.8 0.76 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.359 177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 1.5 m-20 -68.98 -179.5 1.51 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.498 0.666 . . . . 0.0 110.632 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -152.54 153.33 33.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.8 mm -131.16 158.2 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.62 140.52 9.04 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.5 mt -123.84 126.92 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.43 147.56 66.61 Favored Pre-proline 0 N--CA 1.452 -0.326 0 O-C-N 123.224 0.328 . . . . 0.0 110.689 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 88.4 Cg_endo -76.8 174.02 13.52 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 124.812 3.674 . . . . 0.0 110.749 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 57.6 Cg_endo -67.99 166.66 23.99 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.234 2.623 . . . . 0.0 110.431 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.65 -11.07 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 93.0 p -160.13 4.59 0.08 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.043 0.838 . . . . 0.0 113.068 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.5 47.44 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 117.241 -1.866 . . . . 0.0 110.755 -179.88 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.442 ' CG ' ' N ' ' A' ' 3' ' ' MET . 53.5 t60 -153.68 169.11 24.1 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.981 0.512 . . . . 0.0 110.332 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.442 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.0 mtp -139.88 101.11 4.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 174.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.03 132.42 52.86 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -80.38 130.81 35.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.05 -173.79 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.282 0.563 . . . . 0.0 110.504 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -128.12 157.98 39.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.384 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.5 t -134.51 131.2 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -115.16 137.95 51.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.353 0.661 . . . . 0.0 109.532 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.3 mm? -110.26 160.01 16.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -145.05 159.17 43.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.67 -152.63 0.12 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.313 0.245 . . . . 0.0 110.756 -172.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -53.77 -14.06 0.85 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.59 -30.6 70.26 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.111 0.869 . . . . 0.0 109.844 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -70.57 -36.58 73.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.454 0.702 . . . . 0.0 109.967 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -40.52 81.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.73 0.412 . . . . 0.0 110.995 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.18 -27.43 59.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.792 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.31 -18.23 39.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.214 -0.303 . . . . 0.0 110.56 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.26 3.09 64.45 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.9 p -145.25 149.54 41.83 Favored Pre-proline 0 C--O 1.232 0.133 0 C-N-CA 123.642 0.777 . . . . 0.0 109.822 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.78 -24.65 11.43 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.182 2.588 . . . . 0.0 110.946 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -164.87 163.23 21.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.53 0.332 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.4 pt? -160.42 155.33 20.85 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 123.487 0.715 . . . . 0.0 110.724 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.59 154.01 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.16 2.573 . . . . 0.0 110.29 172.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -161.3 -174.39 4.28 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.038 0.935 . . . . 0.0 108.889 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 m -148.86 161.09 42.55 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 120.761 0.315 . . . . 0.0 111.749 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.19 155.93 9.85 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.08 -24.03 43.77 Favored 'General case' 0 C--O 1.23 0.056 0 O-C-N 122.091 -0.652 . . . . 0.0 109.97 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.51 172.92 12.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.727 0.811 . . . . 0.0 109.659 -178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.42 -43.44 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.6 tp -63.76 -36.01 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -68.65 -22.03 64.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.424 0.556 . . . . 0.0 111.055 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 95.2 t -86.64 -46.0 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.3 mt -64.43 -29.4 70.45 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.444 0.298 . . . . 0.0 111.58 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 35' ' ' LEU . 32.7 mt -75.18 -16.45 60.5 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.2 t -88.67 -30.99 18.73 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 109.979 175.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.95 -48.68 80.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.429 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 70.5 p -70.2 -15.64 62.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.237 0.615 . . . . 0.0 111.769 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.81 -38.53 73.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.324 0.511 . . . . 0.0 111.847 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -104.49 -18.25 14.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.138 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -116.86 75.5 7.35 Favored Pre-proline 0 N--CA 1.453 -0.32 0 C-N-CA 124.115 0.966 . . . . 0.0 108.884 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -64.7 -16.55 55.85 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.042 2.495 . . . . 0.0 110.47 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.23 -0.9 10.92 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.819 0.848 . . . . 0.0 111.486 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.5 mt -123.53 -5.09 8.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.967 0.907 . . . . 0.0 110.958 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 76.9 tttt -63.63 -24.69 67.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.85 31.54 5.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.34 0.59 . . . . 0.0 109.46 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.23 -41.03 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.05 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -131.61 163.94 26.97 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.493 0.664 . . . . 0.0 110.989 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.83 172.13 12.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.614 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -121.49 35.06 4.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.366 1.067 . . . . 0.0 108.905 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.3 -7.96 64.76 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.758 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -146.35 130.14 17.12 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.608 0.704 . . . . 0.0 109.107 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.02 16.24 10.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.741 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -134.88 7.55 3.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.696 0.798 . . . . 0.0 110.716 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m -148.89 164.92 33.07 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.496 1.118 . . . . 0.0 110.015 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.23 3.29 31.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.65 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -65.34 127.27 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.46 169.91 16.78 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.717 0.807 . . . . 0.0 110.218 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.8 mt -144.3 133.21 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 62' ' ' CYS . 2.0 tt -57.99 127.82 34.0 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.413 ' N ' HD23 ' A' ' 61' ' ' LEU . 49.6 t -54.75 144.17 23.09 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.301 0.572 . . . . 0.0 111.34 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.33 15.65 16.88 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.968 0.794 . . . . 0.0 112.019 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.1 m -135.77 -8.96 2.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.266 0.626 . . . . 0.0 111.988 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mm -87.36 159.77 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.252 0.549 . . . . 0.0 110.326 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -127.64 126.63 42.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.2 145.22 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.7 mt -129.16 159.49 35.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.9 mm -130.71 108.24 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 55.33 10.5 0.46 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.198 0.599 . . . . 0.0 111.333 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.28 -2.1 40.3 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.15 0.881 . . . . 0.0 112.424 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -81.14 1.65 30.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 -173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.57 101.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.84 1.256 . . . . 0.0 114.079 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.3 pt -50.5 -26.41 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.964 -0.46 . . . . 0.0 112.214 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -60.87 -11.61 8.37 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -122.91 13.38 9.84 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.491 0.716 . . . . 0.0 111.278 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.04 -84.91 0.66 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.697 0.399 . . . . 0.0 110.558 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -144.35 1.64 1.08 Allowed 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 118.481 0.582 . . . . 0.0 111.772 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.67 -141.29 28.29 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.4 mt -58.4 1.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -128.63 25.38 5.7 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.602 0.637 . . . . 0.0 111.834 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' THR . 91.4 m -63.71 0.81 0.71 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.9 mt 51.66 84.85 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.76 170.42 1.13 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 111.619 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 64.5 mttp -139.48 167.2 22.62 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.449 1.1 . . . . 0.0 111.657 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -64.29 4.31 0.36 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -173.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.2 t -153.07 16.03 0.55 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.074 -0.391 . . . . 0.0 110.201 174.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 6.7 m-20 -67.32 177.36 1.9 Allowed 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.963 0.887 . . . . 0.0 111.351 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -148.07 151.15 35.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.44 1.096 . . . . 0.0 108.55 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.11 153.36 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.19 133.98 7.16 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.46 128.58 74.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mp -135.61 147.45 61.59 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 122.705 0.402 . . . . 0.0 111.006 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -79.41 174.2 12.21 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 125.052 3.835 . . . . 0.0 110.467 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 59.8 Cg_endo -68.88 172.3 12.01 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.139 2.559 . . . . 0.0 111.291 175.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.5 p 43.8 31.95 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.542 1.537 . . . . 0.0 113.053 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.6 t -154.87 174.2 15.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.069 -0.395 . . . . 0.0 110.713 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -162.73 14.93 0.12 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.717 -0.491 . . . . 0.0 112.352 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.434 -1.759 . . . . 0.0 110.773 -179.135 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.445 ' CG ' ' N ' ' A' ' 3' ' ' MET . 69.4 t60 -154.05 168.71 25.53 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.25 0.62 . . . . 0.0 110.43 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.445 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.9 mtp -142.43 104.36 4.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 174.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.61 130.95 48.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.39 132.58 39.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -143.27 -173.47 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.18 0.592 . . . . 0.0 110.14 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -128.01 158.41 38.0 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.3 t -130.05 138.12 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -119.75 152.29 37.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.934 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.9 mt -128.49 155.58 44.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -144.03 159.22 42.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.73 -146.18 0.27 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.432 0.293 . . . . 0.0 111.17 -174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -56.69 -10.68 1.08 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.4 mt -75.05 -30.52 61.06 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.342 0.974 . . . . 0.0 110.125 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -70.39 -33.49 71.47 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.076 0.55 . . . . 0.0 109.6 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -72.01 -21.98 61.47 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.468 0.707 . . . . 0.0 111.718 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.21 1.98 56.7 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.288 -176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.27 -7.54 2.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.326 0.65 . . . . 0.0 110.709 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.4 9.0 48.23 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.662 -0.521 . . . . 0.0 112.337 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 p -141.26 144.75 35.56 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.056 0.928 . . . . 0.0 110.39 -178.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -78.22 -22.4 9.77 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.319 2.68 . . . . 0.0 111.574 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -167.07 160.82 14.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.517 0.327 . . . . 0.0 110.639 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.64 154.42 23.07 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.524 0.73 . . . . 0.0 111.698 -178.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.06 152.65 24.58 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.684 2.923 . . . . 0.0 110.976 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.9 mt -163.6 -173.17 3.18 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.994 0.518 . . . . 0.0 110.284 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -148.36 160.64 42.81 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 120.806 0.336 . . . . 0.0 111.099 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 168.2 149.48 6.15 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -81.24 -24.8 37.11 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-N 117.708 0.754 . . . . 0.0 110.388 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -132.22 170.82 14.48 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.245 1.018 . . . . 0.0 109.227 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -55.68 -48.33 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.51 -32.32 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.628 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -68.77 -22.61 64.28 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 121.654 -0.654 . . . . 0.0 110.703 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.65 -45.03 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -38.79 71.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.121 0.968 . . . . 0.0 111.821 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.7 mt -74.22 -14.34 60.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.91 -26.21 16.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 174.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -64.09 -49.65 71.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.3 p -68.3 -14.25 62.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.902 0.481 . . . . 0.0 111.484 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.96 -44.98 64.92 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.089 0.404 . . . . 0.0 111.397 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -95.44 -17.84 21.19 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -118.69 76.57 13.83 Favored Pre-proline 0 N--CA 1.452 -0.337 0 C-N-CA 123.859 0.864 . . . . 0.0 109.666 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -17.19 57.96 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.102 2.535 . . . . 0.0 111.03 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.44 2.02 8.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.334 0.654 . . . . 0.0 111.358 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.0 -7.08 8.38 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.556 0.743 . . . . 0.0 110.718 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -64.09 -24.2 67.61 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.891 0.477 . . . . 0.0 112.198 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -121.17 28.57 7.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.938 0.495 . . . . 0.0 109.989 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -126.3 -36.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.272 1.029 . . . . 0.0 108.244 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.5 mt -86.05 -25.4 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.607 0.763 . . . . 0.0 109.187 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.24 161.84 30.3 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.992 0.517 . . . . 0.0 110.791 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -83.81 141.41 31.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -74.49 43.84 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.064 1.346 . . . . 0.0 110.994 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.78 -21.36 69.22 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.584 -0.565 . . . . 0.0 112.491 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -151.33 117.85 5.71 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.798 0.809 . . . . 0.0 110.175 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -88.48 0.8 55.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.6 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -137.2 7.89 2.91 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 121.607 -0.683 . . . . 0.0 112.676 -173.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -143.52 166.16 25.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.453 0.644 . . . . 0.0 111.095 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -1.59 21.31 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 58' ' ' ILE . 4.6 mp -77.05 127.0 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.1 mt -138.86 168.77 19.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.6 mt -142.13 122.79 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.84 125.43 21.32 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 34.2 t -53.18 146.54 11.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.069 0.461 . . . . 0.0 111.086 -174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.61 16.85 43.16 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.923 0.773 . . . . 0.0 111.584 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 64.9 m -134.26 -9.98 2.56 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.46 0.704 . . . . 0.0 111.495 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.24 161.03 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 122.871 0.468 . . . . 0.0 110.202 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -128.98 126.58 39.88 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.81 145.99 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.9 mt -129.53 160.76 32.23 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.99 0.516 . . . . 0.0 109.642 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.13 105.58 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 55.07 8.61 0.26 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.039 0.536 . . . . 0.0 111.856 -169.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.88 -3.88 32.03 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.066 0.841 . . . . 0.0 112.419 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -76.4 -0.15 21.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 49.33 99.43 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.842 1.257 . . . . 0.0 114.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 27.2 pt -51.07 -21.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.62 -11.67 12.53 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -119.58 9.02 11.37 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.755 0.822 . . . . 0.0 111.541 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.4 mt -124.73 -156.47 0.72 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.059 0.944 . . . . 0.0 109.485 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.89 -5.67 22.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.39 -139.44 20.29 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.82 2.08 0.12 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.896 0.878 . . . . 0.0 113.132 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -129.22 25.87 5.47 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.398 0.545 . . . . 0.0 111.553 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 82' ' ' THR . 88.9 m -62.16 -0.57 0.55 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.762 0.825 . . . . 0.0 112.991 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.29 83.51 0.06 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.72 170.89 0.72 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.039 1.335 . . . . 0.0 111.896 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -138.36 167.88 20.95 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.27 1.028 . . . . 0.0 110.404 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -64.94 7.35 0.17 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.8 t -152.86 17.21 0.58 Allowed 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.889 -0.507 . . . . 0.0 110.599 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -71.72 -179.34 2.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.557 0.694 . . . . 0.0 111.199 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -153.42 155.26 36.02 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.386 0.674 . . . . 0.0 109.576 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.5 mm -125.79 155.13 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.01 120.95 1.63 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 173.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.7 mt -108.97 129.97 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -133.72 149.04 70.88 Favored Pre-proline 0 N--CA 1.453 -0.323 0 C-N-CA 122.632 0.373 . . . . 0.0 110.763 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 73.1 Cg_endo -78.34 174.75 11.95 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 125.007 3.804 . . . . 0.0 110.076 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 45.9 Cg_endo -65.17 157.56 56.82 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.65 2.233 . . . . 0.0 111.344 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.2 m -142.67 172.94 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.658 1.183 . . . . 0.0 110.053 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -142.41 165.55 27.12 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 110.649 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.54 -15.01 0.15 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-O 119.895 -0.392 . . . . 0.0 112.395 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 CA-C-O 117.313 -1.826 . . . . 0.0 110.692 178.59 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 3' ' ' MET . 51.1 t60 -153.09 169.57 22.62 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.341 0.656 . . . . 0.0 110.008 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.435 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 85.6 mtp -139.5 100.69 4.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 174.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.75 131.91 50.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.437 -174.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.56 130.08 35.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.228 0.537 . . . . 0.0 109.753 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.69 -172.42 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.342 0.592 . . . . 0.0 110.659 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -129.88 155.98 45.14 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.903 171.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -128.83 135.27 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -115.87 139.12 50.52 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.965 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.7 mm? -110.8 160.13 17.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -145.75 159.98 42.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.62 -147.06 0.22 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.219 0.207 . . . . 0.0 111.094 -174.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -56.47 -12.51 1.75 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.3 mt -72.51 -31.87 65.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.937 0.79 . . . . 0.0 110.006 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -70.92 -32.81 69.84 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.76 -33.55 72.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.337 178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.87 -24.71 26.57 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.265 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.68 -18.97 33.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.556 0.217 . . . . 0.0 110.677 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 3.17 63.01 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.8 p -144.3 148.45 41.01 Favored Pre-proline 0 N--CA 1.454 -0.274 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.35 -23.69 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.004 2.47 . . . . 0.0 110.883 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -163.58 162.51 24.41 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.4 0.28 . . . . 0.0 111.39 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.67 154.36 26.6 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.634 0.774 . . . . 0.0 111.515 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.77 151.59 21.92 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.599 2.866 . . . . 0.0 110.649 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.3 mt -162.0 -175.3 4.56 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.251 0.62 . . . . 0.0 110.04 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -147.74 162.11 39.86 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 111.444 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.14 152.26 7.7 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.51 -26.66 60.13 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.561 0.68 . . . . 0.0 110.467 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -139.9 174.43 10.53 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 109.897 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.3 t -56.76 -45.51 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 tp -63.79 -34.64 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -67.95 -22.6 65.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.466 0.575 . . . . 0.0 110.985 -178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.0 -44.76 16.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.38 -29.87 70.92 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.198 -0.313 . . . . 0.0 111.425 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 35' ' ' LEU . 38.8 mt -74.2 -17.89 60.83 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.143 -0.348 . . . . 0.0 111.472 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.435 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -91.62 -25.09 19.33 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.021 0.439 . . . . 0.0 110.419 175.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.7 -49.09 76.48 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 81.8 p -68.68 -16.51 63.85 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.744 0.418 . . . . 0.0 111.571 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -69.69 -46.24 66.47 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.207 0.458 . . . . 0.0 111.809 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -94.0 -18.77 21.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.166 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -117.26 76.83 9.29 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 123.804 0.841 . . . . 0.0 109.881 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.06 -16.86 57.31 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.792 2.328 . . . . 0.0 110.481 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.01 2.16 7.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.792 0.837 . . . . 0.0 111.287 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.2 mt -126.77 -3.41 6.55 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.639 0.776 . . . . 0.0 110.958 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 75.9 tttt -62.53 -24.46 67.51 Favored 'General case' 0 N--CA 1.457 -0.125 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.464 ' CD2' ' HE2' ' A' ' 51' ' ' LYS . 24.2 m-85 -124.17 29.44 6.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.428 0.632 . . . . 0.0 109.422 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 t -126.41 -10.91 4.73 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 124.526 1.13 . . . . 0.0 108.895 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.2 mt -121.44 -18.38 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.835 0.854 . . . . 0.0 109.131 175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -132.96 161.12 35.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.793 0.437 . . . . 0.0 110.961 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -69.44 168.63 14.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.72 0.808 . . . . 0.0 110.427 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HE2' ' CD2' ' A' ' 46' ' ' TYR . 33.8 ttmt -114.18 28.04 9.05 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.799 0.84 . . . . 0.0 110.579 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.18 3.21 78.23 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 -178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -141.13 124.75 16.83 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.38 11.4 3.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.473 0.709 . . . . 0.0 110.953 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -138.87 6.3 2.42 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.558 0.743 . . . . 0.0 111.369 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -147.58 159.22 44.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.784 0.833 . . . . 0.0 110.155 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -80.46 1.52 28.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.448 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.19 131.74 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.0 mt -139.55 171.99 13.46 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.499 0.72 . . . . 0.0 110.107 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.9 mt -141.18 135.46 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -58.24 142.23 48.35 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.458 ' H ' HD13 ' A' ' 61' ' ' LEU . 4.5 t -58.54 -2.31 0.2 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -174.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.19 3.84 7.24 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.808 1.194 . . . . 0.0 114.749 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.1 m -137.23 -4.37 1.9 Allowed 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.35 1.075 . . . . 0.0 111.894 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.5 mm -81.61 159.9 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.328 0.651 . . . . 0.0 109.375 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -118.71 126.43 51.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.7 mm -116.26 144.09 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 40.0 mt -128.14 159.45 35.1 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.73 107.95 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.67 10.75 0.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.26 0.624 . . . . 0.0 111.628 -170.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.49 -3.49 37.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.036 0.827 . . . . 0.0 112.436 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -77.26 -0.64 26.11 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.7 t-20 51.46 100.57 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.696 1.198 . . . . 0.0 113.751 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.2 pt -51.3 -21.55 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -64.32 -11.42 31.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.966 0.506 . . . . 0.0 112.224 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -116.86 8.95 13.7 Favored 'General case' 0 N--CA 1.46 0.038 0 C-N-CA 123.66 0.784 . . . . 0.0 110.77 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.5 -155.63 0.69 Allowed 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.053 0.941 . . . . 0.0 109.201 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -70.59 -3.23 17.19 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 81' ' ' GLU . . . 79.74 -140.17 22.24 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 -177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.15 3.25 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.993 0.917 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 79' ' ' GLY . 42.6 mt-10 -128.34 22.72 6.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.535 0.734 . . . . 0.0 111.513 -174.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 82' ' ' THR . 86.2 m -62.15 0.65 0.39 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.524 1.13 . . . . 0.0 113.333 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt 52.27 85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.778 0.799 . . . . 0.0 112.999 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.34 171.69 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.158 1.383 . . . . 0.0 111.409 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 37.7 mtmm -139.41 166.28 24.97 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 124.428 1.091 . . . . 0.0 110.88 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -64.3 5.25 0.28 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 t -152.7 16.6 0.59 Allowed 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 117.883 0.311 . . . . 0.0 110.503 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 7.0 m-20 -67.44 177.57 1.88 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.878 0.847 . . . . 0.0 111.344 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.18 151.48 34.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.192 0.997 . . . . 0.0 108.526 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.52 154.39 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.39 132.37 6.06 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 174.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 mt -115.21 129.22 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mp -134.93 144.37 50.11 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 122.654 0.382 . . . . 0.0 110.439 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -80.12 169.09 18.04 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 124.57 3.513 . . . . 0.0 111.174 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -72.16 -179.24 3.78 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.787 2.991 . . . . 0.0 111.055 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.84 154.37 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 123.2 0.6 . . . . 0.0 109.806 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.3 t -147.94 17.35 1.11 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.813 0.339 . . . . 0.0 111.545 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -155.11 16.99 0.53 Allowed Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.872 -0.517 . . . . 0.0 112.198 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.089 0 CA-C-O 117.23 -1.872 . . . . 0.0 111.125 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 64.8 t60 -152.6 169.25 23.14 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.007 0.523 . . . . 0.0 110.384 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 87.2 mtp -140.46 104.64 4.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.37 127.2 30.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.74 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.99 128.38 34.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.6 m -140.65 -172.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.35 0.595 . . . . 0.0 110.677 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -124.87 153.97 41.78 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.956 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.3 t -124.62 133.02 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -114.59 136.1 53.41 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.443 0.465 . . . . 0.0 109.811 176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.4 mm? -107.49 160.34 15.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -144.94 160.19 41.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.68 -146.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.393 0.277 . . . . 0.0 110.991 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -57.71 -11.59 2.29 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.5 mt -72.13 -29.05 63.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.354 0.979 . . . . 0.0 109.922 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -69.98 -32.01 70.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.144 0.578 . . . . 0.0 109.472 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -73.17 -23.2 60.4 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 111.249 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.84 -5.72 52.88 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.676 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB1' ' CE2' ' A' ' 41' ' ' TYR . . . -115.15 -11.34 12.05 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.164 0.586 . . . . 0.0 110.319 173.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.26 3.01 36.08 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.6 p -143.71 149.51 47.04 Favored Pre-proline 0 N--CA 1.452 -0.345 0 C-N-CA 123.896 0.878 . . . . 0.0 109.548 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -75.07 -22.9 14.21 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.829 2.353 . . . . 0.0 110.994 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.48 163.57 22.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.898 0.317 . . . . 0.0 111.547 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.03 153.98 23.34 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.893 0.877 . . . . 0.0 111.298 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.44 151.07 19.83 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.684 2.923 . . . . 0.0 110.796 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -161.7 -175.54 4.78 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.646 0.778 . . . . 0.0 110.002 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 m -148.58 159.06 44.44 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.92 0.391 . . . . 0.0 111.736 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.18 154.54 10.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.94 -27.81 57.72 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 117.603 0.701 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -137.62 165.87 25.3 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.026 0.93 . . . . 0.0 109.698 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -46.05 -52.16 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 122.966 0.506 . . . . 0.0 110.196 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 tp -61.0 -32.45 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -67.98 -21.22 65.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.52 -0.737 . . . . 0.0 111.137 -177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.0 t -87.15 -45.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -54.77 -37.52 66.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.534 0.734 . . . . 0.0 111.446 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 35' ' ' LEU . 41.7 mt -73.97 -16.8 61.06 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.44 -26.12 17.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.939 0.399 . . . . 0.0 110.025 174.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.0 tm? -63.0 -50.24 71.5 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.406 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 72.1 p -67.51 -16.17 64.05 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.59 -45.57 65.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.852 0.296 . . . . 0.0 111.467 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -93.97 -18.32 22.02 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.247 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 18' ' ' ALA . 9.2 m-30 -118.31 77.42 13.25 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 123.955 0.902 . . . . 0.0 109.909 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.75 -17.58 59.95 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.873 2.382 . . . . 0.0 110.867 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.72 1.78 7.81 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.539 0.735 . . . . 0.0 111.445 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.8 mt -124.35 -5.83 7.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.704 0.802 . . . . 0.0 110.858 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.2 tttt -65.17 -23.32 67.08 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -124.27 28.06 6.84 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.0 t -124.43 -39.4 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.8 mt -82.78 -28.06 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.25 164.08 23.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.476 0.655 . . . . 0.0 110.891 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -73.9 171.99 12.41 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.277 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -125.03 64.42 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.382 1.073 . . . . 0.0 108.676 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.16 11.93 5.83 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.265 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.15 143.52 57.82 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.666 0.746 . . . . 0.0 110.943 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -73.68 45.52 0.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.376 1.47 . . . . 0.0 110.94 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 56.33 47.38 19.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.222 0.609 . . . . 0.0 110.62 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.8 m -139.95 165.63 26.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.634 1.173 . . . . 0.0 110.854 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -78.12 -2.51 37.82 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.66 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.53 129.7 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -136.11 176.21 8.9 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.361 0.664 . . . . 0.0 110.534 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.18 126.59 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.0 tp -57.7 136.13 56.83 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.7 t -59.68 151.98 23.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.859 0.362 . . . . 0.0 110.42 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.94 17.4 36.84 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.579 0.609 . . . . 0.0 111.981 -174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.0 p -138.59 -8.73 1.44 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.063 0.545 . . . . 0.0 112.403 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.5 mm -85.31 157.6 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.218 0.607 . . . . 0.0 110.854 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -128.38 123.16 33.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 37.9 mm -110.0 145.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -133.32 159.39 40.41 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.923 0.889 . . . . 0.0 109.21 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.407 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 34.8 mm -130.06 109.25 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 170.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.42 5.88 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.328 0.651 . . . . 0.0 111.996 -169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.18 -2.6 23.94 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.028 0.823 . . . . 0.0 112.811 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 69' ' ' ILE . 18.8 p30 -74.64 -3.39 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -171.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 48.42 93.03 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.555 1.142 . . . . 0.0 113.421 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -46.89 -23.85 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.4 mtt-85 -63.34 -19.49 64.67 Favored 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -102.64 2.46 36.01 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.4 mt -122.87 -153.89 0.57 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.445 1.098 . . . . 0.0 109.675 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -64.08 -15.03 58.69 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.952 0.901 . . . . 0.0 112.146 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.7 -138.22 16.61 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.18 1.33 0.12 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.187 0.995 . . . . 0.0 112.87 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -129.39 25.61 5.44 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.687 0.676 . . . . 0.0 111.625 -175.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.9 m -62.04 -8.51 5.43 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.79 0.836 . . . . 0.0 112.706 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.7 mt 62.47 125.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.689 1.196 . . . . 0.0 112.164 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 4.5 mp -100.4 174.4 6.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.038 1.335 . . . . 0.0 110.422 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -139.91 168.61 19.42 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.535 1.134 . . . . 0.0 109.752 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -68.04 8.14 0.45 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.6 t -151.95 18.28 0.68 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.006 -0.434 . . . . 0.0 109.939 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.01 178.92 2.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.548 0.69 . . . . 0.0 110.585 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.99 149.73 29.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 mt -133.24 151.21 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.4 134.68 7.72 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 108.404 -1.879 . . . . 0.0 108.404 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.01 128.66 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -134.21 148.19 66.87 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 65.5 Cg_endo -80.48 174.81 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.934 3.756 . . . . 0.0 109.94 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 58.3 Cg_endo -66.83 169.08 15.4 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.695 2.263 . . . . 0.0 111.26 174.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.5 t -142.45 149.41 19.22 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.671 0.788 . . . . 0.0 109.02 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.1 t -152.02 170.74 19.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.538 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 178.15 -179.75 48.4 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 117.494 -1.726 . . . . 0.0 110.817 -179.649 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.215 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 3' ' ' MET . 62.2 t60 -154.15 168.7 25.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.06 0.544 . . . . 0.0 110.193 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.444 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.4 mtp -139.82 101.48 4.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 174.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 132.55 52.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.14 128.11 33.3 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.32 -172.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 123.376 0.671 . . . . 0.0 110.781 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -129.85 154.78 46.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.617 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -129.26 136.1 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -118.16 138.14 52.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.037 175.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -110.04 160.35 16.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.88 160.38 41.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.65 -146.89 0.23 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.284 0.234 . . . . 0.0 111.085 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -57.49 -10.38 1.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.7 mt -73.96 -30.71 62.66 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.129 0.877 . . . . 0.0 110.06 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -71.76 -32.07 67.31 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.975 0.51 . . . . 0.0 109.772 176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -70.21 -30.79 67.98 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.0 111.531 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.79 -24.54 22.59 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.536 -176.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -18.34 35.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.696 0.284 . . . . 0.0 110.692 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.83 2.11 60.45 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 149.27 45.5 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 123.82 0.848 . . . . 0.0 109.193 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -75.98 -20.79 14.68 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.07 2.513 . . . . 0.0 111.519 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -165.54 162.2 18.99 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.965 0.348 . . . . 0.0 111.359 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.02 155.75 26.87 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.603 0.761 . . . . 0.0 111.582 178.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.62 153.02 20.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.859 3.039 . . . . 0.0 110.846 173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.4 mt -162.96 -173.46 3.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.252 0.621 . . . . 0.0 110.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.1 m -147.75 161.78 40.53 Favored 'General case' 0 C--N 1.337 0.057 0 CA-C-O 120.711 0.291 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 154.2 8.39 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -79.94 -30.45 39.93 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 117.489 0.644 . . . . 0.0 110.117 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -133.34 172.13 13.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.1 0.96 . . . . 0.0 109.589 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -56.92 -43.24 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -64.15 -34.63 70.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -68.49 -21.71 64.59 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 121.781 -0.574 . . . . 0.0 110.876 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.77 -44.33 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.71 -29.31 70.29 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.219 -0.301 . . . . 0.0 111.391 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.1 mt -75.83 -13.93 60.28 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.991 0.359 . . . . 0.0 111.451 178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.402 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -96.09 -24.05 16.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.937 0.399 . . . . 0.0 109.966 175.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.4 -48.65 76.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.482 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.0 p -68.72 -17.87 64.13 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.009 0.524 . . . . 0.0 111.427 178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -68.75 -44.24 74.17 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.155 -0.34 . . . . 0.0 111.725 -176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -96.2 -18.8 19.81 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.164 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -118.17 75.53 11.4 Favored Pre-proline 0 N--CA 1.455 -0.217 0 C-N-CA 123.807 0.843 . . . . 0.0 109.855 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -64.49 -16.35 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.734 2.29 . . . . 0.0 110.367 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.59 1.6 7.93 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.933 0.893 . . . . 0.0 111.587 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -125.38 -4.65 7.25 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.632 0.773 . . . . 0.0 111.176 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 36.9 ttpt -64.39 -27.84 69.29 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.78 26.21 10.55 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.406 0.683 . . . . 0.0 110.039 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 t -129.1 -11.38 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.972 0.909 . . . . 0.0 109.16 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.8 mt -120.45 -20.21 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.565 0.746 . . . . 0.0 109.174 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.84 159.83 38.68 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.611 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -70.06 154.19 42.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.636 0.774 . . . . 0.0 110.12 176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -87.08 30.16 0.78 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.667 0.787 . . . . 0.0 111.558 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.35 178.72 43.22 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 44.83 48.62 9.08 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.829 0.852 . . . . 0.0 112.159 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.4 13.97 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.4 1.08 . . . . 0.0 113.87 -177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -134.65 7.38 3.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.466 0.706 . . . . 0.0 111.428 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -146.68 166.81 25.46 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.476 0.71 . . . . 0.0 110.499 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.27 1.17 38.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.468 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.4 mm -68.43 131.96 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.4 mt -136.41 171.38 14.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.584 0.754 . . . . 0.0 110.046 175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.4 mt -139.22 134.24 40.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -58.33 143.62 44.3 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.427 ' H ' HD13 ' A' ' 61' ' ' LEU . 4.6 t -57.63 -2.26 0.13 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -175.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.63 5.14 6.31 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.771 1.176 . . . . 0.0 114.932 177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.3 m -139.03 -4.73 1.51 Allowed 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.497 1.149 . . . . 0.0 111.928 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.3 mm -80.58 160.3 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.479 0.712 . . . . 0.0 109.546 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.84 126.94 52.19 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.88 146.9 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.95 161.55 30.64 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 33.0 mm -132.37 108.3 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 170.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 54.29 10.05 0.28 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.286 0.635 . . . . 0.0 111.701 -170.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.58 -2.38 36.67 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.109 0.862 . . . . 0.0 112.586 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -79.75 1.91 24.87 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -173.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.39 99.89 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.77 1.228 . . . . 0.0 114.063 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.3 pt -50.12 -25.93 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -62.46 -10.01 10.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.313 0.645 . . . . 0.0 112.581 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -122.43 12.66 10.13 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.595 0.758 . . . . 0.0 111.105 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.14 -83.94 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 119.19 -0.434 . . . . 0.0 110.906 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -144.25 2.7 1.15 Allowed 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.629 0.65 . . . . 0.0 111.558 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.35 -142.58 30.5 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.67 6.28 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -129.45 20.25 5.7 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.269 0.627 . . . . 0.0 111.301 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 92.6 m -61.35 -8.16 3.67 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.027 0.931 . . . . 0.0 113.403 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.7 mt 61.32 132.69 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.956 1.302 . . . . 0.0 112.537 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.78 176.44 5.14 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.137 0.975 . . . . 0.0 110.319 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 88' ' ' ASP . 98.6 mttt -144.4 166.28 25.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.141 0.977 . . . . 0.0 110.716 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -65.31 6.06 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -153.61 16.59 0.52 Allowed 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.175 -0.328 . . . . 0.0 110.376 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 85' ' ' LYS . 4.4 m-20 -67.55 176.6 2.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.844 0.83 . . . . 0.0 111.097 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -148.58 151.06 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.9 mt -131.75 151.36 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.25 132.83 6.69 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.4 mt -114.9 129.03 71.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mp -135.32 145.63 54.66 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 122.827 0.451 . . . . 0.0 110.102 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -78.84 170.84 17.46 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 124.108 3.206 . . . . 0.0 110.307 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.2 -7.64 21.68 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.398 2.732 . . . . 0.0 112.356 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.57 146.73 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 122.847 0.459 . . . . 0.0 110.013 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 26.6 t -153.6 171.42 18.81 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.678 0.391 . . . . 0.0 110.139 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -165.37 15.53 0.09 OUTLIER Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.73 -0.483 . . . . 0.0 112.318 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 117.3 -1.834 . . . . 0.0 111.148 -178.706 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.65 20.6 0.4 Allowed 'General case' 0 C--O 1.23 0.045 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.7 mtp 54.96 85.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.486 0.66 . . . . 0.0 110.938 -169.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.29 142.93 56.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.711 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.58 134.22 35.18 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 m -143.17 -175.48 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 122.998 0.519 . . . . 0.0 110.392 -173.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -126.79 155.9 42.09 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.48 169.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.72 117.71 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 123.686 0.794 . . . . 0.0 108.956 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -92.36 158.81 15.88 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.873 0.469 . . . . 0.0 109.96 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.8 mt -134.24 152.18 51.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -141.33 158.75 43.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 48.04 -148.15 0.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.482 0.313 . . . . 0.0 110.693 -173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -55.33 -14.44 1.86 Allowed 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.2 mt -68.91 -30.35 68.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.016 0.825 . . . . 0.0 110.263 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -69.01 -30.97 69.46 Favored 'General case' 0 C--N 1.338 0.108 0 C-N-CA 123.227 0.611 . . . . 0.0 110.038 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -76.99 -18.69 58.05 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.694 0.798 . . . . 0.0 111.611 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.91 2.33 56.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.431 0.292 . . . . 0.0 111.042 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.56 -5.39 2.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.506 0.722 . . . . 0.0 111.109 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.9 10.31 38.42 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.636 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 80.8 p -142.9 144.08 27.9 Favored Pre-proline 0 C--N 1.341 0.205 0 CA-C-N 117.893 0.847 . . . . 0.0 110.069 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.42 -20.23 14.32 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 123.39 2.727 . . . . 0.0 111.462 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -165.6 161.31 18.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.209 0.604 . . . . 0.0 110.486 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 153.3 26.97 Favored Pre-proline 0 N--CA 1.454 -0.234 0 C-N-CA 122.645 0.378 . . . . 0.0 110.862 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.79 152.03 32.24 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.469 2.779 . . . . 0.0 109.897 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 25' ' ' LEU . 5.9 mt -161.86 -174.37 4.14 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -147.33 162.46 38.92 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.987 0.423 . . . . 0.0 110.776 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.34 151.91 8.44 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.3 -25.35 46.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -140.46 173.83 11.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.824 1.25 . . . . 0.0 108.961 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.4 t -54.87 -51.37 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.6 tp -59.19 -33.94 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -67.0 -20.71 65.92 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 121.416 -0.802 . . . . 0.0 111.157 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.3 t -86.43 -45.18 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.29 -38.5 71.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.196 0.999 . . . . 0.0 111.632 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 35' ' ' LEU . 48.4 mt -72.85 -16.91 61.59 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 t -88.62 -32.06 18.26 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.821 0.344 . . . . 0.0 110.161 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.57 -46.43 90.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 p -73.14 -13.05 61.1 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.502 0.321 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.84 -42.91 63.27 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -100.66 -19.07 16.25 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.37 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -117.97 77.81 12.45 Favored Pre-proline 0 N--CA 1.451 -0.406 0 C-N-CA 123.627 0.771 . . . . 0.0 108.996 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.96 -15.94 52.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.641 2.228 . . . . 0.0 110.158 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.19 2.22 4.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.492 1.117 . . . . 0.0 111.55 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.1 mt -124.23 -9.8 7.56 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 123.818 0.847 . . . . 0.0 110.675 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -61.86 -25.6 67.64 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -123.68 26.92 7.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.103 0.478 . . . . 0.0 109.728 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.13 -10.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 C-N-CA 124.571 1.148 . . . . 0.0 108.658 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.53 -20.55 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.78 0.832 . . . . 0.0 109.326 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -128.97 159.1 36.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 110.752 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 52' ' ' GLY . 25.4 mt-10 -79.59 136.78 36.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.416 0.686 . . . . 0.0 109.439 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -73.65 32.63 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.975 1.31 . . . . 0.0 110.891 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 50' ' ' GLU . . . -91.05 31.3 5.72 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.175 0.893 . . . . 0.0 111.971 -174.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -125.24 17.75 8.34 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.54 0.736 . . . . 0.0 111.884 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -69.98 3.01 2.95 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -139.17 3.84 2.2 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.25 1.02 . . . . 0.0 110.914 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.7 m -141.38 -167.38 2.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.802 0.841 . . . . 0.0 110.2 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.79 22.73 4.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.109 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.3 mm -125.75 115.3 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.116 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.21 170.93 15.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.222 0.609 . . . . 0.0 110.646 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.7 mt -143.27 134.03 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.01 144.43 56.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.8 t -61.0 169.65 1.88 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.153 0.501 . . . . 0.0 110.594 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.97 21.07 13.84 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -137.76 -0.75 2.09 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.854 0.862 . . . . 0.0 111.909 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.97 151.42 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.132 0.573 . . . . 0.0 110.117 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -121.86 129.39 52.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 60.9 mt -124.39 148.12 28.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.391 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.4 mt -129.13 160.14 33.8 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.332 -174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.415 HG12 ' CG2' ' A' ' 74' ' ' ILE . 32.5 mm -132.43 109.79 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 170.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 54.06 11.39 0.36 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.059 0.544 . . . . 0.0 111.714 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.19 -1.63 43.82 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.035 0.826 . . . . 0.0 112.509 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -80.29 0.42 32.88 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -172.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 52.43 99.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.623 1.169 . . . . 0.0 113.652 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.415 ' CG2' HG12 ' A' ' 69' ' ' ILE . 30.5 pt -51.29 -21.55 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 112.071 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtp-105 -66.67 -10.42 46.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.516 0.727 . . . . 0.0 112.23 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -119.56 9.92 11.64 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.769 0.828 . . . . 0.0 110.211 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.81 -156.27 0.71 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.876 0.871 . . . . 0.0 108.947 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.73 -2.33 14.3 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.58 -136.77 19.85 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.61 1.76 0.08 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.17 0.988 . . . . 0.0 113.35 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -129.72 23.57 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.589 0.631 . . . . 0.0 111.917 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' THR . 88.8 m -63.37 0.24 0.73 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.938 0.895 . . . . 0.0 113.354 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt 52.73 85.53 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.74 171.1 0.95 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.018 1.327 . . . . 0.0 111.364 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -140.72 164.59 29.79 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.643 1.177 . . . . 0.0 109.891 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -60.01 3.81 0.06 Allowed 'General case' 0 C--O 1.231 0.087 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 t -152.4 18.07 0.63 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 110.013 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.59 177.24 3.59 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.696 0.76 . . . . 0.0 110.355 174.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -149.39 153.76 37.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -135.16 157.19 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.37 133.72 5.02 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.5 mt -117.96 134.33 61.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 mp -131.3 144.37 53.19 Favored Pre-proline 0 N--CA 1.454 -0.24 0 C-N-CA 123.383 0.673 . . . . 0.0 110.29 -176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 95' ' ' PRO . 66.6 Cg_endo -80.41 175.26 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.693 3.595 . . . . 0.0 110.187 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 94' ' ' PRO . 77.1 Cg_endo -72.18 5.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.168 2.578 . . . . 0.0 112.176 174.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t 43.64 38.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.569 1.148 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.3 m 49.96 17.43 0.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -175.78 11.17 0.03 OUTLIER Glycine 0 CA--C 1.53 0.984 0 CA-C-N 119.15 0.886 . . . . 0.0 114.956 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.493 -1.726 . . . . 0.0 111.346 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 N-CA-C 111.191 -0.763 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 3' ' ' MET . 52.4 t60 -154.92 170.01 22.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.304 0.641 . . . . 0.0 110.102 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.447 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 84.5 mtp -140.07 101.33 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.85 128.02 34.35 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.109 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.21 128.75 35.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 110.282 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 m -140.18 -175.09 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.14 0.495 . . . . 0.0 110.643 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -122.21 154.18 37.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.809 171.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -125.24 132.36 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -109.73 147.63 32.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.6 mt -126.1 155.53 41.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -143.64 159.55 42.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.37 -147.18 0.2 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.458 0.303 . . . . 0.0 111.033 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -56.13 -13.65 2.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.59 -30.94 66.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.16 0.891 . . . . 0.0 110.072 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.83 -30.13 67.56 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.347 0.659 . . . . 0.0 109.711 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -78.89 -18.66 53.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.282 0.633 . . . . 0.0 112.133 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -95.28 3.23 54.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.763 -177.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.02 -8.99 3.87 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.789 0.836 . . . . 0.0 110.673 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.48 8.25 50.54 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.406 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.6 p -141.35 144.48 34.27 Favored Pre-proline 0 N--CA 1.457 -0.12 0 CA-C-N 118.05 0.925 . . . . 0.0 110.41 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.84 -21.14 12.77 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.244 2.629 . . . . 0.0 111.197 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -164.93 159.6 18.34 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.738 0.415 . . . . 0.0 110.776 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -156.49 156.15 29.7 Favored Pre-proline 0 CA--C 1.531 0.241 0 C-N-CA 123.367 0.667 . . . . 0.0 111.759 -179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.58 150.24 16.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.669 2.913 . . . . 0.0 111.741 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.1 mt -160.63 -176.77 5.75 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.257 1.023 . . . . 0.0 109.817 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -149.06 158.16 43.96 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.06 158.15 15.54 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -79.75 -26.84 40.62 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 117.51 0.655 . . . . 0.0 109.703 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -137.92 165.9 25.39 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.178 0.991 . . . . 0.0 109.437 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.1 t -46.73 -47.89 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.766 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 tp -62.85 -32.48 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -68.92 -20.68 64.23 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.382 0.537 . . . . 0.0 111.439 -176.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.9 t -93.04 -39.63 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.035 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.34 -29.26 69.98 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.321 0.51 . . . . 0.0 110.921 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.9 mt -76.87 -16.15 59.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.323 0.249 . . . . 0.0 111.221 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' HD22 ' A' ' 25' ' ' LEU . 1.8 m -94.34 -21.45 18.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.879 0.872 . . . . 0.0 110.362 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.4 tm? -67.84 -49.63 61.13 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.9 p -67.75 -16.03 63.92 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.038 0.535 . . . . 0.0 111.247 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -68.34 -44.41 75.38 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -97.7 -18.13 19.03 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.251 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -118.56 76.17 13.12 Favored Pre-proline 0 N--CA 1.455 -0.219 0 C-N-CA 123.385 0.674 . . . . 0.0 109.778 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.42 -17.22 58.88 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.89 2.393 . . . . 0.0 110.444 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.3 1.17 8.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 111.666 176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -123.58 -6.38 8.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.487 0.715 . . . . 0.0 111.183 177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 35.7 ttpt -63.11 -26.95 69.06 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.547 ' CE2' ' HE2' ' A' ' 51' ' ' LYS . 20.7 m-85 -117.38 27.45 9.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.204 0.526 . . . . 0.0 109.89 178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.0 t -127.95 -9.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.407 1.083 . . . . 0.0 108.817 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.78 -20.2 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.118 0.967 . . . . 0.0 109.268 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -131.69 162.76 29.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.131 0.491 . . . . 0.0 110.695 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -83.98 132.61 34.74 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.274 0.63 . . . . 0.0 109.988 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HE2' ' CE2' ' A' ' 46' ' ' TYR . 51.6 tttm -70.95 41.86 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.115 1.366 . . . . 0.0 111.976 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.45 -2.0 77.22 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -79.58 22.57 0.45 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.848 0.859 . . . . 0.0 112.249 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -66.9 -5.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.98 -0.45 . . . . 0.0 111.958 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -138.17 3.28 2.39 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.166 0.986 . . . . 0.0 111.191 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.9 m -142.05 -169.4 2.92 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.185 0.994 . . . . 0.0 110.245 -176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -131.45 23.72 4.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.778 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.5 mm -124.01 116.31 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.145 0.978 . . . . 0.0 109.872 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.33 171.32 15.05 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.225 0.61 . . . . 0.0 110.984 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -140.65 125.26 18.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.217 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -57.29 131.28 49.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.428 ' N ' HD13 ' A' ' 61' ' ' LEU . 14.6 t -57.16 160.03 4.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.783 0.433 . . . . 0.0 111.635 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.12 18.29 55.85 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.5 m -136.38 -1.55 2.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.595 0.758 . . . . 0.0 111.657 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.96 157.45 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 122.918 0.487 . . . . 0.0 110.458 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.24 146.15 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -129.95 163.18 26.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.715 0.406 . . . . 0.0 110.403 -176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 34.8 mm -134.05 105.62 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 170.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 55.07 7.69 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.195 0.598 . . . . 0.0 111.952 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.14 -4.64 31.73 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.731 0.681 . . . . 0.0 112.175 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -73.12 -2.57 22.02 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 51.08 96.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.573 1.149 . . . . 0.0 113.729 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.5 pt -50.72 -20.1 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 42.1 mtp85 -66.01 -10.01 35.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.947 0.499 . . . . 0.0 111.655 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -117.79 8.21 12.64 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.532 0.733 . . . . 0.0 110.656 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.8 mt -124.01 -156.68 0.72 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.269 1.028 . . . . 0.0 109.162 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -71.0 -3.44 19.54 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -137.62 20.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.12 -0.66 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -127.91 25.32 5.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.303 0.502 . . . . 0.0 111.349 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 88.1 m -65.77 -2.29 3.58 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.352 0.661 . . . . 0.0 111.381 177.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt 60.37 166.32 0.08 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.257 1.023 . . . . 0.0 110.958 -175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -138.47 171.55 14.21 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.829 0.852 . . . . 0.0 110.343 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -139.96 167.29 22.46 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.892 0.877 . . . . 0.0 109.86 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -66.97 8.39 0.28 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.0 t -151.78 17.67 0.69 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.06 -179.7 2.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.75 0.786 . . . . 0.0 109.993 175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -153.54 153.37 32.27 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.6 mm -128.99 156.88 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.49 138.34 8.38 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.01 127.62 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.81 144.87 55.05 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 122.935 0.494 . . . . 0.0 110.623 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.98 173.13 12.28 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.621 3.547 . . . . 0.0 110.397 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.13 -8.61 24.02 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.911 2.407 . . . . 0.0 111.723 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 p 44.78 19.84 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.618 1.967 . . . . 0.0 114.603 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -161.22 -32.94 0.05 Allowed 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.559 -0.713 . . . . 0.0 111.996 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.81 -21.47 1.63 Allowed Glycine 0 C--N 1.338 0.689 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.219 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 CA-C-O 117.403 -1.776 . . . . 0.0 110.938 179.275 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.2 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.439 ' CG ' ' N ' ' A' ' 3' ' ' MET . 54.4 t60 -153.59 169.86 22.22 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.124 0.57 . . . . 0.0 110.123 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.439 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.2 mtp -140.46 101.0 4.01 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.63 127.38 31.69 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.069 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.25 128.87 35.77 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 109.974 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.3 m -139.72 -172.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.206 0.527 . . . . 0.0 110.688 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -125.52 155.48 40.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.312 172.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.76 134.74 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -115.56 137.02 52.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.083 0.553 . . . . 0.0 109.901 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 10' ' ' LEU . 1.5 mm? -109.76 160.62 16.17 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -145.62 159.07 43.67 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 46.92 -146.04 0.22 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 122.503 0.321 . . . . 0.0 111.101 -174.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -56.66 -12.82 2.02 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.5 mt -72.41 -31.35 65.44 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 119.07 0.85 . . . . 0.0 110.018 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -70.9 -31.04 67.56 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.003 0.521 . . . . 0.0 110.168 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.41 -33.12 69.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.783 0.433 . . . . 0.0 111.332 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.55 -23.24 25.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.615 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.5 -19.56 33.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.197 0.199 . . . . 0.0 110.495 174.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.97 1.98 60.66 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.6 p -144.47 149.95 45.95 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 123.798 0.839 . . . . 0.0 109.575 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.64 -24.52 11.77 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.776 2.317 . . . . 0.0 110.876 177.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.95 161.73 22.99 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.935 0.334 . . . . 0.0 111.395 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -158.36 155.74 26.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.472 0.709 . . . . 0.0 111.59 -178.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.22 149.6 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.963 3.109 . . . . 0.0 111.733 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 36' ' ' SER . 10.0 mt -159.99 -177.11 6.08 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.265 1.026 . . . . 0.0 109.432 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 m -148.47 158.32 44.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.867 0.365 . . . . 0.0 111.71 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.27 158.07 15.6 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.9 -27.39 49.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.355 0.577 . . . . 0.0 109.982 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -138.54 166.24 24.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.185 0.994 . . . . 0.0 109.588 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.1 t -46.62 -47.85 7.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.951 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 tp -62.24 -32.93 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -68.91 -21.89 64.2 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.474 0.579 . . . . 0.0 111.412 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.05 -38.08 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -66.29 -30.45 70.87 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.633 -0.667 . . . . 0.0 110.87 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.3 mt -76.49 -16.51 59.64 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.488 0.315 . . . . 0.0 111.386 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.53 ' HB3' HD22 ' A' ' 25' ' ' LEU . 3.5 m -92.53 -23.3 19.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.887 0.875 . . . . 0.0 110.613 176.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.2 tm? -66.91 -50.89 61.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 77.2 p -67.12 -15.11 63.51 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 122.965 0.506 . . . . 0.0 111.085 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.74 -44.22 74.26 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -98.29 -17.45 18.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.228 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -117.8 75.3 10.03 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 123.767 0.827 . . . . 0.0 109.665 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.54 -17.39 59.42 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 110.415 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.99 1.63 6.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.665 0.786 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.3 mt -125.32 -3.59 7.41 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.724 0.81 . . . . 0.0 110.763 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 77.4 tttt -64.53 -23.69 67.36 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -123.19 27.68 7.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.285 0.564 . . . . 0.0 109.583 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.43 -14.57 3.88 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 C-N-CA 124.231 1.012 . . . . 0.0 108.832 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 97.4 mt -117.35 -21.27 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 C-N-CA 123.955 0.902 . . . . 0.0 108.938 176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.44 160.69 33.29 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.778 0.431 . . . . 0.0 109.889 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -84.03 136.59 33.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.916 0.486 . . . . 0.0 110.099 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.61 38.49 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.957 1.303 . . . . 0.0 111.027 175.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.9 21.78 9.08 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 123.818 0.723 . . . . 0.0 112.378 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -138.52 131.73 30.09 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.379 0.609 . . . . 0.0 110.0 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -137.54 4.07 2.59 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.114 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -142.82 3.86 1.45 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.325 0.65 . . . . 0.0 111.621 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.6 m -145.09 -166.55 2.45 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.672 0.789 . . . . 0.0 109.498 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.78 19.09 6.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 111.179 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 58' ' ' ILE . 4.3 mp -85.64 129.65 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -115.54 166.13 12.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.98 0.912 . . . . 0.0 109.816 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.56 121.55 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD13 ' N ' ' A' ' 62' ' ' CYS . 0.8 OUTLIER -56.84 128.0 34.5 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.417 ' N ' HD13 ' A' ' 61' ' ' LEU . 23.8 t -54.68 149.53 10.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.161 0.505 . . . . 0.0 111.4 -175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.78 16.53 56.46 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.5 m -133.64 -6.47 2.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.487 0.715 . . . . 0.0 111.506 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 mm -90.61 157.6 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 122.979 0.511 . . . . 0.0 110.128 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -124.75 123.54 40.2 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.2 mm -109.6 144.97 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 37.8 mt -128.51 161.41 29.62 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 123.161 0.584 . . . . 0.0 109.836 -177.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.2 mm -133.09 107.37 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 170.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 54.86 9.66 0.31 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.24 0.616 . . . . 0.0 111.623 -169.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.14 -4.08 35.51 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 123.899 0.761 . . . . 0.0 112.258 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -74.72 -1.36 21.54 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 50.81 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.6 1.16 . . . . 0.0 113.994 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.42 -21.92 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -62.08 -15.6 46.28 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.917 0.487 . . . . 0.0 112.267 177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 m-70 -113.55 8.02 17.59 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.427 0.691 . . . . 0.0 110.643 176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -123.75 -155.61 0.67 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.371 1.068 . . . . 0.0 108.986 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.08 -2.62 19.13 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.937 -0.477 . . . . 0.0 112.012 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.6 -140.17 21.57 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 80' ' ' LEU . 3.7 mm? -60.87 -5.43 1.34 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.444 0.698 . . . . 0.0 112.591 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.82 22.55 12.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.417 0.687 . . . . 0.0 111.944 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 82' ' ' THR . 92.7 m -66.08 0.65 1.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.661 0.784 . . . . 0.0 112.12 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.5 mt 59.63 169.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.581 0.753 . . . . 0.0 110.645 -174.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.54 170.76 15.18 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 124.759 1.224 . . . . 0.0 109.231 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.9 167.26 22.52 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 123.951 0.9 . . . . 0.0 109.929 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -66.56 7.59 0.32 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.4 t -151.92 17.61 0.68 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.992 0.425 . . . . 0.0 110.211 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.7 178.49 2.55 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.86 0.838 . . . . 0.0 110.313 175.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -153.35 149.67 28.09 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.69 153.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.39 136.35 8.44 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.6 mt -118.31 128.4 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.57 146.36 60.19 Favored Pre-proline 0 N--CA 1.454 -0.268 0 C-N-CA 122.884 0.473 . . . . 0.0 110.511 -177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.25 173.46 13.83 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.688 3.592 . . . . 0.0 110.497 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.05 167.58 21.36 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.984 2.456 . . . . 0.0 111.02 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.6 p -146.25 6.66 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.352 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -160.17 177.26 10.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.073 -0.392 . . . . 0.0 110.471 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.49 -16.69 0.06 OUTLIER Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.028 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 CA-C-O 117.52 -1.711 . . . . 0.0 110.734 178.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' CG ' ' N ' ' A' ' 3' ' ' MET . 72.0 t60 -153.17 168.62 25.33 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 123.012 0.525 . . . . 0.0 110.224 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.438 ' N ' ' CG ' ' A' ' 2' ' ' HIS . 86.4 mtp -142.05 104.87 4.55 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 174.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.99 130.68 46.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -76.99 132.02 38.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.7 m -142.25 -172.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.299 0.571 . . . . 0.0 110.593 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -130.35 153.97 48.15 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.254 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 68.2 t -129.58 137.58 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -117.74 150.01 39.81 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.659 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.9 mt -127.26 156.78 41.37 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.29 160.31 41.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.35 -147.63 0.19 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.588 0.355 . . . . 0.0 111.108 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -56.86 -10.91 1.19 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.79 -31.58 63.34 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.41 1.005 . . . . 0.0 110.189 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -69.35 -32.4 71.45 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.086 0.554 . . . . 0.0 109.679 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -73.44 -21.7 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 111.637 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.15 1.8 56.82 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.306 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.18 -7.02 3.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.54 0.736 . . . . 0.0 110.709 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 8.69 43.9 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.556 -0.58 . . . . 0.0 112.481 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.0 p -142.15 143.98 29.89 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 117.996 0.898 . . . . 0.0 110.215 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.45 -17.69 12.74 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.463 2.775 . . . . 0.0 111.732 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -164.28 160.14 20.71 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.159 -0.338 . . . . 0.0 111.259 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.484 HD13 ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.72 154.61 25.32 Favored Pre-proline 0 N--CA 1.453 -0.309 0 C-N-CA 123.665 0.786 . . . . 0.0 111.47 177.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.49 153.0 20.54 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.848 3.032 . . . . 0.0 110.518 173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 25' ' ' LEU . 4.8 mt -162.95 -174.81 4.06 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.715 0.406 . . . . 0.0 110.341 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 m -146.62 160.78 41.73 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.052 175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.27 146.69 4.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -77.52 -25.42 50.25 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 117.668 0.734 . . . . 0.0 110.973 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.2 mttp -134.45 170.89 15.07 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 124.097 0.959 . . . . 0.0 109.792 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.404 HG22 HD21 ' A' ' 84' ' ' LEU . 46.2 t -56.67 -44.35 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.1 tp -62.84 -34.64 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -69.94 -23.39 63.19 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.731 -0.606 . . . . 0.0 110.842 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -85.31 -45.15 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.12 -30.08 71.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.625 0.37 . . . . 0.0 111.733 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 mt -75.57 -16.81 60.2 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.149 0.431 . . . . 0.0 111.419 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.414 ' HB3' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -91.25 -25.28 19.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.988 0.423 . . . . 0.0 110.007 175.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.453 HD13 ' C ' ' A' ' 37' ' ' LEU . 3.1 tm? -63.88 -50.5 68.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.425 ' CG2' ' HA ' ' A' ' 45' ' ' LYS . 71.5 p -67.51 -15.09 63.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.15 0.58 . . . . 0.0 111.579 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.29 -44.27 68.7 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 118.263 0.483 . . . . 0.0 111.377 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -95.85 -17.98 20.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.506 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -118.48 76.1 12.81 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 123.843 0.857 . . . . 0.0 109.512 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.53 -17.61 60.15 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.118 2.545 . . . . 0.0 111.013 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.66 1.72 9.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.56 0.744 . . . . 0.0 111.257 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.46 -6.14 8.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.724 0.81 . . . . 0.0 111.048 176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' CG2' ' A' ' 38' ' ' THR . 79.3 tttt -64.0 -23.44 67.34 Favored 'General case' 0 C--N 1.338 0.096 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CD2' ' HD3' ' A' ' 51' ' ' LYS . 22.2 m-85 -122.77 28.23 7.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.114 0.483 . . . . 0.0 109.834 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.57 -37.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.03 -24.58 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 123.489 0.716 . . . . 0.0 109.125 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.75 160.98 32.74 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.116 0.566 . . . . 0.0 110.584 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -84.91 138.6 32.41 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 46' ' ' TYR . 26.8 ttpp -80.09 60.06 3.49 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.07 0.548 . . . . 0.0 110.002 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.04 -3.54 70.03 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.907 -175.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -146.15 131.58 18.65 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -118.39 13.14 13.53 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.869 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -137.16 3.37 2.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.343 0.657 . . . . 0.0 111.23 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m -149.25 165.02 33.15 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.058 0.943 . . . . 0.0 110.404 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -81.12 3.09 24.68 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.603 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mm -63.55 127.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.0 mt -141.29 172.46 12.65 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.729 0.811 . . . . 0.0 110.099 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.5 mt -140.5 125.44 19.21 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.97 122.85 14.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.98 133.32 54.78 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.53 0.332 . . . . 0.0 110.745 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.18 -13.06 72.91 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m -89.73 -18.91 25.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.097 0.559 . . . . 0.0 111.881 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 mm -82.48 159.24 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.72 0.408 . . . . 0.0 110.276 -177.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -127.08 126.47 43.07 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.85 144.83 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 73' ' ' ASN . 38.7 mt -128.11 160.27 32.51 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.7 mm -130.64 107.76 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 54.74 9.92 0.32 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.224 0.609 . . . . 0.0 111.704 -170.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.78 -4.47 34.34 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.197 0.903 . . . . 0.0 112.504 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.89 0.05 22.38 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . 1.6 t-20 49.84 99.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.858 1.263 . . . . 0.0 114.145 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.7 pt -51.3 -21.6 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -61.95 -13.06 21.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -117.85 9.68 12.99 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.596 0.759 . . . . 0.0 111.018 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 83.6 mt -124.81 -155.94 0.7 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.04 0.936 . . . . 0.0 109.497 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -70.89 -2.83 16.33 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.922 0.489 . . . . 0.0 112.092 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.77 -138.2 21.19 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.9 mp -60.15 0.06 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.782 0.833 . . . . 0.0 112.689 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.54 23.78 6.27 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.144 0.578 . . . . 0.0 111.453 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 82' ' ' THR . 84.9 m -62.12 -0.26 0.5 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.916 0.886 . . . . 0.0 113.297 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.0 mt 52.56 83.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD21 HG22 ' A' ' 30' ' ' VAL . 4.1 mm? -58.08 169.86 0.74 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.924 1.289 . . . . 0.0 110.962 175.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -139.99 167.75 21.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 124.371 1.069 . . . . 0.0 109.924 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -63.48 5.95 0.16 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -172.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.1 t -153.48 17.37 0.54 Allowed 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 121.894 -0.503 . . . . 0.0 110.184 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -69.09 177.06 2.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.559 0.695 . . . . 0.0 111.049 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -149.54 151.47 33.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -175.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.4 mt -132.29 152.57 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.08 129.95 4.97 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 mt -111.45 130.92 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.05 147.96 64.78 Favored Pre-proline 0 N--CA 1.453 -0.289 0 C-N-CA 122.801 0.44 . . . . 0.0 110.593 -177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -79.63 174.01 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.637 3.558 . . . . 0.0 110.584 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.51 168.77 17.24 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.186 2.591 . . . . 0.0 110.68 174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.54 154.35 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 C-N-CA 123.087 0.555 . . . . 0.0 109.902 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.8 p -147.89 2.29 0.69 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.22 -16.59 0.15 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.261 0 CA-C-O 117.7 -1.611 . . . . 0.0 110.814 179.161 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.242 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.39 21.69 0.55 Allowed 'General case' 0 C--N 1.338 0.085 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.6 mtp 47.81 84.22 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.087 0.955 . . . . 0.0 110.896 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.77 131.03 45.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.822 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -77.52 134.29 38.34 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -142.25 -175.32 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.168 0.509 . . . . 0.0 110.31 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -118.48 154.94 31.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.225 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.84 124.57 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.9 153.1 25.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.25 176.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.7 mt -127.02 157.6 39.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -144.49 159.47 42.7 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 47.19 -146.6 0.21 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.53 0.332 . . . . 0.0 111.26 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -56.94 -10.71 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.58 -30.11 61.59 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.258 0.935 . . . . 0.0 110.292 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -71.62 -33.24 68.79 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 123.303 0.641 . . . . 0.0 109.708 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -73.09 -23.71 60.56 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.692 0.797 . . . . 0.0 112.04 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.43 1.87 56.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.32 -175.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.8 -6.46 4.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.491 0.717 . . . . 0.0 110.581 176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.87 10.42 45.55 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.522 -0.599 . . . . 0.0 112.661 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.9 p -140.84 143.89 33.57 Favored Pre-proline 0 N--CA 1.455 -0.196 0 CA-C-N 117.853 0.826 . . . . 0.0 110.288 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.89 -20.87 10.02 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.379 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -166.99 162.81 15.8 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.921 0.328 . . . . 0.0 111.242 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.1 155.97 16.28 Favored Pre-proline 0 N--CA 1.456 -0.148 0 C-N-CA 123.632 0.773 . . . . 0.0 110.407 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.28 156.13 33.04 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.054 2.503 . . . . 0.0 110.08 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 6.1 mt -161.61 -176.22 5.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.134 0.973 . . . . 0.0 108.85 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -149.63 158.69 44.4 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.867 0.365 . . . . 0.0 111.689 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.62 156.45 13.32 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -77.8 -26.83 49.88 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.358 0.579 . . . . 0.0 110.051 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -139.36 166.34 24.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.605 1.162 . . . . 0.0 109.547 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.9 t -45.82 -48.61 4.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.898 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 tp -62.27 -33.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -68.11 -20.19 64.9 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.604 0.638 . . . . 0.0 111.304 -176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.9 t -89.41 -43.42 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.1 mt -63.29 -27.54 69.4 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.336 -0.228 . . . . 0.0 111.108 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.07 -18.53 57.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.8 t -86.81 -31.22 20.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.065 0.459 . . . . 0.0 110.356 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -57.8 -48.98 78.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.98 0.512 . . . . 0.0 109.654 177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.6 p -71.64 -15.2 62.23 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.887 0.475 . . . . 0.0 111.405 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -73.46 -38.55 65.41 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 118.249 0.477 . . . . 0.0 111.179 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.49 -23.25 17.19 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -121.52 79.22 37.85 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 123.899 0.879 . . . . 0.0 109.22 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.82 -17.28 58.99 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.022 2.481 . . . . 0.0 110.232 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.41 0.92 7.13 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.162 0.985 . . . . 0.0 111.374 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.98 -5.53 6.8 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.7 0.8 . . . . 0.0 111.11 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -63.02 -24.1 67.76 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -122.06 25.31 9.13 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.303 0.641 . . . . 0.0 109.808 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 t -125.04 -9.96 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 124.228 1.011 . . . . 0.0 108.899 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.23 -19.84 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.778 0.831 . . . . 0.0 109.509 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -130.66 161.05 32.47 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 121.116 0.484 . . . . 0.0 110.937 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -71.22 152.35 43.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.547 0.739 . . . . 0.0 109.634 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -87.66 24.61 1.67 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.356 0.662 . . . . 0.0 111.567 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.03 174.65 42.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 44.75 41.24 4.85 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.662 0.785 . . . . 0.0 112.071 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -65.97 15.46 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.996 1.109 . . . . 0.0 113.996 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -131.33 7.62 4.59 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.674 0.789 . . . . 0.0 110.822 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.5 m -145.63 168.18 21.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.268 1.027 . . . . 0.0 110.447 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -81.44 0.53 37.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.483 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.0 mm -71.04 130.82 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.3 mt -137.96 168.73 19.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.792 0.837 . . . . 0.0 109.999 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -142.29 132.63 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.81 141.98 56.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.9 t -61.09 159.81 11.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.954 0.407 . . . . 0.0 110.486 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.96 19.44 54.42 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 123.589 0.614 . . . . 0.0 111.746 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.0 p -140.66 -5.5 1.19 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.192 0.597 . . . . 0.0 112.344 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.5 mm -90.79 159.08 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 123.073 0.549 . . . . 0.0 110.33 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -124.15 123.82 41.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.0 mm -111.9 144.36 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 34.7 mt -127.79 162.18 27.24 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.6 mm -133.09 105.88 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 55.23 8.4 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.133 0.573 . . . . 0.0 112.137 -169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 108.26 -4.84 33.49 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.973 0.797 . . . . 0.0 112.349 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.47 -1.99 20.7 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 49.49 98.6 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.887 1.275 . . . . 0.0 113.808 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -49.8 -21.29 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -63.02 -13.62 37.72 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -114.52 7.75 16.24 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.491 0.716 . . . . 0.0 110.556 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.5 mt -123.73 -154.95 0.63 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.025 0.93 . . . . 0.0 109.345 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.2 -13.2 61.74 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.06 0.944 . . . . 0.0 112.3 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.91 -141.54 18.62 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.8 mt -61.38 4.14 0.1 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.901 0.88 . . . . 0.0 113.333 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.03 23.15 5.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.177 0.591 . . . . 0.0 111.181 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 82' ' ' THR . 86.5 m -66.49 -1.82 4.0 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.1 mt 60.54 167.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.549 0.74 . . . . 0.0 110.747 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -138.63 170.53 15.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.761 0.824 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -141.35 166.5 24.59 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.57 1.148 . . . . 0.0 109.888 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.96 -5.55 0.45 Allowed 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.9 t -143.77 14.87 1.75 Allowed 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.89 179.04 2.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.494 0.664 . . . . 0.0 110.569 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.73 152.63 30.98 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.0 mm -131.75 155.18 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -145.94 135.18 5.75 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 172.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.5 mt -118.85 127.97 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.8 146.56 62.34 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 122.733 0.413 . . . . 0.0 110.467 -176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.31 172.71 14.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.653 3.569 . . . . 0.0 110.353 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.08 159.09 53.71 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.843 2.362 . . . . 0.0 110.592 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -143.23 161.56 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.076 0.95 . . . . 0.0 110.15 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.1 m 54.14 -171.52 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.002 0.921 . . . . 0.0 112.821 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.61 179.74 47.46 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.195 -1.892 . . . . 0.0 110.98 -179.988 . . . . . . . . 0 0 . 1 stop_ save_